,paragraph_id,text,length
0,0,"THE MAIN TEA ETA AUTOMAT U TEMAMA ANATUAN US 20180282715A1 ( 19 ) United States ( 12 ) Patent Application Publication ( 10 ) Pub . No . : US 2018 / 0282715 A1 Carter et al . ( 43 ) Pub . Date : Oct . 4 , 2018 
 ( 54 ) NOVEL CRISPR - ASSOCIATED ( CAS ) PROTEIN 
 ( 71 ) Applicant : Caribou Biosciences , Inc . , Berkeley , 
 CA ( US ) 
 ( 72 ) Inventors : Matthew Merrill Carter , Berkeley , CA ( US ) ; Paul Daniel Donohoue , Berkeley . 
 CA ( US ) Publication Classification 
 ( 51 ) Int . Cl . 
 C12N 9 / 22 ( 2006 . 01 ) 
 C12N 15 / 11 ( 2006 . 01 ) C12N 15 / 85 ( 2006 . 01 ) 
 C12N 15 / 113 ( 2006 . 01 ) 
 ( 52 ) U . S . Cl . ??? . . . . C12N 9 / 22 ( 2013 . 01 ) ; C12N 15 / 11 
 ( 2013 . 01 ) ; C12N 2800 / 22 ( 2013 . 01 ) ; C12N 15 / 1136 ( 2013 . 01 ) ; C12N 2310 / 20 ( 2017 . 05 ) ; C12N 15 / 85 ( 2013 . 01 ) 
 ABSTRACT 
 A new CRISPR - associated ( Cas ) protein , termed “ CasM , ” is described , as well as polynucleotides encoding the same and methods of using CasM for site - specific genome engineer ing . CasM proteins are capable of targeting and cleaving 
 single - stranded RNA . Specification includes a Sequence Listing . ( 21 ) Appl . No . : 15 / 937 , 840 
 ( 57 ) ( 22 ) Filed : Mar . 27 , 2018 
 Related U . S . Application Data 
 ( 60 ) Provisional application No . 62 / 477 , 494 , filed on Mar . 28 , 2017 , provisional application No . 62 / 629 , 641 , filed on Feb . 12 , 2018 .",1413
1,1,"Patent Application Publication Oct . 4 , 2018 Sheet 1 of 5 US 2018 / 0282715 A1 
RKHK FIG . 1",93
2,2,"Patent Application Publication Oct . 4 , 2018 Sheet 2 of 5 US 2018 / 0282715 A1 
 472 
 471 20 
 . LIILOTTI 475 104 
Loe 470 - - - 473 
 @ @ @ 
 O 
 4 - 
 474 
 FIG . 2",168
3,3,"Patent Application Publication Oct . 4 , 2018 Sheet 3 of 5 US 2018 / 0282715 A1 
| 1 | 2 | 3 | 4 5 6 7 1 2 . 3 4 5 6 
 + 480 
 - 481 
 FIG . 3",142
4,4,"Patent Application Publication Oct . 4 , 2018 Sheet 4 of 5 US 2018 / 0282715 A1 
 472 471 
 490 TIID 491 
 473 473 470 
 FIG . 4 
 492 493 494 
 TIID - 
 am 31 5 AL O ETSERIER 
 RET 
 495 495 495 
 496 - 
 AP 
 543 ' 498 496 53 ' 497 53 3 497 499 
 FIG . 5",256
5,5,"Patent Application Publication Oct . 4 , 2018 Sheet 5 of 5 US 2018 / 0282715 A1 
 . . . 
 . . . . . . . . . . . . . 
 . . . . 1 . . 1 . iii 
 st | 03 | | 41 | 4 | 01 | * * | 4 | 99 | 0 | 71 711 FIG . 6 
 501 - 500 - 502 503",223
6,6,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 NOVEL CRISPR - ASSOCIATED ( CAS ) PROTEIN 
 CROSS - REFERENCE TO RELATED 
 APPLICATIONS 
 [ 0001 ] This application claims the benefit under 35 U . S . C . $ 119 ( e ) ( 1 ) of U . S . Provisional Application Nos . 62 / 477 , 494 , filed 28 Mar . 2017 , and 62 / 629 , 641 , filed 12 Feb . 2018 , which applications are incorporated herein by reference in their entireties . 
 TECHNICAL FIELD 
 [ 0002 ] The present invention relates to Clustered Regu larly Interspaced Short Palindromic Repeats ( CRISPR ) sys 
 tems . In particular , the invention relates to a new CRISPR associated ( Cas ) protein , termed “ CasM , ” and the uses of CasM for site - specific nucleic acid engineering . 
 BACKGROUND OF THE INVENTION 
 [ 0003 ] Clustered Regularly Interspaced Short Palindromic 
 Repeats ( CRISPR ) and CRISPR - associated ( Cas ) proteins 
 are found in prokaryotic immune systems . These systems 
 provide resistance against exogenous genetic elements , such as viruses and plasmids , by targeting their nucleic acids for degradation , in a sequence - specific manner . 
 [ 0004 ] There are several different CRISPR - Cas systems and the nomenclature and classification of these have changed as the systems have been characterized . In particu lar , CRISPR - Cas systems have now been reclassified into two classes , containing several types and subtypes ( Ma 
 karova et al . , Nature Reviews Microbiology ( 2015 ) 13 : 1 - 15 ; Shmakov et al . , Nature Reviews Microbiology ( 2017 ) 15 : 169 - 182 ) . This classification is based upon identifying all cas genes in a CRISPR - Cas locus and then determining the 
 signature genes in each CRISPR - Cas locus , thereby deter 
 mining whether the CRISPR - Cas systems should be placed 
 in either Class 1 or Class 2 based upon the genes encoding the effector module , i . e . , the proteins involved in the inter ference stage . 
 [ 0005 ] There remains a need to discover and characterize new CRISPR - associated ( Cas ) proteins , and their potential use for site - specific nucleic acid engineering . [ 0008 ] In further embodiments , the invention is directed to a complex comprising a CasM protein , and a cognate nucleic 
 acid guide . In certain embodiments , the cognate nucleic acid guide in the complex comprises a repeat sequence and a 
 spacer sequence , wherein the repeat sequence and the spacer 
 sequence do not naturally occur together . In certain embodi ments , the cognate nucleic acid guide comprises a modified base analog 
 [ 0009 ] In additional embodiments , the cognate nucleic acid guide comprises RNA , such as , but not limited to , crRNA . In some embodiments , the cognate nucleic acid guide , such as crRNA , comprises a spacer sequence that is 
 complementary to a DNA or RNA target sequence that occurs in a prokaryotic or eukaryotic cell . 
 [ 0010 ] In further embodiments , the crRNA / CasM protein complex is capable of binding to a first RNA target sequence complementary to the crRNA spacer sequence , wherein binding of the crRNA / CasM protein complex results in the cleavage of a first RNA target . In additional embodiments , after cleavage of the first RNA target sequence by the crRNA / CasM protein complex , the complex is capable of 
 non - specific endonuclease activity toward any single stranded RNA in a sequence independent manner . 
 [ 0011 ] In further embodiments , the complex modifies the transcription or translation of a target locus in cell . 
 [ 0012 ] In additional embodiments , the invention is directed to an isolated polynucleotide encoding a CasM protein , wherein the CasM protein is capable of producing a single - strand break at an RNA target site when guided to 
 the RNA target site by a cognate nucleic acid guide . In 
 certain embodiments , the cognate nucleic acid guide com 
 prises RNA , such as crRNA . In additional embodiments , the 
 CasM protein encoded by the polynucleotide comprises an 
 amino acid sequence selected from the group consisting of 
 the amino acid sequence of SEQ ID NOS : 37 - 44 or 45 ; an 
 ortholog of the amino acid sequence of SEQ ID NOS : 37 - 44 or 45 , i . e . , a CasM sequence from a species other than the 
 species producing the reference sequence ; and a variant of 
 the amino acid sequence of SEQ ID NOS : 37 - 44 or 45 , e . g . , an active homolog of the reference amino acid sequence . 
 [ 0013 ] In further embodiments , the invention is directed to a modified polynucleotide encoding a CasM protein , 
 wherein the CasM protein is capable of producing a single 
 strand break at an RNA target site when guided to the RNA target site by a cognate nucleic acid guide , wherein the 
 polynucleotide is modified relative to its native sequence , 
 such as modified for expression in a selected host cell . In 
 additional embodiments , the CasM protein encoded by the polynucleotide comprises an amino acid sequence selected 
 from the group consisting of the amino acid sequence of 
 SEQ ID NOS : 37 - 44 or 45 ; an ortholog of the amino acid sequence of SEQ ID NOS : 37 - 44 or 45 , i . e . , a CasM sequence from a species other than the species producing the 
 reference sequence ; and a variant of the amino acid sequence of SEQ ID NOS : 37 - 44 or 45 , e . g . , an active homolog of the reference amino acid sequence . 
 [ 0014 ] In certain embodiments , the polynucleotide is modified for expression in a bacterial cell , such as for expression in an Escherichia coli cell . In certain embodi ments , the polynucleotide comprises the sequence of SEQ ill 
 NOS : 2 - 8 or 9 . 
 [ 0015 ] . In other embodiments , the polynucleotide is modi fied for expression in a eukaryotic cell , e . g . , a mammalian SUMMARY 
 [ 0006 ] The present invention is based on the discovery of 
 a new Cas protein , termed “ CasM ” herein . This protein shares no homology to any known Cas protein or to any known protein family . 
 [ 0007 ] Accordingly , in one aspect , the invention is directed to an isolated CasM protein capable of producing a single - strand break at an RNA target site when guided to the RNA target site by a cognate nucleic acid guide . In certain embodiments , the cognate nucleic acid guide comprises 
 RNA , such as crRNA . In additional embodiments , the CasM protein comprises an amino acid sequence selected from the group consisting of the amino acid sequence of SEQ ID NOS : 37 - 44 or 45 ; an ortholog of the amino acid sequence of 
 SEQ ID NOS : 37 - 44 or 45 , i . e . , a CasM sequence from a species other than the species producing the reference sequence ; and a variant of the amino acid sequence of SEQ ID NOS : 37 - 44 or 45 , e . g . , an active homolog of the refer ence amino acid sequence .",6734
7,7,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 cell , such as a human cell . In certain embodiments , the polynucleotide comprises the sequence of SEQ ID NOS : 10 
 17 or 18 . [ 0016 ] In additional embodiments , the polynucleotide is modified for expression in a plant cell , such as for expres 
 sion in a Zea mays ( corn ) cell . In certain embodiments the polynucleotide comprises the sequence of SEQ ID NOS : 19 
 26 or 27 . [ 0017 ] In further embodiments , the invention is directed to a recombinant vector comprising a polynucleotide or modi fied polynucleotide as described herein , and at least one control element operably linked to the polynucleotide , whereby a CasM coding sequence in the polynucleotide is capable of being transcribed and translated in a host cell . In 
 certain embodiments , at least one of the control elements is heterologous to the coding system . 
 [ 0018 ] In additional embodiments , the CasM protein encoded by the polynucleotide comprises an amino acid sequence selected from the group consisting of the amino acid sequence of SEQ ID NOS : 37 - 44 or 45 ; an ortholog of 
 the amino acid sequence of SEQ ID NOS : 37 - 44 or 45 ; and a variant of the amino acid sequence of SEQ ID NOS : 37 - 44 
 or 45 . 
 [ 0019 ] In further embodiments , the invention is directed to a host cell transformed with a recombinant vector described herein . In certain embodiments , the host cell is a prokaryotic or eukaryotic cell . [ 0020 ] In additional embodiments , the invention is directed to a method of producing a CasM protein compris ing providing a population of host cells transformed with a recombinant vector as described herein ; and culturing the population of cells under conditions whereby the CasM protein encoded by the polynucleotide present in the recom binant vector is expressed . 
 [ 0021 ] In further embodiments , the invention is directed to a eukaryotic host cell comprising a CasM protein of a complex comprising the CasM protein , as described herein . 
 [ 0022 ] In additional embodiments , the invention is directed to a method of directing a CasM protein to a selected nucleic acid target sequence , comprising contacting the selected nucleic acid target sequence with a cognate nucleic acid guide / CasM complex that targets said selected nucleic acid target sequence , whereby the CasM protein is 
 delivered to the nucleic acid target sequence . In certain embodiments , the nucleic acid target sequence comprises 
 RNA , such as mRNA . In further embodiments , the method comprises producing one or more single - or double - strand breaks in the target sequence . 
 10023 ] . In additional embodiments , the method is per formed in a cell , such as a prokaryotic or eukaryotic cell . In certain embodiments , the cell constitutively expresses the CasM protein . In other embodiments , e . g . , when the cell does not constitutively express the CasM protein , the cog 
 nate nucleic acid guide is complexed to the CasM protein prior to delivery to the nucleic acid target sequence . In other embodiments , the cell constitutively expresses the CasM protein and the cognate nucleic acid guide . In additional 
 embodiments , the complex modifies the transcription or 
 translation of a selected nucleic acid sequence in a host cell , such as a RNA sequence . 
 [ 0024 ] In further embodiments of the methods , the CasM protein comprises an amino acid sequence selected from the group consisting of the amino acid sequence of SEQ ID NOS : 37 - 44 or 45 ; an ortholog of the amino acid sequence of SEQ ID NOS : 37 - 44 or 45 ; and a variant of the amino acid sequence of SEQ ID NOS : 37 - 44 or 45 . 
 [ 0025 ] In other embodiments of the methods , a donor polynucleotide is delivered to the region of the selected nucleic acid target sequence . [ 0026 ] In additional embodiments , the CasM protein is capable of processing the CRISPR repeat - spacer array into 
 individual repeat - spacer elements . The CasM protein 
 cleaves the array within the 5 ' region of each repeat 
 sequence , giving rise to a processed crRNA comprising , in 
 a 5 ' to 3 ' direction , a repeat sequence and a spacer element . 
 [ 0027 ] In some embodiments the repeat sequence com prises a secondary structure that is recognized by the CasM protein . The secondary structure of the repeat may comprise 
 a stem , a stem - loop duplex , a pseudoknot , or a tripartite duplex . CasM protein homologs may only recognize the 
 repeat sequence or secondary structure of their cognate repeat elements . Alternatively , CasM protein homologs may recognize the repeat sequence or secondary structure of 
 non - cognate repeat elements . 
 [ 0028 ] In some embodiments the crRNA / CasM complex is capable of sequence - specific single - stranded RNA activ ity . Recognition and cleavage of an initial ssRNA comple mentary to the crRNA target sequence activates the CasM protein to carry out endonuclease activity toward any single 
 stranded RNA in a sequence - independent manner . The sequence - specific recognition of RNA of the crRNA / CasM complex facilitates the target knockdown of gene transcripts 
 perturbing translation of a specific protein . The non - specific endonuclease activity of an activated crRNA / CasM complex 
 in a cellular environment can result in cell death due to depletion of RNA encoding for essential gene transcripts . 
 The specific RNA targeting and collateral endonuclease activity of an activated crRNA / CasM complex enables the sequence - specific selection of cells expressing a RNA tran 
 script . 
 [ 0029 ] In a further aspect , the present invention relates to a method of screening and killing cells that have not been modified by a DNA targeting nuclease ( e . g . , a Type II Cas9 nuclease ) . This method comprises contacting a crRNA / Cas9 
 complex to a locus of interest in a population of cells . 
 Contacting the NATNA / Cas9 complex results in DNA cleav age and subsequent repair of the break by the endogenous 
 cellular repair machine and the introduction of insertion and 
 deletions ( ' indels "" ) at the break site . The targeting of the 
 NATNA / Cas9 to a targeted locus that encodes an RNA transcript results in indels in an RNA transcript sequence . This modified RNA transcript sequence is different com pared to a transcript from an unmodified cell ( a wild - type cell ) . A cognate nucleic acid guide / CasM complex can then be targeted to the unmodified transcript , wherein recognition of the unmodified transcript by the complex results in activation of the sequence independent , single - stranded RNA targeting activity of the CasM protein and subsequent cell death . Alternatively , this method can be adapted to 
 screen for the incorporation of a donor - polynucleotide into 
 NATNA / Cas9 break site . ( 0030 ] These aspects and other embodiments of the pres ent invention will readily occur to those of ordinary skill in 
 the art in view of the disclosure herein . 
 INCORPORATION BY REFERENCE 
 ( 0031 ] All publications , patents , and patent applications 
 mentioned in this specification are herein incorporated by er meget me re spielen",7142
8,8,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 reference to the same extent as if each individual publica tion , patent , or patent application was specifically and indi vidually indicated to be incorporated by reference . 
 SEQUENCE LISTING 
 [ 0032 ] The sequences referred to herein are listed in the Sequence Listing submitted as an ASCII text file entitled “ CB1025 10 _ ST25 . txt ” - 300 KB and was created on Mar . 22 , 2018 . The Sequence Listing entitled “ CB1025 10 _ ST25 . txt "" is incorporated herein by reference in its entirety . 
 BRIEF DESCRIPTION OF THE FIGURES 
 [ 0033 ] FIG . 1 depicts a representative CasM operon from 
 Eubacterium siraeum ( NCBI Accession No . NZ _ DS499551 . 1 ) . [ 0034 ] FIG . 2 shows a structure of a CasM repeat sequence ( SEQ ID NO : 51 ) . [ 0035 ] FIG . 3 shows the results of the in vitro CRISPR array cleavage assay described in the Examples . 
 [ 0036 ] FIG . 4 shows a depiction of a synthetic CasM CRISPR array . [ 0037 ] FIG . 5 shows a representation of the results of the in vitro CRISPR array cleavage assay results shown in FIG . 
 3 and described in the Examples . 
 [ 0038 ] FIG . 6 shows the results of the CasM ssRNA cleavage assay described in the Examples . 
 DETAILED DESCRIPTION OF THE INVENTION 
 [ 0039 ] It is to be understood that the terminology used herein is for the purpose of describing particular embodi 
 ments only , and is not intended to be limiting . As used in this specification and the appended claims , the singular forms 
 “ a , "" "" an ” and “ the ” include plural referents unless the context clearly dictates otherwise . Thus , for example , ref erence to a “ guide / Cas complex ” includes one or more such complexes , reference to “ a polynucleotide ” includes one or more polynucleotides , etc . 
 [ 0040 ] Unless defined otherwise , all technical and scien tific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the 
 invention pertains . Although other methods and materials 
 similar , or equivalent , to those described herein can be used in the practice of the present invention , preferred materials 
 and methods are described herein . [ 0041 ] In view of the teachings of the present specifica tion , one of ordinary skill in the art can apply conventional techniques of immunology , biochemistry , chemistry , molecular biology , microbiology , cell biology , genomics , and recombinant polynucleotides , as taught , for example , by the following standard texts : Antibodies : A Laboratory 
 Manual , Second edition , E . A . Greenfield , 2014 , Cold Spring Harbor Laboratory Press , ISBN 978 - 1 - 936113 - 81 - 1 ; Culture of Animal Cells : A Manual of Basic Technique and Special ized Applications , 6th Edition , R . I . Freshney , 2010 , Wiley 
 Blackwell , ISBN 978 - 0 - 470 - 52812 - 9 ; Transgenic Animal Technology , Third Edition : A Laboratory Handbook , 2014 , C . A . Pinkert , Elsevier , ISBN 978 - 0124104907 ; The Labo ratory Mouse , Second Edition , 2012 , H . Hedrich , Academic Press , ISBN 978 - 0123820082 ; Manipulating the Mouse Embryo : A Laboratory Manual , 2013 , R . Behringer , et al . , Cold Spring Harbor Laboratory Press , ISBN 978 - 1936113019 ; PCR 2 : A Practical Approach , 1995 , M . J . McPherson , et al . , IRL Press , ISBN 978 - 0199634248 ; Meth ods in Molecular Biology ( Series ) , J . M . Walker , ISSN 1064 - 3745 , Humana Press ; RNA : A Laboratory Manual , 2010 , D . C . Rio , et al . , Cold Spring Harbor Laboratory Press , ISBN 978 - 0879698911 ; Methods in Enzymology 
 ( Series ) , Academic Press ; Molecular Cloning : A Laboratory 
 Manual ( Fourth Edition ) , 2012 , M . R . Green , et al . , Cold Spring Harbor Laboratory Press , ISBN 978 - 1605500560 ; Bioconjugate Techniques , Third Edition , 2013 , G . T . Her 
 manson , Academic Press , ISBN 978 - 0123822390 ; Methods in Plant Biochemistry and Molecular Biology , 1997 , W . V . 
 Dashek , CRC Press , ISBN 978 - 0849394805 ; Plant Cell Culture Protocols ( Methods in Molecular Biology ) , 2012 , V . M . Loyola - Vargas , et al . , Humana Press , ISBN 978 1617798177 ; Plant Transformation Technologies , 2011 , C . N . Stewart , et al . , Wiley - Blackwell , ISBN 978 - 0813821955 ; Recombinant Proteins from Plants ( Methods in Biotechnol ogy ) , 2010 , C . Cunningham , et al . , Humana Press , ISBN 978 - 1617370212 ; Plant Genomics : Methods and Protocols ( Methods in Molecular Biology ) , 2009 , D . J . Somers , et al . , 
 Humana Press , ISBN 978 - 1588299970 ; Plant Biotechnol 
 ogy : Methods in Tissue Culture and Gene Transfer , 2008 , R . 
 Keshavachandran , et al . , Orient Blackswan , ISBN 978 8173716164 . 
 [ 0042 ] As used herein , “ a CasM protein ” refers to a CRISPR protein capable of targeting RNA and causing single - strand RNA breaks when guided to a target site by a crRNA , without the necessity of association with a tracr RNA . CasM proteins typically include two or more higher eukaryotic and prokaryotic nucleotide - binding ( HEPN ) 
 domains found in protein family PF05168 in the C - terminal region of the CasM sequence . CasM proteins show synteny with one or more WYL domain - containing proteins and sometimes with RtcB ( RNA 3 ' - terminal phosphate cyclase , group B ) domain - containing proteins . Based on the forego 
 ing characteristics , CasM may be classified as a Class 2 Type VI CRISPR - Cas system because it is a single effector protein containing two HEPN domains used for targeted ssRNA 
 interference . However , CasM has a very low degree of sequence similarity to other Type VI subtypes . Exemplary 
 CasM proteins are shown in SEQ ID NOS : 37 - 45 , and are encoded by polynucleotides shown in SEQ ID NOS : 28 - 36 , respectively . These proteins display approximately 13 . 59 % to 99 . 82 % sequence identity to each other and show less than 8 % sequence identity with other known CRISPR - Cas proteins . As used herein , the term “ CasM protein ” refers to 
 a CasM protein derived from any species , subspecies , or 
 strain of bacteria that encodes the CasM protein , as well as an ortholog of the CasM protein , i . e . , a CasM protein from a species other than the species producing the reference 
 CasM protein . For example , CasM orthologs of Eubacte rium siraeum CasM , shown in Table 1 , display approxi mately 13 . 59 % to 99 . 82 % sequence identity to each other . Thus , CasM orthologs are identified based on the CasM characteristics detailed herein . Reference to a CasM protein also encompasses a variant of the reference CasM protein , 
 e . g . , an active homolog of the reference amino acid sequence . Thus , CasM proteins include , but are not limited to , those proteins depicted in SEQ ID NOS : 37 - 45 , orthologs 
 thereof , or variants thereof . Non - limiting examples of such 
 proteins include CasM proteins from Eubacterium siraeum ; 
 Ruminococcus sp . , such as from Ruminococcus bicirculans ; 
 Ruminococcus flavefaciens , such as , but not limited to , FD - 1 and strain XPD3002 ; Ruminococcus albus such as , but not",7082
9,9,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 limited to , strain KH2T6 ; Ruminococcus sp . isolates , such as but not limited to , isolates 2789STDY5834971 , 2789STDY5608892 and 2789STDY5834894 . [ 0043 ] By “ dCasM protein ” is meant a deactivated CasM protein lacking activity , such as catalytic and / or binding 
 activity , also termed "" dead CasM . ” Such molecules lack all or a portion of biological activity , such as nuclease and / or binding activity , and are therefore unable to bind and / or 
 cleave a target nucleic acid of interest , respectively . In some 
 embodiments , these deactivated CasM proteins can be used to regulate genes in a nucleic acid - guided manner . This is accomplished by introducing mutations that inactivate CasM nuclease function and typically involves mutating catalytic residues of the gene encoding CasM . dCasM can be used alone or in fusions to synthetically repress ( CRISPR interference or CRISPRi ) or activate ( CRISPR activation or CRISPR? ) gene expression . CRISPRI can work indepen 
 dently of host cellular machineries . In some embodiments a dCasM protein and a customized nucleic acid - targeting nucleic acid , i . e . , a cognate nucleic acid guide designed with a complementary region to any gene of interest , are used to 
 direct d?asM to a chosen genomic location . In other 
 embodiments , dCasM can be fused to a transcription factor , such as a repressor , and the fused dCasM - transcription 
 factor can then work in concert with cellular machineries . CRISPRa is carried out by dCasM - transcription factor ( acti 
 vator ) fusions . 
 [ 0044 ] A “ nucleic acid - targeting nucleic acid ” ( NATNA ) , as used herein , refers to one or more polynucleotides that guide a protein , such as a CasM protein , to preferentially 
 target a nucleic acid target sequence present in a polynucle 
 otide ( relative to a polynucleotide that does not comprise the nucleic acid target sequence ) . Such NATNAs are also known herein as "" cognate nucleic acid guides , ” or “ cognate guides . ” NATNAs can comprise ribonucleotide bases ( e . g . , RNA ) , deoxyribonucleotide bases ( e . g . , DNA ) , combina 
 tions of ribonucleotide bases and deoxyribonucleotide bases ( e . g . , RNA / DNA ) , nucleotides , nucleotide analogs , modified nucleotides , and the like , as well as synthetic , naturally occurring , and non - naturally occurring modified backbone 
 residues or linkages . Thus , a NATNA as used herein site - specifically guides a CasM , or a deactivated CasM , to a target nucleic acid . Many such NATNAs are known , such as but not limited to sgRNA ( including miniature and truncated 
 single - guide RNAs ) , crRNA , dual - guide RNA , including but not limited to , crRNA / tracrRNA molecules , as described herein , and the like , the use of which depends on the particular Cas protein . For a non - limiting description of exemplary NATNAS , see , e . g . , PCT Publication No . WO 2014 / 150624 to May et al . , published Sep . 29 , 2014 ; PCT Publication No . WO 2015 / 200555 to May et al . , published Mar . 10 , 2016 ; PCT Publication No . WO 2016 / 201155 to Donohoue et al . , published Dec . 15 , 2016 ; PCT Publication No . WO 2017 / 027423 to Donohoue et at , published Feb . 16 , 2017 ; and PCT Publication No . WO 2016 / 123230 to May et al . , published Aug . 4 , 2016 ; each of which is incorporated 
 herein by reference in its entirety . 
 [ 0045 ] With reference to a NATNA or a cognate nucleic acid guide , a “ spacer , "" "" spacer sequence , ” or “ spacer ele ment , ” as used herein , refers to the polynucleotide sequence that can specifically hybridize to a target nucleic acid 
 sequence . The spacer element interacts with the target nucleic acid sequence through hydrogen bonding between complementary base pairs ( i . e . , paired bases ) . A spacer element binds to a selected nucleic acid target sequence . Accordingly , the spacer element is the nucleic acid target 
 binding sequence . The spacer element determines the loca tion of a Cas protein ' s site - specific binding and nucleolytic cleavage . Spacer elements range from approximately 17 to approximately 84 nucleotides in length and have an average 
 length of 36 nucleotides ( see , e . g . , Marraffini , et al . , “ CRISPR interference : RNA - directed adaptive immunity in 
 bacteria and archaea , ” Nature reviews Genetics ( 2010 ) 11 : 181 - 190 ) . Variability of the functional length for a spacer element is known in the art ( e . g . , U . S . Patent Publication 2014 / 0315985 to May et al . , published Oct . 23 , 2014 , incorporated herein by reference in its entirety ) . The terms “ nucleic acid target binding sequence ” and “ spacer sequence ” are used interchangeably herein . [ 0046 ] The term "" gRNA ” typically refers to a single guide RNA i . e . , a single , contiguous polynucleotide 
 sequence ) that essentially comprises a crRNA connected at its 3 ' end to the 5 ' end of a tracrRNA through a "" loop "" sequence ( see , e . g . , U . S . Published Patent Application No . 
 2014 / 0068797 to Duudna et al . , published 6 Mar . 2014 , incorporated herein by reference in its entirety ) . SgRNA interacts with a cognate Cas protein essentially as described 
 for tracrRNA / crRNA polynucleotides . Similar to crRNA , sgRNA has a spacer , a region of complementarity to a potential DNA or RNA target sequence , adjacent a second 
 region that forms base - pair hydrogen bonds that form a 
 secondary structure , typically a stem structure . The term includes truncated single - guide RNAs ( tru - sgRNAs ) of approximately 17 - 18 nucleotides ( nt ) ( see , e . g . , Fu et . al . , Nat Biotechnol . ( 2014 ) 32 : 279 - 284 ) . The term also encom passes functional miniature sgRNAs with expendable fea 
 tures removed , but that retain an essential and conserved module termed the “ nexus ” located in the portion of sgRNA that corresponds to tracrRNA ( not crRNA ) . See , e . g . , U . S . Patent Publication 2014 / 0315985 to May et al . , published Oct . 23 , 2014 , incorporated herein by reference in its entirety ; Briner et al . , “ Guide RNA Functional Modules Direct Cas9 Activity and Orthogonality , ” Molecular Cell ( 2014 ) 56 : 333 - 339 . 
 ( 0047 ] As used herein , "" dual - guide RNA ” refers to a two - component RNA system for a polynucleotide compo 
 nent capable of associating with a cognate Cas protein . A 
 representative CRISPR Class 2 Type II CRISPR - Cas - asso 
 ciated dual - guide RNA includes a Cas - crRNA and Cas tracrRNA , paired by hydrogen bonds to form secondary 
 structure ( see , e . g . , U . S . Published Patent Application No . 2014 / 0068797 to Doudna et al . , published 6 Mar . 2014 , incorporated herein by reference in its entirety ; see also 
 Jinek M . , et al . , Science 337 : 816 - 21 ( 2012 ) ) . A Cas - dual guide RNA is capable of forming a nucleoprotein complex with a cognate Cas protein , wherein the complex is capable of targeting a nucleic acid target sequence complementary to the spacer sequence . 
 [ 0048 ] As used herein , the term "" cognate ” typically refers to a Cas protein ( e . g . , CasM protein ) and one or more polynucleotides ( e . g . , a CRISPR - CasM - associated cognate 
 nucleic acid guide ) capable of forming a nucleoprotein complex for site - directed binding to a nucleic acid target sequence complementary to the nucleic acid target binding sequence present in one of the one or more polynucleotides . [ 0049 ] The terms "" wild - type , ” “ naturally - occurring , "" “ native , "" and "" unmodified ” are used herein to mean the typical ( or most common ) form , appearance , phenotype , or",7664
10,10,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 strain existing in nature ; for example , the typical form of cells , organisms , characteristics , polynucleotides , proteins , 
 macromolecular complexes , genes , RNAs , DNAs , or 
 genomes as they occur in and can be isolated from a source in nature . The wild - type form , appearance , phenotype , or strain serve as the original parent before an intentional 
 modification . Thus , mutant , variant , engineered , recombi 
 nant , and modified forms are not wild - type forms . 
 [ 0050 ] As used herein , the terms "" engineered , "" "" geneti cally engineered , ” “ recombinant , "" "" modified , ” and “ non naturally occurring ” are interchangeable and indicate inten tional human manipulation . [ 0051 ] “ Covalent bond , "" "" covalently attached , "" "" cova lently bound , "" "" covalently linked , "" "" covalently connected , ” 
 and “ molecular bond ” are used interchangeably herein , and 
 refer to a chemical bond that involves the sharing of electron 
 pairs between atoms . Examples of covalent bonds include , but are not limited to , phosphodiester bonds and phospho 
 rothioate bonds . [ 0052 ] “ Non - covalent bond , ” “ non - covalently attached , ” "" non - covalently bound , ” “ non - covalently linked , ” “ non - co 
 valent interaction , "" and "" non - covalently connected ” are used interchangeably herein , and refer to any relatively weak chemical bond that does not involve sharing of a pair of electrons . Multiple non - covalent bonds often stabilize the 
 conformation of macromolecules and mediate specific inter 
 actions between molecules . Examples of non - covalent 
 bonds include , but are not limited to hydrogen bonding , ionic interactions ( e . g . , Na + Cl - ) , van der Waals interactions , and hydrophobic bonds . [ 0053 ] As used herein , “ hydrogen bonding , "" "" hydrogen base pairing , ” and “ hydrogen bonded ” are used interchange ably and refer to canonical hydrogen bonding and non canonical hydrogen bonding including , but not limited to , “ Watson - Crick - hydrogen - bonded base pairs ” ( W - C - hydro gen - bonded base pairs or W - C hydrogen bonding ) ; “ Hoog steen - hydrogen - bonded base pairs ” ( Hoogsteen hydrogen 
 bonding ) ; and “ wobble - hydrogen - bonded base pairs "" . ( wobble hydrogen bonding ) . W - C hydrogen bonding , including reverse W - C hydrogen bonding , refers to purine 
 pyrimidine base pairing , that is , adenine : thymine , guanine : 
 cytosine , and uracil : adenine . Hoogsteen hydrogen bonding , 
 including reverse Hoogsteen hydrogen bonding , refers to a 
 variation of base pairing in nucleic acids wherein two nucleobases , one on each strand , are held together by hydrogen bonds in the major groove . This non - W - C hydro 
 gen bonding can allow a third strand to wind around a duplex and form triple - stranded helices . Wobble hydrogen bonding , including reverse wobble hydrogen bonding , refers 
 to a pairing between two nucleotides in RNA molecules that 
 does not follow Watson - Crick base pair rules . There are four major wobble base pairs : guanine : uracil , inosine ( hypoxan 
 thine ) : uracil , inosine - adenine , and inosine - cytosine . Rules for canonical hydrogen bonding and non - canonical hydro 
 gen bonding are known to those of ordinary skill in the art 
 ( see , e . g . , The RNA World , Third Edition ( Cold Spring Harbor Monograph Series ) , R . F . Gesteland , Cold Spring Harbor Laboratory Press , ISBN 978 - 0879697396 ( 2005 ) ; The RNA World , Second Edition ( Cold Spring Harbor Monograph Series ) , R . F . Gesteland , et al . , Cold Spring Harbor Laboratory Press , ISBN 978 - 0879695613 ( 1999 ) ; The RNA World ( Cold Spring Harbor Monograph Series ) , 
 R . F . Gesteland , et al . , Cold Spring Harbor Laboratory Press , 
 ISBN 978 - 0879694562 ( 1993 ) ( see , e . g . , Appendix 1 : Struc tures of Base Pairs Involving at Least Two Hydrogen Bonds , I . Tinoco ) ; Principles of Nucleic Acid Structure , W . Saenger , Springer International Publishing AG , ISBN 978 - 0 - 387 90761 - 1 ( 1988 ) ; Principles of Nucleic Acid Structure , First Edition , S . Neidle , Academic Press , ISBN 978 01236950791 ( 2007 ) ) . 
 [ 0054 ] “ Connect , "" "" connected , ” and “ connecting ” are used interchangeably herein , and refer to a covalent bond or a non - covalent bond between two macromolecules ( e . g . , polynucleotides , proteins , and the like ) . Thus , CasM and a 
 cognate nucleic acid guide are “ connected ” in a cognate nucleic acid guide / CasM complex . 
 [ 0055 ] As used herein , the terms “ nucleic acid , ” “ nucleic acid sequence , ” “ nucleotide sequence , "" "" oligonucleotide , "" and “ polynucleotide ” are interchangeable and refer to a polymeric form of nucleotides . The nucleotides may be deoxyribonucleotides ( DNA ) , ribonucleotides ( RNA ) , ana logs thereof , or combinations thereof , and may be of any length . Polynucleotides may perform any function and may 
 have any secondary and tertiary structures . The terms 
 encompass known analogs of natural nucleotides and 
 nucleotides that are modified in the base , sugar and / or phosphate moieties . Analogs of a particular nucleotide have the same base - pairing specificity ( e . g . , an analog of A base pairs with T ) . A polynucleotide may comprise one modified 
 nucleotide or multiple modified nucleotides . Examples of 
 modified nucleotides include fluorinated nucleotides , meth ylated nucleotides , and nucleotide analogs . Nucleotide structure may be modified before or after a polymer is assembled . Following polymerization , polynucleotides may 
 be additionally modified via , for example , conjugation with a labeling component or target binding component . A 
 nucleotide sequence may incorporate non - nucleotide com 
 ponents . The terms also encompass nucleic acids comprising 
 modified backbone residues or linkages , which are synthetic , naturally occurring , and non - naturally occurring , and have similar binding properties as a reference polynucleotide 
 ( e . g . , DNA or RNA ) . Examples of such analogs include , but are not limited to , phosphorothioates , phosphoramidates , methyl phosphonates , chiral - methyl phosphonates , 2 - 0 
 methyl ribonucleotides , peptide - nucleic acids ( PNAS ) , Locked Nucleic Acid ( LNATM ) ( Exiqon , Inc . , Woburn , Mass . ) nucleosides , glycol nucleic acid , bridged nucleic acids , and morpholino structures . 
 [ 0056 ] Peptide - nucleic acids ( PNAs ) are synthetic homologs of nucleic acids wherein the polynucleotide phos phate - sugar backbone is replaced by a flexible pseudo peptide polymer . Nucleobases are linked to the polymer . PNAs have the capacity to hybridize with high affinity and specificity to complementary sequences of RNA and DNA . 
 [ 0057 ] In phosphorothioate nucleic acids , the phosphoro 
 thioate ( PS ) bond substitutes a sulfur atom for a non bridging oxygen in the polynucleotide phosphate backbone . 
 This modification makes the internucleotide linkage resis tant to nuclease degradation . In some embodiments , phos phorothioate bonds are introduced between the last 3 to 5 
 nucleotides at the 5 ' - end or 3 ' - end sequences of a polynucle 
 otide sequence to inhibit exonuclease degradation . Place ment of phosphorothioate bonds throughout an entire oli gonucleotide helps reduce degradation by nucleases as well . 
 [ 0058 ] Threose nucleic acid ( TNA ) is an artificial genetic polymer . The backbone structure of TNA comprises repeat ing threose sugars linked by phosphodiester bonds . TNA",7571
11,11,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 polymers are resistant to nuclease degradation . TNA can self - assemble by base - pair hydrogen bonding into duplex 
 structures . [ 0059 ] Linkage inversions can be introduced into poly nucleotides through use of “ reversed phosphoramidites ” ( see , e . g . , ucalgary . ca / dnalab / synthesis / - modifications / link ages ) . A 3 ' - 3 ' linkage at a terminus of a polynucleotide stabilizes the polynucleotide to exonuclease degradation by creating an oligonucleotide having two 5 ' - OH termini but lacking a 3 ' - OH terminus . Typically , such polynucleotides have phosphoramidite groups on the 5 - OH position and a dimethoxytrityl ( DMT ) protecting group on the 3 ' - OH posi tion . Normally , the DMT protecting group is on the 5 ' - OH and the phosphoramidite is on the 3 ' - OH . [ 0060 ] Polynucleotide sequences are displayed herein in 
 the conventional 5 ' to 3 ' orientation unless otherwise indi 
 cated . 
 [ 0061 ] As used herein , the term "" complementarity ” refers to the ability of a nucleic acid sequence to form hydrogen bond ( s ) with another nucleic acid sequence ( e . g . , through traditional Watson - Crick base pairing ) . A percent comple mentarity indicates the percentage of residues in a nucleic 
 acid molecule that can form hydrogen bonds with a second nucleic acid sequence . When two polynucleotide sequences have 100 % complementarity , the two sequences are per fectly complementary , i . e . , all of a first polynucleotide ' s contiguous residues hydrogen bond with the same number of contiguous residues in a second polynucleotide . 
 [ 0062 ] As used herein , "" binding ” refers to a non - covalent 
 interaction between macromolecules ( e . g . , between a protein and a polynucleotide , between a polynucleotide and a poly 
 nucleotide , or between a protein and a protein , and the like ) . 
 Such non - covalent interaction is also referred to as "" asso ciating ” or “ interacting ” ( e . g . , if a first macromolecule 
 interacts with a second macromolecule , the first macromol 
 ecule binds to second macromolecule in a non - covalent manner ) . Some portions of a binding interaction may be sequence - specific ( the terms “ sequence - specific binding , ” “ sequence - specifically bind , "" "" site - specific binding , ” and "" site specifically binds ” are used interchangeably herein ) . Sequence - specific binding , as used herein , typically refers to 
 one or more cognate nucleic acid guides ( i . e . , NATNAs ) capable of forming a complex with a protein ( e . g . , a CasM 
 protein ) to cause the protein to bind a nucleic acid sequence ( e . g . , a RNA or DNA sequence ) comprising a nucleic acid target sequence ( e . g . , a RNA or DNA target sequence ) preferentially relative to a second nucleic acid sequence ( e . g . , a second RNA or DNA sequence ) without the nucleic acid target binding sequence ( e . g . , the RNA or DNA target binding sequence ) . All components of a binding interaction 
 do not need to be sequence - specific , such as contacts of a protein with phosphate residues in a DNA backbone . Bind 
 ing interactions can be characterized by a dissociation constant ( Kd ) . “ Binding affinity ” refers to the strength of the binding interaction . An increased binding affinity is corre lated with a lower Kd . [ 0063 ] As used herein , a Cas protein ( e . g . , a CasM protein ) is said to “ target ” a polynucleotide if a cognate nucleic acid / Cas protein nucleoprotein complex associates with , binds and / or cleaves a polynucleotide at the nucleic acid target sequence within the polynucleotide . 
 [ 0064 ] As used herein , “ single - strand break ” ( SSB ) refers to cleavage of a single strand of RNA or DNA . A "" double 
 strand break ” ( DSB ) refers to both strands of a double - stranded segment of nucleic acid being severed . In some instances , if such a break occurs , one strand can be said to have a "" sticky end ” wherein nucleotides are exposed and not hydrogen bonded to nucleotides on the other strand . In other 
 instances , a “ blunt end ” can occur wherein both strands remain fully base paired with each other . 
 [ 0065 ] As used herein , the term “ recombination ” refers to a process of exchange of genetic information between two polynucleotides . 
 10066 ] As used herein , “ nucleic acid repair , ” such as but not limited to DNA repair , encompasses any process whereby cellular machinery repairs damage to a nucleic acid 
 molecule contained in the cell . The damage repaired can include single - strand breaks or double - strand breaks 
 ( DSBs ) . At least three mechanisms exist to repair DSBs : homology - directed repair ( HDR ) , classical non - homologous 
 end joining ( C - NHEJ ) , and microhomology - mediated end joining ( MMEJ ) , all defined below . “ Nucleic acid repair ” is also used herein to refer to nucleic acid repair resulting from human manipulation , wherein a target locus is modified , e . g . , by inserting , deleting , or substituting nucleotides , all of which represent forms of genome editing . 
 [ 0067 ] As used herein , the term “ homology - directed repair ” or “ HDR ” refers to nucleic acid repair that takes place in cells , for example , during repair of double - strand and single - strand breaks in a nucleic acid molecule , such as DNA . HDR requires nucleotide sequence homology and uses a “ donor template ” ( donor template nucleic acid , such as DNA , polynucleotide donor , or oligonucleotide ( used interchangably herein ) to repair the sequence where the double - strand break occurred ( e . g . , DNA target sequence ) . This results in the transfer of genetic information from , for example , the donor template DNA to the DNA target sequence . HDR may result in alteration of the nucleic acid target sequence ( e . g . , insertion , deletion , mutation ) if the donor template sequence or oligonucleotide sequence differs 
 from the target sequence and part or all of the donor template polynucleotide or oligonucleotide is incorporated into the 
 target sequence . In some embodiments , an entire donor 
 template polynucleotide , a portion of the donor template 
 polynucleotide , or a copy of the donor polynucleotide is 
 copied or integrated at the site of the target sequence . 
 [ 0068 ] By “ donor polynucleotide ” is meant a polynucle otide that can be directed to , and inserted into a target site of interest , such as an integration locus , to modify the target 
 nucleic acid . All or a portion of the donor polynucleotide can 
 be inserted into the target nucleic acid . The donor poly 
 nucleotide can be used for repair of the break in the target nucleic acid sequence resulting in the transfer of genetic 
 information ( i . e . , polynucleotide sequences ) from the donor 
 at the site or in close proximity of the break . Accordingly , new genetic information ( i . e . , polynucleotide sequences ) 
 may be inserted or copied at a target site . The donor polynucleotide can be double - or single - stranded RNA , 
 DNA , a vector , plasmid , or the like . Thus , a donor poly 
 nucleotide can be an insertion cassette , a recombinase expression vector , and the like . Non - symmetrical polynucle 
 otide donors can also be used that are composed of two oligonucleotides . They are partially complementary , and 
 each can include a flanking region of homology . The donor can be used to insert or replace polynucleotide sequences in a target sequence , for example , to introduce a polynucleotide 
 that encodes a protein or functional RNA ( e . g . , siRNA ) , to introduce a protein tag , to modify a regulatory sequence of",7670
12,12,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 a gene , or to introduce a regulatory sequence to a gene ( e . g . 
 a promoter , an enhancer , an internal ribosome entry sequence , a start codon , a stop codon ; a localization signal , or polyadenylation signal ) , to modify a nucleic acid sequence ( e . g . , introduce a mutation ) , and the like . 
 [ 0069 ] Targeted nucleic acid modifications using donor polynucleotides for large changes ( e . g . , more than 100 base 
 pair ( bp ) insertions or deletions ) traditionally use plasmid based donor templates that contain homology arms flanking the site of alteration . Each arm can vary in length , but is typically longer than about 100 bp , such as 100 - 1500 bp , 
 e . g . , 100 . . . 200 . . . 300 . . . 400 . . . 500 . . . 600 . . . 700 . . . 800 . . . 900 . . . 1000 . . . 1500 bp or any integer between these values . However , these numbers can vary , depending on the size of the donor polynucleotide and the target polynucleotide . This method can be used to generate large modifications , including insertion of reporter genes such as fluorescent proteins or antibiotic resistance markers . For transfection in cells , such as HEK cells , approximately 100 - 1000 nanograms ( ng ) , e . g . , 100 . . . 200 . . . 300 . . . 400 
 . . . 500 . . . 600 . . . 700 . . . 800 . . . 900 . . . 1000 ng or any integer between these values , of a typical size donor plasmid ( e . g . , approximately 5 kb ) containing a NATNA / 
 Cas vector , can be used for one well in 24 - well plate . ( See , e . g . , Yang et al . , "" One Step Generation of Mice Carrying Reporter and Conditional Alleles by CRISPR / Cas - Mediated Genome Engineering ” Cell ( 2013 ) 154 : 1370 - 1379 ) . 
 [ 0070 ] Single - stranded and partially double - stranded oli gonucleotides , such as DNA oligonucleotides , have been 
 used in place of targeting plasmids for short modifications 
 ( e . g . , less than 50 bp ) within a defined locus without cloning . To achieve high HDR efficiencies , single - stranded oligo nucleotides containing flanking sequences on each side that are homologous to the target region can be used , and can be 
 oriented in either the sense or antisense direction relative to the target locus . The length of each arm can vary , but the length of at least one arm is typically longer than about 10 bases , such as from 10 - 150 bases , e . g . , 10 . . . 20 . . . 30 . . . 40 . . . 50 . . . 60 . . . 70 . . . 80 . . . 90 . . . 100 . . . 110 . . . 120 . . . 130 . . . 140 . . . 150 , or any integer within these ranges . However , these numbers can vary , depending on the size of the donor polynucleotide and the target polynucle 
 otide . In some embodiments , the length of at least one arm 
 is 10 bases or more . In other embodiments , the length of at 
 least one arm is 20 bases or more . In yet other embodiments , the length of at least one arm is 30 bases or more . In some 
 embodiments , the length of at least one arm is less than 100 
 bases . In further embodiments , the length of at least one arm is greater than 100 bases . In some embodiments , the length 
 of at least one arm is zero bases . For single - stranded oligonucleotide design , typically an oligonucleotide with 
 around 100 - 150 bp total homology is used . The mutation is introduced in the middle , giving 50 - 75 bp homology arms for a donor designed to be symmetrical about the target site . 
 In other cases , no homology arms are required , and the 
 donor polynucleotide is inserted using non - homologous repair mechanisms . [ 0071 ] A “ genomic region ” is a segment of a chromosome in the genome of a host cell that is present on either side of the nucleic acid target sequence site or , alternatively , also includes a portion of the nucleic acid target sequence site . 
 The homology arms of the donor polynucleotide have suf 
 ficient homology to undergo homologous recombination with the corresponding genomic regions . In some embodi ments , the homology arms of the donor polynucleotide share significant sequence homology to the genomic region imme diately flanking the nucleic acid target sequence site ; it is 
 recognized that the homology arms can be designed to have sufficient homology to genomic regions farther from the 
 nucleic acid target sequence site . 
 10072 ] As used herein the terms “ classical non - homolo 
 gous end joining ” or “ C - NHEJ ” refer to the repair of double strand breaks in DNA by direct ligation of one end of the 
 break to the other end of the break without a requirement for 
 a donor template DNA . NHEJ in the absence of a donor 
 template DNA often results in small insertions or deletions 
 of nucleotides at the site of the double - strand break , also referred to as “ indels . ” This DNA repair pathway is geneti cally defined and requires the activity of Ligase IV , DNA 
 PKcs , Polu , Pola , and the Ku70 / 80 heterodimer , among other proteins ( see , e . g . , Sfeir and Symington , Trends Bio chem Sci ( 2015 ) 40 : 701 - 714 ) . [ 0073 ] “ Microhomology - mediated end joining ( MMEJ ) , "" a form of alternative nonhomologous end - joining ( alt 
 NHEJ ) , is another pathway for repairing double - strand 
 breaks in DNA . MMEJ is associated with deletions flanking a DSB and involves alignment of microhomologous 
 sequences internal to the broken ends before joining . The proposed mechanism entails 5 ' - 3 ' resection of the DNA ends at a DSB , annealing of the microhomologies ( 1 - 16 nucleo tides of homology ) , removal of heterologous flaps , gap filling DNA synthesis , and ligation . MMEJ is genetically defined and requires the activity of CtIP , PARP1 , Po10 , Ligl and Lig3 , among other proteins ( see , e . g . , Sfeir and Sym ington , “ Microhomology - Mediated End Joining : A Back - up 
 Survival Mechanism or Dedicated Pathway ? ” Trends Bio 
 chem Sci ( 2015 ) 40 : 701 - 714 ) . [ 0074 ] Alternative mechanisms of nucleic acid insertion that do not require sequence homology between the donor and the target sequence can also be used for nucleic acid 
 insertion . These mechanisms involve various components of 
 the cellular repair machinery and it is to be understood that 
 the scope of the invention is not bound by the use of any 
 particular mechanism for insertion of nucleic acid after target nucleic acid is cut or nicked by a site - specific poly 
 nucleotide . 
 [ 0075 ] “ Gene , ” as used herein , refers to a polynucleotide sequence comprising exon ( s ) and related regulatory sequences . A gene may further comprise intron ( s ) and / or 
 untranslated region ( s ) ( UTR ( S ) ) . [ 0076 ] As used herein , “ expression ” refers to transcription of a polynucleotide from a DNA template , resulting in , for example , a messenger RNA ( mRNA ) or other RNA tran script ( e . g . , non - coding , such as structural or scaffolding 
 RNAs ) . The term further refers to the process through which transcribed mRNA is translated into peptides , polypeptides , or proteins . Transcripts and encoded polypeptides may be referred to collectively as “ gene product ( s ) . ” Expression may include splicing the mRNA in a eukaryotic cell , if the polynucleotide is derived from genomic DNA . 
 [ 0077 ] As used herein , the term “ modulate ” refers to a change in the quantity , degree or amount of a function . For example , a cognate nucleic acid guide / CasM protein com plex , as disclosed herein , may modulate the activity of a promoter sequence by binding to a nucleic acid target 
 sequence at or near the promoter . Depending on the action occurring after binding , the cognate nucleic acid guidel CasM protein complex can induce , enhance , suppress , or",7700
13,13,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 inhibit transcription of a gene operatively linked to the promoter sequence . Thus , “ modulation ” of gene expression includes both gene activation and gene repression . [ 0078 ] Modulation can beassayed by determining any characteristic directly or indirectly affected by the expres 
 sion of the target gene . Such characteristics include , e . g . , changes in RNA or protein levels , protein activity , product 
 levels , expression of the gene , or activity level of reporter 
 genes . Accordingly , the terms “ modulating expression , ” 
 "" inhibiting expression , "" and "" activating expression "" of a 
 gene can refer to the ability of a cognate guide / CasM protein 
 complex to change , activate , or inhibit transcription of a gene . 
 [ 0079 ] The terms “ vector ” and “ plasmid ” are used inter changeably and as used herein refer to a polynucleotide vehicle to introduce genetic material into a cell . Vectors can 
 be linear or circular . Vectors can integrate into a target genome of a host cell or replicate independently in a host 
 cell . Vectors can comprise , for example , an origin of repli 
 cation , a multicloning site , and / or a selectable marker . An expression vector typically comprises an expression cas 
 sette . Vectors and plasmids include , but are not limited to , integrating vectors , prokaryotic plasmids , eukaryotic plas mids , plant synthetic chromosomes , episomes , viral vectors , cosmids , and artificial chromosomes . An expression vector typically comprises an expression cassette . 
 [ 0080 ] As used herein the term "" expression cassette ” is a polynucleotide construct , generated recombinantly or syn thetically , comprising regulatory sequences operably linked 
 to a selected polynucleotide to facilitate expression of the 
 selected polynucleotide in a host cell . For example , the 
 regulatory sequences can facilitate transcription of the 
 selected polynucleotide in a host cell , or transcription and 
 translation of the selected polynucleotide in a host cell . An expression cassette can , for example , be integrated in the 
 genome of a host cell or be present in a vector to form an expression vector . 
 10081 ] As used herein , a "" targeting vector ” is a recombi nant DNA or RNA construct typically comprising tailored DNA or RNA arms , homologous to genomic DNA or RNA 
 derived therefrom , that flank elements of a target gene or nucleic acid target sequence ( e . g . , a SSB or DSB ) . A targeting vector comprises a donor polynucleotide . Elements 
 of the target sequence can be modified in a number of ways 
 including deletions and / or insertions . A defective target gene can be replaced by a functional target gene , or in the 
 alternative a functional gene can be knocked out . Optionally , the donor polynucleotide of a targeting vector comprises a 
 selection cassette comprising a selectable marker that is introduced into the target gene . Targeting regions ( i . e . , 
 nucleic acid target sequences ) adjacent or within a target gene or region can be used to affect regulation of gene expression . 
 [ 0082 ] As used herein , the terms “ regulatory sequences , ” 
 “ regulatory elements , "" and "" control elements ” are inter changeable and refer to polynucleotide sequences that are 
 upstream ( 5 ' non - coding sequences ) , within , or downstream ( 3 ' non - translated sequences ) of a polynucleotide target to be expressed . Regulatory sequences influence , for example , the 
 timing of transcription , amount or level of transcription , 
 RNA processing or stability , and / or translation of the related structural nucleotide sequence . Regulatory sequences may include activator binding sequences , enhancers , introns , polyadenylation recognition sequences , promoters , tran scription start sites , repressor binding sequences , stem - loop 
 structures , translational initiation sequences , internal ribo some entry sites ( IRES ) , translation leader sequences , tran scription termination sequences ( e . g . , polyadenylation sig nals and poly - U sequences ) , translation termination sequences , primer binding sites , and the like . [ 0083 ] Regulatory elements include those that direct con stitutive , inducible , and repressible expression of a nucleo 
 tide sequence in many types of host cells and those that direct expression of the nucleotide sequence only in certain host cells ( e . g . , tissue - specific regulatory sequences ) . In 
 some embodiments , a vector comprises one or more pol III promoters , one or more pol II promoters , one or more pol I 
 promoters , or combinations thereof . Examples of pol III 
 promoters include , but are not limited to , U6 and H1 promoters . Examples of pol II promoters include , but are not 
 limited to , the retroviral Rous sarcoma virus ( RSV ) LTR promoter ( optionally with the RSV enhancer ) , the cyto megalovirus ( CMV ) promoter ( optionally with the CMV enhancer ; see , e . g . , Boshart , M . , et al . , Cell 41 : 521 - 530 ( 1985 ) ) , the SV40 promoter , the dihydrofolate reductase promoter , the ß - actin promoter , the phosphoglycerol kinase ( PGK ) promoter , and the EFla promoter . It will be appre ciated by those skilled in the art that the design of an expression vector may depend on such factors as the choice 
 of the host cell to be transformed , the level of expression 
 desired , and the like . A vector can be introduced into host cells to thereby produce transcripts , proteins , or peptides , 
 including fusion proteins or peptides , encoded by nucleic 
 acids as described herein . [ 0084 ] As used herein the term "" operably linked ” refers to polynucleotide sequences or amino acid sequences placed 
 into a functional relationship with one another . For instance , a promoter or enhancer is operably linked to a coding sequence if it regulates , or contributes to the modulation of , the transcription of the coding sequence . Operably linked DNA sequences encoding regulatory sequences are typically 
 contiguous to the coding sequence . However , enhancers can function when separated from a promoter by up to several 
 kilobases or more . Accordingly , some polynucleotide ele 
 ments may be operably linked but not contiguous . 
 [ 0085 ] As used herein , the term "" expression ” refers to transcription of a polynucleotide from a DNA template , resulting in , for example , an mRNA or other RNA transcript 
 ( e . g . , non - coding , such as structural or scaffolding RNAs ) . 
 The term further refers to the process through which tran scribed mRNA is translated into peptides , polypeptides , or proteins . Transcripts and encoded polypeptides may be referred to collectively as "" gene product . ” Expression may 
 include splicing the mRNA in a eukaryotic cell , if the polynucleotide is derived from genomic DNA . 
 [ 0086 ] As used herein , the term “ sequence identity ” gen erally refers to the percent identity of bases or amino acids determined by comparing a first polynucleotide or polypep tide to a second polynucleotide or polypeptide using algo 
 rithms having various weighting parameters . Sequence iden 
 tity between two polypeptides or two polynucleotides can be 
 determined using sequence alignment by various methods 
 and computer programs ( e . g . , BLAST , CS - BLAST , FASTA , 
 HMMER , L - ALIGN , etc . ) , available through the worldwide web at sites including GENBANK ( ncbi . nlm . nih . gov / gen bank / ) and EMBL - EBI ( ebi . ac . uk . ) . Sequence identity between two polynucleotides or two polypeptide sequences is generally calculated using the standard default parameters",7661
14,14,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 of the various methods or computer programs . Generally , Cas proteins , such as CasM homologs , for use herein will have at least about 75 % or more sequence identity to the wild - type or naturally occurring sequence of the Cas protein 
 of interest , such as about 80 % , such as about 85 % , 90 % , 91 % , 92 % , 93 % , 94 % , 95 % , 96 % , 97 % , 98 % , 99 % , or complete identity . CasM orthologs can vary widely from the 
 reference sequence . For example , CasM orthologs shown in Table 1 display approximately 13 . 59 % to 99 . 82 % sequence identity to each other . Thus , CasM orthologs are identified 
 based on the CasM characteristics detailed herein . 
 [ 0087 ] As used herein , “ hybridization , ” “ hybridize , "" or “ hybridizing "" is the process of combining two complemen 
 tary single - stranded DNA or RNA molecules so as to form 
 a single double - stranded molecule ( DNA / DNA , DNA / RNA , RNA / RNA ) through hydrogen base pairing . Hybridization 
 stringency is typically determined by the hybridization tem perature and the salt concentration of the hybridization buffer ; e . g . , high temperature and low salt provide high 
 stringency hybridization conditions . Examples of salt con 
 centration ranges and temperature ranges for different hybridization conditions are as follows : high stringency , approximately 0 . 01M to approximately 0 . 05M salt , hybrid ization temperature 5° C . to 10° C . below Tmi moderate stringency , approximately 0 . 16M to approximately 0 . 33M salt , hybridization temperature 20° C . to 29° C . below Tmi and low stringency , approximately 0 . 33M to approximately 
 0 . 82M salt , hybridization temperature 40° C . to 48° C . 
 below Tm . Tm of duplex nucleic acids is calculated by 
 standard methods well - known in the art ( see , e . g . , Maniatis , T . , et al . , Molecular Cloning : A Laboratory Manual , Cold Spring Harbor Laboratory Press : New York ( 1982 ) ; Casey , 
 J . , et al . , Nucleic Acids Research 4 : 1539 - 1552 ( 1977 ) ; Bodkin , D . K . , et al . , Journal of Virological Methods 10 ( 1 ) : 
 45 - 52 ( 1985 ) ; Wallace , R . B . , et al . , Nucleic Acids Research 9 ( 4 ) : 879 - 894 ( 1981 ) ) . Algorithm prediction tools to estimate Tm are also widely available . High stringency conditions for hybridization typically refer to conditions under which a polynucleotide complementary to a target sequence pre 
 dominantly hybridizes with the target sequence , and sub stantially does not hybridize to non - target sequences . Typi cally , hybridization conditions are of moderate stringency , preferably high stringency . 
 [ 0088 ] As used herein , the term “ amino acid ” refers to natural and synthetic ( unnatural ) amino acids , including amino acid analogs , modified amino acids , peptidomimetics , glycine , and D or L optical isomers . 
 [ 0089 ] As used herein , the terms “ peptide , ” “ polypeptide , "" and “ protein ” are interchangeable and refer to polymers of amino acids . A polypeptide may be of any length . It may be 
 branched or linear , it may be interrupted by non - amino 
 acids , and it may comprise modified amino acids . The terms 
 may be used to refer to an amino acid polymer that has been modified through , for example , acetylation , disulfide bond formation , glycosylation , lipidation , phosphorylation , cross 
 linking , and / or conjugation ( e . g . , with a labeling component 
 or ligand ) . Polypeptide sequences are displayed herein in the 
 conventional N - terminal to C - terminal orientation . 
 [ 0090 ] Polypeptides and polynucleotides can be made using routine techniques in the field of molecular biology ( see , e . g . , standard texts set forth above ) . Further , essentially any polypeptide or polynucleotide can be custom ordered 
 from commercial sources . [ 0091 ] The terms “ fusion protein ” and “ chimeric protein , "" as used herein , refer to a single protein created by joining two or more proteins , protein domains , or protein fragments that do not naturally occur together in a single protein . For 
 example , a fusion protein can contain a first domain from a 
 CasM protein and a second domain from a different Cas 
 protein . The modification to include such domains in fusion proteins may confer additional activity on the modified site - directed polypeptides . Such activities can include nucle ase activity , methyltransferase activity , demethylase activity , DNA or RNA repair activity , DNA or RNA damage activity , deamination activity , dismutase activity , alkylation activity , depurination activity , oxidation activity , pyrimidine dimer forming activity , integrase activity , transposase activity , 
 recombinase activity , polymerase activity , ligase activity , 
 helicase activity , photolyase activity , glycosylase activity , 
 acetyltransferase activity , deacetylase activity , kinase activ ity , phosphatase activity , ubiquitin ligase activity , deubiq uitinating activity , adenylation activity , deadenylation activ ity , SUMOylating activity , deSUMOylating activity , ribosylation activity , deribosylation activity , myristoylation activity , or demyristoylation activity ) that modifies a poly peptide associated with nucleic acid target sequence ( e . g . , a histone ) . A fusion protein can also comprise epitope tags ( e . g . , histidine tags , FLAG® ( Sigma Aldrich , St . Louis , Mo . ) tags , Myc tags ) , reporter protein sequences ( e . g . , 
 glutathione - S - transferase , beta - galactosidase , luciferase , 
 green fluorescent protein , cyan fluorescent protein , yellow 
 fluorescent protein ) , and / or nucleic acid binding domains ( e . g . , a DNA binding domain , an RNA binding domain ) . A fusion protein can also comprise activator domains ( e . g . , 
 heat shock transcription factors , NFKB activators ) or repres 
 sor domains ( e . g . , a KRAB domain ) . As described by Lupo , A . , et al . , Current Genomics 14 ( 4 ) : 268 - 278 ( 2013 ) , the KRAB domain is a potent transcriptional repression module 
 and is located in the amino - terminal sequence of most C2H2 zinc finger proteins ( see , e . g . , Margolin , J . , et al . , Proceed ings of the National Academy of Sciences of the United States of America 91 : 4509 - 4513 ( 1994 ) ; Witzgall , R . , et al . , Proceedings of the National Academy of Sciences of the 
 United States of America 91 : 4514 - 4518 ( 1994 ) ) . The KRAB domain typically binds to co - repressor proteins and / or tran scription factors via protein - protein interactions , causing transcriptional repression of genes to which KRAB zinc finger proteins ( KRAB - ZFPs ) bind ( see , e . g . , Friedman J . R . , et al . , Genes & Development 10 : 2067 - 2678 ( 1996 ) ) . In some embodiments , linker nucleic acid sequences are used to join the two or more proteins , protein domains , or protein fragments . 
 [ 0092 ] A “ moiety , ” as used herein , refers to a portion of a molecule . A moiety can be a functional group or describe a portion of a molecule with multiple functional groups ( e . g . , that share common structural aspects ) . The terms "" moiety ” and “ functional group ” are typically used interchangeably ; 
 however , a “ functional group ” can more specifically refer to 
 a portion of a molecule that comprises some common 
 chemical behavior . “ Moiety ” is often used as a structural 
 description . In some embodiments , a 5 ' terminus , a 3 ' 
 terminus , or a 5 ' terminus and a 3 ' terminus ( e . g . , a non 
 native 5 ' terminus and / or a non - native 3 ' terminus in a first stem element ) can comprise one or more moieties . 
 [ 0093 ] As used herein , the term “ isolated ” can refer to a nucleic acid or polypeptide that , by the hand of a human , 
 exists apart from its native environment and is therefore not",7855
15,15,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 geese ; and the like . The term does not denote a particular age or gender . Thus , the term includes adult , young , and new 
 born individuals as well as male and female . In some embodiments , a host cell is derived from a subject ( e . g . , stem cells , progenitor cells , or tissue - specific cells ) . In some embodiments , the subject is a non - human subject . [ 0099 ] As used herein , “ transgenic organism ” refers to an 
 organism whose genome is genetically modified . The term includes the progeny ( any generation ) of a transgenic organ 
 ism , provided that the progeny has the genetic modification . a product of nature . Isolated means substantially pure . An isolated nucleic acid or polypeptide can exist in a purified 
 form and / or can exist in a non - native environment such as , for example , in a recombinant cell . 
 0094 ] As used herein , a “ host cell ” generally refers to a 
 biological cell . A cell is the basic structural , functional and / or biological unit of an organism . A cell can originate 
 from any organism having one or more cells . Examples of 
 host cells include , but are not limited to : a prokaryotic cell , eukaryotic cell , a bacterial cell , an archaeal cell , a cell of a single - cell eukaryotic organism , a protozoal cell , a cell from a plant ( e . g . , cells from plant crops ( such as soy , tomatoes , sugar beets , pumpkin , hay , cannabis , tobacco , plantains , yams , sweet potatoes , cassava , potatoes , wheat , sorghum , soybean , rice , corn , maize , oil - producing Brassica ( e . g . , oil - producing rapeseed and canola ) , cotton , sugar cane , sunflower , millet , and alfalfa ) , fruits , vegetables , grains , seeds , flowering plants , conifers , gymnosperms , ferns , club mosses , hornworts , liverworts , mosses ) , an algal cell , ( e . g . , Botryococcus braunii , Chlamydomonas reinhardtii , Nanno chloropsis gaditana , Chlorella pyrenoidosa , Sargassum pat ens C . agardh , and the like ) , seaweeds ( e . g . , kelp ) , a fungal 
 cell ( e . g . , a yeast cell or a cell from a mushroom ) , an animal 
 cell , a cell from an invertebrate animal ( e . g . , fruit fly , 
 cnidarian , echinoderm , nematode , and the like ) , a cell from a vertebrate animal ( e . g . , fish , amphibian , reptile , bird , or 
 mammal ) , a cell from a mammal ( e . g . , a pig , a cow , a goat , 
 a sheep , a rodent , a rat , a mouse , a non - human primate , a 
 human , and the like ) . Furthermore , a cell can be a stem cell or a progenitor cell . 
 [ 0095 ] As used herein , “ stem cell ” refers to a cell that has the capacity for self - renewal , i . e . , the ability to go through 
 numerous cycles of cell division while maintaining the undifferentiated state . Stem cells can be totipotent , pluripo tent , multipotent , oligopotent , or unipotent . Stem cells can 
 be embryonic , fetal , amniotic , adult , or induced pluripotent 
 stem cells . [ 0096 ] As used herein , “ induced pluripotent stem cells ” refers to a type of pluripotent stem cell that is artificially 
 derived from a non - pluripotent cell , typically an adult somatic cell , by inducing expression of specific genes . 
 [ 0097 ] “ Plant , ” as used herein , refers to whole plants , plant organs , plant tissues , germplasm , seeds , plant cells , and progeny of the same . Plant cells include , without limitation , cells from seeds , suspension cultures , embryos , 
 meristematic regions , callus tissue , leaves , roots , shoots , gametophytes , sporophytes , pollen , and microspores . Plant parts include differentiated and undifferentiated tissues 
 including , but not limited to roots , stems , shoots , leaves , pollens , seeds , tumor tissue , and various forms of cells and culture ( e . g . , single cells , protoplasts , embryos , and callus tissue ) . The plant tissue may be in plant or in a plant organ , 
 tissue or cell culture . “ Plant organ ” refers to plant tissue or a group of tissues that constitute a morphologically and functionally distinct part of a plant . 
 [ 0098 ] “ Subject , ” as used herein , refers to any member of the phylum Chordata , including , without limitation , humans and other primates , including non - human primates such as rhesus macaques , chimpanzees and other monkey and ape 
 species ; farm animals , such as cattle , sheep , pigs , goats , and 
 horses ; domestic mammals , such as dogs and cats ; labora - tory animals , including rabbits , mice , rats , and guinea pigs ; birds , including domestic , wild , and game birds , such as chickens , turkeys , and other gallinaceous birds , ducks , and CRISPR Systems 
 [ 0100 ] The CRISPR ( Clustered Regularly Interspaced Short Palindromic Repeats ) genomic locus is found in the genomes of many prokaryotes ( e . g . , bacteria and archaea ) . 
 CRISPR loci provide resistance to foreign invaders ( e . g . , virus , phage ) in prokaryotes . In this way , the CRISPR system functions as a type of immune system to help defend 
 prokaryotes against foreign invaders . There are three main 
 stages in CRISPR - Cas immune systems : ( 1 ) acquisition , ( 2 ) expression , and ( 3 ) interference . Acquisition involves cleav ing the genome of invading viruses and plasmids and integrating segments ( termed protospacers ) of the genomic DNA into the CRISPR locus of the host organism . The segments that are integrated into the host genome are known as spacers , which mediate protection from subsequent attack 
 by the same ( or sufficiently related ) virus or plasmid . 
 Expression involves transcription of the CRISPR locus and subsequent enzymatic processing to produce short mature CRISPR RNAs , each containing a single spacer sequence . 
 Interference is induced after the CRISPR RNAs associate with Cas proteins to form effector complexes , which are then targeted to complementary protospacers in foreign genetic 
 elements to induce nucleic acid degradation . 
 [ 0101 ] Currently , two classes of CRISPR systems have been described , Class 1 and Class 2 , based upon the genes encoding the effector module , i . e . , the proteins involved in the interference stage . Class 1 systems have a multi - subunit crRNA - effector complex , whereas Class 2 systems have a 
 single protein , such as Cas9 , Cpfi , C2c1 , c2c2 , C2c3 , or a crRNA - effector complex . Class 1 systems comprise Type I , Type III and Type IV systems . Class 2 systems comprise Type II , Type V and Type VI systems . [ 0102 ] To date , there are six types ( Types I - VI ) and 19 subtypes of CRISPR systems categorized within these classes ( Makarova et al . , Nature Reviews Microbiology ( 2015 ) 13 : 1 - 15 ; Shmakov et al . , Nature Reviews Microbi ology ( 2017 ) 15 : 169 - 182 ) . 0103 ] CRISPR loci are currently characterized as includ 
 ing a number of short repeating sequences referred to as “ repeats . ” Repeats can form hairpin structures and / or repeats 
 can be unstructured single - stranded sequences . The repeats occur in clusters . Repeats frequently diverge between spe cies . Repeats are regularly interspaced with unique inter vening sequences , referred to as “ spacers , ” resulting in a repeat - spacer - repeat locus architecture . Spacers are identical 
 to or are homologous with known foreign invader 
 sequences . In some instances , a spacer - repeat unit encodes a crisprRNA ( crRNA ) . A crRNA refers to the mature form 
 of the spacer - repeat unit . A crRNA contains a spacer sequence that is involved in targeting a target nucleic acid 
 ( e . g . , possibly as a surveillance mechanism against foreign 
 nucleic acid ) . Thus , crRNA has a region of complementarity to a potential DNA or RNA target sequence and in some",7742
16,16,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 se cases , e . g . , in currently characterized Type II systems , a 
 second region that forms base - pair hydrogen bonds with a transactivating CRISPR RNA ( tracrRNA ) to form a second 
 ary structure , typically to form at least a stem structure . In this context , the tracrRNA and a crRNA interact through a number of base - pair hydrogen bonds to form secondary 
 RNA structures . Complex formation between tracrRNAI crRNA and a Cas protein results in conformational change 
 of the Cas protein that facilitates binding to DNA , nuclease activities of the Cas protein , and crRNA - guided site - specific DNA cleavage by the nuclease . For a Cas protein / tracrRNA / crRNA complex to cleave a DNA target sequence , the DNA target sequence is adjacent to a cognate protospacer adjacent 
 motif ( PAM ) . [ 0104 ] A CRISPR locus comprises polynucleotide sequences encoding for CRISPR Associated Genes ( cas ) genes . Cas genes are involved in the biogenesis and / or the interference stages of crRNA function . Cas genes display extreme sequence ( e . g . , primary sequence ) divergence 
 between species and homologs . Some Cas genes comprise homologous secondary and / or tertiary structures . Cas genes are typically named according to the organism from which they are derived . For example , Cas genes in Staphylococcus 
 epidermidis can be referred to as Csm - type , Cas genes in Streptococcus thermophilus can be referred to as Csn - type , and Cas genes in Pyrococcus furiosus can be referred to as Cmr - type . [ 0105 ] The integration stage of a CRISPR system refers to the ability of the CRISPR locus to integrate new spacers into the crRNA array upon being infected by a foreign invader . Acquisition of the foreign invader spacers can help confer 
 immunity to subsequent attacks by the same foreign invader . Integration typically occurs at the leader end of the CRISPR locus . Cas proteins are involved in integration of new spacer sequences . Integration proceeds similarly for some types of 
 CRISPR systems ( e . g . , Types I - III ) . [ 0106 ] Mature crRNAs are processed from a longer poly cistronic CRISPR locus transcript ( i . e . , pre - crRNA array ) . A pre - crRNA array comprises a plurality of crRNAs . The repeats in the pre - crRNA array are recognized by cas genes . 
 Cas genes bind to the repeats and cleave the repeats . This 
 action can liberate the plurality of crRNAs . crRNAs can be subjected to further events to produce the mature crRNA form such as trimming ( e . g . , with an exonuclease ) . A crRNA 
 may comprise all , some , or none of the CRISPR repeat sequence . 
 [ 0107 ] Interference refers to the stage in the CRISPR system that is functionally responsible for combating infec 
 tion by a foreign invader . CRISPR interference follows a similar mechanism to RNA interference ( RNAi : e . g . , wherein a target RNA is targeted ( e . g . , hybridized ) by a short interfering RNA ( siRNA ) ) , which results in target RNA 
 degradation and / or destabilization . Currently characterized 
 CRISPR systems perform interference of a target nucleic acid by coupling crRNAs and Cas genes , thereby forming 
 CRISPR ribonucleoproteins ( RNPs ) . crRNA of the RNP 
 guides the RNP to foreign invader nucleic acid , ( e . g . , by recognizing the foreign invader nucleic acid through hybrid ization ) . Hybridized target foreign invader nucleic acid crRNA units are subjected to cleavage by Cas proteins . Target nucleic acid interference typically requires a proto spacer adjacent motif ( PAM ) in a target nucleic acid . 
 [ 0108 ] By a “ CRISPR - Cas system ” as used herein , is meant any of the various CRISPR - Cas classes , types , and subtypes . Class 1 systems comprise Type I , Type III , and 
 Type IV systems . Type I systems are currently characterized as having a Cas3 protein that has helicase activity and cleavage activity . Type I systems are further divided into 
 several subtypes that have a defined combination of signa ture genes and distinct features of operon organization . [ 0109 ] To date , it appears that all Type III systems possess a cas 10 gene , which encodes a multidomain protein con taining a Palm domain ( a variant of the RNA recognition motif ( RRM ) ) that is homologous to the core domain of numerous nucleic acid polymerases and cyclases and that is the largest subunit of Type III crRNA - effector complexes . 
 All Type III loci also encode the small subunit protein , one Cas5 protein and typically several Cas7 proteins . Type III is 
 also further divided into several subtypes . [ 0110 ] Type IV systems encode a minimal multisubunit crRNA - effector complex comprising a partially degraded 
 large subunit , Csfi , Cas5 , Cas7 , and in some cases , a putative small subunit . Type IV systems lack cas1 and cas2 genes . Type IV systems do not have subtypes , but there are 
 two distinct variants . One Type IV variant has a DinG family 
 helicase , whereas a second Type IV variant lacks a DinG family helicase , but has a gene encoding a small a - helical protein . An example of an organism with a Type IV system is Acidithiobacillus ferrooxidans . [ 0111 ] Class 2 systems comprise Type II , Type V , and Type VI systems . Type II systems include casi , cas2 and cas9 
 genes . There are two strands of RNA in Type II systems , a crRNA and a tracrRNA , that hybridizes to a complementary 
 region of pre - crRNA causing maturation of the pre - crRNA 
 to crRNA . The duplex formed by the tracrRNA and crRNA 
 is recognized by , and associates with a multidomain protein , 
 Cas9 , encoded by the cas9 gene , which combines the functions of the crRNA - effector complex with target DNA 
 cleavage . Cas9 is directed to a target nucleic acid by a 
 sequence of the crRNA that is complementary to , and 
 hybridizes with , a sequence in the target nucleic acid . [ 0112 ] In Type V systems , nucleic acid target sequence 
 binding involves a Cas12a protein and the crRNA , as does the nucleic acid target sequence cleavage . In Type V sys 
 tems , the RuvC - like nuclease domain of Cas12a protein cleaves both strands of the nucleic acid target sequence in a sequential fashion ( Swarts , et al . , Mol . Cell ( 2017 ) 66 : 221 233 . e4 ) , producing 5 ' overhangs , which contrasts with the blunt ends generated by Cas9 protein cleavage . [ 0113 ] The Cas12a protein cleavage activity of Type V systems does not require hybridization of crRNA to tracr RNA to form a duplex ; rather Type V systems use a single 
 crRNA that has a stem - loop structure forming an internal duplex . Cas12a protein binds the crRNA in a sequence - and structure - specific manner by recognizing the stem loop and sequences adjacent to the stem loop , most notably the nucleotides 5 ' of the spacer sequence , which hybridizes to 
 the nucleic acid target sequence . This stem - loop structure is typically in the range of 15 to 19 nucleotides in length . Substitutions that disrupt this stem - loop duplex abolish 
 cleavage activity , whereas other substitutions that do not disrupt the stem - loop duplex do not abolish cleavage activ ity . 
 [ 0114 ] Type VI systems include the Cas13a protein ( also known as Class 2 candidate 2 protein , or C2c2 ) which does not share sequence similarity with other CRISPR effector proteins ( see Abudayyeh , et al . , Science ( 2016 ) 353 : aaf5573 ) . Cas13a proteins have two HEPN domains and",7453
17,17,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 possess single - stranded RNA cleavage activity . Cas13a pro 
 teins are similar to Cas12a proteins in requiring a crRNA for nucleic acid target sequence binding and cleavage , but not 
 requiring tracrRNA . Also , similar to Cas12a protein , the crRNA for Cas13a proteins forms a stable hairpin , or stem loop structure , that aids in association with the Cas13a protein . Type VI systems have a single polypeptide RNA 
 endonuclease that utilizes a single crRNA to direct RNA cleavage in a target - dependent fashion . Additionally , after hybridizing to the target RNA complementary to the spacer , 
 Cas13a protein becomes a promiscuous RNA endonuclease 
 exhibiting non - specific endonuclease activity toward any 
 single - stranded RNA in a sequence independent manner ( see East - Seletsky , et al . , Nature ( 2016 ) 538 : 270 - 273 ) . [ 0115 ] As is readily apparent , the discovery and charac terization of CRISPR systems is currently evolving . 
 Production of CRISPR Components 
 [ 0116 ] In all of the embodiments described herein , the various components can be produced by synthesis , or for example , using expression cassettes encoding CasM , a cog nate guide , etc . The various components can be provided to 
 a cell or used in vitro . These components can be present on 
 a single cassette or multiple cassettes , in the same or different constructs . Expression cassettes typically comprise 
 regulatory sequences functional in host cells into which they 
 are introduced . Regulatory sequences are involved in one or more of the following : regulation of transcription , post 
 transcriptional regulation , and regulation of translation . 
 Expression cassettes can be present in expression vectors and introduced into a wide variety of host cells including 
 bacterial cells , yeast cells , plant cells , and mammalian cells . [ 0117 ] In one aspect , all or a portion of the various components for use herein are produced in vectors , includ ing expression vectors , comprising polynucleotides encod 
 ing therefor . Vectors useful for producing components for 
 use in the present methods include plasmids , viruses ( includ ing phage ) , and integratable nucleic acid fragments ( i . e . , fragments integratable into the host genome by homologous 
 recombination ) . A vector replicates and functions indepen dently of the host genome , or may , in some instances , integrate into the genome itself . Suitable replicating vectors 
 will contain a replicon and control sequences derived from species compatible with the intended expression host cell . In 
 some embodiments , polynucleotides encoding one or more 
 of the various components are operably linked to an induc ible promoter , a repressible promoter , or a constitutive promoter . Expression vectors can also include polynucle otides encoding protein tags ( e . g . , poly - His tags , hemagglu tinin tags , fluorescent protein tags , bioluminescent tags , nuclear localization tags ) . The coding sequences for such protein tags can be fused to the coding sequences or can be included in an expression cassette , for example , in a target ing vector . [ 0118 ] General methods for construction of expression 
 vectors are known in the art . Expression vectors for most 
 host cells are commercially available . There are several commercial software products designed to facilitate selec tion of appropriate vectors and construction thereof , such as 
 insect cell vectors for insect cell transformation and gene expression in insect cells , bacterial plasmids for bacterial 
 transformation and gene expression in bacterial cells , yeast plasmids for cell transformation and gene expression in yeast and other fungi , mammalian vectors for mammalian cell transformation and gene expression in mammalian cells 
 or mammals , viral vectors ( including retroviral , lentiviral , 
 and adenoviral vectors ) for cell transformation and gene expression and methods to easily enable cloning of such polynucleotides . SnapGeneTM ( GSL Biotech LLC , Chicago , 
 Ill . ; snapgene . com / resources / plasmid _ files / your _ time _ is _ 
 valuable / ) , for example , provides an extensive list of vec tors , individual vector sequences , and vector maps , as well 
 as commercial sources for many of the vectors . 
 [ 0119 ] Several expression vectors have been designed for expressing guide polynucleotides . See , e . g . , Shen et al . Nat . 
 Methods ( 2014 ) 11 : 399 - 402 . Additionally , vectors and expression systems are commercially available , such as 
 from New England Biolabs ( Ipswich , Mass . ) and Clontech Laboratories ( Mountain View , Calif . ) . Vectors can be designed to simultaneously express a target - specific 
 NATNA using a U2 or U6 promoter , a CasM and / or d?asM , 
 and if desired , a marker protein , for monitoring transfection 
 efficiency and / or for further enriching / isolating transfected cells by flow cytometry . 
 10120 ] For example , the various components can be incor 
 porated into mammalian vectors for use in mammalian cells . A large number of mammalian vectors suitable for use with the systems of the present invention are commercially available ( e . g . , from Life Technologies , Grand Island , N . Y . ; 
 NeoBiolab , Cambridge , Mass . ; Promega , Madison , Wis . ; DNA2 . 0 , Menlo Park , Calif . , Addgene , Cambridge , Mass . ) . 
 [ 0121 ] Vectors derived from mammalian viruses can also be used for expressing the various components of the present 
 methods in mammalian cells . These include vectors derived from viruses such as adenovirus , papovirus , herpesvirus , 
 polyomavirus , cytomegalovirus , lentivirus , retrovirus , vac 
 cinia and Simian Virus 40 ( SV40 ) ( see , e . g . , Kaufman , R . J . , Molec . Biotech . ( 2000 ) 16 : 151 - 160 ; Cooray et al . , Methods Enzymol . ( 2012 ) 507 : 29 - 57 ) . Regulatory sequences oper 
 ably linked to the components can include activator binding 
 sequences , enhancers , introns , polyadenylation recognition sequences , promoters , repressor binding sequences , stem 
 loop structures , translational initiation sequences , translation 
 leader sequences , transcription termination sequences , trans 
 lation termination sequences , primer binding sites , and the 
 like . Commonly used promoters are constitutive mammalian 
 promoters CMV , EFla , SV40 , PGK1 ( mouse or human ) , Ubc , CAG , CaMKIIa , and beta - Act , and others known in the art ( Khan , K . H . Advanced Pharmaceutical Bulletin ( 2013 ) 3 : 257 - 263 ) . Furthermore , mammalian RNA polymerase III promoters , including H1 and U6 , can be used . 
 0122 ] Numerous mammalian cell lines have been utilized for expression of gene products including HEK 293 ( Human embryonic kidney ) and CHO ( Chinese hamster ovary ) . These cell lines can be transfected by standard methods ( e . g . , using calcium phosphate or polyethyleneimine ( PEI ) , or electroporation ) . Other typical mammalian cell lines 
 include , but are not limited to : HeLa , U2OS , 549 , HT1080 , CAD , P19 , NIH 3T3 , L929 , N2a , Human embryonic kidney 
 293 cells , MCF - 7 , Y79 , SO - Rb50 , Hep G2 , DUKX - X11 , 
 J558L , and Baby hamster kidney ( BHK ) cells . [ 0123 ] Vectors can be introduced into and propagated in a prokaryote . Prokaryotic vectors are well known in the art . Typically a prokaryotic vector comprises an origin of rep 
 lication suitable for the target host cell ( e . g . , oriC derived 
 from E . coli , PUC derived from pBR322 , PSC101 derived from Salmonella ) , 15A origin ( derived from p15A ) and 
 bacterial artificial chromosomes ) . Vectors can include a",7678
18,18,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 known CRISPR - Cas proteins . CasM has been found in several species and isolates including , without limitation , 
 Eubacterium siraeum ; Ruminococcus sp . , such as from 
 Ruminococcus bicirculans ; Ruminococcus flavefaciens , 
 such as , but not limited to , FD - 1 and strain XPD3002 ; Ruminococcus albus such as , but not limited to , strain KH2T6 ; Ruminococcus sp . isolates , such as but not limited 
 to , isolates 2789STDY5834971 , 2789STDY5608892 and 
 2789STDY5834894 . However , is it to be understood that the term “ CasM ” refers to a protein derived from any species , 
 subspecies or strain of bacteria that encodes a CasM protein , 
 as well as orthologs thereof , or variants thereof . Represen 
 tative CasM proteins include , but are not limited to , those proteins depicted as SEQ ID NOS : 37 - 45 ( see Table 1 ) , orthologs thereof , or variants thereof . CasM proteins are approximately 800 to approximately 1000 amino acids in length . selectable marker ( e . g . , genes encoding resistance for ampi cillin , chloramphenicol , gentamicin , and kanamycin ) . Zeo cinTM ( Life Technologies , Grand Island , N . Y . ) can be used as a selection in bacteria , fungi ( including yeast ) , plants and mammalian cell lines . Accordingly , vectors can be designed that carry only one drug resistance gene for Zeocin for 
 selection work in a number of organisms . Useful promoters are known for expression of proteins in prokaryotes , for 
 example , T5 , 17 , Rhamnose ( inducible ) , Arabinose ( induc ible ) , and Pho A ( inducible ) . Furthermore , 17 promoters are widely used in vectors that also encode the T7 RNA poly merase . Prokaryotic vectors can also include ribosome bind ing sites of varying strength , and secretion signals ( e . g . , mal , 
 sec , tat , ompC , and pelB ) . In addition , vectors can comprise RNA polymerase promoters for the expression of NATNAs . 
 Prokaryotic RNA polymerase transcription termination 
 sequences are also well known ( e . g . , transcription termina tion sequences from Streptococcus pyogenes ) . [ 0124 ] Expression of proteins in prokaryotes is typically carried out in E . coli with vectors containing constitutive or inducible promoters directing the expression of either fusion 
 or non - fusion proteins . 
 [ 0125 ] In some embodiments , a vector is a yeast expres 
 sion vector comprising one or more components of the 
 above - described methods . Examples of vectors for expres 
 sion in Saccharomyces cerivisae include , but are not limited to , the following : p YepSecl , pMFa , PJRY88 , pYES2 , and picZ . Methods for gene expression in yeast cells are known in the art ( see , e . g . , Methods in Enzymology , Volume 194 , “ Guide to Yeast Genetics and Molecular and Cell Biology , 
 Part A . ” ( 2004 ) Christine Guthrie and Gerald R . Fink ( eds . ) , 
 Elsevier Academic Press , San Diego , Calif . ) . Typically , expression of protein - encoding genes in yeast requires a 
 promoter operably linked to a coding region of interest plus 
 a transcriptional terminator . Various yeast promoters can be used to construct expression cassettes for expression of 
 genes in yeast . TABLE 1 
 Representative CasM Proteins 
 Species / Isolate SEQ ID NO 
 Eubacterium siraeum 
 Ruminococcus sp . , isolate 2789STDY5834971 
 Ruminococcus bicirculans 
 Ruminococcus sp . , isolate 2789STDY5608892 
 Ruminococcus sp . CAG : 57 
 Ruminococcus flavefaciens FD - 1 
 Ruminococcus albus strain KH2T6 
 Ruminococcus flavefaciens strain XPD3002 Ruminococcus sp . , isolate 2789STDY5834894 SEQ ID NO : 37 
 SEQ ID NO : 38 
 SEQ ID NO : 39 
 SEQ ID NO : 40 
 SEQ ID NO : 41 SEQ ID NO : 42 
 SEQ ID NO : 43 SEQ ID NO : 44 
 SEQ ID NO : 45 
 CasM Proteins 
 [ 0126 ] CasM , a new CRISPR - Cas protein , is described herein . CasM displays nucleic acid binding activity and 
 produces breaks , such as singe - strand breaks ( SSBs ) or 
 DSBs , when brought into proximity with a nucleic acid target sequence , e . g . , by association with a cognate nucleic acid guide , such as a cognate crRNA . As shown in the Examples herein , CasM targets RNA and is capable of cleaving SSRNA , such as when delivered to a genomic target 
 when complexed with a crRNA , without the necessity of 
 association with a tracrRNA . CasM proteins typically include two or more higher eukaryotic and prokaryotic nucleotide - binding ( HEPN ) domains found in protein family PF05168 , in the C - terminal region of the CasM sequence . CasM proteins show synteny with one or more WYL 
 domain - containing proteins and sometimes with RtcB ( RNA 3 ' - terminal phosphate cyclase , group B ) domain - containing 
 proteins . Based on the foregoing characteristics , CasM may be classified as a Class 2 Type VI CRISPR - Cas system . However , CasM has a very low degree of sequence simi larity to other Type VI subtypes . [ 0127 ] Exemplary CasM proteins are shown in SEQ ID NOS : 37 - 45 , and are encoded by polynucleotides shown in SEQ ID NOS : 28 - 36 , respectively . These proteins display approximately 13 . 59 % to 99 . 82 % sequence identity to each other and show less than 8 % sequence identity with other [ 0128 ] Analysis of these CasM protein sequences indi cates the presence of two HEPN domains in the C - terminal region of the sequences . The HEPN domain is often involved in nucleic acid binding and can function as a metal - independent RNase in certain instances . 
 [ 0129 ] CasM systems display strong synteny with an open 
 reading frame in WYL domain - ( protein family PF13280 ) containing proteins . The sequences for WYL domains in 
 various species that encode CasM proteins are shown as 
 SEQ ID NOS : 52 - 59 ( see Table 2 ) . WYL domains share similarities with CRISPR - associated Rossman fold ( CARF ) domains and are thought to bind ligands derived from host - virus conflict and regulate CRISPR - Cas systems . A WYL domain protein ( s117009 ) has been shown to be a negative regulator of the I - D CRISPR - Cas system in Syn echocystis sp . ( Hein et al . , RNA Biol . ( 2013 ) 10 : 852 - 864 . In some instances , the WYL - containing protein contains at least two WYL domains . These duplications are consistent 
 with the hypothesized multimeric assembly of these ligand 
 binding domains ( Schumacher et al . , EMBO J . ( 2002 ) 
 21 : 1210 - 1218 ) . The N - termini of these WYL domains con tain homology to transcriptional repressor CopG and the 
 ParD anti - toxin domain . For use in eukaryotes , the WYL domain - containing proteins can be modified with a N - or C - terminal nuclear localization signal sequence ( NLS ) . SEQ ID NOS : 61 - 68 present exemplary WYL domain - containing 
 proteins modified with a seven amino acid C - terminal NLS tag derived from the SV40 Large T - antigen .",6824
19,19,"US 2018 / 0282715 A1 Oct . 4 , 2018 14 
 TABLE 2 
 WYL domain sequences in various CasM - containing species 
 Species / Isolate SEQ ID NO 
 Eubacterium siraeum Ruminococcus sp . , isolate 2789STDY5834971 
 Ruminococcus bicirculans 
 Ruminococcus sp . , isolate 2789STDY5608892 Ruminococcus sp . CAG : 57 Ruminococcus flavefaciens FD - 1 Ruminococcus albus strain KH2T6 Ruminococcus flavefaciens strain XPD3002 SEQ ID NO : 52 SEQ ID NO : 53 SEQ ID NO : 54 SEQ ID NO : 55 SEQ ID NO : 56 SEQ ID NO : 57 SEQ ID NO : 58 SEQ ID NO : 59 For example , the CasM protein may include up to about 5 - 10 
 conservative or non - conservative amino acid substitutions , or even up to about 15 - 100 or more , e . g . , 50 or more , conservative or non - conservative amino acid substitutions , 
 or any number between 5 - 100 , so long as the desired function of the molecule remains intact . 
 [ 0134 ] In other embodiments , it may be desirable to modify one or more catalytic domains in order to render a 
 nuclease - deactivated CasM protein , also termed "" catalyti cally inactive , "" "" catalytically dead CasM , "" "" dead CasM , "" or "" dCasM , ” such that the protein either fails to produce nucleic acid breaks , and / or binds a target sequence but does 
 not cleave it . Such molecules lack all or a portion of nuclease activity and are unable to cleave a nucleic acid of interest and can therefore be used to regulate genes in a nucleic 
 acid - guided manner . These dCasM proteins can be used alone or in fusions to synthetically repress ( CRISPRi ) or activate ( CRISPR? ) gene expression . [ 0135 ] The CasM proteins can either be directly isolated and purified from bacteria , or synthetically or recombinantly produced using polynucleotides encoding the same . 
 CasM Polynucleotides 
 [ 0136 ] Nucleic acid sequences encoding representative CasM proteins are shown in SEQ ID NOS : 28 - 36 ( see Table 3 ) and these polynucleotides can be used to produce CasM proteins as described herein . 
 TABLE 3 
 Representative CasM DNA Sequences 
 Species / Isolate SEQ ID NO [ 0130 ] RtcB ( RNA 3 ' - terminal phosphate cyclase , group B ) is a protein domain superfamily and a RtcB homolog 
 ( SEQ ID NO . 60 ) proximal to the CasM loci has been 
 identified . It has previously been reported that the CARF 
 domain has sequence similarity with the N - terminal domain of the RtCR protein , which acts as the regulator of the Rtc RNA repair system . The Rtc system is comprised of the 
 3 ' - terminal phosphate cyclase Rtc . and the RNA ligase RtCB . The RtcB domain - containing proteins can be modified 
 with a N - or C - terminal NLS for use in eukaryotes . A RtcB 
 domain with an associated NLS derived from the SV40 Large T - antigen is shown in SEQ ID NO : 69 . [ 0131 ] A modified CasM protein can have a low degree of sequence identity , a moderate degree of sequence identity , or a high degree of sequence identity over its length to a 
 reference CasM protein , depending on the intended function of the CasM in question . By a “ high degree of sequence identity ” is meant approximately 90 % sequence identity to 100 % sequence identity , for example , about 90 % . . . 95 % . . . 98 % sequence identity or higher . A “ moderate degree of sequence identity ” is typically between about 80 % sequence identity to about 85 % sequence identity , for example , about 80 % identity or higher , such as about 85 % sequence identity . A “ low degree of sequence identity ” is typically between 
 about 50 % identity and 75 % identity , for example , about 50 % identity , preferably about 60 % identity to about 75 % identity . 
 [ 0132 ] In some embodiments , the amino acid sequence of the reference CasM protein may be modified by deletion , 
 insertion , or substitution of one or more amino acid residues 
 ( either conservative or non - conservative in nature ) , such that the activity of the CasM protein is either largely retained , enhanced , or reduced . These modifications may be deliber ate , as through site - directed mutagenesis , or may be acci 
 dental , such as through mutations of hosts that produce the proteins or errors due to PCR amplification . 
 [ 0133 ] Conservative substitutions are generally those sub stitutions that take place within a family of amino acids that are related in their side chains . Specifically , amino acids are generally divided into four families : ( 1 ) acidic — aspartate and glutamate ; ( 2 ) basic — lysine , arginine , histidine ; ( 3 ) 
 non - polar - alanine , valine , leucine , isoleucine , proline , phenylalanine , methionine , tryptophan ; and ( 4 ) uncharged polar - glycine , asparagine , glutamine , cysteine , serine threonine , tyrosine . Phenylalanine , tryptophan , and tyrosine 
 are sometimes classified as aromatic amino acids . It is reasonably predictable that an isolated replacement of leu cine with isoleucine or valine , an aspartate with a glutamate , a threonine with a serine , or a similar conservative replace ment of an amino acid with a structurally related amino acid , will not have a major effect on the desired biological activity . Eubacterium siraeum Ruminococcus sp . , isolate 2789STDY5834971 Ruminococcus bicirculans Ruminococcus sp . , isolate 2789STDY5608892 
 Ruminococcus sp . CAG : 57 
 Ruminococcus flavefaciens FD - 1 Ruminococcus albus strain KH2T6 Ruminococcus flavefaciens strain XPD3002 Ruminococcus sp . , isolate 2789STDY5834894 SEQ ID NO : 28 
 SEO ID NO : 29 
 SEQ ID NO : 30 SEQ ID NO : 31 SEQ ID NO : 32 SEQ ID NO : 33 
 SEQ ID NO : 34 SEQ ID NO : 35 SEQ ID NO : 36 
 [ 0137 ] These polynucleotides can be designed to encode native CasM proteins , such as the proteins depicted in SEQ ID NOS : 37 - 45 ( see Table 1 ) ; homologs thereof , including orthologs found in other species ; or other variants thereof . Moreover , a casM polynucleotide sequence can be modified to have a low degree of sequence identity , a moderate degree of sequence identity , or a high degree of sequence identity , over its length to a reference casM polynucleotide , depend ing on the intended function of the encoded CasM in question . By “ a high degree of sequence identity ” is meant approximately 90 % sequence identity to 100 % sequence identity , for example , about 90 % . . . 95 % . . . 98 % sequence identity or higher . A “ moderate degree of sequence identity ” is typically between about 80 % sequence identity to about 85 % sequence identity , for example , about 80 % identity or higher , such as about 85 % sequence identity . A “ low degree of sequence identity ” is typically between about 50 % iden tity and 75 % identity , for example , about 50 % identity , preferably about 60 % identity to about 75 % identity . 
 [ 0138 ] In some embodiments , the polynucleotide sequences are modified to enhance expression in a selected host cell . Codon usage bias refers to differences in the",6901
20,20,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 TABLE 5 
 Representative casM DNA Sequences Modified 
 for Expression in Human Cells 
 Species / Isolate SEQ ID NO 
 Eubacterium siraeum Ruminococcus sp . , isolate 2789STDY5834971 Ruminococcus bicirculans Ruminococcus sp . , isolate 2789STDY5608892 Ruminococcus sp . CAG : 57 Ruminococcus flavefaciens FD - 1 Ruminucuccus albus strain KH2T6 Ruminococcus flavefaciens strain XPD3002 Ruminococcus sp . , isolate 2789STDY5834894 SEQ ID NO : 10 SEQ ID NO : 11 SEQ ID NO : 12 SEQ ID NO : 13 SEQ ID NO : 14 SEQ ID NO : 15 SEQ ID NO : 16 SEQ ID NO : 17 SEQ ID NO : 18 
 TABLE 6 
 Representative casM DNA Sequences Modified for Expression in Zea mays 
 Species / Isolate SEQ ID NO frequency of occurrence of synonymous codons in coding 
 DNA . For example , for the 20 standard amino acids in the genetic code , there are 64 different codons ( 61 codons encoding for amino acids , and 3 stop codons ) . The over 
 abundance in the number of codons allows several amino acids to be encoded by more than one codon . The genetic 
 codes of different organisms are often biased towards the usage of one of the several codons that encode a particular 
 amino acid . Thus , a greater frequency of one codon will be found than expected by chance in particular organisms . Accordingly , in order to enhance expression in a particular host cell , it is often desirable to manipulate polynucleotides 
 to include codons that are biased for expression in the 
 selected host cell . Several software packages are available 
 online for this purpose . For example , a database from 
 Integrated DNA Technologies , Coralville , Iowa ( idtdna . com / CodonOpt ) , is a tool for producing modified sequences for expression in dozens of organisms . GeneScript , Piscat away , N . J . , also provides modification tools through the OptimumGeneTM algorithm ( genscript . com / codon opt . 
 html ? src = google & gclid = CIX3uoqexdICFRSUfgodu3sAIQ ) . See also , U . S . Pat . No . 8 , 326 , 547 , incorporated herein by reference in its entirety . 
 [ 0139 ] Typically , polynucleotide sequences modified for expression in particular host cells will display from about 50 % - 99 % sequence identity to the native sequences , such as 
 60 % - 95 % , e . g . 65 % . . . 70 % . . . 75 % . . . 80 % . . . 85 % . . . 90 % . . . 95 % or more sequence identity , or any integer between these ranges , to the native sequences . 
 [ 0140 ] Using these tools , polynucleotide sequences can be modified for expression in any commonly used host cell , such as but not limited to , bacterial cells and eukaryotic 
 cells , including without limitation , bacterial cells such as E . 
 coli , Lactoccocus lactis , Pseudomonas systems , Streptomy 
 ces systems , Bacillus subtilis systems , Brevibacillus sys 
 tems , coryneform bacteria , and halophilic bacteria ; algal 
 cells ; yeast and other fungal cells ; plant cells ; mammalian 
 cells such as human cells ; insect cells , and the like . 
 [ 0141 ] SEQ ID NOS : 1 - 9 show representative CasM - en coding polynucleotide sequences modified for expression in E . coli cells ( see Table 4 ) . SEQ ID NOS : 10 - 18 show representative CasM - encoding polynucleotide sequences 
 modified for expression in human cells ( see Table 5 ) . SEQ ID NOS : 19 - 27 show CasM - encoding polynucleotide sequences modified for expression in Zea mays cells ( see 
 Table 6 ) . Eubacterium siraeum Ruminococcus sp . , isolate 2789STDY5834971 
 Ruminococcus bicirculans 
 Ruminococcus sp . , isolate 2789STDY5608892 
 Ruminococcus sp . CAG : 57 Ruminococcus flavefaciens FD - 1 Ruminococcus albus strain KH2T6 Ruminococcus flavefaciens strain XPD3002 Ruminococcus sp . , isolate 2789STDY5834894 SEQ ID NO : 19 SEQ ID NO : 20 
 SEQ ID NO : 21 SEQ ID NO : 22 SEQ ID NO : 23 SEQ ID NO : 24 SEQ ID NO : 25 SEQ ID NO : 26 SEQ ID NO : 27 
 [ 0142 ] The casM polynucleotides can also be modified to include sequences encoding N - or C - terminal nuclear local 
 ization signal sequences ( NLS ) , such as for expression in 
 eukaryotic cells . Such sequences are known , and include , 
 without limitation , an NLS tag derived from the SV40 Large 
 T - antigen . Such as tag is present at the C - terminus of the proteins shown in SEQ ID NOS : 61 - 69 ( i . e . , the last seven amino acids in these sequences ) . [ 0143 ] The casM polynucleotides can be used to recom binantly produce CasM proteins using methods well known in the art . 
 TABLE 4 
 Representative casM DNA Sequences Modified for Expression in E . coli CasM Complexes 
 [ 0144 ] CasM proteins can be complexed to a cognate nucleic acid guide ( cognate guide / CasM complex ) in order to deliver CasM in proximity with a target nucleic acid sequence . A cognate guide , such as a crRNA , is a polynucle otide that site - specifically guides a CasM nuclease , or a deactivated CasM nuclease , to a target nucleic acid region . The binding specificity is determined jointly by the comple mentary region on the cognate guide and a short DNA motif ( protospacer adjacent motif or PAM ) juxtaposed to the complementary region . The spacer present in the guide specifically hybridizes to a target nucleic acid sequence and determines the location of a Cas protein ' s site - specific binding and nucleolytic cleavage . [ 0145 ] Cognate guide / CasM complexes can be produced 
 using methods well known in the art . For example , the guide 
 components of the complexes can be produced in vitro and CasM components can be recombinantly produced and then the guides and CasM proteins can be complexed together 
 using methods known in the art . Additionally , cell lines constitutively expressing CasM proteins can be developed 
 and can be transfected with the guide components , and Species / Isolate SEQ ID NO 
 Eubacterium siraeum 
 Ruminococcus sp . , isolate 2789STDY5834971 Ruminococcus bicirculans Ruminococcus sp . , isolate 2789STDY5608892 Ruminococcus sp . CAG : 57 Ruminococcus flavefaciens FD - 1 Ruminococcus albus strain KH2T6 Ruminococcus flavefaciens strain XPD3002 Ruminococcus sp . , isolate 2789STDY5834894 SEQ ID NO : 1 SEQ ID NO : 2 SEQ ID NO : 3 
 SEQ ID NO : 4 SEQ ID NO : 5 SEQ ID NO : 6 
 SEQ ID NO : 7 SEQ ID NO : 8 SEQ ID NO : 9",6244
21,21,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 complexes can be purified from the cells using standard purification techniques , such as but not limited to affinity , ion exchange and size exclusion chromatography . See , e . g . , Jinek M . , et al . , “ A programmable dual - RNA - guided DNA endonuclease in adaptive bacterial immunity , ” Science ( 2012 ) 337 : 816 - 821 . [ 0146 ] Alternatively , the components , i . e . , the cognate guides and casM polynucleotides may be provided sepa 
 rately to a cell , e . g . , using separate constructs , or together , in 
 a single construct , or in any combination , and complexes can 
 be purified as above . 101471 . Methods of designing particular guides , such as for 
 use in the complexes , are known . See , e . g . , Briner et al . , “ Guide RNA Functional Modules Direct Cas9 Activity and Orthogonality , ” Molecular Cell ( 2014 ) 56 : 333 - 339 . To do so , the genomic sequence for the gene to be targeted is first 
 identified . The exact region of the selected gene to target will depend on the specific application . For example , in order to activate or repress a target gene using , for example , Cas 
 activators or repressors , cognate guide / CasM complexes can be targeted to the promoter driving expression of the gene of 
 interest . For genetic knockouts , guides are commonly designed to target 5 ' constitutively expressed exons which reduces the chances or removal of the targeted region from 
 mRNA due to alternative splicing . Exons near the N - termi 
 nus can be targeted because frameshift mutations here will increase the likelihood of the production of a nonfunctional protein product . Alternatively , cognate guides can be 
 designed to target exons that code for known essential 
 protein domains . In this regard , non - frameshift mutations 
 such as insertions or deletions are more likely to alter protein 
 function when they occur in protein domains that are essen tial for protein function . For gene editing using HDR , the 
 target sequence should be close to the location of the desired edit . In this case , the location where the edit is desired is identified and a target sequence is selected nearby . 
 10148 ] The guides can be delivered to a cell . If the cell 
 constitutively expresses a CasM nuclease , the CasM nucle 
 ase will then be recruited to the target site to cleave the target 
 nucleic acid . If the cell does not express a CasM nuclease , complexes of cognate guide / CasM can be delivered to the cells to make breaks in the genome , thereby triggering the repair pathways in the cells . 
 [ 0149 ] Treated cells are then screened using methods well known in the art , such as using high - throughput screening 
 techniques including , but not limited to , fluorescence - acti vated cell sorting ( FACS ) - based screening platforms , micro 
 fluidics - based screening platforms , and the like . These tech niques are well known in the art . See , e . g . , Wojcik et al . , Int . J . Molec . Sci . ( 2015 ) 16 : 24918 - 24945 . The cells can then be expanded and re - transfected with additional cognate guide / 
 CasM complexes to introduce further diversity and this process can be repeated iteratively until a population with 
 the desired properties is obtained . Single cell clones are sorted from the population , expanded and sequenced to 
 recover the mutations that resulted in the desired function . tion and cleavage of an initial ssRNA complementary to the crRNA target sequence activates the CasM protein to carry out endonuclease activity toward any single - stranded RNA in a sequence - independent manner . The sequence - specific 
 recognition of RNA of the crRNA / CasM complex facilitates the target knockdown of gene transcripts perturbing trans 
 lation of a specific protein . The non - specific endonuclease activity of an activated crRNA / CasM complex in a cellular environment can result in cell death due to depletion of RNA encoding for essential gene transcripts . Thus , the specific 
 RNA targeting and collateral endonuclease activity of an activated crRNA / CasM complex enables the sequence - spe cific selection of cells expressing a RNA transcript . [ 0152 ] Thus , in further aspects , CasM complexes , such as , but not limited to crRNA / CasM complexes , can be used in methods of screening and killing cells , such as bacterial 
 cells , that have not been modified by a DNA targeting 
 nuclease ( i . e . , a Type II Cas9 nuclease ) . This method com prises contacting a NATNA / Cas9 complex to a locus of interest in a population of cells . Contacting the NATNA / Cas9 complex with the locus results in DNA cleavage and subsequent repair of the break by the endogenous cellular 
 repair machine and the introduction of indels at the break site . The targeting of the NATNA / Cas9 complex to a tar geted locus that encodes an RNA transcript results in indels in an RNA transcript sequence . This modified RNA tran 
 script sequence is different compared to a transcript from an 
 unmodified cell ( a wild - type cell ) . A crRNA / CasM complex can then be targeted to the unmodified transcript , wherein crRNA / CasM recognition of the unmodified transcript results in activation of the sequence independent , single 
 stranded RNA targeting activity of the CasM protein and subsequent cell death . Alternatively , this method can be 
 adapted to screen for the incorporation of a donor - poly 
 nucleotide into NATNA / Cas9 break site . [ 0153 ] In another aspect , CasM complexes can by targeted to a eukaryotic exon coding region to cause exon skipping . 
 This method comprises contacting a crRNA / deactivated 
 CasM complex , such as , but not limited to a crRNA / dCasM 
 complex , with either a donor site ( 5 ' end of an intron ) , a branch site ( proximal to the 3 ' end of an intron ) , or an acceptor site ( 5 ' of an exon ) of a pre - mRNA . Contacting the crRNA / dCasM complex to the various regions involved in exon splice events prevents the proper splicing of one of 
 more exons together and causes the target exon to be “ skipped ” , and thus is not included in the mature mRNA and therefore omitted from the translated polypeptide sequence . 
 0154 ] In yet another aspect , CasM complexes are used for 
 the detection of one or more target molecules in vitro . This method comprises contacting a cognate guide / CasM com 
 plex , such as a crRNA complex , with a ssRNA target of 
 interest within a pool of nucleic acids . The crRNA / CasM complex can be added to a sample potential containing the 
 SSRNA target of interest , in combination with a quenched 
 fluorescent RNA reporter , for example a RNA hexamer with a 6 - Carboxyfluorescein at the 5 ' end and a lowa Black® FQ quencher ( Integrated DNA Technologies , Coralville , Iowa ) at the 3 ' end . Contacting of the crRNA / CasM complex with the ssRNA target , activates the CasM protein to carry out collateral cleavage of the quenched fluorescent RNA reporter where cleavage of the reporter and resulting in an 
 increase fluorescence that can by read out using a spectro photometer . The gain in fluorescence is used as a measure of the presents of a ssRNA target of interest . Applications of CasM 
 [ 0150 ] Due to its RNA - targeting abilities , CasM can be used to edit RNA and in some embodiments , to treat diseases caused by toxic RNA or improperly spliced RNA . [ 0151 ] In some embodiments cognate guide / CasM com plexes , such as , but not limited to crRNA / CasM complexes , are capable of sequence - specific ssRNA activity . Recogni",7583
22,22,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 17 
 [ 0155 ] In another aspect , CasM can be used for the tar geted cleavage of an endogenous mRNA transcript while simultaneously delivering an exogenous mRNA transcript in cells . This method comprises contacting a cognate guidel CasM complex , with a disease - associated endogenous mRNA transcript , while simultaneously delivering of a mRNA coding for the non - disease exogenous polypeptide into a cell . Thus , the disease - associated phenotype is repressed while the non - disease phenotype is restored . 
 [ 0156 ] The CasM proteins described herein can also be used with associated cognate guides in order to activate or repress a target gene , to knockout a gene , to produce a 
 nonfunctional protein product , or to alter protein function . 
 The present invention includes methods of modulating in vitro or in vivo transcription using the various components and complexes described herein . In one embodiment , a cognate guide / CasM protein complex can repress gene 
 expression by interfering with transcription when the cog nate guide directs nucleic acid target binding of the complex to the promoter region of the gene . Use of the complexes to reduce transcription also includes complexes wherein the 
 CasM protein is fused to a known down - regulator of a target gene ( e . g . , a repressor polypeptide ) . For example , expres 
 sion of a gene is under the control of regulatory sequences to which a repressor polypeptide can bind . A cognate guide can direct nucleic acid target - binding of a repressor protein complex to the sequences encoding the regulatory sequences 
 or adjacent the regulatory sequences such that binding of the repressor protein complex brings the repressor protein into 
 operable contact with the regulatory sequences . Similarly , 
 CasM can be fused to an activator polypeptide to activate or increase expression of a gene under the control of regulatory sequences to which an activator polypeptide can bind . 
 0157 ] In one embodiment , CasM can be fused with a 
 nuclease , or a mutant or an active portion thereof , as well as a cognate guide , in order to bring the nuclease into proximity 
 with a target nucleic acid sequence , wherein the nuclease can produce a single - strand or double - strand break . In this way , a locus - specific cut in a target nucleic acid can be achieved using a cognate guide in combination with CasM , 
 and the nuclease of interest . For example , it may be desirable to associate CasM with a restriction endonuclease in order to cleave at a particular restriction site in a target nucleic acid sequence . The restriction endonuclease can be selected from 
 any of the various types of restriction endonucleases , such 
 as , but not limited to , type I , II , III or IV . See , e . g . , PCT 
 Publication No . WO 2013 / 098244 to Brouns et al . , pub lished 4 Jul . 2013 , incorporated herein by reference in its entirety , for methods of producing complexes between a Cas protein and a restriction endonuclease . 
 [ 0158 ] Using the methods described herein , any desired nucleic acid sequence , and in particular RNA sequences , for 
 modification can be targeted , including without limitation , protein coding mRNA sequences , in order to reduce or restore the function of the gene product ; regions that have a 
 propensity to incorporate nucleotide sequences from a donor 
 template , termed “ HDR hotspots ” herein ; safe harbor 
 regions , i . e . , regions where nucleotide sequences can be 
 inserted without disrupting neighboring gene function ; non coding regulatory regions in nucleic acid sequences ; and the like . 
 [ 0159 ] Protein coding sequences , including RNA such as 
 mRNA , for targeting by the methods described herein include , but are not limited to , mammalian antibodies ( ABS ) ( IgG , IgA , IgM , IgE ) , antibody fragments such as Fc regions , antibody Fab regions , antibody heavy chains , anti 
 body light chains , antibody CDRs , nanobodies , chimeric 
 antibodies and other IgG domains ; T cell receptors ( TCR ) ; 
 endonucleases and exonucleases , such as TALENS , 
 CRISPR nucleases such as Cas9 , Cas3 , Cpfi , ZnFN , mega 
 nucleases , nuclease domains such as HNH domain , RuvC domain ; recombinases such as Cre , Tre , Brecl , Flp , y - inte grase , Int14 integrase , XerD recombinase , HP1 integrase ; DNA topoisomerases ; transposons such as the Tc1 / mariner family , To12 , piggyBac , Sleeping beauty ; RAG proteins ; 
 retrotransposons such as LTR - retrotransposons and non LTR retrotransposons ( Alu , SINE , LINE ) ; enzymes includ ing but not limited to arginases , glycosydases , proteases , kinases , and glycosylation enzymes such as glycosyltrans 
 ferase ; anticoagulants such as protein C , Protein S and 
 antithrombin ; coagulants such as thrombin ; nucleases such as DNAses , RNAses , helicases , GTPases ; DNA or RNA binding proteins ; reporter molecules , such as Green Fluo 
 rescent Protein ( GFP ) ; cell penetrating peptides and their fusions with cargo proteins ; membrane proteins such as GPCRs , pain receptors such as TRP channels and ion 
 channels ; cell surface receptors including but not limited to EGFR , FGFR , VEGFR , IGFR and ephrin receptor ; cell adhesion molecules like integrins and cadherins ; ion chan nels ; rhodopsins ; immunoreceptors such as CD28 , CD80 , 
 PD - 1 , PD - L1 , CTLA - 4 , CXCR4 , CXCR5 , B2M , TRACA , TRBC ; proteins known to be involved with genetic defects ; secreted proteins including but not limited to hormones , cytokines , growth factors ; vaccine antigens such as viral proteins from human immunodeficiency virus ( HIV ) , Den gue , cytomegalovirus ( CMV ) , Ebola , Zika and oncolytic viruses ; snake toxin proteins and peptides including but not limited to phospholipases and metalloproteases ; ribosomal cyclic peptides . 
 [ 0160 ] The present invention also encompasses genome engineering methods for preventing or treating diseases , 
 disorders , and conditions using the various methods described herein . In one embodiment , a genome engineering method uses the introduction of nucleic acid sequences into an organism or cells of an organism ( e . g . , patient ) to achieve 
 expression of components of the present invention to pro 
 vide modification of a target function . For example , cells 
 from an organism may be engineered , ex vivo , by ( i ) introduction of vectors comprising expression cassettes 
 expressing the various components , ( ii ) direct introduction of a NATNA and / or donor polynucleotides and CasM pro teins , or ( iii ) introduction of combinations of these compo nents . The engineered cells are provided to an organism 
 ( e . g . , patient ) to be treated . [ 0161 ] Examples of genome engineering and techniques for therapy are known in the art ( see , e . g . , Kay , M . A . , Nature Reviews Genetics ( 2011 ) 12 : 316 - 328 ; Wang et al . , Discov . Med . ( 2014 ) 18 : 67 - 77 ; Wang et al . , Discov . Med . ( 2014 ) 18 : 151 - 61 ; “ The Clinibook : Clinical Gene Transfer State of the Art , ” Odile Cohen - Haguenauer ( Editor ) , EDP Sciences ( Oct . 31 , 2012 ) , ISBN - 10 : 2842541715 ) . 
 [ 0162 ] In some aspects , components of the present inven tion are delivered using nanoscale delivery systems , such as nanoparticles . Additionally , liposomes and other particulate 
 delivery systems can be used . For example , vectors includ ing the components of the present methods can be packaged in liposomes prior to delivery to the subject or to cells 
 derived therefrom , such as described in U . S . Pat . Nos .",7623
23,23,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 5 , 580 , 859 ; 5 , 264 , 618 ; 5 , 703 , 055 , each of which is incorpo rated herein by reference in its entirety . Lipid encapsulation is generally accomplished using liposomes that are able to 
 stably bind or entrap and retain nucleic acid . 
 [ 0163 ] The methods described herein can also be used to generate non - human genetically modified organisms , such as mice , plants , and the like . [ 0164 ] While preferred embodiments of the present inven tion have been shown and described herein , it will be 
 obvious to those skilled in the art that such embodiments are provided by way of example only . From the above descrip 
 tion and the following Examples , one skilled in the art can 
 ascertain essential characteristics of this invention , and without departing from the spirit and scope thereof , can 
 make changes , substitutions , variations , and modifications of the invention to adapt it to various usages and conditions . 
 Such changes , substitutions , variations , and modifications are also intended to fall within the scope of the present disclosure . included PFAM ( which includes a large collection of protein families ; http : / / pfam . xfam . org / ) , PDB ( protein databank ; wwpdb . org ) , CDD ( conserved domain database ; ncbi . nlm . nih . gov / Structure / cdd / cdd . shtml ) , and KEGG ( Kyoto Ency clopedia of Genes and Genomes ; genome . jp / kegg ) . 
 [ 0171 ] Using these tools , ORFs encoding a new putative 
 CRISPR - associated protein , termed “ CasM , ” was found in 
 several species in the Clostridia family . The ORFs are 
 proximal to a predicted HTH DNA binding protein with 
 homology to a CRISPR - associated WYL domain . See FIG . 1 for a representative map of a CRISPR operon found in 
 Eubacterium siraeum ( Genome Accession No . NZ _ DS499551 . 1 , coordinates 211 . 800 - 220 . 497 ) . The vari 
 ous CRISPR locus features are described in Table 7 . 
 TABLE 7 
 CasM CRISPR locus for Eubacterium siraeum ( FIG . 1 ) 
 101 corresponds to the CasM open reading frame ( ORF ) ( Protein 
 accession : WP _ 005358205 . 1 ) 102 corresponds to a CRISPR Array 103 corresponds to an ORF containing a RctB RNA ligase domain ( Protein accession : WP _ 005358214 . 1 ) 104 corresponds to an ORF containing a WYL DNA binding domain ( Protein accession : WP _ 005358216 . 1 ) EXPERIMENTAL 
 [ 0165 ] Aspects of the present invention are further illus trated in the following Examples . Efforts have been made to 
 ensure accuracy with respect to numbers used ( e . g . , 
 amounts , concentrations , percent changes , etc . ) but some 
 experimental errors and deviations should be accounted for . Unless indicated otherwise , temperature is in degrees Cen tigrade and pressure is at or near atmospheric . It should be 
 understood that these Examples , while indicating some 
 embodiments of the invention , are given by way of illustra tion only . [ 016 ] The following Examples are not intended to limit the scope of what the inventors regard as various aspects of the present invention . [ 0172 ] The results of HHPred analysis were analyzed to determine if the CasM - encoding ORFs had predicted 
 domains commonly found in CRISPR - associated proteins . 
 No annotations were found for CasM , thus indicating that the protein was novel . 
 [ 0173 ] The sequences for the various native CasM pro teins are shown in SEQ ID NOS : 37 - 45 ( see Table 1 ) and the native polynucleotides encoding therefor are shown in SEQ 
 ID NOS : 28 - 36 ( see Table 3 ) . This protein has no significant homology to any known protein families or to any Class 2 
 Cas effectors . Example 1 
 Discovery of a New CRISPR - Associated ( Cas ) Protein in Silico PTOLCI Example 2 
 Codon Modification of Native casM Sequences [ 0167 ] This Example describes the in silico discovery of a new Cas protein , termed "" CasM , ” from genomic sequencing data . The overall approach used was similar to methods 
 described in Shmakov et al . , “ Discovery and functional characterization of diverse Class 2 CRISPR - Cas systems ” Molecular Cell ( 2015 ) 60 : 385 - 397 . In particular a compu tational pipeline was used to search sequencing data for CRISPR arrays in whole genomes and metagenic contigs . 
 [ 0168 ] Every contig or genome in the data set was 
 inspected to determine if it contained a CRISPR array using 
 Minced ( github . com / ctSkennerton / minced ) and PILERCR 
 ( drive5 . com / pilercr / ) . [ 0169 ] Any time a CRISPR array was found in a contig or genome , the surrounding DNA sequence ( up to 10 kilobases on either side of the CRISPR array ) was further inspected for open reading frames ( ORFs ) using the tool getorf ( emboss . sourceforge . net / apps / cvs / emboss / apps / getorfhtml ) . [ 0170 ] The primary amino acid sequence of each predicted ORF was analyzed for potential functional domain annota 
 tions using the tool HHPred ( homology detection & struc ture prediction by HMM - HMM comparison ; toolkit . tuebin gen . mpg . de / hhpred ) . HHPred allows the user to specify which databases to compare the amino acid sequence against to find similar protein domains . The databases searched [ 0174 ] This Example describes the process of codon opti mizing CasM coding sequences to improve expression in 
 selected host cells . 
 [ 0175 ] Native casM nucleotide sequences were retrieved from the reference genomes or metagenomic contigs of the 
 host microbes as described in Example 1 . The amino acid sequences of the coding regions were generated with the 
 ExPASY DNA translation tool ( web . expasy . org / translate / ) . Next , these amino acid sequences were entered into the 
 Integrated DNA Technologies ( Coralville , Iowa ) Codon Optimization tool ( idtdna . com / CodonOpt ) . “ Amino acid ” was chosen for the “ Sequence Type ” option and “ Gene ” was chosen for the “ Product Type ” option . For each native casM 
 sequence , codon modifications were performed to increase expression in E . coli , human , and Zea mays cells . 
 [ 0176 ] SEQ ID NOS : 1 - 9 show the modified sequences for use in E . coli ( see Table 4 ) . SEQ ID NOS : 10 - 19 show the modified sequences for use in human cells ( see Table 5 ) . 
 SEQ ID NOS : 20 - 27 show the modified sequences for use in Z . mays cells ( see Table 6 ) . Table 8 shows the percent identity of the modified sequences to the native sequences .",6412
24,24,"US 2018 / 0282715 A1 Oct . 4 , 2018 19 
 TABLE 8 
 Percent Sequence Identity to Native casM Sequences 
 modified 
 for modified modified 
 for human cells Z . mays cells for casM bacterial strain E . coli cells 
 75 % 
 77 % 77 % 
 76 % 77 % 
 76 % 
 76 % 76 % 77 % 
 76 % 75 % 77 % Eubacterium siraeum 
 Ruminococcus sp . , isolate 
 2789STDY5834971 
 Ruminococcus bicirculans Ruminococcus sp . , isolate 2789STDY5608892 Ruminococcus sp . CAG : 57 
 Ruminococcus flavefaciens 
 FD - 1 
 Ruminococcus albus strain 
 KH2T6 
 Ruminococcus flavefaciens strain XPD3002 
 Ruminococcus sp . , isolate 
 2789STDY5834894 randomized PAM sequence of 7 nucleotides . Plasmid librar ies containing randomized PAM sequences are assembled by annealing a DNA oligonucleotide containing a target with a 
 7 nt randomized PAM region with a primer and extended 
 with Klenow Fragment ( New England Biolabs , Ipswitch , 
 Mass . ) . The double - stranded DNA is digested with EcoRI and Ncol and ligated into a pUC19 backbone . The ligated 
 library is transformed into E . coli DH5a and cells are 
 harvested , the plasmids extracted and purified . 200 ng of the pooled library is transformed into electro - competent E . coli harboring a CRISPR locus or a control plasmid with no locus . The transformed cells are plated on selective media containing carbenicillin ( 100 mg L - 1 ) and chloramphenicol 
 ( 30 mg L - ) for 30 hours at 25° C . Plasmid DNA is extracted and the PAM sequence is amplified with adapters for Illu mina sequencing . The 7 nt PAM region is extracted and 
 PAM frequencies calculated for each 7 nt sequence . PAM sequences depleted above the specified threshold are used to generate a sequence logo with WebLogo ( weblogo . berkeley . 
 edu ) . If depleted PAMs are present , this shows that the 
 nuclease is a double - stranded DNA nuclease . 76 % 
 76 % 77 % 
 77 % 76 % 
 76 % 
 76 % 77 % 77 % 
 76 % 77 % 77 % 
 75 % 76 % 76 % 78 % 
 Example 3 Example 5 
 Production of CasM Expression Plasmids for DNA Interference Assays 
 [ 0177 ] This Example describes the production of plasmids that express the CasM protein . [ 0178 ] The modified casM nucleotide sequences set forth in Example 2 were synthesized in vitro . The DNA sequences were cloned into an appropriate plasmid for expression in E . coli . [ 0179 ] For E . coli expression , the E . coli - modified sequences were cloned into a p14A plasmid backbone using appropriate restriction nucleases . The plasmid backbone contained a T7 promoter upstream of the CasM coding sequence to facilitate transcription in cells . 
 [ 0180 ] The p14A plasmid backbone also contained a clon ing site enabling the insertion of a minimal CRISPR array . The minimal CRISPR array contained one repeat sequence , followed by one spacer sequence , followed by one repeat sequence . The plasmid backbone also contained a 17 pro moter upstream of the CRISPR array site , a kanamycin resistance gene , and a ColEl origin of replication . [ 0181 ] Similar techniques are used for preparing plasmids for expression in human and Zea mays cells . Once the plasmids are produced , they are transfected into the selected cell , e . g . , E . coli , human , or plant cells ( e . g . , Zea mays cells ) . Targeted Modification of HEK293 Cells Using 
 CasM 
 [ 0185 ] This Example illustrates the use of CasM to modify human embryonic kidney ( HEK293 ) cells at specific target 
 locations . [ 0186 ] casM polynucleotides are transfected into HEK293 cells constitutively expressing a CasM - GFP fusion 
 ( HEK293 - CasM - GFP ) , using the NucleofectorTM 96 - well Shuttle System ( Lonza , Allendale , N . J . ) and the following protocol . The casM polynucleotides are designed to target the FUT8 gene . Equal molar amounts of casM polynucle 
 otide components are prepared in an annealing buffer ( 1 . 25 
 mM HEPES , 0 . 625 mM MgCl2 , 9 . 375 mM KCl at pH 7 . 5 ) , 
 incubated for 2 minutes at 95° C . , removed from the thermocycler , allowed to equilibrate to room temperature , and dispensed in a 10 uL final volume in a 96 - well plate . Culture medium is aspirated from HEK293 - CasM - GFP cells , and the cells are washed once with calcium and magnesium - free PBS and then trypsinized by the addition of 
 TrypLE ( Life Technologies , Grand Island , N . Y . ) followed by 
 incubation at 37° C . for 3 - 5 minutes . Trypsinized cells are gently pipetted up and down to form a single cell suspension and added to DMEM complete culture medium composed of DMEM culture medium ( Life Technologies , Grand Island , N . Y . ) containing 10 % FBS ( Fisher Scientific , Pittsburgh , 
 Pa . ) and supplemented with penicillin and streptomycin ( Life Technologies , Grand Island , N . Y . ) . [ 0187 ] The cells are then pelleted by centrifugation for 3 minutes at 200xg , the culture medium aspirated and cells resuspended in PBS . The cells are counted using the Count essTM II Automated Cell Counter ( Life Technologies , Grand Island , N . Y . ) . 2 . 2x107 cells are transferred to a 50 ml tube and pelleted . The PBS is aspirated and the cells resuspended in NucleofectorTM SF ( Lonza , Allendale , N . J . ) solution to a density of 1x107 cells / mL . 20 uL of the cell suspension are 
 then added to individual wells containing 10 uL of casM polynucleotide components and the entire volume is trans 
 ferred to the wells of a 96 - well NucleocuvetteTM Plate ( Lonza , Allendale , N . J . ) . The plate is loaded onto the NucleofectorTM 96 - well ShuttleTM ( Lonza , Allendale , N . J . ) Example 4 
 Plasmid Interference Assay 
 [ 0182 ] This Example describes the use of CasM in an assay to evaluate its ability to cleave double - stranded DNA in the form of a target plasmid . The overall approach is 
 similar to methods used in Burnstein et al . , Nature ( 2016 ) 
 542 : 237 - 241 . [ 0183 ] The CasM expression plasmid in Example 3 is transformed into E . coli cells . The cells are grown in a medium containing kanamycin to select only for cells that contain the CasM expression plasmid . 
 [ 0184 ] A target plasmid is constructed that contains the spacer sequence contained in the CRISPR array of the CasM expression plasmid . Adjacent to the spacer sequence is a",6218
25,25,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 20 
 Example is readily modifiable by one of ordinary skill in the 
 art for other gene targets . 
 [ 0194 ] This procedure can provide data to verify the CasM 
 RNP and to detect nucleic acid - guided nuclease activity at 
 targeted loci in HEK293 cells . 
 Example 6 
 CasM CRISPR Array Processing Assay 
 [ 0195 ] This Example describes the CRISPR array process ing activity of a CasM protein . The following method may 
 be practiced with other CasM protein homologs to charac terize their CRISPR array processing capabilities . 
 [ 0196 ] A . Identification of the CRISPR Array Repeat 
 Sequence 
 [ 0197 ] The CRISPR array of the CasM protein homolog 
 ( SEQ ID NO : 39 ) was analyzed in silico and the repeat 
 sequence identified . The in silico structure of a CRISPR repeat sequence ( SEQ ID NO : 51 ) associated with the CasM protein ( SEQ ID NO : 39 ) as predicted using an RNA folding 
 algorithm ( rna . urmc . rochester . edu / RNA structureWeb / Serv 
 ers / Predict1 . html ) is shown in FIG . 2 ( SEQ ID NO : 51 ) . The 
 various CRISPR repeat sequence structural components 
 represented in FIG . 2 are described in Table 9 . and cells are nucleofected using the 96 - CM - 130 Nucleofec torTM program ( Lonza , Allendale , N . J . ) . Post - nucleofection , 70 °L DMEM complete culture medium is added to each well and 50 uL of the cell suspension are transferred to a collagen coated 96 - well cell culture plate containing 150 UL 
 pre - warmed DMEM complete culture medium . The plate is 
 then transferred to a tissue culture incubator and maintained at 37° C . in 5 % CO2 for 48 hours . 
 [ 0188 ] Genomic DNA ( gDNA ) is prepped using the 
 QuickExtract DNA extraction solution ( Illumina , San Diego , Calif . ) pursuant to the manufacturer instructions . Sequencing amplicons of between 150 bp to 200 bp are 
 designed to span the CasM RNP FUT8 target site . Using previously isolated gDNA , a first PCR is performed using 
 Herculase II Fusion DNA PolymeraseTM ( Agilent , Santa Clara , Calif . ) with primers comprising an adapter sequences and a sequence specific to the region flanking the FUT8 
 target site . A second PCR is performed using the amplicons 
 of the first round of PCR as template at 1 / 200h the volume of 
 the PCR reaction volume . The second PCR uses a second set of primers comprising a sequence complementary to the 
 adapter sequence of the first primer pair , a barcode index 
 sequence unique to each sample , and a flow cell adapter sequence . Amplicons are pooled and analyzed on a 2 % TBE 
 gel and bands of expected amplicon sizes are gel purified 
 using the QIAEX II Gel extraction KitTM ( Qiagen , Venlo , Luxembourg ) . The concentrations of purified amplicons are 
 evaluated using the double - stranded DNA BR Assay Kit and Qubit SystemTM ( Life Technologies , South San Francisco , Calif . ) and library quality determined using the Agilent DNA100Chip and Agilent Bioanalyzer 2100 SystemTM 
 ( Agilent , Santa Clara , Calif . ) . After validation of library quality , the library is sequenced on a MiSeq Benchtop 
 SequencerTM ( Illumina , San Diego , Calif . ) with the MiSeq Reagent Kit v2TM ( 300 cycles , Illumina , San Diego , Calif . ) 
 per manufacturer instructions for 151 bp paired end reads . 
 [ 0189 ] The identity of products in the sequencing data is analyzed based upon the index barcode sequence adapted 
 onto the amplicon in the second round of PCR . A compu tational script is used to process the MiSeq data by executing the following tasks : 
 [ 0190 ] 1 . Joining paired end reads with the aid of fastq 
 join ( Aronesty 2011 : code . google . com / p / ea - utils ) ; 
 [ 0191 ] 2 . Validating the sequence reads for appropriate primer sequences being present at both 5 ' and 3 ' ends of the 
 read sequence using fastx _ barcode _ splitter ( hannonlab . cshl . 
 edu / fastx _ toolkit / index . html ) ; reads lacking correct primer 
 sequences at both ends are discarded . 
 [ 0192 ] 3 . Comparing Read sequences to expected wild 
 type FUT8 sequence ; identical read sequences are classified 
 as having the same indel modification . 
 [ 0193 ] Other chromosomal loci within HEK293 cells are similarly modified by selection of an appropriate spacer 
 sequence for the CasM RNP . Selection is specific to a specific gene target and the procedure outlined in this TABLE 9 
 Numerical Indicators Used to Illustrate CasM CRISPR 
 Repeat Sequence Structural Components ( FIG . 2 ) 
 470 corresponds to a 5 ' repeat handle sequence 
 471 corresponds to a stem - duplex formed by a first stem duplex stand 
 hybridized to a second stem duplex strand 
 472 corresponds to a loop sequences 
 473 corresponds to a 5 ' repeat handle sequence 
 474 corresponds to the 3 ' attachment point of a spacer sequence 
 475 corresponds to the CRISPR repeat processing positions performed 
 by CasM upon guide binding 
 10 indicates the tenth nucleotide position 
 20 indicates the twentieth nucleotide position 
 30 indicates the thirtieth nucleotide position 
 The repeat sequence was used to design a CRISPR array by 
 incorporating spacer sequences 5 ' , 3 ' , or both 5 ' and 3 ' of the 
 repeat sequence . The sequences were used for synthesis as 
 RNA . 
 The synthetic CasM CRISPR array is represented in FIG . 4 
 and structural components 470 - 473 are detailed in Table 9 . Additional components 490 and 491 correspond to a first 5 ' and a first 3 ' spacer sequence , respectively . The CRISPR array components are shown in Table 10 .",5554
26,26,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 21 
 TABLE 10 
 CRISPR Array Components 
 SEQ ID CRISPR Array Configuration Size ( nt ) NO : Sequence 
 96 SEQ ID NO : 46 spacer - repeat spacer UGAUACUGCUUUGAUGUCAGCAUUGC AUAUCUACUAUACUGGUGCGAAUUUG 
 CACUAGUCUAAAAUCUAUAACCAUAA 
 GUUCUUCUGCGUUCAUAU 
 spacer - repeat SEQ ID 
 NO : 47 UGAUACUGCUUUGAUGUCAGCAUUGC 66 
 AUAUCUACUAUACUGGUGCGAAUUUG 
 CACUAGUCUAAAAU 
 repeat - spacer SEQ ID 
 NO : 48 CUACUAUACUGGUGCGAAUUUGCACU 66 
 AGUCUAAAAUUGAUACUGCUUUGAUG UCAGCAUUGCAUAU 
 * CRISPR repeat sequence is underlined 
 initiated by addition of CasM protein to denatured CRISPR arrays in a final reaction volume of 12 uL , followed by incubation at 37° C . for 15 minutes . The reaction was terminated by heat inactivation at 95° C . for 2 minutes , and 
 6 uL of the reaction was mixed with 6 uL of 2xRNA loading 
 buffer ( New England Biolabs , Ipswich , Mass . ) . Low Range 
 SSRNA LadderTM ( New England Biolabs , Ipswich , Mass . ) 
 was diluted 125 - fold in water and 7 uL were mixed with 7 
 uL of 2xRNA Loading DyeTM ( New England Biolabs , 
 Ipswich , Mass . ) and incubated at 90° C . for 4 minutes and then incubated on ice for 5 minutes . CRISPR array process 
 ing reactions and ssRNA ladder were analyzed on a Mini 
 PROTEAN 15 % TBE - UreaTM ( Bio - RAD , Hercules , Calif . ) run at 200 V for 1 hour in 1xTBE running buffer . The gel was stained using 2xSYBR GoldTM ( Millipore Sigma , St . 
 Louis , Mich . ) for 15 minutes and visualized using a Gel 
 DocTM EZ SystemTM ( Bio - RAD , Hercules , Calif . ) . The 
 results of the CRISPR array processing reactions are shown 
 in FIG . 3 and lane order is presented in Table 11 . 
 TABLE 11 [ 0198 ] SEQ ID NO : 46 comprises , in a 5 ' to 3 ' orientation , CRISPR array structural components 490 , 470 - 473 , and 
 491 . SEQ ID NO : 47 comprises , in a 5 ' to 3 ' orientation , 
 CRISPR array structural components 490 and 470 - 473 . SEQ 
 ID NO : 48 comprises , in a 5 ' to 3 ' orientation , CRISPR array structural components 470 - 473 and 491 . 
 [ 0199 ) Alternative to synthesis , CRISPR arrays may be made via PCR using 3 ' overlapping primers containing DNA sequences corresponding to CRISPR array components and incorporation of a 17 promoter sequence 5 ' of the CRISPR arrays , followed by in vitro transcription . 
 T02001 B . CasM Purification [ 0201 ] The CasM protein coding sequence was codon optimized for expression in E . coli and incorporated into a 
 modified PET plasmid backbone downstream of a maltose binding protein ( MBP ) using appropriate restriction nucle 
 ases . The plasmid backbone contained a 17 - Lac promoter upstream of the MBP - CasM coding sequence to facilitate transcription in cells . Additionally , the plasmid backbone contained an kanamycin resistance gene and a ColEl origin of replication . [ 0202 ] The CasM expression plasmid was transformed into Rosetta2 ( DE3 ) cells , and cells were grown in two IL shake flasks at 37° C . until cells reached an optical density of 0 . 6 , after which protein expression was induced by addition of 0 . 5 mM IPTG . Cells were then incubated at 16° C . overnight . 
 [ 0203 ] Cells were collected via centrifugation and lysed via sonication . Cell debris was pelleted , and the clarified lysate was purified using a combination of His Trap column chromatography , followed by cleavage of the MBP tag , and finally cation exchange column chromatography . Final puri fied protein was quantified using a NanoDropTM 2000 spec 
 trophotometer ( Thermo Fisher , Waltham , Mass . ) , and stored at - 80° C . [ 0204 ] C . In Vitro CRISPR Array Processing [ 0205 ] Synthetic CRISPR array reagents were resus pended in water to a final concentration of 250 uM and diluted to a working concentration of 250 nM . CRISPR 
 arrays were incubated at 95° C . for two minutes and cooled by 0 . 5° C . / sec in a thermocycler to a final temperature of 25° 
 C . 
 10206 ] CasM was diluted to a final concentration of 500 nM in 1x cleavage buffer ( 20 mM HEPES , 100 mM KC1 , 5 mM MgCl2 , and 5 % glycerol at pH 7 . 4 ) . The reaction was CRISPR Array Cleavage Gel Lane Order 
 CRISPR Array Configuration Lane SEQ ID NO : CasM 
 TL vau AWNE Low Range ssRNA Ladder spacer - repeat - spacer SEQ ID NO : 46 spacer - repeat SEQ ID NO : 47 
 repeat - spacer SEQ ID NO : 48 spacer - repeat - spacer SEQ ID NO : 46 
 spacer - repeat SEQ ID NO : 47 repeat - spacer SEQ ID NO : 48 + 
 + 
 + 
 at [ 0207 ] The results of the CRISPR array cleavage assays ( FIG . 3 ) demonstrated that the CasM protein is capable of processing a cognate CRISPR array . The three bands shown in Lane 1 correspond to 150 , 80 and 50 nucleotide standards of the Low Range ssRNA LadderTM ( New England Biolabs , 
 Ipswich , Mass . ) , respectively ) . Indicator 480 in FIG . 3 corresponds to a processed CasM crRNA comprising a portion of the CRISPR repeat sequence and a spacer 
 sequence . Indicator 481 corresponds to RNA species cleaved from the 5 ' end of the CRISPR array following addition of CasM .",5037
27,27,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 [ 0208 ] The CasM cleaved nucleotides in the 5 ' region of the repeat element ( FIG . 3 , comparing Lane 2 to 5 ; com 
 paring Lane 3 to Lane 6 ) , and exhibited no cleavage 3 ' of the repeat element ( FIG . 3 , comparing Lane 4 to Lane 7 ) . 
 crRNA proceeded from the CasM CRISPR array and there 
 fore had a 5 ' repeat element and a spacer element 3 ' of the repeat . In the absence of CasM , no cleavage of the crRNA 
 was observed ( FIG . 3 , Lanes 2 , 3 , and 4 ) . [ 0209 ] Schematics of the crRNA processing regimes are depicted in FIG . 5 . In FIG . 5 , panel I corresponds to the 
 reaction in FIG . 3 , Lane 5 ; FIG . 5 panel II corresponds to the 
 reaction in FIG . 3 , Lane 6 ; and FIG . 5 panel III corresponds to the reaction in FIG . 3 , Lane 7 . The various components represented in FIG . 5 are described in Table 12 . 
 TABLE 12 
 Numerical Indicators Used to Illustrate the Results of the in vitro CRISPR Array Cleavage Assay ( FIG . 5 ) 
 492 corresponds to a spacer - repeat - spacer CRISPR array ( SEQ ID . 
 NO : 46 ) 493 corresponds to a spacer - repeat CRISPR array ( SEQ ID . NO : 47 ) 494 corresponds to a repeat - spacer CRISPR array ( SEQ ID . NO : 48 ) 495 corresponds to a CasM protein 496 corresponds to a processed crRNA 497 corresponds to a RNA species cleaved from the 5 ' end of the CRISPR array 498 corresponds to a processed CRISPR repeat sequence 
 499 corresponds to a RNA species cleaved from the 5 ' end of the CRISPR repeat sequence [ 0213 ] The primers were present at a concentration of 400 nM each . PCR reactions were performed using Q5 Hot Start High - Fidelity 2x Master MixTM ( New England Biolabs , Ipswich , Mass . ) following the manufacturer ' s instructions with 10 ng of plasmid template . PCR assembly reactions 
 were carried out using the following thermal cycling con 
 ditions : 98° C . for 2 minutes ; 20 cycles of 10 seconds at 98° C . ; 15 seconds at 60° C . ; 30 seconds at 72° C . ; and a final 
 extension at 72° C . for 2 minutes . DNA product quality was evaluated after the PCR reaction by agarose gel electropho resis ( 1 . 5 % , SYBR® Safe ; Life Technologies , Grand Island , N . Y . ) . 
 [ 0214 ] Between 0 . 1 - 0 . 5 ug of the amplified ssRNA target DNA template was used as a template for transcription using 
 T7 High Yield RNA Synthesis KitTM ( New England Biolabs , Ipswich , Mass . ) for approximately 16 hours at 37° C . 
 Transcription reactions were treated with DNase I ( New England Biolabs , Ipswich , Mass . ) and purified using Gene 
 Jet RNA Cleanup and Concentration KitTM ( Life Technolo gies , Grand Island , N . Y . ) . The quality of the transcribed RNA was checked by agarose gel electrophoresis ( 2 % , SYBR® Safe ; Life Technologies , Grand Island , N . Y . ) and quantified using the Quant - iTTM RNA Assay KitTM ( Ther 
 moFisher , Waltham , Mass . ) . 
 [ 0215 ] B . Designing CasM crRNA 
 [ 0216 ] The 224 nucleotide ssRNA target sequence was probed in silico for a 30 nucleotide target sequence . The target sequence was appended in silico to the 3 ' end of the CasM crRNA repeat sequence and the crRNA sequence was provided to a commercial manufacturer for synthesis . 
 [ 0217 ] C . ssRNA Cleavage Assay 
 [ 0218 ] Synthetic crRNA reagents were resuspended in 
 water to a final concentration of 250 uM and diluted to a suitable working concentration of 250 nM . In vitro tran 
 scribed ssRNA target was diluted to 43 ng / uL in water . Both the crRNA and the ssRNA target reagents were separately 
 incubated at 95° C . for two minutes and cooled by 0 . 5° C . / sec in a thermocycler to a final temperature of 25° C . The 
 CasM protein was diluted to various concentrations in water 
 and lx cleavage buffer . Denatured crRNA was added at 
 various concentrations to the CasM protein and incubated in a thermocycler for 10 minutes at 37° C . The cleavage 
 reactions were initiated by the addition of the ssRNA target 
 to a final concentration of 56 . 4 nM in a final reaction volume of 12 uL . The concentration of each component in the various reactions is shown in Table 14 . Example 7 
 CasM ssRNA Cleavage Assay 
 [ 0210 ] This Example illustrates the use of a crRNA / CasM protein complex to carry out ssRNA cleavage . The following 
 method may be practiced with other CasM protein and 
 crRNA to cleave ssRNA targets . [ 0211 ] A . Generation of ssRNA Target [ 0212 ] A ssRNA target was generated via PCR amplifica tion of a 224 nucleotide target sequence from a plasmid . A T7 promoter sequence was incorporated into the 5 ' end of the 
 reverse PCR primer ( SEQ ID NO : 50 ) for transcription . The primers used for ssRNA target DNA template are presented 
 in Table 13 , 
 TABLE 13 
 SSRNA Target DNA Template Primers 
 SEQ ID NO : Name Sequence 
 SEO ID NO : 49 Forward primer CGAAATTAATACGACTCACTATAGGTTTCGAT 
 TATGCGGCCGTGT 
 SEQ ID NO : 50 Reverse primer AGGAGATATACCATGGGCAGCA 
 * T7 Promoter sequence underlined .",4980
28,28,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 23 
 TABLE 14 TABLE 15 - continued 
 SSRNA Targeting Reaction Component Concentrations SSRNA Cleavage Gel Lane Order 
 Molar ratio 
 CasM : crRNA : SSRNA 
 target NM crRNA Reaction Molar ratio 
 CasM : crRNA : SSRNA 
 target NM ssRNA target nM CasM Lane 
 11 . 3 
 22 . 5 56 . 4 
 56 . 4 
 56 . 4 13 
 14 1 : 0 : 1 
 0 : 3 : 1 
 1 : 3 : 0 33 . 8 15 
 56 . 4 SOO vauAWNE 45 . 1 
 56 . 4 
 112 . 7 
 225 . 5 338 . 2 
 450 . 9 
 563 . 7 
 0 . 0 
 56 . 4 
 0 . 0 
 0 . 0 33 . 8 
 67 . 6 
 101 . 5 
 135 . 3 
 169 . 1 
 338 . 2 
 676 . 4 
 1014 . 6 
 1352 . 8 
 1691 . 0 
 0 . 0 
 0 . 0 
 169 . 1 
 169 . 1 56 . 4 
 56 . 4 
 56 . 4 
 56 . 4 
 56 . 4 
 56 . 4 
 56 . 4 
 56 . 4 
 56 . 4 
 0 . 0 0 . 2 : 0 . 6 : 1 
 0 . 4 : 1 . 2 : 1 
 0 . 6 : 1 . 8 : 1 
 0 . 8 : 2 . 4 : 1 
 1 : 3 : 1 
 2 : 6 : 1 
 4 : 12 : 1 
 6 : 18 : 1 
 8 : 24 : 1 
 10 : 30 : 1 
 0 : 3 : 1 
 1 : 0 : 1 
 0 : 3 : 1 
 1 : 3 : 0 [ 0220 ] The results of the ssRNA cleavage assay shown in FIG . 6 demonstrated that a CasM : crRNA protein complex was capable of ssRNA target cleavage . The results of this procedure demonstrate that increasing the amount of CasM : crRNA complexes resulted in decreased amounts of ssRNA target ( FIG . 6 , indicator 500 ) visualized on the gel ( FIG . 6 , Lanes 1 - 10 ) . 
 Example 8 [ 0219 ] Samples were mixed and centrifuged briefly before being incubated for 1 hour at 37° C . Reactions were termi nated by incubating the reaction at 95° C . for 2 minutes followed by the addition of 100 U / ?L of Proteinase K ( New England Biolabs , Ipswich , Mass . ) , 4 M urea , 5 ?M DTT , 50 UM EDTA and incubation at 37° C . for 15 minutes . 7 uL of each reaction was mixed with 6 uL of 2xRNA Loading Dye ( New England Biolabs , Ipswich , Mass . ) and incubated at 90° C . for two minutes . Low Range ssRNA LadderTM ( New England Biolabs , Ipswich , Mass . ) was diluted 125 - fold in water and 7 uL were mixed with 7 uL of 2xRNA Loading DyeTM ( New England Biolabs , Ipswich , Mass . ) and incu 
 bated at 90° C . for 4 minutes and then incubated on ice for 5 minutes . Cleavage reactions and ssRNA ladder were analyzed on a Mini - PROTEAN 15 % TBE - UreaTM ( Bio 
 RAD , Hercules , Calif . ) , run at 200 V for 1 hour in 1xTBE running buffer . Gel was stained using 2xSYBR GoldTM ( Life 
 Technologies , Grand Island , N . Y . ) for 15 minutes and visu 
 alized with using a Gel Doc EZ SystemTM ( BioRAD , Her cules , Calif . ) . The results of the crRNA cleavage assay are shown in FIG . 6 and the components of each lane shown in 
 Table 15 . Numerical indicator 500 corresponds to the SSRNA target . Numerical indicator 501 corresponds to a SSRNA target hybridized to the spacer sequences of the 
 CasM crRNA . Numerical indicator 502 corresponds to an unprocessed CasM crRNA . Numerical indicator 503 corre sponds to the processed CasM crRNA species . Production of CasM and RtcB Expression Plasmids for MS2 Phage Drop Plaque Assays 
 [ 0221 ] This Example describes the production of plasmids 
 for the expression of CasM , RtcB ( RNA 3 ' - terminal phos phate cyclase , group B ) , and a corresponding CRISPR array 
 in E . coli for use in a MS2 phage drop plaque assay . The following method can be practiced with other CasM , RtcB , and CRISPR array homologs . 
 [ 0222 ] . The casM and rtcB nucleotide sequence from 
 Eubacterium siraeum ( SEQ ID NO : 37 and SEQ ID NO : 60 , respectively ) are selected and codon optimized for expres sion in E . coli . The E . coli - modified sequences are cloned into a p14A plasmid backbone using appropriate restriction nucleases . The plasmid backbone contains a 17 promoter 
 upstream of each protein coding sequence to facilitate transcription in cells . Two control plasmids , one containing 
 only the casM gene sequence under the control of a 17 promoter and the other plasmid only containing the rtcB 
 gene sequence under the control of a 17 promoter , can also 
 constructed . [ 0223 ] A spacer sequence that has homology with the MS2 
 phage genome is engineered in silico flanked 5 ' and 3 ' by the Eubacterium siraeum CasM CRISPR repeat sequence . A non - targeting spacer with no homology to the MS2 phage or E . coli genome , is similarly engineered as a control . Both 
 sequences are subcloned into separate plasmids between an upstream T7 promoter sequence and a downstream tran 
 scription terminator sequence . TABLE 15 
 SSRNA Cleavage Gel Lane Order Example 9 Molar ratio 
 CasM : crRNA : SSRNA 
 target Lane 
BEGOVOU AWNA 0 . 2 : 0 . 6 : 1 
 0 . 4 : 1 . 2 : 1 
 0 . 6 : 1 . 8 : 1 
 0 . 8 : 2 . 4 : 1 
 1 : 3 : 1 2 : 6 : 1 
 4 : 12 : 1 
 6 : 18 : 1 
 8 : 24 : 1 
 10 : 30 : 1 
 SSRNA Ladder 
 0 : 3 : 1 MS2 Phage Drop Plaque Assay 
 [ 0224 ] This Example describes the use of CasM and RtcB in an assay to evaluate the ability of the RtcB protein to 
 modulate CasM ' s sequence - specific and collateral nuclease 
 activity in E . coli . The method set forth herein is adapted 
 from Smargon et al . , Molec . Cell ( 2017 ) 65 : 618 - 630 . Not all of the following steps are required for screening , nor must 
 the order of the steps be as presented . ( 0225 ) The expression plasmids constructed in Example 8 
 are individually and in combination transformed into BL21 ( AI ) E . coli cells from a commercial provider , such as Invitrogen ( Carlsbad , Calif . ) . Transformed cells are grown",5389
29,29,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 24 
 overnight at 37° C . , with shaking , in lysogeny broth ( LB ) 
 supplemented with 100 ug / mL carbenicillin , to select for cells that contain the CasM expression plasmid . [ 0226 ] The following day , cells are diluted 1 : 100 and then grown at 37° C . , with shaking , to an OD600 of 2 . 0 . The cells are then mixed with 4 mL of carbenicillin - containing top Agar ( 10 g / L tryptone , 5 g / L yeast extract , 10 g / L sodium chloride , 5 g / L agar ) and poured onto LB - antibiotic base 
 plates . The top agar also contains 0 . 2 % arabinose to induce expression of the cash , rtcB and CRISPR array coding sequences . 10 - fold serial dilutions of MS2 phage ( ATCC 
 15597 - B1 , Manassas Va . ) are made in LB and then spotted 
 onto hardened top agar with a multi - channel pipette . Plaque formation is assessed after overnight incubation of the spotted plates at 37° C . 
 [ 0227 ] To assess whether the RtcB protein modulates CasM cleavage activity , the relative plaque formation is determined by comparing cells expressing CasM , RtcB , and the CRISPR array targeting MS2 phage ; cells expressing CasM and the CRISPR array targeting MS2 phage ; and cells expressing CasM and the CRISPR array not targeting MS2 phage ; cells expressing CasM and RtcB only . 
 Example 10 
 Introduction of CasM RNP Complexes into Target 
 Cells 
 [ 0228 ] This Example illustrates the design and delivery of CasM and crRNA ribonucleoprotein ( RNP ) complexes into 
 human cells to enable mRNA cleavage of the human epi dermal growth factor receptor ( EGFR ) gene and subsequent knockdown of EGFR gene expression . [ 0229 ] A . Production of CasM Complexes and Transfor mation into Cells [ 0230 ] Mature crRNAs ( SEQ ID NOS : 70 - 165 ) were designed to target the EGFR locus in the human genome . 
 Each crRNA contained a 5 ' 36 nt repeat ( SEQ ID NO : 51 ) followed by a 30 nt spacer . crRNAs were designed to target 72 unique sequences complementary to the egfr mRNA 
 within exons 1 - 3 . Sequences were designed such that flank ing sequences within 1 bp were not biased by any nucleo tide . As negative controls , not predicted to induce cleavage , crRNAs were also designed to target ( 1 ) eight genomic sequences upstream of the predicted egfr mRNA ; ( 2 ) eight sequences complementary to the vegfa mRNA exon 1 ; and 
 ( 3 ) eight sequences identical to the egfr mRNA . [ 0231 ] Double - stranded DNA ( dsDNA ) guide templates containing upstream T7 promoter sequences were created by annealing complementary oligonucleotides ( Integrated 
 DNA Technologies , Coralville , Iowa ) at a final concentra tion of 10 uM in annealing buffer ( 30 mM HEPES , 300 mM KCL ) , then incubating at 95° C . for two minutes , and then slowly cooled to approximately 25° C . , and incubated for an additional 20 minutes . Following annealing , guides were transcribed with T7 RNA polymerase HiScribeTM T7 High Yield RNA Synthesis KitTM ( New England Biolabs , Ipswich , 
 Mass . ) according to manufacturer ' s instructions . Next , samples were digested with RNase - free DNase - I ( New 
 England Biolabs , Ipswich , Mass . ) according to manufactur er ' s instructions , then purified using RNAClean XPTM beads ( Beckman Coulter , Indianapolis , Ind . ) . 0232 For RNAClean XPTM bead purification , 30 uL of 
 sample was combined with 155 uL of 100 % isopropanol and 10 uL of 3 M sodium acetate and then mixed thoroughly . Next , 50 uL of RNAClean XPTM beads were incubated on a magnet for three minutes to allow separation of the liquid 
 and beads , and the supernatant was removed . Subsequently , 
 the samples containing crRNA were added to the beads , 
 mixed , incubated at approximately 25° C . for five minutes , then incubated on a magnet for three minutes . Finally , the supernatant was removed , the beads were washed once with 85 % ethanol , dried , and then the crRNA was eluted in 20 ul of molecular biology grade water . crRNAs were quantified using ribogreen and then normalized to 1 ug / uL . 
 [ 0233 ] To assemble CasM RNPs , 120 pmols of each unique crRNA were added to a well then incubated at 95° C . for two minutes followed by 25° C . for approximately 10 
 minutes . Next , the denatured crRNA guides were combined 
 with 20 pmol of CasM ( SEQ ID NO : 39 ) in RNP assembly 
 buffer ( 20 mM HEPES ; pH 7 . 4 , 10 mM MgCl2 , 150 mm KC1 , 5 % glycerol ) and then incubated at 37° C . for 10 
 minutes . 
 [ 0234 ] B . Transfection of CasM RNP Complexes into Eukaryotic Cells 
 [ 0235 ] HeLa cells ( ATCC , Manassas , Va . ) were cultured in suspension in DMEM medium supplemented with 10 % 
 FBS and 1x Antibiotic - Antimycotic Solution ( Mediatech , Inc . , Manassas , Va . ) at 37° C . , 5 % CO2 and 100 % humidity . 
 HeLa cells were transfected using the Nucleofector® 96 - well Shuttle System ( Lonza , Allendale , N . J . ) . Prior to 
 nucleofection , 5 ul of the CasM : crRNA RNPs were assembled in individual wells of a 96 - well plate . HeLa cells were transferred to a 50 ml conical centrifuge tube and centrifuged at 200xG for five minutes . The media was 
 aspirated and the cell pellet was washed in calcium and magnesium - free PBS . The cells were centrifuged once more and resuspended in Nucleofector SFTM buffer ( Lonza , Allen dale , N . J . ) at a concentration of 5x100 cells / ml . 20 ul of this cell suspension was added to the CasM : crRNA RNPs in the 
 96 well plate , mixed , and then the entire volume was transferred to a 96 - well NucleocuvetteTM Plate . The plate was then loaded into the Nucleofector 96 - well ShuttleTM and cells were nucleofected using the 96 - CN - 114 Nucleofec 
 torTM program ( Lonza , Allendale , N . J . ) . Immediately fol 
 lowing nucleofection , 75 ul of complete DMEM medium was added to each well of the 96 - well NucleocuvetteTM 
 Plate . Half of the contents of each well were then transferred 
 to a 96 - well tissue culture plate containing 150 ul of com plete DMEM medium . This procedure was then repeated in 
 order to plate a duplicate for each well , one which would be used for lysis and genomic DNA analysis , and one for FACS analysis . The cells were cultured at 37° C . , 5 % CO2 and 100 % humidity for approximately 5 days . 
 [ 0236 ] C . FACS Analysis of CasM Mediated EGFR Knockdown 
 [ 0237 ] Fluorescence activated cell sorting ( FACS ) analy sis was performed 5 days after nucleofection of HeLa cells with EGFR - targeting CasM2 RNPs . In brief , 2x10 $ - 4x105 cells / well were detached with TrypLE Express ( Gibco ) . 
 stained with 2 uL APC anti - human EGFR ( Clone AY13 , Sony Biotechnology ) in 100 uL total volume and then analyzed using Intellicyte Flow Cytometer ( Intellicyt , Albu 
 querque , N . Mex . ) . Results from these experiments are 
 shown in Table 16 .",6814
30,30,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 25 
 TABLE 16 TABLE 16 - continued 
 CasM Mediated EGFR knockdown CasM Mediated EGFR knockdown 
 % EGFR negative 
 cells crRNA SEQ ID transcription NO . % EGFR negative 
 cells Name Name CrRNA SEQ ID NO . transcription 
 2 % 9 % 
 5 % 9 % 
 8 % S 6 % 
 9 % 
 8 % 5 % 
 6 % 6 % 11 % 
 12 % 12 % 
 10 % 
 4 % 
 6 % 5 % 
 5 % 
 4 % 
 6 % 
 5 % 
 6 % 9 % 
 11 % 
 40 % 
 17 % 
 15 % 
 12 % 
 21 % 
 48 % 
 41 % 
 19 % 
 9 % 19 % 8 % 69 % 4 % Untransfected reference cell Intergenic target - 1 Intergenic target - 2 Intergenic target - 3 Intergenic target - 4 Intergenic target - 5 
 Intergenic target - 6 Intergenic target - 7 Intergenic target - 8 
 Exon 1 target - 1 Exon 1 target - 2 Exon 1 target - 3 Exon 1 target - 4 Exon 1 target - 5 Exon 1 target - 6 Exon 1 target - 7 
 Exon 1 target - 8 Exon 1 target - 9 Exon 1 target - 10 Exon 1 target - 11 Exon 1 target - 12 Exon 1 target - 13 Exon 1 target - 14 Exon 1 target - 15 Exon 1 target - 16 Exon 1 target - 17 Exon 1 target - 18 Exon 1 target - 19 Exon 1 target - 20 
 Exon 1 target - 21 
 Exon 1 target - 22 
 Exon 1 target - 23 Exon 1 target - 24 Exon 2 target - 1 Exon 2 target - 2 Exon 2 target - 3 Exon 2 target - 4 Exon 2 target - 5 Exon 2 target - 6 Exon 2 target - 7 Exon 2 target - 8 Exon 2 target - 9 
 Exon 2 target - 10 Exon 2 target - 11 Exon 2 target - 12 Exon 2 target - 13 Exon 2 target - 14 Exon 2 target - 15 Exon2 target - 16 Exon 2 target - 17 Exon 2 target - 18 Exon 2 target - 19 Exon 2 target - 20 Exon 2 target - 21 Exon 2 target - 22 Exon 2 target - 23 Exon 2 target - 24 Exon 3 target - 1 Exon 3 target - 2 3 % 3 % 2 % 
 4 % 
 4 % 
 5 % 
 4 % 
 6 % 
 6 % 
 6 % 
 5 % 5 % 5 % 6 % 
 5 % 
 6 % 
 7 % 
 11 % 
 5 % n / a Intergenic 
 Intergenic Intergenic 
 Intergenic Intergenic Intergenic Intergenic 
 Intergenic 
 Exon 1 / 28 Exon 1 / 28 
 Exon 1 / 28 Exon 1 / 28 
 Exon 1 / 28 
 Exon 1 / 28 
 Exon 1 / 28 Exon 1 / 28 Exon 1 / 28 
 Exon 1 / 28 Exon 1 / 28 
 Exon 1 / 28 Exon 1 / 28 Exon 1 / 28 
 Exon 1 / 28 Exon 1 / 28 
 Exon 1 / 28 
 Exon 1 / 28 Exon 1 / 28 
 Exon 1 / 28 
 Exon 1 / 28 
 Exon 1 / 28 
 Exon 1 / 28 
 Exon 1 / 28 
 Exon 2 / 28 Exon 2 / 28 Exon 2 / 28 
 Exon 2 / 28 Exon 2 / 28 Exon 2 / 28 Exon 2 / 28 Exon 2 / 28 Exon 2 / 28 
 Exon 2 / 28 
 Exon 2 / 28 
 Exon 2 / 28 
 Exon 2 / 28 Exon 2 / 28 
 Exon 2 / 28 
 Exon 2 / 28 
 Exon 2 / 28 Exon 2 / 28 
 Exon 2 / 28 Exon 2 / 28 
 Exon 2 / 28 
 Exon 2 / 28 
 Exon 2 / 28 
 Exon 2 / 28 Exon 3 / 28 Exon 3 / 28 Exon 3 target - 3 Exon 3 target - 4 Exon 3 target - 5 Exon 3 target - 6 Exon 3 target - 7 Exon 3 target - 8 Exon 3 target - 9 Exon 3 target - 10 Exon 3 target - 11 Exon 3 target - 12 Exon 3 target - 13 
 Exon 3 target - 14 
 Exon 3 target - 15 
 Exon 3 target - 16 Exon 3 target - 17 Exon 3 target - 18 Exon 3 target - 19 Exon 3 target - 20 Exon 3 target - 21 Exon 3 target - 22 Exon 3 target - 23 Exon 3 target - 24 VEGFA target - 1 
 VEGFA target - 2 VEGFA target - 3 VEGFA target - 4 VEGFA target - 5 VEGFA target - 6 
 VEGFA target - 7 VEGFA target - 8 Nontargeting target - 1 Nontargeting target - 2 Nontargeting target - 3 Nontargeting target - 4 Nontargeting target - 5 Nontargeting target - 6 Nontargeting target - 7 Nontargeting target - 8 8 % SEQ ID NO : 70 SEQ ID NO : 71 SEQ ID NO : 72 SEQ ID NO : 73 
 SEQ ID NO : 74 SEQ ID NO : 75 SEQ ID NO : 76 SEQ ID NO : 77 
 SEQ ID NO : 78 SEQ ID NO : 79 
 SEQ ID NO : 80 SEQ ID NO : 81 
 SEQ ID NO : 82 
 SEQ ID NO : 83 
 SEQ ID NO : 84 SEQ ID NO : 85 SEQ ID NO : 86 
 SEQ ID NO : 87 SEQ ID NO : 88 
 SEQ ID NO : 89 SEQ ID NO : 90 SEQ ID NO : 91 
 SEQ ID NO : 92 SEQ ID NO : 93 
 SEQ ID NO : 94 
 SEQ ID NO : 95 SEQ ID NO : 96 SEQ ID NO : 97 
 SEQ ID NO : 98 
 SEQ ID NO : 99 SEQ ID NO : 100 SEQ ID NO : 101 SEQ ID NO : 102 SEQ ID NO : 103 SEQ ID NO : 104 
 SEQ ID NO : 105 SEQ ID NO : 106 SEQ ID NO : 107 SEQ ID NO : 108 SEQ ID NO : 109 SEQ ID NO : 110 
 SEO ID NO : 111 
 SEQ ID NO : 112 
 SEQ ID NO : 113 
 SEQ ID NO : 114 SEQ ID NO : 115 
 SEQ ID NO : 116 
 SEQ ID NO : 117 
 SEQ ID NO : 118 SEQ ID NO : 119 
 SEQ ID NO : 120 SEQ ID NO : 121 SEQ ID NO : 122 SEQ ID NO : 123 
 SEO ID NO : 124 
 SEQ ID NO : 125 SEQ ID NO : 126 SEQ ID NO : 127 Exon 3 / 28 
 Exon 3 / 28 
 Exon 3 / 28 
 Exon 3 / 28 Exon 3 / 28 Exon 3 / 28 
 Exon 3 / 28 
 Exon 3 / 28 
 Exon 3 / 28 
 Exon 3 / 28 
 Exon 3 / 28 Exon 3 / 28 
 Exon 3 / 28 
 Exon 3 / 28 
 Exon 3 / 28 
 Exon 3 / 28 
 Exon 3 / 28 
 Exon 3 / 28 Exon 3 / 28 Exon 3 / 28 
 Exon 3 / 28 
 Exon 3 / 28 
 Exon 1 / 8 
 Exon 1 / 8 
 Exon 1 / 8 
 Exon 1 / 8 
 Exon 1 / 8 
 Exon 1 / 8 
 Exon 1 / 8 
 Exon 1 / 8 
 Exon 1 / 28 
 Exon 1 / 28 
 Exon 1 / 28 
 Exon 1 / 28 
 Exon 1 / 28 
 Exon 1 / 28 Exon 1 / 28 Exon 1 / 28 SEQ ID NO : 128 
 NO : 129 
 NO : 130 
 SEQ ID NO : 131 SEQ ID NO : 132 SEQ ID NO : 133 SEQ ID NO : 134 SEQ ID NO : 135 
 SEQ ID NO : 136 SEQ ID NO : 137 SEQ ID NO : 138 SEQ ID NO : 139 
 SEQ ID NO : 140 
 SEO ID NO : 141 
 SEQ ID NO : 142 
 NO : 143 
 NO : 144 
 SEQ ID NO : 145 SEQ ID NO : 146 SEQ ID NO : 147 
 SEQ ID NO : 148 SEQ ID NO : 149 SEQ ID NO : 150 SEQ ID NO : 151 SEQ ID NO : 152 SEQ ID NO : 153 
 SEQ ID NO : 154 SEQ ID NO : 155 SEQ ID NO : 156 
 SEQ ID NO : 157 
 SEQ ID NO : 158 
 SEO ID NO : 159 
 SEQ ID NO : 160 SEQ ID NO : 161 SEQ ID NO : 162 SEQ ID NO : 163 SEQ ID NO : 164 SEQ ID NO : 165 6 % 
 6 % 8 % 8 % 7 % 
 8 % 7 % 6 % 8 % 
 5 % 
 7 % 
 6 % 6 % 6 % 6 % 
 7 % 
 6 % 4 % 
 8 % 
 11 % 
 10 % 
 13 % 
 8 % 
 10 % 
 8 % 
 13 % 
 16 % 
 19 % 
 11 % 
 10 % 
 19 % 
 20 % 
 25 % 
 15 % 
 17 % 
 14 % 
 12 % 0238 ] The data presented in Table 16 shows that CasM 
 did not produce egfr knockdown when targeted to ( 1 ) sequences upstream of the predicted exon 1 start site using 
 SEQ ID NOS : 70 - 77 ; ( 2 ) an unrelated vascular endothelial growth factor A ( vegfa ) gene using SEQ ID NOS : 150 - 157 ) ; or ( 3 ) the reverse complement of sequences contained in egfr exon 1 mRNA using SEQ ID NOS : 158 - 165 . Con versely , CasM enabled approximately 40 % egfr knockdown 
 when targeted to mRNA sequences contained in exon 2 
 using SEQ ID NOS : 102 - 125 , and exon 3 of egfr using SEQ ID NOS : 126 - 149 . [ 0239 ] Although preferred embodiments of the subject 
 methods have been described in some detail , it is understood 
 that obvious variations can be made without departing from the spirit and the scope of the invention as defined by the appended claims . 7 % 7 % 
 SEQUENCE LISTING 
 < 160 > NUMBER OF SEQ ID NOS : 165 
 < 210 > SEQ ID NO 1 
 < 211 > LENGTH : 2862 
 < 212 > TYPE : DNA",6511
31,31,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 - continued 
 < 213 > ORGANISM : Artificial Sequence 
 < 220 > FEATURE : < 223 > OTHER INFORMATION : Synthetic : CasM DNA sequence from Eubacterium siraeum , modified for expression in Escherichia coli 
 < 400 > SEQUENCE : 1 
 atggggaaga agattcatgc gcgcgattta cgcgaacaac gcaaaacgga tcgcactgag 60 
 aaatttgcgg atcaaaacaa aaagcgcgag gccgagcgcg ctgttcctaa aaaggacgcc 120 
 gcagtctcgg ttaagagtgt atcgtccgtg tcttcaaaaa aggacaacgt cactaaaagc 180 
 atggcgaagg ccgctggtgt aaagtctgta tttgccgtag gtaacacggt atacatgaca 240 
 togttcggcc gcggcaacga cgctgtactg gagcaaaaga tcgtggatac atcccatgaa 300 
 ccacttaaca tcgacgatcc agcatatcaa ttgaacgttg ttacaatgaa cggttattcc 360 
 gtcaccggcc accgcggaga gaccgtttct gcagtaacgg acaacccttt acgccgtttc 420 
 aatggccgca aaaaggacga acctgagcaa tcggttccaa ctgacatgct ttgtcttaaa 480 
 cctacgttag agaagaagtt cttcggcaag gagtttgacg acaacatcca catccagttg 540 
 atttataaca ttttagatat tgaga agatc ttagcagttt attcaaccaa tgcaatttac 600 
 gctttgaaca acatgagcgc cgacgaaaac atcgaaaatt cggatttttt catgaaacgt 660 
 accacagacg aaacctttga cgactttgaa aagaaaaaag aatctactaa ctcacgcgaa 720 
 aaggcagact tcgacgcgtt tgaaaaattt attggaaact accgtcttgc gtacttcgcg 780 
 gatgctttct atgtcaataa aaaaaaccct aagggaaagg ctaagaatgt tctgcgtgaa 840 
 gataaggagc tttactcggt cttaactctt atcggtaaac tgcgccattg gtgcgtacat 900 
 agcgaggagg gacgtgcaga gttctggctg tataagttag acgagttaaa agacgatttt 960 
 aaaaatgtat tggacgtcgt gtacaaccgt cccgtggaag aaatcaacaa ccgctttatt 1020 
 gagaataaca aagttaatat ccaaattctg gggagcgtgt acaaaaacac agacatcgct 1080 
 gaacttgtgc gctcgtatta cgaattcttg attaccaaaa aatacaaaaa tatgggcttt 1140 
 tctattaaga aacttcgtga atcaatgttg gaaggtaaag gttacgcaga caaggaatat 1200 
 gactccgtcc gtaataagtt gtaccaaatg acagacttca ttctgtatac gggatacatc 1260 
 aacgaagact cagatcgtgc agacgatctg gtcaataccc tgcgctcttc tctgaaggag 1320 
 gatgataaga cgactgtata ctgtaaagag gccgactatt tgtggaagaa gtatcgcgaa 1380 
 togatccgtg aggttgcgga tgcactggat ggtgataaca tcaagaagtt gagtaagtcg 1440 
 aacatcgaga tccaagagga taaacttcgt aagtgcttca ttagttatge agactccgtt 1500 
 tcagagttca caaaactgat ctacctgctg acccgcttcc tgagcggaaa ggaaattaat 1560 
 gacctggtaa ctactcttat caataaattt gataacatcc gctcttttct tgagattatg 1620 
 gacgagctgg gattagatcg tacgtttacc gccgaatatt cgttctttga aggctcaacg 1680 
 aaatacttgg cggagcttgt agagttaaat tcttttgtaa aatcttgctc ttttgatatt 1740 
 aacgccaagc gcacaatgta tcgcgacgcc ttagacattt tggggattga atcggacaag 1800 
 actgaagagg atattgaaaa gatgattgat aatatccttc agattgatgc gaatggcgac 1860 
 aagaaactta agaaaaataa tggcctgcgt aacttcattg caagtaacgt tattgacagt 1920 
 aaccgtttca aatacttagt acgctacggg aaccctaaaa aaatccgcga aacagctaag 1980 
 tgcaaaccgg ctgttcgctt cgtgttgaac gagatccccg acgcacagat cgagcgctat 2040 
 tacgaggcat gctgtccaaa gaacacagcc ctttgctcag cgaacaagcg tcgcgagaag 2100",2801
32,32,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 27 
 - continued 
 ttagctgaca tgattgccga gattaagttc gagaacttct ctgacgctgg aaattatcaa 2160 
 aaagctaacg ttacctcgcg cacatcagag gcggaaatca aacgtaaaaa ccaggcgatt 2220 
 attcgcttgt atttgacggt catgtacatt atgctgaaga acttagtcaa cgtgaacgct 2280 
 cgttacgtga tcgcatttca ctgtgtggag cgtgatacta agttgtatgc cgaatctgga 2340 
 ttggaggttg ggaacattga aaagaataaa actaatctta ccatggccgt aatgggagtt 2400 
 aagcttgaga atggtatcat caagactgag tttgataaat cttttgcgga aaacgcagca 2460 
 aatcgttacc ttcgtaacgc acgctggtat aaacttatct tagacaattt aaaaaagtca 2520 
 gaacgcgcgg tagtaaacga atttcgtaac acagtatgtc atttaaacgc catccgcaac 2580 
 attaacatta acatcaagga gattaaggag gtagaaaatt attttgcctt gtaccactat 2640 
 ttgatccaaa aacatttgga gaaccgtttc gccgacaaaa aagttgaacg cgatacgggt 2700 
 gactttattt ccaaattgga agagcataag acgtactgta aggactttgt aaaagcatac 2760 
 2820 tgtacgccgt ttggatataa tttagtacgt tataagaact tgactattga cggacttttc 
 gataaaaact accctgggaa ggatgattct gatgaacaga aa 2862 
 < 210 > SEQ ID NO 2 
 < 211 > LENGTH : 2757 
 < 212 > TYPE : DNA 
 < 213 > ORGANISM : Artificial Sequence < 220 > FEATURE : < 223 > OTHER INFORMATION : Synthetic : CasM DNA sequence from Ruminococcus sp . , isolate 2789STDY5834971 , modified for expression in Escherichia coli 
 < 400 > SEQUENCE : 2 
 atggcaaaga aaaataaaat gaagccgcgc gagttacgcg aggcccagaa gaaagctcgt 60 
 caattaaaag cggccgagat caacaataac gcagccccag caattgcago aatgccagcg 120 
 gccgaagtga ttgcgccggc tgcagagaag aagaagagct cagtcaaggc agcagggatg 180 
 aagagcatcc ttgttagcga gaacaagatg tacattacat cttttgggaa aggaaactca 240 
 gcggtattgg aatacgaggt tgataacaac gattacaatc agacgcagtt atcatccaag 300 
 gacaacagca acatccaact gggtggcgtc aatgaggtca acattacttt ttcaagcaag 360 
 cacggctttg aaagtggcgt ggaaattaac acttctaatc cgacacaccg ttcaggagaa 420 
 agttcccctg ttcgtggcga tatgttaggg cttaagtcag aactggaaaa gcgcttcttc 480 
 ggtaagacct tcgatgataa cattcacatt caacttatct acaacatcct tgatattgaa 540 
 aagatccttg cagtgtacgt tacgaacatc gtctacgctc tgaataatat gttaggtgtc 600 
 aaggggtctg aatcccatga tgacttcatt ggttacttgt cgacaaataa tatctacgat 660 
 gtcttcattg atccagataa tagttccttg agcgacgaca agaaagcaaa cgtacgtaaa 720 
 agtcttagta aatttaatgc gttgttaaaa actaaacgtc tgggctattt cggattagag 780 
 gaaccaaaga ccaaagacaa ccgtgtaagc caggcgtata agaagcgtgt gtatcacatg 840 
 cttgccattg tcgggcaaat tcgtcaatgc gtatttcatg acaaaagcgg tgccaaacgt 900 
 tttgatcttt attctttcat taaca atatt gatocagagt accgtgacac gottgattat 960 
 ttggtagaag agcgcctgaa gtcaattaac aaagacttta ttgaagacaa caaagtaaac 1020 
 atcagccttt taattgatat gatgaagggt tacgaggcgg acgatatcat tcgcctgtac 1080 
 tacgacttca ttgtattaaa atctcagaaa aacctggggt tctctattaa gaagttacgt 1140",2657
33,33,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 - continued 
 gagaagatgc tggacgagta tggtttccgt ttcaaagata aacaatacga ttctgttcgt 1200 
 tccaagatgt ataaattgat ggattttttg cttttttgta actattaccg caatgatatt 1260 
 gctgcggggg aatctctggt acgtaaactg cgtttttcga tgacagacga tgaaaaggag 1320 
 ggcatttatg cggacgaagc cgctaaattg tgggggaaat ttcgtaatga ctttgagaat 1380 
 atcgcggacc acatgaatgg cgatgttatt aaggagttgg gaaaagctga catggatttc 1440 
 gacgaaaaga tcttggattc tgagaagaaa aacgcttccg acctgctgta tttttcaaaa 1500 
 atgatttata tgctgacata tttcttagat gggaaagaga ttaacgactt gctgacgact 1560 
 ctgatttcaa aatttgacaa tatcaaagag tttttgaaaa ttatgaagtc ttctgcagtc 1620 
 gatgtagagt gtgaacttac agctgggtac aagctgttca atgacagtca acgtatcacc 1680 
 aacgaattat ttatcgttaa aaatattgcc tccatgcgta agccagccgc aagtgccaag 1740 
 ctgacaatgt tccgcgatgc actgacgatt ctgggaattg acgataagat tacggatgac 1800 
 cgtatttcag gaatcttgaa gottaaagag aagggcaagg gcattcatgg acttogtaac 1860 
 ttcatcacca acaacgtgat cgagagtagc cgttttgttt accttatcaa atatgcgaat 1920 
 gcacaaaaga tccgcgaagt ggcgaaaaac gagaaggtcg taatgttcgt attaggtgga 1980 
 attccagata cgcaaattga gcgctattat aagtcatgtg tagagttccc ggatatgaac2040 
 agctcattag gagtgaaacg ttcagagctg gcgcgcatga ttaagaatat cagttttgac 2100 
 gatttcaaga acgtgaaaca acaagcgaaa ggacgcgaaa acgtcgcaaa agagcgcgcc 2160 
 aaggccgtca ttgggttgta cttaacggta atgtacttac ttgtcaaaaa cctggttaat 2220 
 gttaacgcgc gctatgtcat cgccatccat tgtctggaac gtgatttcgg tctttataag 2280 
 gagattattc ctgaactggc gtcaaagaac ctgaaaaacg attaccgcat tttatctcag 2340 
 actctgtgtg aactgtgtga taagtctccc aatttgttct tgaagaagaa tgagcgcctg 2400 
 cgtaaatgtg ttgaagtcga catcaataat gcagacagct cgatgactcg taaatatcgc 2460 
 aactgtatcg ctcacttgac tgtcgtccgt gaattaaaag agtacattgg tgatatttgt 2520 
 accgttgact cttatttcag tatttaccat tatgtaatge aacgctgtat cacaaagcgt 2580 
 gaaaacgata ccaagcagga ggaaaaaatc aaatacgaag acgatttgct taagaatcac 2640 
 ggctatacaa aagacttcgt aaaagcattg aactcacctt tcggatacaa catcccgcgt 2700 - 9cgt 
 tttaaaaatc tttcaattga gcaacttttt gatcgtaacg agtatcttac ggaaaaa 2757 
 < 210 > SEQ ID NO 3 
 < 211 > LENGTH : 2754 
 < 212 > TYPE : DNA < 213 > ORGANISM : Artificial Sequence < 220 > FEATURE : < 223 > OTHER INFORMATION : Synthetic : CasM DNA sequence 
 from Ruminococcus bicirculans , 
 modified for expression in Escherichia coli 
 < 400 > SEQUENCE : 3 
 atggcgaaaa agaataaaat gaaacctcgc gaattgcgcg aggcacaaaa gaaagcgcgt 60 
 caattgaaag cagcggagat caacaataac gcagttcccg ccatcgctgc tatgccggcc 120 
 gotgaggccg ctgcccccgc agcggagaaa aagaagtcat cggtcaaagc ggcagggatg 180 
 aagtcaatct tagtctccga gaacaagatg tacatcacca gttttggaaa aggtaactcg 240 
 gcggtcttgg agtacgaggt agacaataat gactataaca aaactcagtt atcctcgaag 300",2667
34,34,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 - continued 
 gataatagca atattgagtt gtgtgatgtggggaaggtta atatcacgtt cagctctcgt 360 
 cgtggctttg aatcgggagt cgagattaat acgagtaacc caacccaccg ctccggagag 420 
 tcgtcgtcag tccgtgggga tatgctgggc ttgaaaagcg agttggaaaa acgttttttt 480 
 ggcaagaatt tcgacgataa tatccatatt caacttattt acaacatctt ggacatcgag 540 
 aagatccttg ctgtgtatgt tacgaacatt gtttacgccc tgaataatat gottggcgaa 600 
 ggggatgaat ctaactacga ctttatgggg tatttgagca cattcaacac atataaagtc 660 
 tttacgaatc cgaatggttc aacgctgtct gatgacaaga aagagaacat tcgcaaatca 720 
 ttatcgaaat ttaatgcttt gttgaaaacg aagcgcttag gttatttcgg gttagaggag 780 
 cctaaaacaa aggacacgcg cgcatcggag gottacaaga aacgcgtata tcacatgctg 840 
 gctatcgttg ggcaaatccg t?agtgcgta tttcatgata agagcggggc caagcgtttc 900 
 gacctttatt catttattaa taacattgat ccagaatatc gtgaaactct ggattacttg 960 
 gtcgacgaac gotttgacag tattaataaa ggatttatcc aaggtaataa agtaaacatc 1020 
 agcttactga tcgatatgat gaagggttac gaggcggatg acatcatccg tctttactac 1080 
 gatttcattg tccttaaatc gcagaaaaac ctgggcttca gtatcaaaaa gttacgcgaa 1140 
 aagatgttgg atgagtatgg ctttcgtttc aaagataagc aatacgatag cgttcgcagc 1200 
 aagatgtata aattaatgga tttcttatta ttctgcaatt actaccgcaa cgacattgca 1260 
 gcgggcgaat ctcttgtccg caagctgcgc tttagtatga ccgatgatga gaaggagggg 1320 
 atctacgcag atgaggctgc aaaactgtgg ggcaaatttc gtaacgactt tgagaacatc 1380 
 gccgaccaca tgaacggtga cgtcattaaa gagttgggga aagcagatat ggactttgat 
 gaaaagatcc ttgattccga aaagaaaaat gcgtcggatc tgttgtattt tagtaaaatg 1440 
 1500 
 1560 atttacatgc ttacgtattt tctggacgga aaagaaatca acgacttact tactacatta 
 atttcgaagt ttgataacat taaggagttt ttaaaaatca tgaaaagcag tgcagttgac 1620 
 gttgaatgtg aacttacagc aggttataaa ttatttaatg acagccaacg catcacaaat 1680 
 gaattgttca tcgtgaagaa tatcgcgtct atgcgcaaac ccgctgcttc ggcgaagctg 1740 
 acaatgtttc gcgacgcttt aacaatcctggggatcgacg ataagatcac tgatgatcgt 1800 
 atttccgaaa tcttaaaatt aaaggagaaa ggaaaaggta tocatggett acgcaatttt 1860 
 atcactaata atgtaattga aagtagccgc tttgtgtacc ttatcaagta cgcaaacgca 1920 
 caaaaaatcc gtgaggtcgc caaaaacgag aaagtcgtta tgtttgtcct gggtgggatt 1980 
 cccgacacac aaatcgaacg ctactacaaa agttgtgtgg aattcccgga catgaactcg 2040 
 agtctgggtg ttaagcgtag tgaattggcc cgtatgatca agaatatcag ttttgacgat 2100 
 ttcaagaatg tgaaacagca ggccaaaggg cgtgagaacg tcgcaaagga acgcgctaaa 2160 
 gctgtgatcg gtttatatct gaccgtgatg tacttgttgg tgaagaattt ggtgaacgtt 2220 
 aacgcgcgtt acgttattgc cattcattgc ttagaacgcg actttggact gtataaggag 2280 
 attattcctg aattagccag caaaaacctg aaaaacgatt atcgtatcct gagccaaacc 2340 
 ctttgcgaac tttgtgataa aagcccaaac ttgtttttaa aaaaaaatga gcgtttacgc 2400 
 aaatgcgtgg aggttgatat taataatgct gattcctcga tgacccgcaa ataccgtaac 2460 
 tgtattgccc atttgacagt agtccgcgag ttgaaggagt acattggaga tatttgcact 2520 
 gtggacagtt acttcagtat ttaccattat gtaatgcaac gctgcattac aaagcgcgag 2580",2812
35,35,"US 2018 / 0282715 A1 Oct . 4 , 2018 30 
 - continued 
 aacgacacta agcaggagga aaaaatcaag tacgaggatg atctgctgaa aaatcatggc 2640 
 tacaccaagg actttgttaa ggccttgaac tctccgttcg ggtataacat tccccgcttc 2700 
 aaaaatctga gtattgagca gttgtttgat cgtaatgagt atcttacaga gaag 2754 
 < 210 > SEQ ID NO 4 
 < 211 > LENGTH : 2766 
 < 212 > TYPE : DNA < 213 > ORGANISM : Artificial Sequence 
 < 220 > FEATURE : < 223 > OTHER INFORMATION : Synthetic : CasM DNA sequence from Ruminococcus sp . , isolate 2789STDY5608892 , modified for expression in 
 Escherichia coli 
 < 400 > SEQUENCE : 4 
 atggccaaaa agaacaaaat gaagccccgc gaacttcgtg aggcccaaaa gaaagctcgc 60 60 
 caattaaaag cagccgagat caacaacaac gcagctccgg ccattgcago aatgcctgct 120 
 gcagaagtga ttgcgccagt cgccgaaaag aagaaatcca gtgttaaagc tgcaggtatg 180 
 aagtctattt tggtttcgga gaacaagatg tatatcacaa gottcgggaa aggtaatagt 240 
 gctgttcttg agtatgaagt agataacaac gactataata aaacccaact tagttctaag 300 
 gataactcta atattgaatt gggggacgtt aatgaggtaa atatcacgtt ctcatcgaag 360 
 catggctttg gttccggggt ggaaatcaat acctctaatc ccactcatcg ttcgggtgaa 420 
 tcctccccag tccgtggtga tatgttgggg cttaaatcgg agttagagaa acgcttcttt 480 
 ggtaaaacct ttgatgataa tattcatatt caattgattt ataacatttt ggatatcgag 540 
 aagattttgg ctgtatacgt tacaaatatc gtgtatgcac ttaataatat gttgggtatt 600 
 aaagattctg aatcgtatga tgatttcatg ggctatttga gcgcacgcaa tacctatgaa 660 
 gtcttcactc atcctgataa aagcaactta agtgataagg ttaaagggaa cattaagaag 720 
 agtttatcaa agttcaatga cttgttaaag accaagcgcc ttgggtactt cggtcttgag 780 
 gaaccgaaga ccaaagatac ccgcgcttct gaggcgtata agaagcgcgt ctaccacatg 840 
 cttgcaatcg taggtcaaat ccgtcagtgt gtgtttcacg acaaatcagg agcgaaacgt 900 
 ttcgatttgt actccttcat taataacatc gacccagagt atcgcgacac tcttgactac 960 
 ttagttgagg aacgtttgaa gtcaattaat aaggatttca ttgagggaaa taaagtaaac 1020 
 attagccttc ttatcgacat gatgaaggga tacgaggccg acgatattat tcgcctgtat 1080 
 tatgatttta ttgtgttgaa atcacaaaag aatttggggt ttagcattaa aaaattgcgc 1140 
 gagaagatgt tggaggagta tgggtttcgc tttaaggata aacagtatga ctcagtccgc 1200 
 tcaaaaatgt ataagttaat ggacttcctg cttttttgta attattaccg taatgacgtc 1260 
 gccgccggtg aagccctggt tcgtaaattg cgcttctcaa tgactgacga tgagaaggag 1320 1 
 ggaatttatg ctgatgaggc tgcgaagtta tgggggaagt ttcgtaacga cttcgaaaat 1380 
 atcgccgacc acatgaatgg agatgttatc aaggagcttg gcaaggcgga tatggatttt 1440 
 gatgaaaaga tccttgacag cgaaaagaag aatgcctccg atttgctgta cttttcgaaa 1500 
 atgatctaca tgcttaccta tttcctggac ggcaaagaga tcaacgatct tttgaccacc 1560 
 cttatttcta agttcgataa tatcaaagag tttttgaaaa tcatgaagag ttcggcggtc 1620 
 gatgttgaat gtgaattaac ggccgggtat aaattattta acgactccca acgtattacg 1680 
 aatgaattat ttatcgttaa aaacatcgct tctatgcgca aaccagcagc gtccgccaaa 1740",2674
36,36,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 31 
 - continued 
 cttacgatgt ttcgtgacgc ccttaccatt ttgggaatcg acgataacat cacagatgat 1800 
 cgcatttctg agatcttgaa gottaaggaa aagggcaagg gcatccatgg tttacgtaat 1860 
 tttatcacaa acaacgtgat cgagtcgagt cgttttgtct atctgatcaa gtatgcaaac 1920 
 gcgcagaaaa ttcgtgaagt ggcaaaaaat gagaaagtag taatgtttgt tttgggtggt 1980 
 atccctgaca cccagattga gcgctactac aagtcgtgtg tagaattccc tgacatgaat 2040 
 agcagcttag aagctaaacg ctctgaactt gcgcgcatga ttaaaaatat ctcgttegat 2100 
 gacttcaaga acgttaaaca acaggccaaa ggccgtgaga atgttgctaa agaacgcgcg 2160 
 aaggctgtaa ttggattata ccttactgta atgtatctgt tagtgaaaaa ccttgtgaac 2220 
 gtcaacgccc gctacgtcat tgcgatccat tgtttggagc gtgactttgg gttatacaag 
 gagatcatcc cagaactggc ctcaaaaaac ttaaaaaatg actaccgtat tttgagtcag 2280 
 2340 
 2400 accttgtgcg aactgtgcga tgaccgtaac gaatcctcga acttgttctt gaagaagaat 
 aaacgtttgc gcaaatgtgt cgaggtagat atcaacaatg cagacagctc tatgacgcgt 2460 
 aagtaccgta actgtattgc tcacttaacc gtagttcgtg aacttaaaga atacattgga 2520 
 gacattogta cagttgatag ctacttcagt atttatcact atgtaatgca gcgctgtatc 2580 
 actaagcgtg gggatgatac gaagcaagaa gagaaaatta agtacgaaga tgacctgttg 2640 
 aaaaaccacg ggtacactaa ggactttgtc aaagctctga attccccgtt cgggtacaat 2700 
 atccctcgtt ttaagaatct gagtattgaa cagttatttg accgcaacga ataccttacg 2760 
 gagaag 2766 
 ? 
 ? 
 ? < 210 > SEQ ID NO 5 < 211 > LENGTH : 2766 
 < 212 > TYPE : DNA < 213 > ORGANISM : Artificial Sequence 
 FEATURE : < 223 > OTHER INFORMATION : Synthetic : CasM DNA sequence from Ruminococcus sp . CAG : 57 , modified for expression in Escherichia coli ? 
 ? 
 < 400 > SEQUENCE : 5 
 atggctaaaa agaataaaat gaaacctcgc gagttgcgcg aagcccagaa aaaagctcgc 60 
 cagttaaagg cagcggaaat taataataat gcagcacccg ccatcgcagc gatgcccgca 120 
 gctgaagtaa tcgcccctgt tgctgaaaag aagaaatcca gcgtgaaagc ggcaggtatg 180 
 aagtccattt tggtcagcga gaataaaatg tacattacgt cgttcgggaa aggcaactcc 240 
 gctgtccttg agtatgaagt agacaacaat gactacaaca aaactcaact gtcaagcaaa 300 
 gacaacagta acatcgaact gggagacgtg aatgaggtga atatcacgtt ttcatcaaaa 360 
 catgggttcg gaagcggtgt ggaaatcaat acaagcaatc cgacccatcg ctcaggggag 420 
 tcgtcgcctg ttcgtggaga catgttgggt cttaagtccg agcttgagaa gcgttttttc 480 
 ggcaagacat tcgatgacaa catccatatt cagttgattt ataatatttt agatatcgaa 540 
 aagattttag ccgtatatgt gaccaacatt gtttatgcgt taaataacat gttagggatt 600 
 aaggactcgg aatcgtatga tgatttcatg ggttacttaa gcgctcgtaa tacttatgaa 660 
 gtcttcactc atcccgataa gagcaatttg agtgataaag tcaagggcaa catcaaaaag 720 
 tctttgtcga aattcaatga cctgttgaaa actaagcgct tgggt tactt cgggt tggaa 780 
 gaaccgaaga ccaaagatac gcgtgccagt gaagcttaca aaaaacgcgt ctatcacatg 840",2611
37,37,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 32 
 - continued 
 ctggcaatcg tgggccaaat ccgtcagtgt gtttttcatg acaaaagtgg agctaaacgc 900 
 tttgatttgt acagcttcat taataacatt gatcctgaat atcgcgacac tttggattat 960 
 ttagtagaag aacgccttaa atctattaat aaagacttta ttgaagggaa taaggtgaac 1020 
 atcagcttac tgatcgacat gatgaagggt tacgaggctg acgacattat ccgcttgtat 1080 
 tatgatttca ttgtattaaa atctcagaaa aacctgggat tcagtattaa gaaattacgc 1140 
 gagaaaatgc ttgaggagta cggattccgt ttcaaggata aacaatatga ttctgtgcgt 1200 
 agtaaaatgt acaaacttat ggacttttta ttgttctgta actattaccg taatgacgtt 1260 
 gccgcaggcg aagccttggt acgtaagtta cgcttcagca tgacagatga cgaaaaggag 1320 
 ggcatttacg cggatgaagc agcgaagctg tggggtaaat tccgcaacga ttttgaaaat 1380 
 attgctgacc acatgaatgg tgatgttatc aaagaactgg gaaaagccga tatggatttc 1440 
 gacgagaaga tcttggacag tgaaaaaaag aatgccagcg atcttttata tttctccaaa 1500 
 atgatctaca tgcttactta tttccttgac gggaaagaga ttaatgatct gctgaccacg 1560 
 ctgattagta agttcgacaa cattaaggag tttttaaaga tcatgaaatc gtccgctgtg 1620 
 gacgtagaat gcgagttgac ggcaggttac a aactgttca acgatagtca acgcatcacc 1680 
 aatgaacttt tcatcgtcaa aaacattgcc tccatgcgca agcccgcggc tagcgctaaa 1740 
 ttaacgatgt tccgtgacgc cttgacgatt ttaggcatcg acgacaacat cacggacgat 1800 
 cgcatttcgg aaatccttaa acttaaggaa aaggggaaag gtatccatgg tctgcgcaat 1860 
 tttatcacta acaatgtaat tgaatcatca cgcttcgttt acttaatcaa atacgcgaat 1920 
 gctcaaaaga ttcgtgaagt agccaaggat gaaaaggttg tcatgtttgt C ctgggcggg 1980 
 attccagaca cccaaattga acgttattac aagtcttgtg tggaattccc cgatatgaat 2040 
 agctccttgg aggccaaacg ctctgagtta goccgcatga ttaagaacat ttccttcgac 2100 
 gattttaaaa atgtcaaaca acaggcaaaa ggccgcgaga atgtagccaa ggagcgtgcc 
 aaggcagtaa tcggattgta tcttactgtc atgtatttgc ttgttaagaa tcttgttaac 2160 
 2220 
 2280 gttaacgcgc gctatgtaat cgctattcat tgcttagaac gcgactttgg cctttataag 
 gagattattc ccgagcttgc atccaaaaat cttaagaacg actaccgtat tttgtcacaa 2340 
 accttatgcg agttatgcga tgaccgcaac gagtcttcca atctgtttct taaaaaaaac 2400 
 aaacgtcttc gcaaatgcgt ggaagtggac atcaacaacg ccgacagtag tatgactcgt 2460 
 aagtatcgta actgtattgc gcacttgact gtagtgcgcg agttgaagga gtatattggg 2520 
 gatatccgca ccgtggattc atacttcagt atctaccact acgtcatgca acgttgcatc 2580 
 acgaaacgtg gagacgacac caaacaagag gaaaagatta agtatgaaga cgaccttttg 2640 
 aagaaccacg gotacaccaa agattttgtt aaggetttga atagtccctt cgggtataac 2700 
 attccccgtt tcaaaaactt gagcattgaa cagctgttcg accgcaatga atacttgaca 2760 
 gaaaag 2766 
 ? . < 210 > SEQ ID NO 6 
 < 211 > LENGTH : 2799 
 < 212 > TYPE : DNA 
 < 213 > ORGANISM : Artificial Sequence 
 < 220 > FEATURE : < 223 > OTHER INFORMATION : Synthetic : CasM DNA sequence from Ruminococcus flavefaciens FD - 1 , modified for expression in Escherichia coli ? 
 ? 
 < 400 > SEQUENCE : 6",2709
38,38,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 33 
 - continued 
 atgaaaaaaa aaatgtctct gcgtgaaaag cgtgaggcgg agaagcaagc aaagaaagcc 
 gcgtattccg ctgctagtaa gaatactgac agcaaacccg cagagaagaa ggcggaaaca 120 
 cccaagcccg cagaaattat ctcggataac tcgcgcaata aaactgctgt taaagccgcc 180 
 ggottgaaat caactatcat cagtggggat aaattataca tgacgtcatt tggtaaggga 240 
 aatgccgccg tgatcgaaca gaagattgat attaatgact actctttttc toccatgaag 300 
 gataccccta gottagaggt tgataaggcc gagagcaagg agatctcttt ttcctctcac 360 
 catcccttcg taaagaatga caaattgacc acttacaacc ccctgtacgg cggcaaggac 420 
 aatccggaaa agccagtggg acgtgacatg ctggggttga aagacaaatt ggaggaacgt 480 
 tattttggat gcactttcaa tgataatctg cacatccaga tcatctacaa tatcttagac 540 
 atcgagaaaa tcctggctgt tcatagcgca aatatcacca ccgcactgga tcacatggta 600 
 gacgaggatg acgaaaaata cttgaactct gactacattg gttacatgaa caccattaat 660 
 acgtacgacg tatttatgga cccgtcaaag aactcttctt tgtcgccgaa agatcgcaag 720 
 aacatcgaca actcccgcgc caagtttgag aagttattgt caacgaagcg tttaggatac 780 
 tttggttttg actatgatgc gaatggcaag gataagaaga agaacgagga gattaagaag 840 
 cgtctgtacc atcttaccgc gtttgcgggt cagcttcgtc agtggtcctt tcacagcgct 900 
 ggcaattatc cacgtacatg gctgtacaaa cttgatagtt tggacaaaga ataccttgat 960 
 acacttgatc actatttoga taaacgcttc aatgacatta atgacgattt cgttacaaag 1020 
 aacgcgacga atttatatat tottaaggaa gtttttccgg aggcgaactt taaagatato 1080 
 gcagatcttt attacgactt catcgtaatc aaatcccaca aaaatatggg tttctctatt 1140 
 aaaaaattgc gtgaaaaaat gttagagtgt gatggtgcgg atcgcatcaa agaacaagat 1200 
 atggacagcg tacgttcaaa gctgtataaa cttattgact tttgcatttt caaatattac 1260 
 catgagttcc cggaactgtc tgagaagaat gttgatatct tacgtgctgc cgtctccgac 1320 
 acgaagaaag ataatcttta tagcgacgag gccgcgcgtc tgtggagtat cttcaaggag 1380 
 aagttcctgg gtttctgtga caaaattgtc gtatgggtga ctggtgaaca tgaaaaagat 1440 
 atcacttcgg taatcgataa agacgcgtat cgcaaccgta gcaatgtcag ttatttttcg 1500 
 aaactgatgt atgcgatgtg ctttttcctt gatggtaagg aaattaacga tttattgaca 1560 
 accctgatta ataaattega taatatcgca aatcagatca aaacggcaaa ggaacttggt 1620 
 attaacacag ccttogtaaa gaattatgac ttttttaacc actcggagaa gtatgtcgac 1680 
 gaactgaata ttgtgaaaaa catcgctcgc atgaaaaagc ctagtagcaa cgctaaaaaa 1740 
 gctatgtacc acgatgcatt gacgatcttg gggattcctg aagatatgga tgagaaagcc 1800 
 ttagatgagg agctggactt gattctggaa aaaaagaccg atccagtaac cgggaagcct 1860 
 ttgaaaggga aaaacccgct tcgcaacttt atcgctaaca atgtaatcga aaactctcgc 1920 
 ttcatctatt tgattaagtt ttgcaatccg gaaaacgtac gtaagattgt taataacacc 1980 
 aaagttacag agtttgtctt gaagcgcatc ccagatgcgc agatcgaacg ctattacaag 2040 
 tcttgtactg actcggaaat gaacccccca acggaaaaga aaattacgga gttagccggg 2100 
 aaacttaagg acatgaattt tggaaacttc cgcaacgtgc gtcaaagtgc aaaggagaac 2160 
 atggaaaagg agcgttttaa agcagtgatt ggtttgtacc ttaccgtagt ctatcgcgtt 2220 
 gtaaaaaatc tggttgatgt taattcccgc tacatcatgg cgtttcattc gctggagcgc 2280",2808
39,39,"US 2018 / 0282715 A1 Oct . 4 , 2018 34 
 - continued 
 gacagtcagt tatataatgt ctcggtcgac aacgactacc tggccttaac cgatacgtta 2340 
 gtaaaagagg gagataattc ccgttcccgt tacttagcgg ggaataaacg cttgcgtgac 2400 
 tgtgtgaaac aggatattga taatgctaag aaatggttcg t?agtgataa gtacaactct 2460 
 atcacaaaat accgtaataa cgtagcacat ttaactgcag tacgtaattg cgccgaattt 2520 
 atcggtgaca ttactaagat cgactcgtat tttgcattat atcactacct tattcagcgt 2580 
 caactggcta agggtttgga tcacgagcgt tcgggatttg accgcaacta tccgcagtat 2640 
 gctccacttt ttaagtggca tacttacgtg aaagacgtgg ttaaagcctt aaatgctccc 2700 
 ttcggataca acatcccacg ctttaagaat ttgtctattg atgctttatt tgatcgcaat 2760 
 gagatcaaaa agaatgacgg agagaagaag tctgatgat 2799 
 < 210 > SEQ ID NO 7 
 < 211 > LENGTH : 2832 
 < 212 > TYPE : DNA 
 < 213 > ORGANISM : Artificial Sequence 
 < 220 > FEATURE : 
 < 223 > OTHER INFORMATION : Synthetic : CasM DNA sequence from Ruminococcus albus strain KH2T6 , modified for expression in Escherichia coli 
 < 400 > SEQUENCE : 7 
 atggcaaaga aatccaaggg gatgtcgtta cgtgagaaac gcgaattgga aaaacagaag 60 
 cgcattcaaa aggctgctgt taactccgtc aacgacactc ctgaaaagac agaagaggct 120 
 aacgtggtat cagtgaatgt gcgcacttct gccgaaaaca agcactccaa aaagtcagcg 180 
 gccaaggett tggggctgaa atctggcttg gtaattggag atgagctgta tctgacatcg 240 
 ttcggtcgcg gcaacgaagc caagttggaa aagaaaatct caggtgatac ggttgagaaa 300 
 ttaggtatcg gcgcttttga ggtagctgag cgtgacgagt cgacgctgac gottgaaagt 360 
 ggacgcatta aggacaagac ggcgcgtcca aaggacccac gtcacattac ggttgataca 420 
 caaggtaaat tcaaagagga tatgctgggt attcgcagcg tgttagaaaa aaagattttt 480 
 gggaagacct ttgacgataa catccatgta caactggcat acaacattct tgatgtcgag540 
 aaaattatgg cacagtatgt cagtgatatt gtttatatgc tgcacaacac ggacaagacg 600 
 gagcgtaatg ataacctgat gggttacatg tcaatccgca acacatacaa gacgttctgt 660 
 gatacttcaa acttgcctga tgatactaaa caaaaagttg aaaaccaaaa acgtgaattt 720 
 gataaaatca ttaagagtgg ccgtctgggc tatttcgggg aagcttttat ggtaaatagc 780 
 ggcaactcta caaaactgcg cccggaaaaa gagatctatc atatttttgc gctgatggcg 840 
 togttacgcc aaagttactt tcatggttat gtcaaagata ccgattacca agggaccact 900 
 tgggcgtata cactggagga caaactgaag gggccctctc acgagttccg cgagacgatt 960 
 gacaaaatct ttgacgaggg attttccaaa atctcgaaag atttcggcaa aatgaacaag 1020 
 gtgaacctgc aaattttgga gcaaatgatc ggggagttgt acgggtccat tgagcgccaa 1080 
 aacttaactt gtgactacta cgatttcatc cagttaaaga aacataagta tcttggcttt 1140 
 agcattaaac gtttacgcga gacgatgctt gagactactc ccgcagagtg ctataaggca 1200 
 gagtgctaca actctgagcg ccagaaactg tacaagttga tcgacttttt aatctacgac 1260 
 ctttattaca atcgtaagcc cgcacgtatc gaagagatog togataagct gcgtgaatct 1320 
 gtgaatgatg aagaaaaaga gtctatttac tcagtagagg ctaagtatgt ctatgaaagc 1380",2641
40,40,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 35 
 - continued 
 ctttcaaaag tccttgacaa gagottgaag aatagtgttt ctggggaaac cattaaagac 1440 
 cttcagaaac gttatgatga tgaaacagct aaccgtattt gggacatctc gcaacattca 1500 
 atcagtggca acgtcaattg cttctgtaaa ttaatttaca tcatgactct tatgctggac 1560 
 ggaaaagaaa tcaatgatct gttgacaacg ctggttaaca aattcgataa cattgccagt 1620 
 ttcattgatg tcatggatga gttaggatta gagcactcat tcactgataa ctataagatg 1680 
 ttcgctgatt ctaaagctat ttgtctggat ttgcaattta tcaattcatt tgcccgtatg 1740 
 tcgaagatcg atgacgaaaa gtcgaaacgt caactttttc gtgacgcgct ggttatttta 1800 
 gatattggta ataaggacga gacatggatt aataactact tagattccga tatctttaag 1860 
 ctggacaagg aaggtaataa gttaaaggga gcccgccatg attttcgcaa ctttatcgca 1920 
 aataacgtga ttaagtcttc acgcttcaaa tatttagtga agtattcgag tgcggatggc 1980 
 atgattaaat taaagacaaa tgagaagctt attgggttcg ttctggataa gttaccagag 2040 
 acgcaaatcg accgttacta cgagtcttgc gggttagaca atgccgtcgt ggacaaaaaa 2100 
 gtccgtattg agaagctgag tgggttaatt cgtgatatga agttcgacga tttttctggc 2160 
 gtaaaaacta gtaacaaagc tggcgacaat gacaagcagg acaaggccaa atatcaggcc 2220 
 attatttogt tataccttat ggtgctttac cagatcgtaa agaacatgat ttacgtcaac 2280 
 tcacgctacg tcattgcttt ccactgttta gaacgcgatt ttgggatgta tggcaaggat 2340 
 tttggaaaat attaccaggg gtgccgcaag ctgactgatc acttcatcga agagaaatac 2400 
 atgaaggaag gaaaattggg atgcaacaaa aaagtaggac gctatcttaa aaataatatt 2460 
 tcctgctgca cggatggact gattaacaca taccgtaacc aggtggatca tttcgcagtg 2520 
 gttcgcaaaa ttggtaacta tgcggcctat atcaaatcta tcggaagctg gttcgaactt 2580 
 taccattatg tgattcaacg tattgtgttt gatgagtatc gtttcgcact taacaacaca 2640 
 gagtccaact ataaaaactc cattatcaaa caccatacgt actgtaaaga tatggtaaag 2700 
 gcattgaata cgccctttgg ctacgacctg cctcgctaca agaacttgtc gatcggggac 2760 
 ttgttcgacc gtaacaatta tttaaacaag acgaaggaat cgattgatge taattcaagc 2820 
 attgattcac ag 2832 
 < 210 > SEQ ID NO 8 
 < 211 > LENGTH : 2901 < 212 > TYPE : DNA < 213 > ORGANISM : Artificial Sequence 
 < 220 > FEATURE : < 223 > OTHER INFORMATION : Synthetic : CasM DNA sequence from Ruminococcus flavefaciens strain XPD3002 , modified for expression in 
 Escherichia coli 
 < 400 > SEQUENCE : 8 
 atgatcgaga aaaaaaaatc ttttgctaag ggcatgggcg ttaagtccac cttggtttca 60 
 ggttctaagg tatatatgac cactttcgca gagggatccg acgcacgtct ggagaaaatt 120 
 gtcgaaggag attcgatccg ttcggtgaat gagggggagg cgttctccgc ggagatggcg 180 
 gacaaaaatg cgggttataa gattggaaac gctaaatttt cccacccgaa aggatacgca 240 
 gtggtagcca ataaccccct ttacacaggg cctgtgcaac aggacatgtt gggattgaag 300 
 gagactttgg aaaagcgcta ttttggtgag tocgcagatg gaaacgataa tatctgtatc 360 
 caggtaattc acaatatott ggatattgaa aagatccttg ctgagtacat taccaacgct 420",2629
41,41,"US 2018 / 0282715 A1 Oct . 4 , 2018 36 
 - continued 
 gcctacgccg tgaataatat ctccggctta gacaaggaca ttattggctt tgggaagttc 480 
 agtaccgtct atacgtatga cgaatttaag gacccagaac accatcgtgc cgccttcaat 540 
 aataatgata agttgatcaa tgcaattaaa gcccagtacg acgaatttga taacttcttg 600 
 gataatcccc gottaggcta cttcgggcaa gctttcttca gtaaggaggg gcgtaactac 660 
 attattaatt acggcaatga gtgttacgat atccttgcat tactttcggg gottcgccac 720 
 tgggttgtac acaataatga ggaagagtca cgcattagcc gcacgtggtt gtataacctt 780 
 gataagaacc ttgacaatga atacatctct accctgaact acttatatga tcgcattacg 840 
 aatgagttaa ccaattcatt ctcaaagaat agtgcagcca acgtcaacta tatcgcagag 900 
 acgctgggta tcaacccggc ggaattcgcc gagcagtatt tccgcttttc aatcatgaag 960 
 gaacaaaaga atctgggttt caatattacc aagttacgtg aagtaatgtt ggatcgtaag 1020 
 gatatgtctg agattcgcaa aaaccataaa gtgtttgaca gcatccgtac gaaggtctac 1080 
 actatgatgg acttcgttat ctaccgctat tacatcgaag aggatgccaa agtggcagcg 1140 
 gegaacaaat cccttccaga caacgagaaa agtctttctg agaaagacat ctttgtaatc 1200 
 aacttgcgcg gttcctttaa tgatgaccag aaagatgcgt tgtactatga tgaagctaat 1260 
 cgtatttggc gtaagt tgga aaacatcatg cataacatta aggagtttcg tgggaacaag 1320 
 acacgtgagt ataaaaaaaa ggatgctcca cgtcttccgc gcattttgcc tgcaggacgc 1380 
 gatgtcagtg ctttcagcaa attaatgtat gcactgacaa tgtttctgga cgggaaggaa 1440 
 atcaatgatc ttctgactac acttattaac aagtttgata atattcagtc cttcttaaag 1500 
 gttatgcctt tgattggtgt aaacgcgaaa tttgtcgaag agtatgcctt tttcaaggat 1560 
 agcgcgaaaa ttgccgacga actgcgtctt attaagagtt tcgctcgtat gggggagcca 1620 
 atcgctgacg cccgccgcgc tatgtacatc gatgctattc gcatcttagg tacaaacttg 1680 
 tcatacgatg aacttaaagc tttagcagac accttttcgc tggatgaaaa cggaaacaag 1740 
 ttgaaaaaggggaagcatgg aatgcgcaat tttattatca ataacgtgat ctcaaataag 1800 
 cgtttccact atcttatccg ttatggagat ccggcacacc tgcatgaaat tgccaagaat 1860 
 gaggccgtgg tgaaattogt tttagggcgc attgctgata ttcagaagaa acaggggcag 1920 
 aatggaaaga atcaaatcga ccgttactat gagacgtgta ttggcaaaga caaggggaaa 1980 
 tcggtttcgg aaaaagttga cgccttgacg aagatcatca cgggcatgaa ctacgaccag 2040 
 tttgacaaaa aacgctcggt aattgaagat accggacgtg agaatgcgga acgtgagaaa 2100 
 tttaaaaaga tcatctcgtt gtatctgacc gtaatttatc atattttaaa aaatatcgta 2160 
 aacatcaacg cacgctatgt gatcgggttc cactgtgtag aacgcgacgc tcaactttat 2220 
 aaagaaaagg ggtatgatat taacttgaaa aagttagagg agaagggatt ctcatcagtc 2280 
 accaagttgt gcgcgggtat tgacgaaacg gcaccggaca agcgcaaaga cgttgaaaag 2340 
 gagatggccg aacgcgccaa ggaaagtatc gactcattag aaagcgcaaa tcccaagctg 2400 
 tatgccaatt atatcaagta tagcgatgag aagaaggcgg aggagtttac gcgccagatc 2460 
 aaccgtgaaa aggccaaaac tgcattgaat gcctacttgc gcaatacgaa atggaatgtg 2520 
 atcatccgtg aggacctgct gcgtatcgat aacaaaacat gtactttatt tcgcaataaa 2580 
 gcggtacatc ttgaagtggc gcgttacgtt cacgcgtata tcaatgacat tgcagaggtt 2640 
 aattcctatt tccagctgta tcactacatt atgcaacgca ttattatgaa cgagcgttac 2700",2817
42,42,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 37 
 - continued 
 gagaaaagca gcggcaaagt atccgaatac tttgacgcag ttaacgatga gaagaaatat 2760 
 aacgaccgct tactgaaatt gctgtgtgta ccttttgggt attgcatccc ccgttttaaa 2820 
 aacctgagta tcgaagctct gtttgaccgc aacgaggccg ccaaatttga taaggaaaag 2880 
 aaaaaggttt cgggaaatag t 2901 
 < 210 > SEO ID NO 9 
 < 211 > LENGTH : 2388 < 212 > TYPE : DNA < 213 > ORGANISM : Artificial Sequence < 220 > FEATURE : < 223 > OTHER INFORMATION : Synthetic : CasM DNA sequence from Ruminococcus sp . , isolate 2789STDY5834894 , modified for expression in 
 Escherichia coli 
 < 400 > SEQUENCE : 9 
 atggaaatca acacttcgaa ccccacccat cgcagcggtg aaagtagcag tgttcgtggg 60 
 gacatgottg gactgaagtc agagctggag aaacgctttt ttggaaagac cttcgacgat 120 
 aacattcata ttcaattgat ctacaatatc ttggacattg aaaaaatcct ggccgtgtac 180 
 gtcactaata ttgtatatge actgaacaat atgctgggag tgaagggcag tgagagctac 240 
 gatgacttca tgggctatct gtcagcgcag aatacatatt acatctttac tcatccagat 300 
 aagtcaaacc tgagtgacaa agtgaaaggc aacattaaaa agagtctgtc caaatttaat 360 
 gatctgctga aaacaaaacg tttgggttat tttggactgg aggagcccaa aactaaggac 420 
 aagcgcgtga gcgaagccta caagaaacgt gtttatcata tgctggcaat tgtgggtcag 480 
 atccgtcaaa gcgtcttcca tgacaagtct aatgaattgg atgagtatct gtactcgttt 540 
 atcgacatta tcgacagcga atatcgtgac acgctggatt atttggttga tgaacgtttc 600 
 gatagcatca ataagggctt cgtccagggg aataaggtaa acatctcgtt actgattgac 660 
 atgatgaagg ggtatgaggc cgatgacatt atccgcttat actatgactt catcgtgttg 720 
 aaatcccaaa aga accttgg cttctccatt aaaaaacttc gtgagaagat gottgatgag 780 
 tacggtttcc gcttcaagga taaacaatac gattcagtgc gtagcaaaat gtacaagttg 840 
 atggattttt tattattctg caactattat cgtaacgacg tggtagcggg cgaggctctt 900 
 gtccgtaaac tgcgcttctc gatgacagat gacgaaaaag aaggcatcta tgccgacgaa 960 
 gccgagaaat tgtggggcaa gttccgtaat gactttgaga atatcgctga tcatatgaat 1020 
 ggagacgtta tcaaggaact tggcaaagcc gacatggatt tcgacgagaa gatcctggat 1080 
 tctgaaaaga agaacgcgtc ggacttgctg tatttttcga agatgatcta tatgottact 1140 
 tatttcttgg atggcaaaga aattaacgac ctgttgacca cactgattag caaatttgat 1200 
 aacattaagg agttccttaa aattatgaag totagcgcag ttgacgtgga gtgcgagctg 1260 
 actgcgggat acaaattgtt taacgacagt caacgtatca cgaatgaact tttcattgtg 1320 
 aagaacattg cgtcgatgcg caagccggct gccagtgcaa agttgaccat gtttcgtgat 
 gctctgacca tcttaggcat tgatgacaag attaccgatg accgcatttc cgaaattctt 1440 
 aagttaaaag aaaaagggaa aggaatccat ggtcttogta actttatcac caacaatgtg 1500 
 atcgagtcct cgcgttttgt ctacttgatt aaatatgcta acgcacaaaa gattcgcgaa 1560 
 gtagctaaaa acgaaaaagt tgtgatgttt gttttaggtg gcattcccga tacccagatt 1620 
 gaacgctact ataaaagctg tgtcgaattc ccggacatga actcatcttt agaggcaaaa 1680",2627
43,43,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 38 
 - continued 
 tgttcagagt tagctcgtat gatcaagaat attagtttcg atgacttcaa gaatgtgaaa 1740 
 cagcaagcaa agggccgcga aaatgtagcc aaagagcgcg ctaaggctgt catcggattg 1800 
 tatctgacag tcatgtacct tcttgtcaag aatttggtca acgtaaatgc tcgctatgtt 1860 
 attgctatcc attgtttaga acgcgacttc ggcttatata aagaaattat tccggagttg 1920 
 gcctcaaaaa acttgaagaa cgattaccgt attttgagtc agaccctgtg cgaactgtgc 1980 
 gacgaccgcg acgagtcacc taacctgttc ttgaagaaaa acaagcgctt acgtaagtgt 2040 
 gtggaggtgg acatcaacaa tgoggatagc tccatgaccc gtaaataccg taattgcatt 2100 
 gcccatctta ccgtggttcg cgaattaaaa gagtatattg gcgatatccg tactgtcgat 2160 
 tottatttca gcatctacca ctacgttatg cagcgttgta tcacgaaacg tgaggacgat 2220 
 accaaacaag aggaaaagat taagtacgaa gacgatctgc tgaaaaacca tgggtatacg 2280 
 aaggacttcg taaaagcgtt gaactccccc ttcggctata acattcctcg cttcaagaac 2340 
 ttatctatcg agcaactttt tgaccgtaac gagtatttaa cggagaaa 2388 
 < 210 > SEQ ID NO 10 
 < 211 > LENGTH : 2862 
 < 212 > TYPE : DNA < 213 > ORGANISM : Artificial Sequence < 220 > FEATURE : < 223 > OTHER INFORMATION : Synthetic : CasM DNA sequence from Eubacterium siraeum , modified for expression in human cells 
 < 400 > SEQUENCE : 10 
 atgggcaaaa aaatccacgc ccgggacttg agggagcaga gaaaaactga tcgcacagaa 60 
 aaattcgccg atcaaaacaa aaaaagggaa gctgagagag ccgtccctaa gaaagatgca 120 
 gcggtctcag tgaaaagcgt gagtagcgtt tccagtaaaa aagacaatgt aaccaagagt 180 
 atggccaagg cagccggcgt aaagt cagtt ttcgcggtgg gtaacactgt ttacatgaca 240 
 agttttggtc gaggaaacga cgctgtattg gagcagaaga ttgtggatac aagccatgaa 300 
 cccctgaaca ttgacgatcc agcctatcaa ctgaatgtgg taaccatgaa cggatactca 360 
 gttacaggcc ataggggtga gactgtttct gccgttaccg acaacccgtt gaggcgcttt 420 
 aatggacgaa aaaaagacga gcctgagcag tccgtaccaa ccgatatgct ttgcctgaag 480 
 cccaccctcg agaaaaaatt ttttgggaag gagttegatg ataatattca catccagctt 540 
 atatacaaca ttctcgacat agaaaagatt cttgctgtct actcaacaaa tgcgatttac 600 
 gcactcaata acatgagcgc cgacgagaat atcgaaaata gcgatttttt catgaaaagg 660 
 actacggacg agacattoga tgactttgaa aagaaaaaag agtccacaaa cagtagggag 720 
 aaggcggatt ttgacgcctt cgagaaattt atcggtaact acaggettgo ctattttgcg 780 
 gacgcgttct atgtgaataa aaaaaatccc aaaggaaaag caaagaatgt gotcagagag 840 
 gataaagaac tgtactcagt tttgacgctc atcggtaagc tccgccactg gtgtgtacat 900 
 tctgaagagg ggagagcgga gttctggctc tataaattgg acgagcttaa ggacgacttc 960 
 aagaacgttc tcgacgtagt gtacaaccga cctgtggaag agataaataa cagatttatc 1020 
 gaaaacaata aggtaaacat ccaaatattg ggctccgtct acaaaaacac agatattgcc 1080 
 gaacttgtca gaagctacta cgagtttttg attaccaaga agtataaaaa catgggattt 1140 
 tcaattaaga agttgagaga aagcatgctc gagggaaaag gttacgcgga taaagagtat 1200 
 gacagcgtga ggaacaaact ttaccaaatg acggacttca ttctctacac aggttacata 1260",2707
44,44,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 39 
 - continued 
 aatgaggaca gcgacagagc agacgatott gtaaatacgc ttcgctcttc cctgaaggaa 1320 
 gacgacaaga ccactgtgta ctgcaaggag gctgattacc tctggaagaa gtaccgagaa 1380 
 tccattcggg aagtagccga cgcacttgac ggcgacaata ttaaaaagtt gagtaaaagc 1440 
 aacattgaga ttcaggaaga taagcttcgc aagtgcttca tctcttatgc ggattctgtc 1500 
 agtgaattca caaagctgat ctacttgctt actagattct tgagtggtaa ggaaattaat 1560 
 gaccttgtta caactttgat caataagttc gacaatatta gatcctttct cgaaattatg 1620 
 gatgagcttg gtctggaccg aactttcact gctgagtact cattctttga aggttcaaca 1680 
 aaatatctgg ctgaattggt tgagctcaac tcctttgtca agagttgtag ctttgacatc 1740 
 aatgcaaagc gcacgatgta togagatgct ttggatatcc tgggaatcga gtctgacaaa 1800 
 acggaagagg acatcgaaaa aatgatagac aatatcttgc agattgacgc aaatggggat 1860 
 aaaaaactca aaaagaataa cggcttgcga aattttattg catctaacgt catagacagc 1920 
 aaccggttca aatacctcgt gcgctatggc aatccaaaaa agattagaga gaccgcaaag 1980 
 tgcaaaccag cggtccggtt tgtgctgaac gaaattcccg acgcacagat tgaacggtat 2040 
 tatgaagcat gctgccctaa aaacacggct ctgtgcagcg cgaataaaag aagggaaaag 2100 
 ttggcggata tgatcgcgga gattaaattc gagaattttt cagatgcagg caactatcaa 2160 
 aaagcgaacg ttacctcacg gacctcagag gotgagataa agaggaaaaa ccaggccatc 2220 
 ataagactgt atcttactgt tatgtacatc atgctgaaaa atctcgtaaa tgtgaacgca 2280 
 cggtacgtaa tagcgttcca ttgcgtcgag cgggatacga agctgtatgc agagtcaggg 2340 
 ctggaggtag gaaatatcga aaagaacaag acgaacctta ctatggcagt C atgggggta 2400 
 aaactcgaaa acggtattat caagactgaa ttcgacaagt cattcgctga gaacgccgca 2460 
 aacaggtatc tgaggaacgc gagatggtac aagctgatat tggataatct gaaaaaaagc 2520 
 gagcgggcgg ttgtaaacga attcagaaac acagtatgcc atttgaatgc tatacgaaac 2580 
 attaacatta acattaagga aataaaggaa gtcgagaatt attttgcatt gtaccactat 2640 
 cttatacaaa aacacctcga aaatcgattt gcagacaaga aggttgaaag agataccggg 2700 
 gattttatct ctaaacttga agagcacaaa acctattgca aagactttgt gaaagcctac 2760 
 tgcacgccgt tcggctataa cttggtccgc tataaaaact tgaccatcga tggattgttc 2820 
 gacaaaaact acccggggaa agacgatagt gatgagcaga ag 2862 
 < 210 > SEQ ID NO 11 
 < 211 > LENGTH : 2757 
 < 212 > TYPE : DNA < 213 > ORGANISM : Artificial Sequence < 220 > FEATURE : < 223 > OTHER INFORMATION : Synthetic : CasM DNA sequence from Ruminococcus 
 sp . , isolate 2789STDY5834971 , modified for expression in human 
 cells 
 < 400 > SEQUENCE : 11 
 atggcaaaaa agaataaaat gaagccgcgg gaacttaggg aagctcagaa aaaggcccga 60 60 
 caacttaaag ctgccgagat aaacaacaac gctgcaccgg cgatagccgc catgcctgca 120 
 gctgaggtga ttgcacctgc tgccgaaaaa aagaaatcaa gcgtgaaagc agccggcatg 180 
 aaatctatcc tcgtgtccga aaataagatg tatattacgt cttttggaaa agggaatagt 240 
 gcggttctcg agtacgaagt agataataat gattataatc aaactcaact gtcatccaag 300",2670
45,45,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 40 
 - continued 
 gacaatagca atatacaact tggcggggtt aacgaggtta acattacctt ttcaagcaag 360 
 cacggctttg agtcaggtgt agaaataaat acaagtaacc ccactcatcg ctcaggggaa 420 
 tcatcacctg tacgcgggga catgctcggg cttaagtcag aactggagaa acgcttcttt 480 
 ggtaaaacat ttgacgacaa tattcatata cagctgatct ataatattct tgatatagag 540 
 aaaatcttgg ctgtatacgt cacaaacatc gtatacgcac ttaataatat gctcggggtt 600 
 aaaggcagcg aaagccatga cgacttcatt ggatacotta gcaccaataa catctacgac 660 
 gtattcatcg acccagacaa tagcagtctg agcgatgaca agaaggctaa cgtgagaaag 720 
 tcactctcca aatttaatgc cttgcttaaa acaaagagat tggggtactt tgggcttgaa 780 
 gagcctaaga cgaaggataa tcgcgtatca caagcctata agaagcgggt ctatcacatg 840 
 ctggcgatog tgggtcaaat tcgccaatgt gttttccacg acaagtctgg cgctaagaga 900 
 ttcgatcttt acagcttcat caacaacatc gaccccgagt accgggacac cctggactac 960 
 ctcgtggagg aaagactcaa gtcaatcaat aaggatttta ttgaagataa caaggtaaat 1020 
 atatccctcc tcatagatat gatgaaaggt tacgaggccg atgatatcat tcgactgtat 1080 
 tacgatttca ttgtactgaa gagtcaaaaa aatctgggct tctcaatcaa aaaactgegg 1140 
 gagaaaatgc tggacgagta tggttttagg ttcaaggata agcaatacga cagtgtccgc 1200 
 agcaagatgt acaagctcat ggattttttg ctcttttgta attactaccg aaatgacata 1260 
 gctgcaggcg agtctttggt gcgaaaattg cgcttttcca tgacagacga tgaaaaggag 1320 
 ggcatatatg ccgatgaagc tgctaaattg tggggaaaat ttcggaacga tttcgaaaac 1380 
 atcgccgacc acatgaatgg agatgtcatc aaggagcttg gtaaagctga tatggacttt 1440 
 gacgaaaaga tattggacag tgaaaaaaaa aacgctagcg atcttcttta tttttccaaq 1500 
 atgatatata tgctgacgta ttttcttgac ggtaaagaaa taaacgacct gctgactaca 1560 
 ttgatttcaa aatttgacaa catcaaggaa tttctgaaaa taatgaagag ttccgcggta 1620 
 gatgtagaat gtgagttgac agccggatac aaattgttca atgatagtca gaggatcacc 1680 
 aatgagttgt tcattgttaa gaatattgcg tctatgagga aaccagcggc aagtgctaag 1740 
 ttgacgatgt ttcgagacgc gottacaatt cttgggatog atgacaaaat cactgacgac 1800 
 cggatttcag ggatactgaa gctcaaggaa aagggaaaag gcattcatgg gottaggaac 1860 
 tttatcacta acaatgtaat tgaatctagc cggttcgtct acttgatcaa gtacgccaat 1920 
 gcgcaaaaga ttagagaagt tgocaagaat gaaaaggtcg tgatgttcgt attggggggt 1980 
 attccagata cacagatcga acgctactac aagtcttgtg ttgagttccc ggacatgaac 2040 
 tcctctctgg gggtgaagcg ctccgaactg gotcggatga ttaagaacat tagcttcgac 2100 
 gatttcaaaa acgtcaagca acaagcgaag gggcgcgaaa acgttgccaa ggagagggct 2160 
 aaagcagtga tcggtcttta tctcacagtg atgtatcttc ttgttaagaa tcttgtcaat 2220 
 gtcaatgcac ggtatgttat agctatacac tgtctcgaac gagacttcgg tctctacaaa 2280 
 gaaattattc cagagcttgc aagtaaaaac ctgaaaaatg attatcgcat cttgtcacag 2340 
 acgttgtgtg agctgtgcga taagtctcca aacctcttcc ttaagaaaaa cgaacgattg 2400 
 cgaaagtgtg tcgaggtgga tatcaataat gcggactctt coatgacccg aaaatataga 2460 
 aactgtattg cgcacttgac cgtagtcaga gaactcaaag agtacatagg ggacatctgt 2520 
 acggttgact catattttag tatctaccac tatgttatgc aacgctgcat aaccaagagg 2580",2817
46,46,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 - continued 
 gagaatgata cgaagcaaga agaaaagata aagtatgaag atgacctctt gaaaaaccac 2640 
 ggttatacga aggacttcgt aaaagctctt aactcaccat ttggttacaa tatcccaaga 2700 
 ttcaagaacc tctcaatega gcaattgttc gatcgaaatg agtatctgac ggagaaa 2757 
 < 210 > SEQ ID NO 12 
 < 211 > LENGTH : 2754 
 < 212 > TYPE : DNA < 213 > ORGANISM : Artificial Sequence 
 < 220 > FEATURE : < 223 > OTHER INFORMATION : Synthetic : CasM DNA sequence from Ruminococcus bicirculans , modified for expression in human cells M ??? ??? 
 < 400 > SEQUENCE : 12 
 atggcaaaga agaacaaaat gaagccgcgc gagttgcggg aggcccaaaa gaaagctcgc 60 
 cagctgaagg ccgccgaaat caataacaac gcagtccctg ccatagctgc catgccagca 120 
 gccgaagccg ccgcaccggc tgcggaaaag aagaagtcct cagtaaaagc tgcgggcatg 180 
 aaaagtatac ttgtgtcaga gaacaagatg tatatcacca gttttggaaa aggcaactcc 240 
 gcagtgcttg agtatgaggt agataacaat gattacaaca agacgcagtt gtccagcaaa 300 
 gataactcaa acattgaact gtgcgacgtt ggcaaggtta atataacttt cagtagtcgc 360 
 cgcggatttg aatcaggggt ggaaatcaat acttctaacc caactcatcg gtctggggag 420 
 agctcttcag tacgcgggga tatgttggga cttaaatctg agctcgaaaa gagatttttt 480 
 ggtaagaact tcgatgataa catccacatc caattgattt ataatatctt ggatatagag 540 
 aagatactcg cagtatatgt gactaacatc gtctacgcgc ttaacaatat gctcggtgag 600 
 ggagatgagt ctaactacga ctttatgggc tatctgagca catttaacac ctataaagtg 660 
 ttcactaatc ccaatggaag tactttgagc gatgacaaga aagaaaacat tcgcaagtca 720 
 ctctctaagt tcaacgccct cctcaagacc aaacgcttgg ggtattttgg tctggaagaa 780 
 cccaaaacga aagacactag agcttcagag gcatacaaga aacgagtata ccatatgctc 840 
 gccattgtcg ggcagatccg ccagtgtgtg tttcatgata agtctggagc aaaacgatto 900 
 gacctgtata gttttatcaa caatatagac cccgagtata gggaaacttt ggactacctt 960 
 gtagatgagc ggtttgactc cataaacaag ggctttatac aaggaaataa agtcaatatc 1020 
 agtctgctca tagatatgat gaaagggtat gaagctgacg acattattcg cctgtactat 1080 
 gactttatcg ttcttaagtc tcagaaaaat cttggcttca gtataaaaaa gctccgcgag 1140 
 aagatgctgg atgagtatgg atttagattc aaggataagc agtacgacag tgtaagatct 1200 
 aaaatgtata aacttatgga ttttctgttg ttctgcaact actaccggaa cgacatcgcc 1260 
 gcgggtgaga gtttggtgag aaagcttcgg ttctccatga ccgacgacga aaaggaaggg 1320 
 atatatgcag atgaagcggc taaactctggggcaagtttc gaaatgactt cgaaaacatt 1380 
 goggatcata tgaacggtga tgtgataaaa gaacttggaa aagccgatat ggactttgat 1440 
 gaaaagatac tggactcaga aaagaaaaac gccagtgacctcctttactt cagcaagatg 1500 
 atctacatgc tcacctactt tctggatggg aaagaaatca atgatttgct tacaaccttg 1560 
 atctctaagt tcgataatat aaaggaattt ttgaagatca tgaaatctag tgctgtggac 1620 
 gtagagtgtg aactcacagc aggatataag ctctttaatg atagccaacg aataacaaac 1680 
 gagcttttca tagtgaaaaa cattgccagc atgcggaagc cggcggcgtc agcaaaattg 1740",2653
47,47,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 - continued 
 accatgttcc gcgatgcact gactattctt gggatcgatg ataaaataac ggatgatcgc 1800 
 ataagcgaga ttctgaaatt gaaggaaaag ggtaagggta tacacggttt gcggaacttc 1860 
 attacgaaca acgtcattga atccagtcga tttgtgtatc tgataaagta cgcgaatgcg 1920 
 cagaaaataa gggaggttgc taaaaatgag aaggtcgtca tgttogtact tggcggcatt 1980 
 cccgacacac aaatcgaaag gtattacaaa agttgtgtag agttcccaga tatgaacagt 2040 
 tccttgggag taaaacggtc tgaactggcg agaatgataa agaatatatc attcgacgac 2100 
 ttcaaaaatg taaagcaaca ggcgaaagga agagagaacg tggctaagga acgggccaaa 21b 2160 
 gccgttattg gactttacct tacggttatg tacttgttgg ttaaaaacct tgttaatgta 2220 
 aacgcacgct atgttatagc aatacattgc ctggagagag acttcgggct ctacaaggaa 2280 
 ataattcccg aactcgcttc aaagaacctt aaaaacgatt accgcattct tagtcaaacg 2340 
 ctctgcgagc tctgcgacaa atcccctaac ctgttcctca aaaaaaatga gagactcagg 2400 
 aagtgcgtcg aggttgacat caataatgca gattctagta tgactcgaaa gtatcggaac 2460 
 tgtatcgcgc acttgacagt tgtgcgcgaa ctgaaagaat acataggcga tatctgtacc 2520 
 gtagactcat atttctcaat ttaccactat gtgatgcaaa gatgcataac caagagggag 2580 
 aacgacacga aacaggagga aaagattaag tacgaggatg acttgttgaa aaaccacggt 2640 
 tatacaaaag attttgtcaa ggcactgaat agtccttttg ggtataatat cccgaggttc 2700 
 aaaaaccttt caattgaaca actcttcgat aggaacgagt acctgacgga gaag 2754 
 < 210 > SEO ID NO 13 
 < 211 > LENGTH : 2766 
 < 212 > TYPE : DNA < 213 > ORGANISM : Artificial Sequence 
 < 220 > FEATURE : < 223 > OTHER INFORMATION : Synthetic : CasM DNA sequence from Ruminococcus sp . , isolate 2789STDY5608892 , modified for expression in human 
 cells 
 < 400 > SEQUENCE : 13 
 atggcaaaaa agaacaagat gaagccccga gagttgcggg aagcgcagaa aaaagcgagg 60 
 cagcttaagg ccgctgaaat caacaacaat gccgctcccg caatagctgc gatgcctgcc 120 
 gcggaggtga ttgcaccagt agcggagaag aagaaaagtt ctgtaaaagc tgcaggtatg 180 
 aaaagcatat tggtaagtga aaacaagatg tatataacta gtttcggcaa aggtaattct 240 
 gccgtgttgg aatatgaggt tgataataac gattacaata aaacccaact ctcctctaaa 300 
 gacaattcaa atatagagct cggcgacgta aatgaagtga acattacgtt ctccagcaaa 360 
 cacggtttcg gctcaggggt ggaaattaat acttctaacc cgacacaccg gagtggtgag 420 
 tcatctccag tgagaggaga tatgctcgga ttgaaatccg aactcgagaa acggttcttc 480 
 ggcaagacat tcgacgacaa catccatatc cagttgattt ataacatact cgacatcgag 540 
 aaaattttgg ccgtgtatgt gacaaacatt gtttatgcat tgaacaacat gctgggtata 600 
 aaagattcag agagctatga cgactttatg gggtacttga gtgcacgcaa tacctacgag 660 
 gtgtttacgc acccagacaa gagtaatttg tutgacaagg tgaagggtaa tattaagaag 720 
 tccctttcaa aatttaacga cttgctgaaa actaaacgct tggggtactt tggactcgaa 780 
 gaaccaaaaa ccaaggatac aagggcatca gaagcctaca agaagagggt gtaccatatg 840 
 ctggctatag taggtcagat tcggcagtgc gtattccacg acaagtcagg tgcaaagaga 900",2668
48,48,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 43 
 - continued 
 tttgatcttt actcattcat aaacaacatt gatccggaat accgggatac gctggactat 960 
 ctggtagaag agcgattgaa gtcaatcaat aaagatttta ttgaaggaaa caaagtgaat 1020 
 attagcctgc tgatcgacat gatgaaaggg tatgaagctg atgacatcat acggctctac 1080 
 tacgacttca tagtactcaa gagtcagaag aacctgggtt tttccatcaa aaaactgega 1140 
 gaaaagatgt tggaagaata cggctttcgc ttcaaagaca aacagtatga ttccgtccga 1200 
 agcaaaatgt ataagcttat ggatttcctg ctcttctgca attattacag aaatgacgta 1260 
 gccgcgggag aagccctggt acgaaagttg agattctcta tgacggatga cgagaaggaa 1320 
 ggcatctatg ctgacgaggc agcgaagctg tggggaaaat tocgcaacga cttcgaaaac 1380 
 atagcggatc atatgaatgg ggacgttata aaagaactcg gaaaagcgga tatggacttt 1440 
 gatgagaaga tcctggattc tgagaaaaaa aacgctagtg atcttctcta tttctctaag 1500 
 atgatttaca tgctcacgta ttttttggat ggcaaagaaa ttaatgatct cctcactacc 1560 
 ctcatttcta agttcgacaa tattaaggaa ttccttaaga tcatgaagag ttcagcggtc 1620 
 gacgtagaat gtgagcttac tgccggatac aaattgttta acgatagcca gcgaatcacg 1680 
 aatgagctgt tcattgtcaa gaatatcgcc agtatgagga agcccgctgc gtctgcaaaa 1740 
 ttgactatgt tccgcgatgc tcttaccatt ctgggcattg acgacaatat aactgacgac 1800 
 cgcatcagtg agatcctgaa gctcaaggag aaggggaagg ggatccacgg attgoggaat 1860 
 ttcatcacaa ataacgtaat tgagagttoc cggttcgtgt atcttattaa atatgccaat 1920 
 gctcaaaaga taagagaagt agcaaaaaac gagaaggtgg tcatgtttgt actgggcgga 1980 
 atacccgaca cccaaatcga acggtattat aaatcttgtg tagaattccc agacatgaac2040 
 agttcactcg aagcgaagag atcagaactc gcgcggatga ttaaaaacat ttccttcgac 2100 
 gacttcaaaa acgtcaaaca gcaggcgaaa ggtagggaga atgttgcgaa agaaagagct 2160 
 aaagcggtaa ttggtctgta tctgaccgtc atgtacctgt tggtgaaaaa tcttgtcaac 2220 
 gtaaatgcgc gatacgtcat cgcgatccat tgtcttgagc gagacttcgg gctctataag 2280 
 gagattatcc ctgagttggc cagtaaaaat cttaaaaacg actacagaat ccttagccag 2340 
 acgctttgtg agctttgtga cgacaggaac gagtcttcca atctgtttct caagaaaaat 2400 
 aagaggctca gaaaatgtgt agaggttgat atcaataacg ctgatagctc tatgactcga 2460 
 aagtatcgga attgtattgc acaccttacg gtagttaggg agctgaaaga atatatcggc 2520 
 gatatacgaa cagtagacag ctatttcagt atataccatt atgtcatgca acgctgcatt 2580 
 accaagaggg gggacgatac caagcaggag gagaaaatca aatacgaaga tgacttgctc 2640 
 aagaatcacg gttatactaa ggattttgtt aaagcgctca atagtccttt tggctacaac 2700 
 atcccccgat tcaagaacct gagtattgaa caacttttcg atagaaacga gtaccttact 2760 
 gagaaa 2766 
 < 210 > SEQ ID NO 14 < 211 > LENGTH : 2766 < 212 > TYPE : DNA 
 < 213 > ORGANISM : Artificial Sequence 
 < 220 > FEATURE : < 223 > OTHER INFORMATION : Synthetic : CasM DNA sequence from Ruminococcus sp . CAG : 57 , modified for expression in human cells M ??? 
 ? ?? 
 < 400 > SEQUENCE : 14 
 atggccaaaa aaaataagat gaaaccacgc gaattgcggg aagctcagaa aaaggctaga 60 60",2696
49,49,"US 2018 / 0282715 A1 Oct . 4 , 2018 44 
 - continued 
 cagttgaagg ccgcggagat aaacaacaat gcagcacctg ctatcgccgc catgccagct 120 
 gccgaggtga ttgcccccgt agcggaaaag aagaaatcct ccgtaaaagc ggcggggatg 180 
 aagagcatcc ttgtgagcga gaacaaaatg tacattacaa gotttggtaa agggaactca 240 
 gctgtgttgg agtacgaagt cgacaataac gactacaaca agacccagct gtcctctaaa 300 
 gacaat agca acatagaact gggcgacgta aacgaggtaa atataacgtt ctcttctaag 360 
 catggctttg gcagtggtgt ggagataaat acttccaacc ccactcatcg aagcggggaa 420 
 agtagcccgg ttaggggaga catgctcggc ttgaaatcag agctggagaa gagatttttt 480 
 gggaaaacat tcgacgataa tatacacatc cagctgatat ataacattct ggatatagaa 540 
 aaaatacttg cagtgtacgt tacgaacatt gtctatgott tgaacaatat gctcggaatt 600 
 aaggattccg agtcctacga tgatttcatg ggttacctga gcgcccgaaa cacgtacgag 660 
 gtgttcactcatccggacaa atccaatctc agtgataaag tgaagggcaa cataaagaaa 720 
 tccctttcta aatttaacga tctcctcaag acgaaaagac tcgggtactt tgggctggag 780 
 gaacctaaaa cgaaagacac tagagccagc gaggettata aaaaaagagt ctaccacatg 840 
 ctcgctatag ttggacaaat taggcaatgt gtgtttcatg acaaaagtgg tgcaaaacgg 900 
 ttcgatctgt actcatttat caacaacatt gatccagagt accgagacac tctcgactat 960 
 ttggttgagg aacgattgaa atctataaac aaggatttca ttgaggggaa caaggtaaat 1020 
 ataagccttc tcattgatat gatgaagggg tacgaagccg acgatataat ccgcctctac 1080 
 tatgatttta ttgtgctgaa aagtcagaag aatctggggt ttagtattaa aaagcttagg 1140 
 gagaagatgc tggaagaata tggttttcgg tttaaagata aacaatatga ctccgtgagg 1200 
 agtaaaatgt acaaacttat ggatttcctc ctgttctgta actattatcg gaatgatgtt 1260 
 gcagcaggcg aagcactcgt ccgcaaactt agattcagta tgacagatga tgagaaggaa 1320 
 ggaatatacg ctgacgaagc ggcgaaactg tgggggaaat ttcgcaacga ctttgagaac 1380 
 atagctgacc atatgaatgg cgacgttatc aaagagctcg gtaaggcgga catggacttc 1440 
 gacgagaaaa ttctcgacag tgagaaaaag aacgccagtg atctgctgta ttttagcaaa 1500 
 atgatataca tgctcacata ctttctcgat ggtaaagaga tcaacgactt gttgaccacg 1560 
 cttattagca aatttgataa catcaaagag ttcttgaaaa taatgaagtc cagtgccgtg 1620 
 gatgtggagt gcgagctcac ggcaggttat aaacttttta acgatagtca acggatcact 1680 
 aatgagctgt tcattgtcaa gaatattgca agcatgcgca agcccgcggc aagtgcaaag 1740 
 cttacgatgt ttcgggacgc cctcacgata ttgggtatag atgacaatat aactgatgat 1800 
 agaatcagtg agatacttaa gctcaaggaa aaggggaaag ggatacacgg tctgcgcaac 1860 
 ttcataacga ataacgtgat tgagagctcc cgatttgtct atctgataaa gtacgccaat 1920 
 gcccaaaaga taagggaagt agctaaagat gaaaaagtgg tcatgttcgt ccttggcggg 1980 
 attcccgaca cgcagattga gaggtactac aagtcttgtg tggagtttcc ggatatgaac2040 
 agctccctcg aggctaagcg cagtgagctg gctagaatga ttaagaatat ttcctttgat 2100 
 gattttaaaa atgtaaagca acaagctaag ggacgggaga acgtcgccaa agaacgggcg 2160 
 aaagcagtga ttgggcttta tctcacggtc atgtatctgc ttgttaagaa cttggtcaac 2220 
 gtcaatgcaa gatatgttat agcgatccac tgccttgaac gagatttcgg gttgtacaaa 2280 
 gaaatcatcc cggagttggc atctaaaaac cttaagaatg actatcgaat actgtcacaa 2340",2810
50,50,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 45 
 - continued 
 accttgtgcg aactctgcga tgaccgaaac gaatcatcta acctcttcct taaaaaaaac 2400 
 aagagactca gaaagtgtgt ggaggtggat atcaataatg ccgattccag tatgactaga 2460 
 aaataccgca actgcatcgc acacctgact gtggtcagag aacttaagga gtacattgga 2520 
 gatattagaa cggtcgactc atattttagc atctatcatt atgtcatgca gaggtgtatc 2580 
 accaagagag gagatgatac aaagcaggaa gagaagataa agtacgagga cgatcttctt 2640 
 aagaaccatg getacactaa ggacttcgta aaagcgttga actccccgtt cgggtataac 2700 
 atacctaggt ttaagaatct ttcaattgag caattgtttg accgcaatga gtaccttaca 2760 
 gagaag 2766 
 < 210 > SEQ ID NO 15 
 < 211 > LENGTH : 2799 
 < 212 > TYPE : DNA < 213 > ORGANISM : Artificial Sequence < 220 > FEATURE : < 223 > OTHER INFORMATION : Synthetic : CasM DNA sequence from Ruminococcus flavefaciens FD - 1 , modified for expression in human cells 
 < 400 > SEQUENCE : 15 
 atgaaaaaga aaatgtcctt gcgagaaaaa agggaagctg aaaaacaagc aaagaaggcc 60 
 gcgtactcag cagcttccaa gaataccgac tccaaaccag cggaaaagaa ggcagaaacc 120 
 ccgaagccgg cagagataat aagtgacaac agtcggaata aaacggctgt gaaagctgcg 180 
 ggccttaaat ctaccattat atctggagat aagctgtaca tgacatcatt tggtaagggg 240 
 aacgctgcgg ttattgaaca gaagatcgac atcaatgact atagcttctc tgctatgaaa 300 
 gatacaccat ccctggaagt ggacaagget gaaagcaagg aaatttcatt tagcagecac 360 
 cacccgtteg tgaaaaatga taaactgacc acctacaacc cattgtatgg tgggaaagat 420 
 aatccggaaa aaccagtagg aagagacatg ctgggactga aggacaagct tgaagaacgg 480 
 tatttcggat gcaccttcaa tgataacttg catattcaga ttatatataa catactcgat 540 
 atcgaaaaga tacttgcagt gcactccgca aacatcacga ccgcgctgga tcacatggtg 600 
 660 gacgaagatg atgagaaata tcttaacagt gattacatcg ggtacatgaa cacaattaac 
 acatacgacg tatttatgga cocttctaaa aattccagcctctcacctaa ggaccgcaag 720 
 aatatcgaca acagtcgagc caagtttgaa aaactgttga gcacgaaaag gottggatat 780 
 ttcggattcg attatgacgc caatggtaag gacaaaaaaa agaatgaaga gataaaaaaa 840 
 cggctgtatc atttgactgc attcgctggc caactgagac agtggtcctt ccattctgct 900 
 gggaactacc ctcgcacgtg gctctacaaa ttggacagct tggacaagga ataccttgac 960 
 acgctggacc attactttga taaacggttc aatgatatta acgatgattt tgttaccaaa 1020 
 aacgccacta acttgtatat actcaaggaa gtatttccgg aggcaaattt caaagacata 1080 
 gccgaccttt actacgactt tattgttatc aagagccaca agaacatggg gttttccatt 1140 
 aaaaaactcc gcgagaagat gctcgaatgc gatggtgctg accgcatcaa ggagcaggat 1200 
 atggactcag taaggagtaa gotttacaaa ctgatcgact tttgtatttt taagtattac 1260 
 cacgaatttc ctgagttgtc agagaagaac gtcgacatac ttcgagcagc ggtttctgat 1320 
 acgaaaaagg ataaccttta ttcagacgag gctgctcggc tgtggagcat attcaaagaa 1380 
 aagttcctcg gottttgtga caaaattgtg gtttgggtca ccggagagca cgaaaaggac 1440",2599
51,51,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 46 
 - continued 
 atcacgtcag tgattgataa agacgcatat cgaaatcgca gtaacgtttc ttacttctcc 1500 
 aagcttatgt acgcaatgtgtttctttctt gatggtaagg agataaacga cctcctcacg 1560 
 acccttatca ataagttega caatatagca aatcagatta agacggccaa agaactcgga 1620 
 ataaacactg catttgtaaa gaactacgac ttcttcaatc atagcgagaa atacgtagac 1680 
 gagctgaata tcgtgaaaaa tatcgctcgg atgaaaaaac ccagttcaaa cgcaaaaaag 1740 
 gcaatgtatc atgacgcatt gacgatattg ggaatcccag aggacatgga tgagaaggct 1800 
 ctcgacgaag aattggacct cattttggag aaaaagactg atccggtgac tggcaaacca 1860 
 ctgaaaggca aaaaccctct gegaaatttc atagccaaca acgtaatega aaacagtaga 1920 
 ttcatatacc ttattaagtt ctgcaacccc gagaatgtcc gcaagatagt caacaacaca 1980 
 aaggtcacgg aattcgttct gaagcgcatt cctgatgccc aaatcgagcg gtactacaag 2040 
 agttgtactg atagtgagat gaaccccccc acggaaaaaa agattacgga gctcgctggt 2100 
 aagctgaaag atatgaattt tgggaacttc aggaacgtaa ggcaatctgc aaaggaaaac 2160 
 atggaaaagg agcgcttcaa agcagtgatt ggcctgtatc tcaccgttgt gtaccgagtc 2220 
 gtcaagaatc ttgtagatgt gaacagtcga tacatcatgg cttttcacag tctggaacgg 2280 
 gatagtcagc tgtacaacgt ctccgtggat aacgattacc tcgcacttac ggacactctt 2340 
 gtcaaggaag gcgacaattc ccggtcacga tatctggccg gaaataaacg ccttcgagat 2400 
 tgtgtaaagc aggatattga taacgcaaag aagtggtttg tgagcgacaa gtacaatago 2460 
 ataactaaat accgaaacaa tgtagctcac cttaccgctg taaggaattg cgcggaattt 2520 
 atcggtgata ttactaagat tgattcctat ttcgcactgt atcattatct gatacagagg 2580 
 caacttgcca agggcctgga ccatgaacgg agtggctttg atcgaaacta tccccaatac 2640 
 gcaccattgt ttaaatggca tacttacgtt aaggacgttg tgaaggctct taatgctcct 2700 
 ttcggttaca atatacctag attcaaaaat ?tgagcatcg atgcactgtt cgaccgcaat 2760 
 gagattaaaa agaacgacgg agagaaaaag tocgacgat 2799 
 < 210 > SEO ID NO 16 
 < 211 > LENGTH : 2832 
 < 212 > TYPE : DNA 
 3 > ORGANISM : Artificial Sequence 
 FEATURE : < 223 > OTHER INFORMATION : Synthetic : CasM DNA sequence from Ruminococcus albus strain KH2T6 , modified for expression in human cells M ?? 
 ? 
 ? 
 < 400 > SEQUENCE : 16 
 atggctaaaa aatcaaaagg aatgagcctc cgcgaaaagc gggaactcga gaagcaaaag 60 
 aggattcaaa aggccgcggt taattcagtg aacgatacac ccgaaaaaac ggaggaagct 120 
 aatgtcgtca gcgtcaacgt tcgaacctca gotgagaata agcactccaa aaaatctgcg 180 
 gccaaagctc tgggccttaa gagtggtctg gttataggag acgaacttta cttgacgagc 240 
 ttcggtcgcg gtaatgaagc gaagttggag aaaaagatta gcggcgacac ggtcgagaag 300 
 ctggggatcg gcgccttoga ggttgctgaa agggacgaat ?tactctcac gctcgagagc 360 
 ggtcgcatca aagacaagac agccagacca aaagatccac ggcatattac tgttgataca 420 
 caaggaaaat tcaaagaaga tatgttgggt atccggagcg tactcgagaa aaaaatattt 480 
 ggcaaaactt ttgatgataa catccacgta caactggcgt ataacattct tgacgttgaa 540 
 aaaatcatgg ctcagtacgt ctcagacata gtatacatgt tgcacaacac ggataagacc 600",2718
52,52,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 47 
 - continued 
 gagcgcaatg ataacctgat gggatatatg tccattcgaa acacatataa gacattttgc 660 
 gacactagca atctgcctga cgacacaaag caaaaagttg aaaaccaaaa gagagagttc 720 
 gataagataa tcaagtccgg ccgactcgga tattttggag aagcatttat ggtaaattca 780 
 ggcaatagta cgaagctccg acctgagaaa gaaatctacc atattttcgc gottatggca 840 
 tccctgcgcc aaagctactt tcatggttac gtcaaggata cagattacca gggtaccacg 900 
 tgggcgtata cgcttgaaga caaactcaag ggtccatctc atgagtttcg agaaacgatc 960 
 gataagattt ttgacgaggg gttttcaaaa atcagtaaag atttcggaaa gatgaacaag 1020 
 gttaatctcc agattttgga acaaatgata ggcgagctgt atggctccat cgagcgccaa 1080 
 aaccttacgt gtgactatta tgattttata cagcttaaaa aacacaaata tctgggtttc 1140 
 tccataaaac gcctcaggga aacgatgott gagacaacac ctgcggaatg ttataaggca 1200 
 gaatgttata actctgagag gcaaaaactg tacaagctga tcgacttcct gatctacgat 1260 
 ctctactaca atcgcaagcc agcacgaatt gaagagatag togataagct gcgggagagc 1320 
 1380 gtgaacgacg aggagaagga gtccatatac tcagttgagg caaagtatgt ctatgagtcc 
 ttgtcaaaag tgctcgacaa gagtctcaaa aactctgtga gcggtgagac gatcaaagac 1440 
 cttcagaaac ggtatgacga tgagacggcc aaccggatct gggacatctc ccagcattcc 1500 
 atatccggta acgtgaactg tttctgtaag cttatctaca toatgacact gatgctcgac 1560 
 ggcaaggaaa tcaatgatct cctgactaca cttgttaaca agttcgataa cattgcttct 1620 
 ttcatagacg ttatggatga gottgggctg gagcacagtt ttaccgataa ctataagatg 1680 
 tttgcagatt ccaaggocat atgottggat ctgcaattta taaattcctt cgctagaatg 1740 
 totaagattg atgacgaaaa atctaaacga cagcttttca gggatgcgct cgtaattctt 1800 
 gacatcggaa ataaagatga gacctggata aaaactact tggattccga catattcaag 1860 
 ttggataagg aaggaaacaa actcaagggt gcccggcatg actttaggaa ctttattgcg 1920 
 aacaacgtca tcaagtcctc ccggtttaag tatctcgtta agtactctag cgctgacggg 1980 
 atgataaagc tgaaaacgaa cgagaaactc atcggattcg tcctggacaa gctgcctgag 2040 
 acgcagatag atcgatatta tgaatcatgc ggccttgaca atgcggtcgt cgacaagaaa 2100 
 gtgcgaatag agaagttgag cggacttatc agggacatga agtttgatga cttctccggc 2160 
 gtgaagactt ctaacaaggc cggagacaat gataaacaag ataaggcgaa gtaccaggct 2220 
 attattagtt tgtatctgat ggtactgtac cagatagtaa aaaacatgat ttacgtcaat 2280 
 tcccgctatg tcattgcttt ccactgcctt gaacgcgact ttgggatgta tggcaaagat 2340 
 tttggaaagt actaccaggg ctgtcggaag ttgaccgacc acttcataga agaaaagtac 2400 
 atgaaggaag gaaagttggg gtgcaacaaa aaggtcgggc ggtacctgaa aaacaatatt 2460 
 tcctgctgta cggacggatt gataaatact taccgaaatc aggtggacca ttttgcggta 2520 
 gtccgaaaga taggaaacta cgcagcctac attaagtcaa taggctcttg gtttgaactg 2580 
 2640 taccactacg taattcagag gattgtcttc gacgaataca gattcgctct taacaacaco 
 gagtcaaatt ataagaatto catcatcaaa catcacacgt attgtaagga tatggtgaag 2700 
 gcgctgaaca cgccgtttgg ttatgatttg ccacggtaca aaaatctctc cattggggat 2760 
 cttttcgacc gcaataacta tctcaacaaa actaaggaaa gcatcgacgc taatagttca 2820 
 atagattctc aa 2832",2769
53,53,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 48 
 - continued 
 < 210 > SEQ ID NO 17 < 211 > LENGTH : 2901 < 212 > TYPE : DNA < 213 > ORGANISM : Artificial Sequence 
 20 > FEATURE : < 223 > OTHER INFORMATION : Synthetic : CasM DNA sequence from Ruminococcus 
 flavefaciens strain XPD3002 , modified for expression in human 
 cells ? 
 < 400 > SEQUENCE : 17 
 atgatagaga aaaaaaaaag ctttgcgaaa gggatgggcg taaaaagtac actggtatca 60 
 ggctctaagg tctacatgac aacgttcgca gaaggaagcg atgcacgcct cgaaaagatt 120 
 gttgagggag atagcattag gtccgtcaat gaaggagaag cctttagtgc agaaatggca 180 
 gacaagaacg ctggatacaa gattggaaac gcaaaatttt cccatccaaa gggatacgca 240 
 gttgtagcta acaatcccct ctataccggg cccgtccagc aagacatgct tggcctcaaa 300 
 gagacgottg agaagaggta ttttggagag agtgctgatg gtaatgacaa tatctgtatc 360 
 caagttattc ataacatcct cgacatagag aaaatccttg cagaatatat caccaacgcc 420 
 gcatatgcag tgaataatat atccggtctg gataaagaca taatcggatt cggcaagttt 480 
 agtacagtat atacctatga cgagttcaaa gacccggagc atcatcgagc cgctttcaat 540 
 aacaacgaca aacttatcaa toccattaag gctcaatatg acgagttcga taattttttg 600 
 gacaatocca gacttgggta tttcggccag gccttctttt ctaaggaagg caggaattac 660 
 atcattaatt acggaaacga atgttacgat atcctcgctt tgctctctgg cctgcgccac 720 
 tgggttgtac acaacaacga ggaggaatct cgaatttcac gaacttggct gtacaatttg 780 
 gataaaaact tggataatga atacatcagt actctgaact atctctacga taggatcacc 840 
 aacgaactta cgaattcatt ttcaaaaaat tccgccgcaa acgttaatta catcgctgag 900 
 acgttgggca taaatccggc cgagttcgcc gagcaatatt ttaggttcag tatcatgaag 960 
 gagcaaaaga atttggggtt caacatcacg aaactccgag aagtcatgct cgaccgaaaa 1020 
 gatatgtccg aaattcggaa gaaccataag gtattcgaca gcatccgcac aaaagtgtac 1080 
 acaatgatgg atttcgttat atacaggtat tatatagagg aagatgcaaa agttgccgcc 1140 
 gcaaacaaaa gtcttccaga taatgaaaag agcttgagtg aaaaagatat ttttgttata 1200 
 aaccttcgcg gttccttcaa tgatgaccaa aaggatgctc tgtactacga cgaggcaaac 1260 
 cgaatctggc gaaaactgga aaacatcatg cataatataa aggaatttcg cgggaacaaa 1320 
 acgagggagt ataagaagaa ggatgctcct cgcctcccca ggatactccc tgcgggcaga 1380 
 gacgtctccg catttagcaa actgatgtat gctctcacta tgtttttgga tgggaaggag 1440 
 ataaacgatc ttctgactac gttgattaac aaatttgaca acattcagag ttttctcaag 1500 
 gtcatgccac ttatcggcgt aaatgcaaag tttgttgagg aatacgcctt ctttaaagac 1560 
 tccgctaaaa tagcggacga gotccgcctg attaaatcct tcgcccgaat gggtgaaccg 1620 
 atagcggatg cccggcgagc tatgtacatc gatgctatca ggatccttgg aactaacttg 1680 
 agctacgacg aacttaaggc tctggcggac actttcagtt tggacgagaa tgggaacaag 1740 
 ctgaaaaagg gaaagcacgg gatgagaaac ttcataataa ataatgtcat ttccaacaag 1800 
 aggttccatt atttgattcg gtatggtgat cctgcgcacc ttcatgaaat tgcgaagaat 1860 
 gaagctgtgg ttaaatttgt tcttggcaga attgccgaca tccaaaaaaa acaggggcaa 1920",2668
54,54,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 49 
 - continued 
 aatggtaaga accaaattga tagatactac gaaacttgca taggtaaaga caaaggtaaa 1980 
 agtgtctctg aaaaggtgga tgccctgacg aaaatcatca caggtatgaa ctatgaccaa 2040 
 ttcgacaaaa agagaagtgt aattgaggat actggtcggg aaaacgctga aagagagaag 2100 
 tttaagaaga ttattagtct ctatcttacc gttatttatcacattctcaa aaacatagte 2160 
 aacatcaatg ccagatatgt catcggattc cactgcgttg aacgagatgc tcagttgtac 2220 
 aaggagaaag gctacgacat caacctcaaa aaactggagg aaaaggggtt tagttccgtt 2280 
 acaaagttgt gcgccggaat tgacgagacg gccccagata aacgaaagga cgttgagaaa 2340 
 gaaatggcgg aacgagcgaa agagtccatc gactctcttg agtcagctaa tcctaaattg 2400 
 tatgcaaact atattaaata ctctgatgag aagaaagcgg aggaattcac acgacagato 2460 
 aatcgggaga aagcaaaaac ggcactgaat gcatacttga ggaacacgaa gtggaacgtg 2520 
 2580 attatcagag aggacctgtt gaggatcgac aataaaacgt gtaccctgtt tagaaataaa 
 gccgttcatc tcgaggtggc ccggtacgtg cacgcctata ttaatgacat tgcggaagtt 2640 
 aattcttatt ttcaactgta ccattacatc atgcagagaa ttatcatgaa tgaacgatac 2700 
 gaaaagagca gcggcaaagt gtctgagtat tttgatgccg tcaatgatga gaaaaaatac 2760 
 aatgacaggc tgttgaagct gctgtgcgta ccatttggtt attgtattcc tcggtttaaa 2820 
 aatcttagta ttgaggctct ttttgatcgg aatgaagccg caaagtttga taaggagaag 2880 
 aaaaaggtat ccggtaacag c 2901 
 < 210 > SEQ ID NO 18 
 < 211 > LENGTH : 2388 < 212 > TYPE : DNA < 213 > ORGANISM : Artificial Sequence < 220 > FEATURE : < 223 > OTHER INFORMATION : Synthetic : CasM DNA sequence from Ruminococcus 
 sp . , isolate 2789STDY5834894 , modified for expression in human 
 cells M E ?? ? ?? 
 < 400 > SEQUENCE : 18 
 atggaaatta atactagtaa toccactcat aggtccggtg aatcttctag cgtacgagga 60 
 gacatgottg gtctcaaatc agagctcgag aagagatttt tcgggaaaac atttgatgat 120 
 aatatccaca ttcaacttat atataatatc cttgatatcg agaagatcct tgcagtctat 180 
 gtgactaata ttgtctacgc acttaacaat atgctcggtg taaaaggctc agagtcctat 240 
 gacgacttta tgggctatct ttcagcacag aatacgtact acatatttac acatcccgac 300 
 aagagcaact tgagcgataa agtgaagggc aatattaaga aatctcttag taaattcaat 360 
 gaccttctga agacgaagcg acttggctat tttgggctgg aggagcccaa aaccaaagat 420 
 aagcgagtgt ctgaagctta taaaaaacga gtgtatcaca tgctggctat agtgggtcaa 480 
 attcgccagt cagtctttca cgacaagtcc aacgaattgg atgagtactt gtattccttt 540 
 atagacatca tcgatagcga gtatcgagac acattggact acctggttga tgaacgattt 600 
 gattccatta acaaaggatt cgttcagggg aataaggtaa acatctcctt gettatcgac 660 
 atgatgaagg gctacgaggc tgatgatata ataagattgt actatgactt tattgtcctc 720 
 aagtctcaaa agaatctggg tttcagtata aaaaaattgc gggagaagat gctcgacgag 780 
 tatggattta ggtttaagga caagcagtat gatagcgttc gctctaagat gtataaactt 840 
 atggactttc ttctgttctg taactactat cggaacgacg tagtcgcagg ggaggcactg 900",2642
55,55,"US 2018 / 0282715 A1 Oct . 4 , 2018 50 
 - continued 
 gttaggaaac tgaggtttag catgaccgac gacgagaaag aaggtattta tgcggacgaa 960 
 gcggagaagc tttggggaaa gtttaggaat gactttgaga acatcgccga tcacatgaac 1020 
 ggtgatgtga taaaggagct cgggaaggcg gatatggact ttgacgagaa aatactggat 1080 
 totgaaaaga agaatgcaag tgacctcctt tacttcagca aaatgatcta catgttgacg 1140 
 tattttttgg atggtaaaga gatcaacgat ctgcttacaa cgcttatttc taaatttgat 1200 
 aacataaagg agtttttgaa gatcatgaaa tcctccgccg tggatgtaga gtgtgagctg 1260 
 accgcgggct ataaactgtt taacgattct caacggataa cgaacgagct cttcatagtg 1320 
 aagaacatcg cttccatgcg caagccggcg gottcagcca aattgactat gttccgcgat 1380 
 gcgctgacaa tactcgggat tgacgataaa attacggacg accgaatatc agaaattctt 1440 
 aaattgaagg aaaagggcaa gggcatccat ggcctgcgga acttcatcac gaacaacgtt 1500 
 atcgagtcta gtcggtttgt ttatcttata aaatacgcga atgcgcagaa aattcgggag 1560 
 gtcgcaaaaa atgaaaaggt ggtaatgttt gtgctcgggg ggattcctga cacacagatt 1620 
 gagoggtact ataaaagttg cgttgagttc cctgacatga attcttcact cgaagccaag 1680 
 tgcagtgagc tggcacggat gatcaagaat atctccttcg atgattttaa gaacgtaaaa 1740 
 caacaagcta aaggacgcga aaatgtggcg aaagagaggg ccaaggcagt catcggtctc 1800 
 taccttacag ttatgtacct ccttgtgaaa aaccttgtaa acgtcaatgc tcggtatgta 1860 
 atagcaatcc actgtttgga gagagatttc ggcctctata aggagatcat cccggagctc 1920 
 gcttcaaaaa acttgaaaaa tgattatcgc attctttctc aaactctttg tgaactttgt 1980 
 gatgacaggg acgagagtcc taacctgttc ttgaagaaga acaaaagact gcggaaatgt 2040 
 gtggaggtcg atataaacaa tgcggattct agcatgaccc ggaaataccg gaattgcatt 2100 
 gcacacotta cagtggtacg cgagctcaag gaatacatcg gtgatatacg caccgtcgac 2160 
 tcctactttt ctatctacca ctatgttatg caacggtgta tcaccaaaag ggaggatgat 2220 
 actaagcaag aagaaaaaat caagtatgaa gatgacctgc ttaagaacca tggatacacg 2280 
 aaagattttg tgaaagccct taatagtcca ttcgggtaca atattccgcg attcaaaaac 2340 
 ctttccatcg aacaactctt cgatcgaaat gagtacctta ccgagaaa 2388 
 < 210 > SEQ ID NO 19 < 211 > LENGTH : 2862 < 212 > TYPE : DNA < 213 > ORGANISM : Artificial Sequence 
 20 > FEATURE : < 223 > OTHER INFORMATION : Synthetic : CasM DNA sequence from Eubacterium siraeum , modified for expression in Zea mays cells ? 
 < 400 > SEQUENCE : 19 
 atgggtaaaa agatacatgc acgggacttg cgcgagcaga ggaagacgga ccggaccgaa 60 
 aaattcgcag accaaaacaa aaaaagagag gctgaacggg cagtccccaa gaaagatgca 120 
 gccgtgtcag tcaaatcggt ctcaagcgtc tcatccaaaa aggacaatgt taccaaatct 180 
 atggcgaaag ccgccggagt caagtctgtt ttcgctgttg gcaatacggt ctacatgaca 240 
 tccttcgggc gcgggaatga tgcggttctt gaacagaaaa ttgttgatac ttcacacgaa 300 
 ccactcaaca ttgatgaccc agcttatcaa ctcaatgtgg ttacgatgaa tgggtattca 360 
 gtgaccgggc ataggggaga aacggtctcg gcagtcacag acaatccctt gagaagatto 420",2639
56,56,"US 2018 / 0282715 A1 Oct . 4 , 2018 51 
 - continued 
 aacggcagaa aaaaggacga gccggaacaa tcagtgccga ctgacatgtt gtgtctcaaa 480 
 ccaaccctgg aaaagaaatt ttttggcaaa gagttcgacg acaatatcca cattcagttg 540 
 atatataaca tcctggatat tgagaaaatt ttggccgtct actcgaccaa cgccatatac 600 
 gctctcaaca acatgtcago agatgagaac attgagaact cagacttttt tatgaaacgc 660 
 accacggatg agaccttcga tgacttcgag aaaaagaaag agtccacgaa cagcagagag 720 
 aaagctgatt tcgatgcgtt cgaaaagttc atcggcaact acaggctggc gtatttcgca 780 
 gatgcatttt atgtcaacaa gaaaaatccc aagggtaagg ccaaaaatgt cctccgcgaa 840 
 gacaaggaac tctactcagt gctcacattg atcggaaagt tgcggcattg gtgcgttcat 900 
 tccgaggagg gtcgggcaga gttctggctt tataaactgg acgaattgaa ggacgatttt 960 
 aagaacgtgc ttgatgtcgt ctacaataga ccagtcgaag aaattaataa ccgctttatt 1020 
 gaaaacaata aggtcaacat acaaatcttg ggatcggtct ataaaaacac cgacatcgca 1080 
 gagctggtca gaagctacta cgagtttctg ataactaaaa agtacaagaa catgggcttc 1140 
 tcaataaaaa aactgcgcga atcaatgott gaaggtaagg gatatgcgga taaagaatac 1200 
 gattctgtta gaaacaagct ctaccagatg actgacttca ttctctatac cggttatata 1260 
 aacgaagata gcgacagggc tgatgacctg gtcaacacac tgcggagctc cctgaaagag 1320 
 gacgataaga ccacagtgta ctgtaaggag gccgattacc tgtggaagaa ataccgcgag 1380 
 tctattaggg aggtcgcgga cgccctggac ggtgacaata ttaaaaaact ctctaaaagc 1440 
 aatatcgaga tacaagaaga caaactgcgc aagtgtttta tatcttatgc ggattcagtc 1500 
 tcggagttca cgaaactgat atatctcctg acacgctttc tgagcgggaa ggagattaat 1560 
 gact tggtga caactttgat taacaagttc gacaacataa ggagctttct tgaaatcatg 1620 
 gatgagctgg gcctcgatag aacgttcacc gcggagtact cgttcttoga gggttcaaca 1680 
 aaatatcttg cggaactcgt tgaattgaat tcgttcgtga aaagctgttc ttttgatata 1740 
 aatgccaaaa gaacaatgta ccgggacgcg cttgatatcc tgggcataga atcggataaa 1800 
 accgaggaag atatcgaaaa gatgatagac aatatcctgc aaatcgacgc aaatggtgac 1860 
 aagaagctta aaaagaataa cggettgcgc aattttatcg cttcgaatgt catcgattcg 1920 
 aacaggttca aatatctggt tcggtacggt aacccgaaga agattagaga aacagctaag 1980 
 tgtaagccag cggtcagatt tgtcttgaac gaaataccgg atgcgcagat cgaaagatat 2040 
 tacgaagcct gctgccctaa gaacaccgca ttgtgtagcg cgaataagcg gcgggagaaa 2100 
 ctcgctgata tgatagcgga gattaaattc gaaaatttct cggacgcggg caactaccaa 2160 
 aaagctaacg ttacttcccg cacttcggag goggagatta aacggaagaa tcaagcgata 2220 
 attagacttt atctgaccgt catgtacatt atgcttaaga atctcgtcaa cgttaatgct 2280 
 agatatgtca tcgcctttca ctgcgtggaa cgcgatacta aactgtatgc cgaatcgggt it 2340 4 
 cttgaagtcg ggaacataga aaaaaataag accaacctta ctatggccgt gatgggtgtc 2400 
 aaactggaga acggcattat caaaactgaa tttgataaaa gottcgccga aaacgcagcg 2460 
 aatcgctatc tgcggaacgc aagatggtat aagcttatac tcgataatct taagaagtcg 2520 
 gaaagggccg tggtcaacga gttccggaat accgtttgcc acttgaacgc gatccggaat 2580 
 attaacatca atatcaaaga aattaaagaa qtcqaaaact actttqoqct ctatcattac 2640 
 ttgatacaga agcatctcga gaatcgcttc gccgataaaa aggtggagag ggacacaggt 2700",2823
57,57,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 - continued 
 gactttattt ccaagctcga agagcataaa acctattgca aggattttgt taaagcatat 2760 
 tgtacgccat tcggttataa tcttgttagg tacaagaatc tgacaatcga cggcttgttc 
 gataaaaatt atccgggcaa ggacgatago gatgagcaga ag 2862 
 < 210 > SEQ ID NO 20 < 211 > LENGTH : 2757 < 212 > TYPE : DNA < 213 > ORGANISM : Artificial Sequence < 220 > FEATURE : < 223 > OTHER INFORMATION : Synthetic : CasM DNA sequence from Ruminococcus sp . , isolate 2789STDY5834971 , modified for expression in Zea mays cells NN PPP 
 < 400 > SEQUENCE : 20 
 atggccaaga agaataaaat gaagccacgc gagctgaggg aggctcaaaa aaaagcccgg 60 
 cagcttaagg ctgcggagat caataataat gctgcccccg ctatcgcagc aatgcccgcc 120 
 gcagaggtca ttgcgccggc cgccgaaaag aaaaaaagct cagtgaaggc tgcaggaatg 180 
 aagtcaattt tggttagcga gaataagatg tatattacct cgtttggcaa gggaaacagc 240 
 gccgtgctgg aatacgaagt tgataacaat gactataacc agacacagct ttcatcgaag 300 
 gataattcca acatccaatt ggggggcgtg aacgaagtta atataacgtt ttcttcaaaa 360 
 catggtttcg aatctggagt cgaaataaat acgtctaatc cgactcatag gtccggtgag 420 
 tccagccctg tccgggggga catgctcggt ctcaagtccg aactcgaaaa acggttttto 480 
 ggtaagactt tcgatgataa tattcatatt cagettatat acaatatott ggatatagag 540 
 aaaattctgg cggtgtatgt cacaaatata gtgtatgctc tgaataatat gctcggtgtg 600 
 aaaggttcgg agagccatga tgatttcatc ggatatcttt ctacaaataa catctacgat 660 
 gtgtttatag acccggataa ctcttctctg agcgatgaca aaaaagccaa tgtgagaaag 720 
 agcctttcga agtttaacgc cctgctcaaa acaaaacgct tgggctattt tggattggaa 780 
 gaaccgaaga caaaagacaa tcgggtttcg caggcctaca aaaagcgcgt gtatcacatg 840 
 cttgcaatcg tcgggcaaat caggcaatgt gtctttcacg acaaaagcgg ggcaaaacgc 900 
 ttcgacctgt actcttttat taataacata gatccggaat atagggatac acttgattac 960 
 ctggtcgaag aacgccttaa atccataaacaaagacttta tagaagacaa taaagtgaat 1020 
 atttctttgc tgatcgacat gatgaagggc tacgaagcgg acgacataat aaggttgtat 1080 
 tatgacttta tcgttcttaa gtcccagaaa aatctggggt tttcaattaa aaagcttagg 1140 
 gaaaaaatgt tggatgagta tggtttccgg ttcaaagata agcaatacga ttcagtcaga 1200 
 tccaaaatgt acaagctcat ggactttctt ctgttctgta attactaccg caatgacata 1260 
 gcagctggtg aaagcctcgt gaggaagttg agattttcca tgaccgacga tgagaaagag 1320 
 ggtatttatg cagatgaggc agccaagctc tggggaaagt ttagaaatga cttcgagaat 1380 
 atcgccgacc atatgaacgg ggatgtcatc aaagagctgg gaaaggcgga tatggacttc 1440 
 gacgagaaaa tactggattc tgaaaaaaaa aatgcgagcg acctccttta cttctccaag 1500 
 atgatctata tgcttactta tttcctcgat ggaaaggaga taaacgacct gctgactaca 1560 
 cttatatcga aattcgacaa tatcaaagaa ttcctcaaaa taatgaagtc ttcagcggtt 1620 
 gatgtggagt gcgaattgac cgctggttac aagctgttta acgattcgca gcggatcacc 1680 
 aatgaattgt ttattgtcaa aaatatcgcctctatgagaa aacctgctgc atctgcgaag 1740",2645
58,58,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 53 
 - continued 
 ctcaccatgt tcagggatgc actcaccata ttgggcattg acgataagat caccgatgac 1800 
 aggatttctg gtatattgaa gottaaggaa aagggtaagg gaatacatgg tctcagaaac 1860 
 tttatcacta acaacgtcat cgaatcctcg cgctttgtct acctgataaa atatgctaac 1920 
 gotcagaaga tccgggaggt tgcgaagaat gaaaaagtcg tcatgttcgt tttggggggg 1980 
 2040 attcccgata cgcaaattga gaggtattat aagtcgtgtg tcgaatttcc tgacatgaac 
 tcatcacttg gcgtcaaacg ctccgaattg gcacggatga tcaaaaacat ttcattcgac 2100 
 gacttcaaaa acgtcaaaca gcaagctaag ggccgcgaga acgttgcaaa ggaaagggca 2160 
 aaggcagtca taggacttta ccttactgtt atgtacctgc tcgttaagaa cctggtcaat 2220 
 gtcaacgcgc ggtatgtcat tgccattcat tgcttggaac gggacttcgg actttacaaa 2280 
 gagattatcc ctgaactggc gtcgaagaac ttgaaaaacg actaccggat tctgagccag 2340 
 acgctctgtg aactttgcga caagagccct aacctttttcttaaaaaaaa cgagoggett 2400 
 aggaaatgtg tggaggtgga tattaacaac gctgatagct cgatgactcg gaagtaccgg 2460 
 aattgtattg cgcacctgac agtcgttcgg gaactgaagg aatacatagg tgatatatgc 2520 
 acggttgact catacttttc catatatcat tacgttatgc aaagatgcat aacgaaaaga 2580 
 gagaacgata ctaaacagga ggaaaagata aagtatgaag atgacttgct taaaaatcac 2640 
 ggctacacta aagactttgt taaagcactc aatagccctt ttggctacaa catacctaga 2700 
 ttcaaaaatc tgtcaattga gcagcttttt gacagaaacg aatatctgac agaaaag 2757 
 < 210 > SEO ID NO 21 
 < 211 > LENGTH : 2754 
 < 212 > TYPE : DNA < 213 > ORGANISM : Artificial Sequence 
 < 220 > FEATURE : < 223 > OTHER INFORMATION : Synthetic : CasM DNA sequence from Ruminococcus 
 bicirculans , modified for expression in Zea mays cells 
 < 400 > SEQUENCE : 21 
 atggcaaaaa agaataagat gaagccgcgg gagcttcgcg aggcccagaa aaaggcgcgg 60 
 cagcttaaag cggctgaaat taataataat gctgtcccag cgatagccgc aatgcctgcg 120 
 gctgaagcgg cggctcccgc ggccgagaag aaaaaatcat ctgttaaagc cgccgggatg 180 
 aaaagcatcc tcgtgtcgga gaataagatg tacattacgt cgttcggtaa ggggaattcg 240 . gcggtccttg aatacgaagt tgataacaat gattataaca aaactcagct ttccagcaaa 300 
 gacaattega atattgagct ctgtgacgtc gggaaagtga atataacgtt ttcttcccgg 360 
 aggggtttcg agagcggtgt ggaaatcaat acaagcaatc caactcatcg gtcgggcgag 420 
 tcctcctctg tgcggggcga catgttgggg cttaagtcgg aacttgaaaa gcggtttttt 480 
 ggaaaaaatt tcgacgacaa tatacacatc caacttatct acaacatact ggacatagag 540 
 aagattttgg cagtgtatgt gaccaatata gtctacgccc tcaacaacat gctgggtgag 600 
 ggcgacgaat caaattacga ctttatgggt tatctgtcaa cttttaacac atataaggtc 660 
 tttacaaacc cgaatgggtc tacattgtcc gacgataaga aagaaaatat aaggaagtcc 720 
 ctttctaaat tcaacgcgct cottaaaaca aagagattgg gctacttcgg ccttgaagag 780 
 cccaagacaa aggacactcg ggcctcagaa gettataaga agagagtcta ccacatgctc 840 
 gccatagtgg gccaaattag gcagtgcgtc ttccacgaca agtctggtgc aaagagattt 900 
 gatctgtact cattcattaa taatatcgat ccagagtacc gcgagacatt ggattatctt 960",2727
59,59,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 54 
 - continued 
 gtcgacgaaa ggttcgatto tatcaataag ggttttatcc aaggtaataa agtcaacatc 1020 
 tccctcctga ttgacatgat gaaaggctat gaagccgatg acatcattag gctgtactac 1080 
 gactttatag ttctcaaatc acagaaaaac ctggggttct ctattaagaa gottagagag 1140 
 aaaatgttgg acgaatacgg tttccgcttc aaagataagc aatacgactc agtgaggtct 1200 
 aaaatgtaca aactcatgga ttttcttctg ttctgtaact actatcggaa tgatatcgca 1260 
 gccggtgaat ctctcgtcag aaaactcagg ttttcgatga cggacgacga gaaagaaggg 1320 
 atatacgcgg acgaagccgc taagttgtgg ggaaaatttc gcaacgattt tgaaaatata 1380 
 gctgatcaca tgaatgggga cgttataaaa gagcttggaa aagccgacat ggattttgac 1440 
 gagaagatat tggactctga gaagaagaat gcgtcagact tgctttattt ttcaaaaatg 1500 
 atatatatgc tcacgtactt cttggacggg aaggagataa acgatctgtt gacgacgctg 1560 
 attagcaaat tcgacaatat caaagagttc ctgaaaataa tgaagagctc agctgtcgat 1620 
 gtcgagtgtg aactgacggc tggctacaaa ttgtttaacg attcgcaacg cattacgaat 1680 
 gagctgttta tagtgaaaaa cattgcatct atgcgcaaac cagctgccag cgctaagctt 1740 
 acaatgtttc gggacgctct gacgattttg ggcatcgacg ataaaattac tgacgatagg 1800 
 atcagcgaga tactgaaatt gaaagagaaa gggaaaggga ttcacggcct cagaaacttt 1860 
 attactaata atgtcatcga atcgtcaagg tttgtgtact tgattaaata tgcaaatgca 1920 
 caaaagattc gggaagtcgc taaaaatgaa aaggttgtta tgtttgtcct cggggggata 1980 
 cccgataccc aaattgagcg gtattacaag agctgcgtgg agtttccaga catgaactcg 2040 
 tctctggggg tgaaacggtc cgaactcgct cgcatgatta aaaacatatc cttcgacgac 2100 
 tttaagaacg tgaagcaaca agctaagggg cgcgagaacg tcgcgaaaga aagggccaaa 2160 
 gcggttatcg gtctgtacct tacggtcatg tacttgttgg tgaaaaacct tgtgaatgtg 2220 
 aacgctcggt acgtgatcgc gatocactgt ctggagcgcg attttgggct gtataaagag 2280 
 2340 atcatcccgg agctggcttc caaaaacctg aaaaatgact accgcatact gtcccagaca 
 ctttgcgagt tgtgcgacaa gagcccgaat ctgtttctga aaaaaaacga gcgcctgcgg 2400 
 aagtgcgttg aggttgatat aaacaacgcc gactcctcaa tgacgagaaa gtacagaaat 2460 
 tgcatagctc atttgaccgt cgtcagggag ctcaaagaat acatagggga catttgcact 2520 
 gtggactcgt atttttccat ctaccactac gtgatgcaaa ggtgtatcac taagcgggaa 2580 
 aacgatacca aacaagagga gaagatcaag tacgaggatg accttttgaa aaatcacggt 2640 
 tatacgaagg acttcgtgaa ggcattgaac tctccgttcg gttataatat ccctaggttc 2700 
 aagaatttgt ccatagaaca gctcttcgat cgcaatgagt atcttacaga aaaa 2754 2754 
 < 210 > SEQ ID NO 22 
 < 211 > LENGTH : 2766 
 < 212 > TYPE : DNA 
 < 213 > ORGANISM : Artificial Sequence 
 < 220 > FEATURE : < 223 > OTHER INFORMATION : Synthetic : CasM DNA sequence from Ruminococcus 
 sp . , isolate 2789STDY5608892 , modified for expression in Zea 
 mays cells 
 < 400 > SEQUENCE : 22 
 atggcaaaga agaacaaaat gaagccacgc gaactgagag aagctcaaaa gaaggcgaga 60 
 cagcttaaag ctgcggagat caataataac gcagctccgg ccattgccgc aatgcccgcc 120",2694
60,60,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 55 
 - continued 
 gctgaagtga tagctccagt tgcggagaag aagaaatctt cagttaaagc agctggaatg 180 
 aaatccattc tcgtctcgga gaataaaatg tatattacgt ccttcggaaa aggaaattcc 240 
 gcggttctcg agtatgaggt ggacaacaac gactacaaca agactcaact gtcgagcaaa 300 
 gacaactcaa atattgaact cggggacgtt aacgaagtca atataacatt ttcctcaaag 360 
 catggattog gcagcggtgt cgaaattaat acttcaaatc cgacacatag gtctggagaa 420 
 tcgtcgcctg tcaggggcga tatgcttggt ttgaagtccg aactggagaa gcggttcttt 480 
 gggaagactt ttgacgataa cattcatata caactgatct acaacatact ggatatcgag 540 
 aaaatcctcg cagtgtatgt cactaatatt gtttacgcct tgaacaacat gctgggcatt 600 
 aaagactctg aatcatatga tgacttcatg gggtatctca gcgccaggaa cacatatgaa 660 
 gtgtttacgc acccggacaa gtctaatctg tctgataagg tcaagggtaa tattaagaag 720 
 tcactcagca agttcaacga cttgottaag acgaagcgcc tcggctactt tgggcttgag 780 
 gaaccaaaaa cgaaggacac cagagcctct gaggettata agaaaagagt gtatcatatg 840 
 ctcgcgatag tcggtcaaat tagacagtgt gttttccacg ataaatctgg agcaaagagg 900 
 ttcgaccttt actcatttat aaacaatatc gaccctgaat atagagacac gctggattac 960 
 cttgtggagg agcggctgaa gtcgattaat aaggacttta tagaaggcaa taaagtcaat 1020 
 atctctctcc tcatagacat gatgaaaggt tatgaagccg acgacataat aaggetttat 1080 
 tacgatttta tcgttcttaa gtcacagaaa aatttgggtt tttcgatcaa aaaacttcgg 1140 
 gaaaagatgt tggaagaata cgggttcaga ttcaaagaca agcagtacga tagcgtgagg 1200 
 tcaaaaatgt acaagctgat ggacttcctgctgttttgca attactacag aaatgatgtc 1260 
 gccgccgggg aggcgttggt tcgcaagctt cgcttttcaa tgacagatga tgaaaaagag 1320 
 gggatttatg cggatgaggc cgccaagctc tggggcaaat ttaggaatga ttttgaaaac 1380 
 attgctgatc atatgaatgg cgatgtgatt aaggaactgg gcaaagcaga catggatttt 1440 
 gatgaaaaga tcctcgactc agaaaagaag aatgccagcg atttgttgta tttctcaaag 1500 
 atgatctaca tgctgacgta ttttttggac ggtaaagaga taaacgatct gctcacgacg 1560 
 ttgatttcta aattcgacaa tattaaggag tttcttaaga ttatgaagtc ttcggcagtt 1620 
 gacgttgaat gcgaactgac tgctggctac aaactcttca acgactcaca acgcatcacc 1680 
 aatgaacttt ttatcgttaa aaatatagcc agcatgcgga agccggcagc ttctgccaag 1740 
 ctcaccatgt ttcgcgatgc tttgaccatc ttgggcattg atgacaatat tacagatgat 1800 
 cggatatctg agatactcaa acttaaggag aaaggcaagg gcatacatgg ccttcggaat 1860 
 ttcattacta ataacgtgat agaaagcagc cgctttgttt acctcattaa atacgcaaat 1920 
 gcccaaaaaa taagggaagt tgctaaaaac gaaaaagtgg tgatgttcgt gottggagga 1980 
 atacctgaca cacaaatcga gcgctattac aagtcgtgtg tcgaattccc cgatatgaat 2040 
 tcttccttgg aggctaaacg gtcagagctc gccagaatga tcaagaacat ttcctttgat 2100 
 gacttcaaaa atgtgaaaca gcaagctaag ggtcgcgaaa acgtcgctaa agagagggcc 2160 
 aaggctgtta tcggcctcta tottacggtg atgtatttgt tggtgaagaa cctcgttaat 2220 
 gtcaacgcca ggtatgttat agcaatacat tgcctcgaac gggattttgg tctttacaaa 2280 
 gagattatcc cagaattggc gtccaagaac ctcaagaacg actatcgcat attgtctcag 2340 
 acgctttgtg aattgtgcga tgaccgcaat gagtcttcca acttgttctt gaaaaagaat 2400",2813
61,61,"US 2018 / 0282715 A1 Oct . 4 , 2018 56 
 - continued 
 aagcggttgc gcaagtgcgt tgaagtggac ataaataacg ccgactcttc aatgactcgc 2460 
 aagtacagaa attgtatago gcacctcact gtcgtgcggg aattgaaaga atacatcgga 2520 
 gacataagga ccgtcgatag ctattttagc atttaccact atgtcatgca aaggtgtata 2580 
 actaaacgcg gtgatgatac caaacaggaa gaaaagatca aatacgaaga cgatctgctc 2640 
 aagaatcatg getacaccaa agatttcgtt aaagcattga atagcccttt cgggtataat 2700 
 attcccagat ttaaaaacct cagcattgaa caactgttcg accgcaacga atacctcacg 2760 
 gaaaag 2766 
 < 210 > SEQ ID NO 23 
 < 211 > LENGTH : 2766 
 < 212 > TYPE : DNA 
 < 213 > ORGANISM : Artificial Sequence < 220 > FEATURE : < 223 > OTHER INFORMATION : Synthetic : CasM DNA sequence from Ruminococcus sp . CAG : 57 , modified for expression in Zea mays cells 
 < 400 > SEQUENCE : 23 
 atggcgaaga agaacaaaat gaaaccacgc gaactcagag aggcacaaaa gaaagcccgg 60 
 cagttgaagg ccgccgagat aaacaacaac goggcaccgg caattgcggc aatgccagct 120 
 gcggaggtca tcgctcccgt cgccgagaag aagaagagct cggtcaaggc agccgggatg 180 
 aaatctattc tggtgtcaga gaataagatg tacattacgt ctttcggcaa gggaaatago 240 
 gcagtcttgg agtatgaagt tgacaacaac gactataaca aaacacaact ttctagcaaa 300 
 gacaactcga atatagaatt gggagatgtc aatgaggtca acataacctt tagctccaag 360 
 catggctttg gctcgggtgt ggaaattaac acgtccaatc ctacccatcg gtcgggcgag 420 
 tcgtcgccag ttagggggga catgctgggt ctcaagagcg agttggagaa aagatttttc 480 
 ggtaagacct tcgatgataa cattcatatc caacttatct ataacatctt ggacatagaa 540 
 aaaatacttg cagtgtacgt cactaatatc gtttatgcct tgaataatat gttgggaatt 600 
 aaggactctg aatcctatga cgattttatg ggctatctga gcgctcggaa tacctacgaa 660 
 gtgtttactc atccagataa aagcaacctt agcgataagg tcaagggcaa cataaaaaag 720 
 tccctgtcaa agtttaacga tcttctcaaa accaaacggc tgggctactt tggactcgag 780 
 gagcctaaga cgaaagacac gcgggcatct gaggcataca agaaaagggt ttatcatatg 840 
 ctggcaatag tcggtcaaat caggcagtgc gtctttcacg acaagagcgg agcgaagcgg 900 
 tttgaccttt attctttcat caataacatc gatccggaat accgcgacac attggattac 960 
 ctggtcgagg aaaggttgaa gtccataaac aaggacttca tcgagggaaa caaggttaac 1020 
 atttcacttc tgattgacat gatgaaaggc tacgaggctg acgatatcat aagactttat 1080 
 tatgacttta tcgtgctgaa atcgcagaaa aatttgggat tttctatcaa aaagctcaga 1140 
 gagaagatgc ttgaggagta tggatttaga tttaaggaca agcagtacga ttctgtgcgc tctgtgcgc 1200 1200 
 totaaaatgt acaagctcat ggattttctc ctcttttgca attactacag gaacgatgtt 1260 
 gccgcaggcg aggctcttgt ccggaagctc cgcttctcca tgacggacga cgaaaaggaa 1320 
 ggcatatacg cggatgaggc agcgaaattg tggggtaagt tcaggaatga ttttgaaaat 1380 
 atagctgatc acatgaacgg tgacgtcatc aaggagctgg ggaaagccga tatggatttt 1440 
 gatgagaaaa tcctggattc ggaaaagaaa aatgcgagcg acttgctcta ctttagcaaa 1500",2612
62,62,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 57 
 - continued 
 atgatttata tgttgaccta tttcctcgat ggcaaagaga tcaacgattt gottacgact 1560 
 ctgataagca aattegataa tataaaagag tttttgaaaa taatgaagtc ctcagcggtt 1620 
 gatgttgaat gegaactgac agccggctat aagcttttca atgattcaca gaggattacc 1680 
 aacgaacttt ttatagtgaa aaacatcgcc tcaatgagga aacccgccgc gagcgcgaag 1740 
 ttgacaatgt ttagggacgc tctgacgatt ttgggaatcg acgataatat cactgacgac 1800 
 aggatttcgg agatcctcaa attgaaagag aagggcaaag ggatccacgg gttgagaaat 1860 
 tttataacca ataacgttat agaatcatcg aggtttgtgt atctgatcaa atacgcgaat 1920 
 gctcaaaaga tcagggaagt ggcaaaggac gagaaggttg tcatgttcgt cctgggtggg 1980 
 atccctgaca cccagataga aagatactat aagtcctgcg tggaattccc tgatatgaat 2040 
 tcttccctcg aggctaaaag atctgagttg gcacggatga tcaagaatat ttcgtttgac 2100 
 gatttcaaaa acgtgaagca acaagctaaa gggcgggaaa acgttgccaa ggaacgggct 2160 
 aaagctgtca ttggccttta cctcactgtg atgtatttgc tcgttaagaa tctcgtgaac 2220 
 gttaacgcaa gatacgtgat cgctatccac tgcttggagc gcgatttcgg actgtacaag 2280 
 gagattatac cagagcttgc ttccaagaat cttaagaatg actatcgcat attgtcccaa 2340 
 actctttgcg agttgtgcga cgatcggaac gagtcttcca atctgttcct taagaaaaat 2400 
 aaaaggctgc ggaaatgcgt cgaagtcgac attaacaatg cggattcttc tatgacgaga 2460 
 aagtaccgca actgcatcgc ccatctcacg gttgtcaggg agctcaagga atacatagga 2520 
 gacattagaa cggtggactc atatttttca atataccatt atgttatgca aaggtgtatt 2580 
 acaaaacggg gggatgacac aaaacaagag gaaaagatta aatatgaaga cgatttgctt 2640 
 aagaaccatg gttacacgaa agatttcgtt aaagcgctta attcgccatt tggttataat 2700 
 attccgagat tcaaaaattt gagcatagag cagcttttcg atagaaatga atacttgacc 2760 
 gagaag 2766 
 < 210 > SEQ ID NO 24 
 < 211 > LENGTH : 2799 
 < 212 > TYPE : DNA < 213 > ORGANISM : Artificial Sequence 
 < 220 > FEATURE : 
 < 223 > OTHER INFORMATION : Synthetic : CasM DNA sequence from Ruminococcus flavefaciens FD - 1 , modified for expression in Zea mays cells 
 < 400 > SEQUENCE : 24 
 atgaaaaaaa agatgagctt gcgggaaaaa agagaggcag aaaagcaggc caagaaagct 60 
 gcatacagcg ctgcgtctaa gaacactgat tccaaaccag cggagaaaaa agcggagact 120 
 ccaaaacctg ccgaaattat atctgataac tcacgcaata agacggcggt caaggcagcg 180 
 ggactcaagt cgacgatcat atcaggcgat aaattgtata tgaccagott tggcaagggc 240 
 aatgcagctg tgatagaaca aaagatagac atcaatgact attcttttag cgcaatgaag 300 
 gacaccccaa gccttgaagt cgacaaggca gaatctaagg aaatatcctt ttcgtcccat 360 
 catccctttg tgaagaacga caagttgacg acatataatc ctctttacgg tgggaaggat 420 
 aacccagaga agccggttgg gcgcgatatg ttggggttga aagataaact tgaggaacgg 480 
 tactttggtt gtacattcaa tgacaacctc cacattcaga tcatttacaa tattttggat 540 
 attgagaaga tcctcgctgt tcattccgca aatattacga cagctcttga tcatatggtg 600 
 gatgaggacg atgagaaata ccttaactct gactatatcg gctacatgaa cacgatcaac 660",2685
63,63,"US 2018 / 0282715 A1 Oct . 4 , 2018 58 
 - continued 
 acctacgacg tcttcatgga tccctctaag aattcctctt tgtcgccaaa agacaggaaa 720 
 aacatcgaca attcgagggc gaagtttgag aagctcctct ctacaaaaag gttggggtac 780 
 tttgggttcg actatgacgc gaacgggaaa gacaaaaaga agaatgagga aattaaaaag 840 
 cggctttacc acttgacggc atttgcaggc cagctgaggc agtggtcctt ccactcagca 900 
 ggaaactatc ccagaacctg gttgtataaa ttggactccc tggataaaga gtatctggac 960 
 acgctcgacc actatttoga taagaggttt aatgatataa atgacgattt tgtcactaaa 1020 
 aacgcaacga acctgtatat actgaaggag gttttccctg aggctaactt taaagatatt 1080 
 goggacttgt attatgactt tattgtcatc aagtcacaca agaacatggg attctcgatc 1140 
 aagaaacttc gggaaaaaat gctcgagtgc gatggagctg accgcatcaa agaacaggat 1200 
 atggattctg tccgctccaa gctctacaag ctcattgatt tttgcatatt caagtattac 1260 
 catgagttcc cagagctcag cgagaagaac gtcgacatcc tgagggctgc cgtgagcgat 1320 
 actaagaagg acaatctcta ctcagatgaa gctgctcggt tgtggtcaat tttcaaggaa 1380 
 aaatttctcg gattttgtga caaaattgtt gtctgggtga ccggagagca tgagaaagat 1440 
 atcacgtctg tcattgataa agacgcctac aggaacagaa gcaatgtctc gtatttttca 1500 
 aagctcatgt acgcaatgtg tttttttctt gatgggaagg agataaacga ccttctgact 1560 
 accttgatta acaagtttga caatatcgcc aaccagatta agacagcaaa ggaattgggg 1620 
 atcaacacgg cgttcgttaa aaactatgac ttcttcaacc attctgagaa atatgtcgac 1680 
 gaattgaaca tagtgaaaaa tatcgctcgg atgaaaaaac cctcttcaaa cgcgaaaaaa 1740 
 gctatgtacc atgacgccct tactattctt ggcattcctg aagatatgga cgaaaaggct 1800 
 ttggatgaag aactcgacct tatactcgaa aaaaagaccg atcccgtcac aggtaaaccg 1860 
 ctgaagggta agaatccttt gcgcaatttt atagctaaca acgttataga gaactctcgg 1920 
 ttcatctacc ttataaaatt ctgtaatccg gaaaacgtga gaaaaattgt gaataacact 1980 
 aaggtgacag agttcgtgct gaaacgcata ccagatgccc aaattgagag gtattacaaa 2040 
 tcttgtacgg atagcgagat gaaccctccg actgaaaaaa aaattaccga gttggctggt 2100 
 aaacttaaag acatgaactt cggcaacttc cggaatgtcc ggcagtctgc aaaagagaat 2160 
 atggagaaag agaggtttaa agccgtcatt ggactgtacc ttaccgttgt gtacagggtg 2220 
 gttaagaatc tcgtcgacgt gaactcaaga tacattatgg cattccattc actcgagaga 2280 
 gactcccaat tgtataacgt ctcagtcgac aacgattatc tggcactgac cgatacactg 2340 
 gtcaaagagg gtgacaactc acgctcacgg tacttggccg ggaataaaag attgcgggat 2400 
 tgtgtcaaac aggatattga taacgcaaaa aagtggtttgttagcgataa atataattcc 2460 
 ataaccaagt ataggaacaa tgtggcgcac ctgaccgccg ttcggaactg tgccgaattt 2520 
 ataggcgaca taacgaagat tgactcctac ttcgccctct accactacct tatccagcgg 2580 
 caactcgcca aaggtctcga tcatgagagg tcaggttttg accgcaatta tccacagtac 2640 
 gcaccactgt tcaagtggca tacttatgtg aaagatgttg tgaaagcgct gaatgcacct 2700 
 ttcggttata atattccaag gttcaagaat ctttccattg acgcactctt cgaccggaat 2760 
 gagatcaaga agaatgatgg agaaaagaaa tctgacgac 2799 
 < 210 > SEQ ID NO 25 
 < 211 > LENGTH : 2832",2698
64,64,"US 2018 / 0282715 A1 Oct . 4 , 2018 59 
 - continued 
 < 212 > TYPE : DNA 
 < 213 > ORGANISM : Artificial Sequence 
 < 220 > FEATURE : 
 < 223 > OTHER INFORMATION : Synthetic : CasM DNA sequence from Ruminococcus albus strain KH2T6 , modified for expression in Zea mays cells 
 < 400 > SEQUENCE : 25 
 atggccaaaa aatctaaagg catgtccctg agggaaaaac gcgagctgga gaagcaaaag 60 
 cggatccaga aagctgcagt gaactctgtc aacgacactc ccgaaaagac cgaggaagca 120 
 aacgttgttt ctgtcaatgt gagaacgtct goggaaaaca agcacagcaa gaagagcgct 180 
 gctaaagctc ttggacttaa atcggggttg gttattgggg acgaattgta cctcacatca 240 
 tttggcagag gaaatgaggc gaaactcgaa aagaaaataa gcggggatac cgtggaaaaa 300 
 ttgggcattg gtgctttcga agtggcggaa agggatgagt ctacactcac acttgaatct 360 
 gggcgcatta aagataaaac toccagaccg aaagatccca gacatattac agtggacaca 420 
 caagggaagt ttaaggaaga tatgctcgga atacgctctg tgcttgagaa aaagatattt 480 
 ggtaagacct tcgatgacaa catccatgtc caacttgcgt acaatatcct cgatgtcgag 540 
 aagatcatgg cacagtacgt ctctgacatt gtttacatgc tccacaacac cgataagacg 600 
 gaacgcaatg acaacctgat ggggtatatg tccatcagga atacttacaa aaccttttgt 660 
 gatacttcca accttccgga cgatacaaaa caaaaggtcg agaatcaaaa acgggaattc 720 
 gacaagataa ttaagtctgg gcgcttggga tactttggcg aggcatttat ggtcaactcc 780 
 ggcaactcta caaaattgcg gcctgagaaa gaaatctatc atattttcgc tctcatggcc 840 
 tcacttaggc agtcctactt ccacgggtat gtgaaggaca cggactacca aggaacaacg 900 
 tgggcgtaca cattggagga caagttgaag ggcccgtcac acgagttcag agaaacaatt 960 
 gata agatat ttgatgaagg attctctaag atatcaaaag acttcgggaa aatgaacaaa 1020 
 gttaatctgc aaattctgga gcagatgata ggcgagctgt acggttctat tgagcgccag 1080 
 aatctcacat gtgattacta cgacttcatc caattgaaga aacataagta cttggggttc 1140 
 tctataaagc ggttgagaga aacgatgttg gaaacgacac cggcggaatg ttacaaggca 1200 
 gaatgctaca atagcgagcg gcagaagctt tacaaactta tagattttct gatctatgat 1260 
 ttgtactata accgcaagcc ggcgcggatc gaggaaattg togataagct tagggagtct 1320 
 gtgaacgatg aggagaaaga atcgatttat agcgtcgaag ctaagtatgt ctatgagtcc 1380 
 ctctccaaag tgctggataa gtccctcaag aactccgttt ccggggagac catcaaagat 1440 
 ctccagaaaa ggtatgatga cgaaactgct aatagaatat gggacatctc gcaacactcg 1500 
 atttctggga acgtcaactg tttctgcaaa ttgatctaca taatgaccct catgctggac 1560 
 gggaaagaaa ttaacgacct ccttacaacg ctcgtgaaca aattcgataa tattgcttca 1620 
 ttcattgatg ttatggacga attgggtttg gaacactcat ttactgataa ttataaaatg 1680 
 tttgcagatt caaaggctat ctgccttgat cttcaattta ttaattcgtt tgcacggatg 1740 
 agcaaaatcg acgatgaaaa atctaagcgc caattgttta gggacgctct ggttatcctc 1800 
 gacataggca ataaggacga gacctggata aataactact tggactccga tattttcaaa 1860 
 ttggataaag agggaaataa gttgaagggc gcaaggcatg actttcggaa ctttattgct 1920 
 aacaacgtga ttaagtcgtc acggtttaaa taccttgtta aatactcgtc agcagatggt 1980 
 atgataaaac tgaaaactaa cgaaaagctt ataggctttg tcctggacaa gotccctgag 2040",2765
65,65,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 - continued 
 acacagatag atagatacta cgaatcgtgt ggacttgata atgctgttgt cgacaaaaaa 2100 
 gtcaggatcg agaagctgtc agggcttata cgcgacatga aatttgatga tttctccggt 2160 
 gtcaaaacat caaataaggc gggcgataac gataagcaag acaaagcaaa gtatcaggca 2220 
 attatcagct tgtaccttat ggttctgtac caaattgtga aaaacatgat ctatgtcaat 2280 
 tcacggtacg tgatcgcgtt ccattgcctt gagagggatt tcggcatgta cggaaaagac 2340 
 ttcgggaaat attaccaggg atgtagaaaa ttgactgacc atttcataga agagaaatat 2400 
 atgaaggaag ggaaacttgg ttgcaataag aaggtgggaa ggtatctcaa aaataatatt 2460 
 tcatgctgta cggatggtct gatcaatacc tataggaacc aagtggacca tttcgctgtt 2520 
 gttcggaaga tagggaatta tgcagcatat atcaaatcta tcggctcatg gtttgaactg 2580 
 tatcactacg tcattcagag gatcgtgttt gatgagtaca gatttgcact gaataatacg 2640 
 gagagcaact acaagaattc aatcattaag caccatactt attgcaaaga catggtgaag 2700 
 gctctcaata cgccttttgg gtatgacctc cccagatata agaatctctc catcggggat 2760 
 cttttcgata gaaacaatta tottaataag acgaaggaat cgatagatge taattccagc 2820 
 attgactcac ag 2832 
 < 210 > SEQ ID NO 26 
 < 211 > LENGTH : 2901 
 < 212 > TYPE : DNA < 213 > ORGANISM : Artificial Sequence < 220 > FEATURE : < 223 > OTHER INFORMATION : Synthetic : CasM DNA sequence from Ruminococcus 
 flavefaciens strain XPD3002 , modified for expression in Zea 
 mays cells 
 < 400 > SEQUENCE : 26 
 atgatcgaga agaaaaagtc tttcgcaaaa ggaatgggag tcaagtctac attggtttct 60 
 ggttcgaagg tttatatgac gacgttcgcc gagggctctg acgcgcgctt ggagaagata 120 
 gtggaggggg attcaatacg gtctgtgaac gaaggcgaag ctttttcggc cgagatggcg 180 
 gacaagaatg cagggtataa aattgggaat gcaaagtttt cgcaccccaa aggttacgca 240 
 gtcgttgcga ataacccgct ctatactggt ccagtccagc aagatatgct cgggctgaaa 300 
 gagaccctcg agaaacgcta ttttggggag agcgcggatg ggaatgacaa tatatgtatc 360 
 caagttatac ataatattct ggatatcgaa aagatccttg ctgaatacat taccaacgct 420 
 gettatgcgg tcaacaatat ttcgggactt gataaagata taatcggctt cggtaaattc 480 
 agcactgtct atacatacga tgagttcaag gatccagagc atcatagagc ggcgttcaat 540 
 aataacgaca aactgattaa cgcaattaaa gcgcaatatg acgagttega caattttctc 600 
 gacaacccac ggcttggcta ctttggccag gcatttttct cgaaggaggg taggaactac 660 
 ataatcaatt atggcaatga atgctatgac atacttgctc tgctttcagg tctcagacat 720 
 tgggtcgttc acaataacga agaagaatct cggatctctc ggacttggct ctataacctt 780 
 gacaagaacc ttgataacga gtacatctct acgctgaact acctttacga cagaatcact 840 
 aacgagctca ccaattcatt ctccaaaaat tctgccgcaa acgtcaacta catcgcggaa 900 
 acccttggga tcaacccagc agagtttgct gaacagtatt ttcgcttctc aatcatgaaa 960 
 gaacagaaaa atctgggctt caatataacg aaactgegcg aggtcatgtt ggatagaaaa 1020 
 gatatgtccg aaatcaggaa aaaccataaa gtcttcgact caataaggac caaagtgtat 1080",2617
66,66,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 - continued 
 accatgatgg attttgtcat ctaccgctat tacatagagg aggatgcaaa agtcgctgcc 1140 
 gctaacaaga gccttccaga taatgaaaag tctctgtcgg aaaaggatat atttgtgatt 1200 
 aatctccggg gaagctttaa cgacgatcaa aaggatgccc tgtactacga tgaggcaaac 1260 
 agaatttgga ggaagctgga aaacattatg cataacatta aggagttocg cgggaataaa 1320 
 acgagggaat ataagaagaa agatgctccg aggttgcctc ggattcttcc tgctggtagg 1380 
 gatgtttcgg cattctcgaa gctgatgtac gcactcacca tgttccttga cggtaaagag 1440 
 atcaacgatc tcttgacaac gottattaat aagtttgata atatacagtc tttccttaag 1500 
 gttatgcccc ttattggagt taatgctaaa ttcgtggaag agtatgcttt cttcaaggac 1560 
 agcgcgaaaa ttgctgacga actgcgcctt atcaagtcct tcgcgcggat gggagagcct 1620 
 atagctgacg ctcgcagggc aatgtatatc gacgccatcc gcatccttgg caccaatctg 1680 
 agctatgatg agcttaaagc cctcgccgac accttcagcc tggacgaaaa cggcaacaaa 1740 
 ctcaagaagg gcaagcacgg catgcgcaat ttcattatca ataacgtgat ctcgaataag 1800 
 agatttcact atctgatacg gtatggcgac ccggcccacc tccatgagat tgcgaaaaac 1860 
 gaagctgttg tgaaatttgt gottggtaga attgcggaca tacaaaaaaa acaaggccaa 1920 
 aatggcaaaa atcaaattga cagatattac gaaacatgca ttggaaagga taagggaaag 1980 
 tctgtgagcg agaaggttga tgcgttgacc aaaataatca caggaatgaa ttacgatcag 2040 
 ttcgataaaa agaggt cagt gatagaagac acggggcggg aaaacgctga acgcgaaaaa 2100 
 tttaagaaaa taatttcgct ctatcttacg gtcatttatc acatcttgaa gaatatagtc 2160 
 aatatcaacg ctagatacgt gattggtttc cattgtgtgg aaagagacgc tcaactgtac 2220 
 aaggaaaagg gttatgatat aaacctcaag aagctggagg aaaagggttt tagctcggtg 2280 
 actaaattgt gcgctggaat cgatgaaacc gcgccagata aaaggaagga tgttgagaag 2340 
 gagatggccg agagagcgaa ggaatctatc gacagcctgg aaagcgcgaa tcccaaactt 2400 
 tatgccaact acatcaagta ctctgacgag aaaaaagcgg aagagtttac tagacaaatc 2460 
 aatcgggaga aagctaagac cgccctcaat gottacttgc gcaataccaa atggaacgtt 2520 
 atcattcgcg aagacctctt gcgcatagat aataaaacat gtacattgtt tagaaataaa 2580 
 gcagtgcacc tcgaggtcgc cagatacgtt cacgcatata taaatgacat cgctgaggtg 2640 
 aactcgtact ttcagctgta ccattacatt atgcaaagga tcataatgaa cgaaaggtac 2700 
 gagaaatcgt caggtaaagt ttccgaatat tttgacgcag tcaatgatga aaagaagtac 2760 
 aacgaccggc ttttgaagtt gctttgtgtg cctttcgggt actgtatccc tcggttcaaa 2820 
 aacctgtcca tagaggcatt gtttgacagg aacgaggcag caaagttega caaggaaaag 2880 
 aaaaaggtgt cgggtaactc g 2901 
 ? A 
 ? A < 210 > SEQ ID NO 27 
 < 211 > LENGTH : 2388 
 < 212 > TYPE : DNA < 213 > ORGANISM : Artificial Sequence < 220 > FEATURE : < 223 > OTHER INFORMATION : Synthetic : CasM DNA sequence from Ruminococcus 
 sp . , isolate 2789STDY5834894 , modified for expression in Zea 
 mays cells M ?? ? ?? 
 ? A 
 M 
 < 400 > SEQUENCE : 27 
 atggaaatta atacgtccaa tccgacacac agatcaggcg aatcttcctc agttagaggt 60",2676
67,67,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 - continued 
 gatatgttgg gacttaaatc cgaattggaa aagaggtttt ttggcaagac attcgatgat 120 
 aacattcaca tacaacttat atataacatc cttgatatag aaaagatact tgctgtgtat 180 
 gtgacaaaca tagtttatgc actgaacaac atgcttggcg tgaagggatc agaaagctac 240 
 gatgatttca tggggtacct ctccgctcag aacacctatt acatattcac gcacccagat 300 
 aaatctaacc tgtcggataa agttaagggg aatattaaga agtcgctttc taaatttaac 360 
 gaccttctta agacaaaaag actgggctac tttgggcttg aggagccaaa gacgaaagac 420 
 aaacgggtta gcgaggcata taaaaagagg gtttatcata tgcttgccat agtgggccag 480 
 atacgccagt ccgtctttca tgataaatct aacgagttgg acgagtatct ttactctttc 540 
 atcgacatca tcgactccga atatagagac acgctcgact atcttgtcga cgaacggttt 600 
 gattcgataa ataagggttt tgtccaaggc aacaaagtca atatatcact cctcatagat 660 
 atgatgaaag gatacgaagc agacgatata atcagacttt attacgactt tattgttctt 720 
 aagagccaga aaaatcttgg attctcaata aagaaactga gggagaaaat gttggacgag 780 
 tatgggtttc ggtttaaaga taaacaatat gactcggtca ggtccaagat gtacaagctt 840 
 atggactttc ttttgttctg taattactat aggaatgacg ttgttgccgg ggaggccttg 900 
 gttagaaaat tgagattcag catgaccgat gacgaaaaag aaggcatcta tgcggatgag 960 
 gcagagaagt tgtgggggaa atttaggaat gactttgaaa acatagocga tcatatgaat 1020 
 ggcgatgtca taaaggagtt ggggaaagct gacatggatt ttgacgaaaa aatcctggat 1080 
 agcgaaaaaa agaatgcttc cgatctgttg tatttctcta agatgatcta tatgctcact 1140 
 tactttctgg acggtaaaga gatcaacgac cttcttacta cccttatttc aaagttcgat 1200 
 aacattaagg aatttctgaa aataatgaaa tcctcggctg tcgacgttga atgcgaactt 1260 
 actgcagggt acaagctgtt taacgactcg caaaggatta ctaatgaact gttcattgtc 1320 
 aagaacatag cgtccatgag aaagcctgca gcaagcgcaa agctgacgat gttccgcgat 1380 
 gctctcacca ttctgggaat tgatgacaag attaccgatg accgcatttc ggagatcctt 1440 
 aagcttaagg aaaaggggaa ggggattcac ggactgagaa attttatcac caataacgtg 1500 
 atcgaatcgt ctaggtttgt ctatttgata aagtatgcca atgcgcaaaa aattcgcgaa 1560 
 gtcgccaaga atgagaaggt cgttatgttc gtgctcggag gaattcccga tacacagatt 1620 
 gaacggtact ataaatcctg tgtggaattc coggatatga actcatccct cgaggccaaa 1680 
 tgctctgagc ttgcgaggat gatcaagaat atctcctttg atgattttaa aaacgtgaag 1740 
 cagcaggcga agggccggga gaatgtggcg aaggagcggg ctaaagctgt gatagggctt 1800 
 tatcttactg ttatgtacct tctcgtgaaa aacctggtga atgtgaacgc caggtacgtt 1860 
 atagcgatcc attgtcttga gcgcgacttc ggtttgtata aggagataat tccagagctg 1920 
 gcatcgaaga acctgaaaaa cgattacaga attctgtcac aaactctctg tgaactctgc 1980 
 gatgaccgcg atgagtcacc gaatctcttc ctcaaaaaaa acaagagget gaggaaatgt 2040 
 gtggaagttg acatcaataa cgcggattcg agcatgacac gcaagtaccg gaattgtatt 2100 
 gctcatctca cagtcgtccg cgagctcaaa gagtatatag gtgatatccg gaccgttgat 2160 
 tcttattttt ctatctatca ttacgttatg cagcggtgca ttacaaaaag ggaagatgat 2220 
 accaaacaag aagaaaaaat aaagtatgag gatgacttgt tgaaaaatca tggatatact 2280 
 aaagactttg tcaaggctct caactcaccg ttcggttaca acatacccag atttaaaaac 2340",2808
68,68,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 63 
 - continued 
 ttgtcaattg aacagttgtt tgaccggaac gaatacctga cagaaaaa 2388 
 < 210 > SEO ID NO 28 
 < 211 > LENGTH : 2865 < 212 > TYPE : DNA 
 < 213 > ORGANISM : Eubacterium siraeum 
 20 > FEATURE : 
 < 221 > NAME / KEY : misc _ feature < 222 > LOCATION : ( 1 ) . . ( 2865 ) < 223 > OTHER INFORMATION : native CasM DNA sequence from Eubacterium 
 siraeum ? 
 < 400 > SEQUENCE : 28 
 atgggtaaga aaatacacgc acgagatctc agagaacaaa gaaagaccga tagaacggaa 60 60 
 aaatttgcag atcagaacaa aaaacgtgaa gcagagaggg cagttccgaa aaaagacgca 120 
 gccgtttctg taaaatcagt ttcttctgtt tcatcaaaaa aagacaatgt aacaaaatct 180 
 atggctaaag ccgcaggcgt gaagtcggtt tttgctgtag gaaatactgt ttatatgact 240 
 tcattcggca gaggaaacga tgctgtactt gagcagaaaa tagtcgatac atcgcacgaa 300 
 ccgctgaata ttgacgatcc tgcatatcag ttgaacgttg tcacaatgaa cggttattcg 360 
 gttaccggtc acagaggtga aacggtatct gccgtaacgg ataatccgct gcgccgtttt 420 
 aacggaagaa agaaagatga accggaacag tctgtgccta cggatatgct gtgcctgaaa 480 . ccgactcttg aaaagaaatt cttcggcaaa gaattcgatg ataatataca tatccagctt 540 
 atttacaata ttcttgacat tgaaaaaata ctggcggttt attcgaccaa cgctatttac 600 
 gcattgaata atatgagtgc tgacgaaaat atcgaaaaca gcgatttctt catgaaacgt 660 
 accaccgatg aaacctttga cgattttgaa aagaaaaagg agagtacaaa cagtcgagag 720 
 aaagccgatt ttgacgcatt tgaaaaattc atcggcaatt acaggctggc ttattttgcc 780 
 gatgcatttt atgtaaataa aaagaatccc aaaggtaaag caaaaaatgt tctgcgtgag 840 
 gataaagaac tttactccgt gotcactctg atcggtaaac tgcgtcattg gtgtgttcac 900 
 agtgaggagg gcagagcaga attctggctg tataagctcg atgaacttaa agatgatttc 960 
 aaaaatgtac tcgacgttgt ttataaccgt cctgttgaag aaataaacaa ccgctttata 1020 
 gaaaacaata aggtaaacat acagatactg ggctcggtat acaagaacac cgatattgcc 1080 
 gaacttgtaa ggtcatatta cgaatttctt atcacaaaga agtataaaaa tatgggcttt 1140 
 tcaataaaga agctccgtga gagtatgctc gaaggtaaag gttacgccga taaagaatat 1200 
 gattctgtaa ggaataagct gtatcagatg acggatttca tcttatacac aggatatatc 1260 
 aacgaagaca gcgatagagc cgacgatctt gtgaacactt tgagaagttc gctcaaagag 1320 
 gatgataaga caaccgtata ttgcaaggaa gcggattatc tgtggaaaaa ataccgtgaa 1380 
 tccataagag aggttgccga tgcgcttgat ggcgataaca ttaaaaagct gagcaaatcg 1440 
 aatattgaaa ttcaggaaga caagctgaga aaatgtttta tcagctatgc cgacagcgta 1500 
 tcggaattta ccaagcttat ttatctgctg acaagatttt taagcggtaa ggagatcaac 1560 
 gatcttgtca caacgctgat aaacaagttt gacaatatca gaagcttcct tgaaataatg 1620 
 gacgagcttg ggcttgacag gaccttcacc gccgagtaca gcttctttga aggcagtaca 1680 
 aagtatcttg ccgagcttgt cgagcttaac agctttgtga aatcgtgttc gtttgatata 1740 
 aacgcaaaaa gaacaatgta tcgcgatgcg ctggatattc tcggcattga atcggataag 1800 
 accgaagaag atattgagaa gatgatcgat aatatccttc agatcgacgc aaacggtgat 1860",2669
69,69,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 64 
 - continued 
 aaaaagctca agaaaaacaa cggtctgaga aatttcattg caagtaacgt tatagattca 1920 
 aaccgattca agtaccttgt gcggtacgga aatccaaaga agattcgtga aacggcaaaa 1980 
 tgcaagcccg ctgtaaggtt tgtgctgaat gagatcccgg acgcacagat cgaaagatat 2040 
 tatgaggott gttgcccaaa aaatacagct ttatgctctg caaataagag acgtgagaaa 2100 
 ctggctgata tgatagctga aataaagttt gagaattttt cggatgccgg caattatcag 2160 
 aaagcaaatg tcacatcaag aacgtctgaa gctgaaatca agcggaagaa tcaggctata 2220 
 atccgtcttt atcttaccgt tatgtacatt atgctgaaga accttgtaaa tgtgaacgcc 2280 
 agatacgtta tcgctttcca ttgcgttgaa agggatacga agctgtatgo ggaaagcggt 2340 
 ctggaagtcg gtaatataga aaaaaacaag acaaatctta ctatggctgt aatgggagtc 2400 
 aagctcgaaa acggaatcat aaaaacggaa tttgacaaga gotttgcaga aaatgccgca 2460 
 aacagatatc tcaggaatgc acgctggtac aagctgatac tggataattt aaagaagtcg 2520 
 gaaagagcgg ttgtcaatga gttcagaaat actgtctgcc atctgaatgc gataaggaat 2580 
 atcaatatca atatcaagga aataaaagag gtcgagaact actttgctct gtaccactac 2640 
 ctcattcaga aacatctcga aaatcgtttt gccgataaaa aagtagaaag agacaccggc 2700 
 gattttataa gcaagctcga agaacacaag acttactgca aggactttgt aaaagcatat 2760 
 tgtacgcctt tcggatataa ccttgtgaga tataaaaacc ttacgataga cgggctgttt 2820 
 gataagaatt accccggaaa agacgattct gatgaacaga aataa 2865 
 < 210 > SEQ ID NO 29 
 < 211 > LENGTH : 2760 < 212 > TYPE : DNA 
 13 > ORGANISM : Ruminococcus sp . 
 20 > FEATURE : 
 < 221 > NAME / KEY : misc feature 
 < 222 > LOCATION : ( 1 ) . . ( 2760 ) < 223 > OTHER INFORMATION : native CasM DNA sequence from Ruminococcus 
 sp . , isolate 2789STDY5834971 
 < 400 > SEQUENCE : 29 
 atggcaaaaa agaataaaat gaagcctaga gagctgcgtg aggctcagaa aaaagccaga 60 
 cagctcaaag cggctgagat aaataataac gctgctcctg caatcgctgc catgcctgct 120 
 gcagaggtca ttgcacctgc ggcagagaag aaaaaatcct ccgtaaaggc ggcaggaatg 180 
 aagtctattc ttgtcagoga aaataaaatg tacataacct ctttcggcaa gggcaattct 240 
 gctgtgcttg aatatgaggt ggataataat gactacaacc aaactcagct ttcttcaaag 300 
 gacaacagca atatccagct tggtggtgta aacgaagtaa acatcacttt ttcaagcaag 360 
 catggctttg agagcggagt ggaaataaac acttcaaacc ctactcacag aagcggtgaa 420 
 agctcgcctg taagagggga tatgctgggg cttaaatcgg agcttgaaaa gcgctttttc 480 
 ggcaaaactt ttgatgataa tatacatatc cagcttattt acaacattct ggatatcgaa 540 
 aagatacttg cggtgtatgt aacgaatatc gtttatgcgc tgaacaatat gctcggtgta 600 
 aagggttcag aaagtcatga cgattttatt gggtatcttt ccacaaataa tatttatgat 660 
 gtttttattg accctgataa cagcagttta tctgatgata agaaagcgaa tgtcagaaaa 720 
 agccttagca agttcaatgc cctgctgaaa actaagcgcc ttggctattt cggtcttgaa 780 
 gagccaaaga cgaaagataa tagagtttcg caagcttaca aaaagcgtgt ttatcatatg 840",2609
70,70,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 65 
 - continued 
 cttgcaattg tgggtcagat aagacagtgt gtttttcatg ataaatcggg tgcaaaaaga 900 
 tttgaccttt acagttttat taacaatatt gatcccgaat acagagacac tcttgactat 960 
 cttgttgagg aacgcttaaa gtccataaac aaggacttta tcgaggacaa caaggtcaat 1020 
 atcagettgc ttattgatat gatgaaaggc tatgaggctg atgatatcat acgcctttat 1080 
 tacgatttca ttgtgottaa atctcagaaa aatctcggtt tttctatcaa aaagcttcgt 1140 
 gagaaaatgc tggacgaata cggcttcaga tttaaggaca agcaatatga ctctgtgcgc 1200 
 tcaaagatgt acaagcttat ggattttctg cttttctgca actactacag aaatgacatt 1260 
 gccgcaggcg aatctcttgt gcgcaaactg cgtttttcaa tgaccgatga tgaaaaagag 1320 
 1380 gggatatatg ctgatgaagc ggcaaagctt tggggcaaat tcaggaatga ttttgaaaat 
 atcgccgacc acatgaacgg tgacgttatc aaggagcttg gcaaggctga catggatttt 1440 
 gatgagaaaa ttcttgacag cgaaaagaag aatgcgtctg accttttgta tttctccaaa 1500 
 atgatatata tgctcacata ttttcttgac ggcaaggaga taaacgacct tcttacaacg 1560 
 cttatcagca agtttgataa catcaaggag tttttgaaga taatgaaaag ctctgctgtt 1620 
 gatgttgagt gtgaacttac ggcgggctac aagctgttca atgacagcca gaggataacc 1680 
 aacgagcttt ttatcgtaaa gaacattgct tccatgagaa agcctgcggc ttcggcgaag 1740 
 cttacgatgt tccgtgacgc actgactata ctcggtatag acgacaagat cacggacgat 1800 
 aggataagcg ggattctaaa acttaaagaa aaaggcaagg gcatacatgg cctgagaaat 1860 
 ttcataacaa acaatgttat cgagtcctct cggtttgtat accttatcaa gtatgcgaac 1920 
 gctcagaaga taagagaagt ggctaagaat gagaaagttg tcatgtttgt tcttgggggt 1980 
 atccctgaca cgcagataga gcgttattac aagagttgtg tggaatttcc tgacatgaac2040 
 agttctttgg gagtaaagcg cagtgagctt gcgagaatga taaagaacat cagctttgat 2100 
 gatttcaaaa atgtgaaaca gcaggcaaag ggcagagaaa acgtggctaa ggagagggca 2160 
 aaggctgtta tcgggcttta tcttacggtc atgtatctgc tggtgaaaaa tcttgtgaat 2220 
 gtcaatgcaa ggtatgttat tgcgatacac tgccttgaac gtgattttgg gotgtataag 2280 
 gagataattc ctgagttggc ttcaaagaac ttgaaaaatg actacaggat actttcacag 2340 
 acgctttgtg aactttgtga taagtcgccg aatttgttct tgaaaaagaa cgagcggctg 2400 
 cgcaagtgcg ttgaagttga tatcaataat gcagacagca gcatgacaag aaaataccgc 2460 
 aactgtattg ctcatcttac tgtagttcgt gaactgaaag aatacatagg agatatttgt 2520 
 acagtggatt cttacttctc catttatcat tatgttatgc agcgctgtat cacgaaaagg 2580 
 gaaaatgaca caaagcaaga agagaaaata aagtatgagg acgatctttt aaaaaatcac 2640 
 ggctatacga aagactttgt aaaggctctc aactcgccgt ttggatacaa cattccgagg 2700 
 tttaaaaatc tttcaattga gcagttgttt gacagaaatg aatatcttac tgaaaagtag 2760 
 < 210 > SEQ ID NO 30 < 211 > LENGTH : 2757 < 212 > TYPE : DNA 
 < 213 > ORGANISM : Ruminococcus bicirculans 
 < 220 > FEATURE : 
 < 221 > NAME / KEY : misc _ feature < 222 > LOCATION : ( 1 ) . . ( 2757 ) < 223 > OTHER INFORMATION : native CasM DNA sequence from Ruminococcus 
 bicirculans 
 < 400 > SEQUENCE : 30",2702
71,71,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 - continued 
 atggcaaaaa agaataaaat gaagcctaga gagctgcgtg aggctcagaa aaaagccaga 
 cagctcaaag cggctgagat aaataataac gctgttcctg caatcgctgc catgcctgct 120 
 gcagaggctg ctgcacctgc ggcagagaag aaaaaatcct ccgtaaaggc ggcaggaatg 180 
 aagtctattc ttgtcagtga aaataaaatg tacataacct ctttcggcaa gggcaattet 240 
 gcggtgottg aatatgaggt ggataataat gactacaaca aaactcagct ttcctcaaag 300 
 gacaacagta atatcgagct ctgtgatgta ggcaaagtaa acatcacttt ttcgagcaga 360 
 cgtggctttg agagcggtgt ggagataaac acttcaaacc ctactcacag aagcggtgaa 420 
 agctcgtctg taagagggga tatgctgggg cttaaatcgg agcttgaaaa gcgctttttc 480 
 ggcaagaatt ttgatgataa tatacatatc cagcttattt acaacattct ggatatcgaa 540 
 aagatacttg cagtgtatgt gacgaatatc gtttatgcac tgaacaatat gottggggaa 600 
 ggcgatgaga gcaattacga tttcatgggg tatctttcca catttaacac ttataaaqtt 660 
 tttactaatc ctaatggcag cactttatcc gacgataaga aagagaatat cagaaaaagt 720 
 cttagcaaat tcaatgccct gotgaaaact aagcgtcttg gctatttcgg ccttgaagag 780 
 ccaaagacaa aggatacaag agcttcggaa gcatacaaaa agcgtgttta tcatatgctt 840 
 gcaattgtgg ggcagataag acagtgtgtt tttcatgata aatcgggtgc aaaaagattt 900 
 gacctttaca gttttattaa caatattgat cocgaataca gagaaaccct tgactatctt 960 
 gtagatgaga gatttgattc tataaataag ggctttatcc agggcaacaa ggtcaatatc 1020 
 agcttgotta ttgatatgat gaaaggctat gaggctgatg atatcatacg cctttattac 1080 
 gatttcattg tgottaaatc tcagaaaaat ctcggttttt ctatcaaaaa gottcgtgag 1140 
 1200 aaaatgctgg acgaatacgg cttcagattt aaggacaagc aatatgactc tgtgcgctca 
 aagatgtaca agcttatgga ttttctgctt ttctgcaact actacagaaa tgacattgcc 1260 
 gcaggcgaat ctcttgtgcg caaactgcgt ttttcaatga ccgatgatga aaaagagggg 1320 
 atatatgctg atgaagcggc aaagctttgg ggcaaattca ggaatgattt tgaaaatatc 1380 
 gccgaccaca tgaacggtga cgttatcaag gagcttggca aggctgacat ggattttgat 1440 
 gagaaaattc ttgacagcga aaagaagaat gcgtctgaccttttgtattt ctccaaaatg 1500 
 atatatatgc tcacatattt tcttgacggc aaggagataa acgaccttct tacaacgctt 1560 
 atcagcaagt ttgataacat caaggagttt ttgaagataa tgaaaagctc tgctgttgat 1620 
 gttgagtgtg aacttacggc gggctacaag ctgttcaatg acagccagag gataaccaac 1680 
 gagcttttta tcgtaaagaa cattgcttcc atgagaaagc ctgcggcttc ggcgaagctt 1740 
 acgatgttcc gtgacgcact gactatactc ggtatagacg acaagatcac ggacgatagg 1800 
 ataagcgaga ttctaaaact taaagaaaaa ggcaagggca tacatggcct gagaaattto 1860 
 ataacaaaca atgttatcga gtcctctcgg tttgtatacc ttatcaagta tgcgaacgct 1920 
 cagaagataa gagaagtggc taagaatgag aaagttgtca tgtttgttct tgggggtatc 1980 
 cctgacacgc agatagagcg ttattacaag agttgtgtgg aatttcctga catgaacagt 2040 
 tctttgggag taaagcgcag tgagcttgcg agaatgataa agaacatcag ctttgatgat 2100 
 ttcaaaaatg tgaaacagca ggcaaagggc agagaaaacg tggotaagga gagggcaaag 2160 
 gctgttatcg ggctttatct tacggtcatg tatctgctgg tgaaaaatct tgtgaatgtc 2220 
 aatgcaaggt atgttattgc gatacactgc cttgaacgtg attttgggct gtataaggag 2280",2802
72,72,"US 2018 / 0282715 A1 Oct . 4 , 2018 67 
 - continued 
 ataattcctg agttggcttc aaagaacttg aaaaatgact acaggatact ttcacagacg 2340 
 ctttgtgaac tttgtgataa gtcgccgaat ttgttcttga aaaagaacga gcggctgcgc 2400 
 aagtgcgttg aagttgatat caataatgca gacagcagca tgacaagaaa ataccgcaac 2460 
 tgtattgctc atcttactgt agttcgtgaa ctgaaagaat acataggaga tatttgtaca 2520 
 gtggattctt acttctccat ttatcattat gttatgcago gctgtatcac gaaaagggaa 2580 
 2640 aatgacacaa agcaagaaga gaaaataaag tatgaggacg atcttttaaa aaatcacggc 
 tatacgaaag actttgtaaa ggctctcaac tcgccgtttg gatacaacat tocgaggttt 2700 
 aaaaatcttt caattgagca gttgtttgac agaaatgaat atcttactga aaagtag 2757 
 < 210 > SEQ ID NO 31 
 < 211 > LENGTH : 2769 
 < 212 > TYPE : DNA < 213 > ORGANISM : Ruminococcus sp . < 220 > FEATURE : 
 < 221 > NAME / KEY : misc _ feature < 222 > LOCATION : ( 1 ) . . ( 2769 ) 
 < 223 > OTHER INFORMATION : native CasM DNA sequence from Ruminococcus 
 sp . , isolate 2789STDY5608892 
 < 400 > SEQUENCE : 31 
 atggcaaaaa agaataaaat gaagcctaga gagctgcgtg aggctcagaa aaaagccaga 60 
 cagctcaaag cggctgagat aaataataac gctgctcctg cgatcgctgc catgcctgct 120 
 gcagaggtca ttgcacctgt ggcagagaag aaaaaatcct ccgtaaaggc ggcaggaatg 180 
 aagtctattc ttgtcagoga aaataaaatg tacataacct ctttcggcaa gggcaattct 240 
 gctgtgcttg aatatgaggt ggacaataat gactacaaca aaactcagct ttcttcaaag 300 
 gacaacagca atatcgagct tggtgatgta aacgaggtaa acatcacttt ttcaagcaag 360 
 420 catggctttg ggagoggagt ggagataaat acttcaaacc ctactcacag aagcggtgaa 
 agctcgcctg taagagggga tatgctgggg cttaaatcgg agcttgaaaa gcgctttttc 480 
 ggcaaaactt ttgatgataa tatacatatc cagcttattt acaacattct ggatatcgaa 540 
 aagatacttg cggtgtatgt aacgaatatc gtttatgcgc tgaacaatat gottggtata 600 
 aaggattctg aaagttatga tgattttatg gggtatcttt ctgcaagaaa tacttatgaa 660 
 gtttttactc accctgacaa aagcaatctt tccgataagg taaagggtaa tatcaagaaa 720 
 agccttagca agtttaatga cttgctgaaa actaagcgcc ttggctattt cggccttgaa 780 
 gagccaaaga caaaagacac aagagcttcg gaagcataca aaaagcgtgt ttatcatatg 840 
 cttgcaattg tggggcagat aagacagtgt gtttttcatg ataaatcggg tgcaaaaaga 900 
 tttgaccttt acagttttat taacaatatt gatcccgaat acagagatac tcttgactat 960 
 cttgttgagg agcgtttaaa gtccataaac aaggacttta tcgagggtaa caaggtcaat 1020 
 atcagcctgc ttattgatat gatgaaagge tatgaggctg atgatatcat acgcctttat 1080 
 tacgatttca ttgtgcttaa atctcagaaa aatctcggct tttctatcaa aaagcttogt 1140 
 gagaaaatgc tggaggaata cggtttcaga tttaaggaca agcaatatga ctctgtgcgc 1200 
 tcaaagatgt acaagcttat ggatttcctg cttttctgca actactacag aaatgacgtt 1260 
 gccgcaggcg aagctcttgt gcgtaaactg cgtttttcaa tgaccgatga tgaaaaagag 1320 
 gggatatatg ctgatgaagc ggcaaagctt tggggcaaat tcaggaatga ttttgaaaat 1380",2624
73,73,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 - continued 
 atcgccgacc acatgaacgg tgacgttatc aaggagcttg gcaaggctga catggatttt 1440 
 gatgagaaaa ttcttgacag tgaaaagaag aatgcgtctg accttttgta tttctccaaa 1500 
 atgatatata tgctcacata ttttcttgac ggcaaggaga taaacgatct tcttacaacg 1560 
 cttatcagca agtttgataa catcaaggag tttttgaaga taatgaaaag ctctgctgtt 1620 
 gatgttgagt gtgagcttac ggcgggctac aagctgttca atgacagcca gaggataacc 1680 
 aacgagcttt ttatcgtaaa gaacattgct tccatgagaa agcctgcggc ttcagcgaag 1740 
 cttacgatgt tccgtgacgc actgactata ctcggtatag acgacaatat cacggacgat 1800 
 aggataagcg agattctaaa acttaaagaa aaaggcaagg gcatacatgg tctgagaaat 1860 
 tttataacaa acaatgttat cgagtcctct cggtttgtat accttatcaa gtatgcgaac 1920 
 gotcagaaga taagagaagt ggctaagaat gagaaagttg tcatgtttgt tcttgggggt 1980 
 atccctgaca cgcagataga gcgttattac aagagttgtg tggagtttcc tgacatgaat 2040 
 agttctttgg aagcaaagcg cagtgagctt gcgagaatga taaagaacat cagctttgat 2100 
 gatttcaaaa atgtgaaaca gcaggcaaag ggcagagaaa acgtggctaa ggagagggca 2160 
 aaggctgtta tcgggcttta tcttacggtc atgtatctgc tggtgaaaaa tcttgtgaat 2220 
 gtcaatgcaa ggtatgttat tgcgatacac tgccttgaac gtgattttgg gctgtataag 2280 
 gagataattc ctgagttggc ttcaaagaac ttgaaaaatg actacaggat actttcacag 2340 
 acgctttgtg aactttgtga tgatcgtaat gagtcgtcga atttgttctt gaaaaagaac 2400 
 aagcggctgc gcaagtgcgt tgaagttgat atcaataatg cagacagcag catgacaaga 2460 
 aaataccgca actgtattgc tcatcttact gtagttcgtg aactgaaaga atacatagga 2520 
 gatattcgta cagtggattc ttacttctcc atttatcatt atgttatgca gcgttgtatc 2580 
 acgaaaaggg gagatgacac aaagcaagaa gagaaaataa agtatgagga cgatctttta 2640 
 aaaaatcacg gctatacgaa agactttgta aaggctctca actcgccgtt tggatacaac 2700 
 attccgaggt ttaaaaatct ttcaattgag cagttgtttg acagaaatga atatcttact 2760 
 gaaaagtag 2769 
 < 210 > SEQ ID NO 32 
 < 211 > LENGTH : 2769 
 < 212 > TYPE : DNA < 213 > ORGANISM : Ruminococcus sp . 
 < 220 > FEATURE : 
 < 221 > NAME / KEY : misc _ feature < 222 > LOCATION : ( 1 ) . . ( 2769 ) < 223 > OTHER INFORMATION : native CasM DNA sequence from Ruminococcus sp . CAG : 57 
 < 400 > SEQUENCE : 32 
 atggcaaaaa agaataaaat gaagcctaga gagctgcgtg aggctcagaa aaaagccaga 60 60 
 cagctcaaag cggctgagat aaataataac gctgctcctg cgatcgctgc catgcctgct 120 
 gcagaggtca ttgcacctgt ggcagagaag aaaaaatcct ccgtaaaggc ggcaggaatg 180 
 aagtctattc ttgtcagoga aaataaaatg tacataacct ctttcggcaa gggcaattct 240 
 gctgtgcttg aatatgaggt ggacaataat gactacaaca a aactcagct ttcttcaaag 300 
 gacaacagca atatcgagct tggtgatgta aacgaggtaa acatcacttt ttcaagcaag 360 
 catggctttg ggagoggagt ggagataaat acttcaaacc ctactcacag aagcggtgaa 420 
 agctcgcctg taagagggga tatgctgggg cttaaatcgg agcttgaaaa gcgctttttc 480",2634
74,74,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 60 
 - continued 
 ggcaaaactt ttgatgataa tatacatatc cagcttattt acaacattct ggatatcgaa 540 
 aagatacttg cggtgtatgt aacgaatatc gtttatgcgc tgaacaatat gottggtata 600 
 aaggattctg aaagttatga tgattttatg gggtatcttt ctgcaagaaa tacttatgaa 660 
 gtttttactc accctgacaa aagcaatctt tccgataagg taaagggtaa tatcaagaaa 720 
 agccttagca agtttaatga cttgctgaaa actaagcgcc ttggctattt cggccttgaa 780 
 gagccaaaga caaaagacac aagagcttcg gaagcataca aaaagcgtgt ttatcatatg 840 
 cttgcaattg tggggcagat aagacagtgt gtttttcatg ataaatcggg tgcaaaaaga 900 
 tttgaccttt acagttttat taacaatatt gatcccgaat acagagatac tcttgactat 960 
 cttgttgagg agcgtttaaa gtccataaac aaggacttta tcgagggtaa caaggtcaat 1020 
 atcagcctgc ttattgatat gatgaaaggc tatgaggctg atgatatcat acgcctttat 1080 
 tacgatttca ttgtgcttaa atctcagaaa aatctcggct tttctatcaa aaagcttcgt 1140 
 gagaaaatgc tggaggaata cggtttcaga tttaaggaca agcaatatga ctctgtgcgc 1200 
 tcaaagatgt acaagcttat ggatttcctg cttttctgca actactacag aaatgacgtt 1260 
 gccgcaggcg aagctcttgt gcgtaaactg cgtttttcaa tgaccgatga tgaaaaagag 1320 
 gggatatatg ctgatgaagc ggcaaagctt tggggcaaat tcaggaatga ttttgaaaat 1380 
 atcgccgacc acatgaacgg tgacgttatc aaggagcttg gcaaggctga catggatttt 1440 
 gatgagaaaa ttcttgacag tgaaaagaag aatgcgtctg accttttgta tttctccaaa 1500 
 atgatatata tgctcacata ttttcttgac ggcaaggaga taaacgatct tcttacaacg 1560 
 cttatcagca agtttgataa catcaaggag tttttgaaga taatgaaaag ctctgctgtt 1620 
 gatgttgagt gtgagcttac ggcgggctac aagctgttca atgacagcca gaggataacc 1680 
 aacgagcttt ttatcgtaaa gaacattgct tccatgagaa agcctgcggc ttcagcgaag 1740 
 cttacgatgt tccgtgacgc actgactata ctcggtatag acgacaatat cacggacgat 1800 
 aggataagcg agattctaaa acttaaagaa aaaggcaagg gcatacatgg tctgagaaat 1860 
 tttataacaa acaatgttat cgagtcctct cggtttgtat accttatcaa gtatgcgaac 1920 
 gctcagaaga taagagaagt ggctaaggat gagaaagttg tcatgtttgt tcttgggggt 1980 
 atccctgaca cgcagataga gcgttattac aagagttgtg tggagtttcc tgacatgaat 2040 
 agttctttgg aagcaaagcg cagtgagctt gcgagaatga taaagaacat cagctttgat 2100 
 gatttcaaaa atgtgaaaca gcaggcaaag ggcagagaaa acgtggotaa ggagagggca 2160 
 aaggctgtta tcgggcttta tottacggtc atgtatctgc tggtgaaaaa tcttgtgaat 2220 
 gtcaatgcaa ggtatgttat tgcgatacac tgccttgaac gtgattttgg gctgtataag 2280 
 gagataattc ctgagttggc ttcaaagaac ttgaaaaatg actacaggat actttcacag 2340 
 acgctttgtg aactttgtga tgatcgtaat gagtcgtcga atttgttctt gaaaaagaac 2400 
 aagcggctgc gcaagtgcgt tgaagttgat atcaataatg cagacagcag catgacaaga 2460 
 aaataccgca actgtattgc tcatcttact gtagttcgtg aactgaaaga atacatagga 2520 
 gatattogta cagtggattc ttacttctcc atttatcatt atgttatgca gcgttgtatc 2580 
 acgaaaaggg gagatgacac aaagcaagaa gagaaaataa agtatgagga cgatctttta 2640 
 aaaaatcacg gctatacgaa agactttgta aaggctctca actcgccgtt tggatacaac 2700 
 attccgaggt ttaaaaatct ttcaattgag cagttgtttgacagaaatga atatcttact 2760",2819
75,75,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 - continued 
 gaaaagtag 2769 
 < 210 > SEQ ID NO 33 < 211 > LENGTH : 2802 < 212 > TYPE : DNA < 213 > ORGANISM : Ruminococcus flavefaciens < 220 > FEATURE : < 221 > NAME / KEY : misc _ feature 
 < 222 > LOCATION : ( 1 ) . . ( 2802 ) < 223 > OTHER INFORMATION : native CasM DNA sequence from Ruminococcus 
 flavefaciens FD - 1 
 < 400 > SEQUENCE : 33 
 atgaaaaaga aaatgtctct ccgtgaaaag cgtgaagccg agaaacaggc taaaaaagct 60 
 gcatattcag cagcttcaaa aaatacagat totaagcctg cggaaaagaa agcagaaact 120 
 ccaaagcctg cggagattat ttccgataat tocagaaata agaccgctgt aaaggcggct 180 
 ggtctgaaat caacaattat cagcggcgat aagctgtata tgacatcttt cggcaagggt 240 
 aacgctgctg ttattgagca gaaaatagat atcaatgatt attctttttc agctatgaaa 300 
 gatactccgt cgcttgaagt tgataaagca gaatcaaaag agatctcttt ttcaagtcac 360 
 catccttttg taaagaatga taagctgaca acatataacc ctttatacgg cggcaaggat 420 
 aaccccgaaa agcctgtcgg cagggatatg ctcggcttaa aagataagct tgaagaacgc 480 
 tatttcggat gtacattcaa tgata atctt cacatccaga ttatctata a catacttgac 540 
 atcgagaaga ttttagctgt tcattctgca aatatcacaa ctgcgcttga ccacatggtt 600 
 gatgaagacg atgaaaaata tcttaacagc gattatatcg getacatgaa taccataaat 660 
 acatatgacg tgtttatgga tccttcaaag aattcttcat taagccctaa agatagaaag 720 
 aatattgaca acagccgtgc aaaatttgag aaactgcttt caactaagcg ccttggctat 780 
 tttggatttg actatgatgc aaacggtaag gacaagaaaa agaacgagga aataaaaaag 840 
 cgtttatatc atctcacagc ttttgcaggt cagctccgtc agtggagttt tcatagtgct 900 
 ggcaattatc cgagaacatg gotttacaag ctcgattcac tggataagga atatcttgat 960 
 actcttgacc attacttoga taaacgtttt aacgatataa acgatgattt cgtaactaag 1020 
 aatgctacca atctctatat tctgaaagaa gtatttcccg aagcaaactt caaggatatt 1080 
 gccgatcttt attacgattt catagttata aagtcgcaca aaaatatggg attctccata 1140 
 aaaaagctga gggagaagat gottgaatgt gatggtgcag acaggataaa agaacaggat 1200 
 atggactctg ttcgctcaaa gctgtataag ctcatagact tttgcatttt caagtattat 1260 
 cacgaatttc ctgaacttag tgaaaagaat gtggatatac tcagagcggc tgtatccgat 1320 
 acaaaaaaag ataaccttta ttctgatgag gctgcacgtt tatggagcat atttaaagaa 1380 
 aaattcctcggcttctgtga taagatagtt gtatgggtaa caggagagca tgagaaagat 1440 
 atcacatccg ttattgataa ggatgcttac aggaacagga gcaatgtttc atatttctca 1500 
 aagctgatgt atgcaatgtg ctttttcctt gacggaaaag agataaatga ccttctcact 1560 
 actcttatca acaaattcga taatatcgct aaccagataa aaacagccaa agaacttggc 1620 
 attaatactg cttttgtaaa gaattacgat ttcttcaatc acagcgagaa atatgtcgat 1680 
 gaactgaaca tcgtcaagaa tattgcaaga atgaagaagc cttcaagtaa tgccaaaaaa 1740 
 gctatgtatc atgatgcgct tactattctc ggaatacctg aggatatgga tgaaaaagct 1800",2560
76,76,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 - continued 
 cttgatgagg aactggattt aattcttgaa aaaaagacag acccagtaac tggcaagcca 1860 
 ctgaaaggta agaatccttt acgtaatttt atcgcaaaca atgtgataga gaattcaaga 1920 
 ttcatatatc ttatcaagtt ctgcaatcct gagaatgtac gtaaaatcgt gaataataca 1980 
 aaggtcactg agtttgtgtt aaagcgtatt cccgatgctc agatcgaacg ctattataag 2040 
 tcgtgtacag attctgaaat gaatccgcct actgaaaaga agatcaccga acttgctggt 2100 
 aagttaaagg atatgaactt tggcaacttc cgaaatgtga gacagtctgc taaagagaat 2160 
 atggagaagg agcgcttcaa agctgttata gggctttatc tcacggtagt atatcgtgtt 2220 
 gtcaagaatc ttgttgatgt aaactcacga tatatcatgg cttttcattc gottgaacgt 2280 
 gattcacaac tgtataacgt atctgttgat aatgattatc ttgcacttac cgatactctt 2340 
 gttaaggagg gagataattc cagaagcaga tatcttgcag gcaacaagcg totgagagat 2400 
 tgtgtgaagc aggatatoga taatgcaaaa aagtggtttg ttagtgataa gtacaatago 2460 
 2520 ataaccaagt acaggaataa cgttgcccat cttaccgctg tacgtaactg cgctgaatto 
 atcggagata taacgaagat agactcctat tttgcattgt atcattatct cattcagaga 2580 
 cagcttgcga aaggtcttga ccatgagcga agtggctttg acagaaacta tccacagtat 2640 
 gcaccgctgt ttaagtggca tacgtatgta aaggatgttg tcaaggctct gaatgctcca 2700 
 tttggctaca atatccctcg tttcaagaat ctcagcatag atgcactttt tgaccgcaac 2760 
 gaaataaaga agaatgacgg cgagaaaaaa tccgatgatt ga 2802 
 < 210 > SEO ID NO 34 
 < 211 > LENGTH : 2835 
 < 212 > TYPE : DNA < 213 > ORGANISM : Ruminococcus albus 
 20 > FEATURE : 
 < 221 > NAME / KEY : misc _ feature < 222 > LOCATION : ( 1 ) . . ( 2835 ) < 223 > OTHER INFORMATION : native CasM DNA sequence from Ruminococcus 
 albus strain KH2T6 
 < 400 > SEQUENCE : 34 
 atggcaaaaa aatcgaaagg tatgagcctt agagaaaaac gtgaacttga aaagcagaaa 60 
 aggatacaaa aggcagctgt gaattcagtt aatgatacac ctgaaaaaac agaagaagca 120 
 aatgtcgtat ctgtaaatgt caggacatcg gctgagaata agcatagtaa aaaatctgct 180 
 gccaaagctt tgggactgaa atccgggctg gttatcggtg atgagctgta ccttacttca 240 
 ttcggcagag gtaacgaagc aaagcttgaa aagaagatat ccggtgacac tgtcgaaaaa 300 
 cttggcattg gtgcttttga agtcgccgaa cgtgacgaat caacgcttac cctcgaaagt 360 
 ggcaggataa aggacaagac cgccagaccc aaagacccca gacatataac cgtcgataca 420 
 caaggtaaat tcaaggaaga tatgcttggg atacgcagtg tactggagaa aaagatattt 480 
 ggcaaaacat ttgatgataa tatccatgtt cagcttgcgt acaatatcct ggatgtcgaa 540 
 aagataatgg cacagtatgt cagcgatatc gtatatatgc tgcataatac tgataaaaca 600 
 gaaagaaacg ataatcttat ggggtatatg agcatcagga atacctataa gacattttgt 660 
 gatacgtcaa atcttcccga tgatacaaaa caaaaagttg aaaatcagaa gagagagttt 720 
 gacaagatca taaaaagcgg cagacttggg tatttcggcg aagcttttat ggtaaacagc 780 
 ggcaatagta ccaagcttag acccgagaaa gagatatatc atatctttgc gottatggcg 840 
 agcctgaggc agagttactt tcacggatat gtaaaagata ccgattatca gggaaccaca 900",2665
77,77,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 - continued 
 tgggcatata ctcttgagga caagctgaaa ggtccgagcc atgagttcag ggaaaccatt 960 
 gataagatat ttgatgaggg attcagcaag atcagcaagg actttggcaa gatgaacaag 1020 
 gtcaaccttc agatacttga acagatgatt ggtgaactgt atggcagtat agaacgacaa 1080 
 aacctcactt gcgattacta tgacttcatt caactgaaaa agcataagta tcttggattt 1140 
 tctataaagc gtcttagaga gaccatgott gaaacaacac cggctgaatg ttataaagct 1200 
 gaatgctata acagcgagcg tcaaaagctg tataagctga tagatttcct gatatatgat 1260 
 ctttactata accgtaagcc tgcacgcatc gaagaaatcg tggacaagct gagggaatct 1320 
 gtgaacgacg aagagaaaga atccatatat tcagttgagg cgaagtatgt ctatgaatca 1380 
 cttagcaaag ttctggataa atcgctgaaa aacagtgtgt ctggtgaaac gataaaggat 1440 
 ctccaaaaga gatatgatga cgaaacagca aacaggatct gggatatctc acagcacagt 1500 
 ataagtggaa atgtcaactg tttctgcaag ctaatttata ttatgaccct gatgottgac 1560 
 ggcaaggaga taaatgatct getgacaacg ctggtaaaca agttegataa catagcatca 1620 
 tttatagatg ttatggacga acttggcttg gagcatagtt ttacagataa ctataaaatg 1680 
 tttgccgaca gcaaggctat atgccttgat ctgcagttca taaacagttt tgcacgtatg 1740 
 tcaaagatcg atgatgagaa gtcaaaaaga cagcttttcc gtgatgcgct tgtcatactg 1800 
 gatatcggta ataaagatga gacttggata aataattatc tggattctga tattttcaaa 1860 
 ctggacaaag aaggtaacaa gttaaagggc gcaaggcatg atttcaggaa ctttatagcc 1920 
 aataatgtta taaagtcatc acgtttcaaa tacctagtaa aatacagcag tgccgatggt 1980 
 atgataaagc tgaaaacgaa tgaaaagctg ataggctttg ttctggataa gottccagaa 2040 
 acgcagatag accgctacta tgaatcatgc ggacttgaca atgcggtagt agataagaaa 2100 
 gtcaggatag aaaagctatc ggggcttatc agagatatga agttcgatga tttcagcggt 2160 
 gtcaaaacct caaacaaagc aggagataat gacaaacagg ataaggcgaa atatcaggcg 2220 
 ataataagcc tgtacctcat ggtgctgtat cagatagtca agaacatgat atatgtcaac 2280 
 tcacgttatg ttatcgcttt ccattgtctt gaacgtgact ttggtatgta tggaaaagat 2340 
 tttggaaagt attatcaagg ctgccgaaaa cttacagatc attttattga agaaaagtac 2400 
 atgaaagagg gtaaacttgg ctgcaataaa aaagtcggca gatatctgaa aaataatatt 2460 
 tcctgctgca ctgatggact gataaatacc taccgtaatc aggttgatca ctttgcagtg 2520 
 gtaaggaaga taggcaacta tgcggcatat atcaagagta tcggttcgtg gtttgaactt 2580 
 tatcactatg taatacagag gatagttttt gacgaataca gatttgcact taacaacact 2640 
 gaaagcaact ataagaacad catcatcaag caccatacct actgtaagga tatggtcaag 2700 
 gcactgaaca cacctttcgg ttatgacctg ccgagataca agaatctttc tatcggtgat 2760 
 ctgtttgatc gcaataatta tctgaataaa acaaaagagt caatagatgc aaatagctct 2820 
 attgacagtc agtga 2835 
 < 210 > SEQ ID NO 35 
 < 211 > LENGTH : 2904 
 < 212 > TYPE : DNA 
 < 213 > ORGANISM : Ruminococcus flavefaciens < 220 > FEATURE : < 221 > NAME / KEY : misc _ feature < 222 > LOCATION : ( 1 ) . . ( 2904 ) < 223 > OTHER INFORMATION : native CasM DNA sequence from Ruminococcus",2686
78,78,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 73 
 - continued 
 flavefaciens strain XPD3002 
 < 400 > SEQUENCE : 35 
 atgatcgaaa agaagaagtc atttgcaaag ggcatgggag taaaatcaac acttgtatcc 60 
 ggttcaaagg tatacatgac gacgttcgca gaaggaagcg atgccagact tgaaaagatc 120 
 gttgaaggcg attctatcag atctgtcaac gaaggagaag cgttctcagc tgaaatggct 180 
 gataagaatg caggctacaa gatcggtaac gcaaagttca gccacccaaa gggctatgct 240 
 gtagttgcaa acaacccctt atacaccgga ccggtacagc aggatatgct cggtctgaag 300 
 gaaacgcttg aaaagagata ttttggagag tctgccgacg gaaatgataa tatctgtatt 360 
 caggtcatcc ataatatcct cgatatcgaa aagatcctcg ctgaatatat aaccaatgct 420 
 gottatgcgg taaacaatat ttccggtctt gataaggata tcatcggttt tggtaagttc 480 
 agtacggtct atacttatga tgagttcaag gatcctgaac atcacagagc agctttcaac 540 
 aataacgata agttaattaa tgccatcaag gcacagtatg atgaatttga caatttcctt 600 
 gataatcctc gtctcggcta ctttggacag gettttttca gta aggaagg cagaaattac 660 
 attatcaatt acggcaacga gtgttatgat attcttgctt tactcagcgg attgcgtcac 720 
 tgggtagtac ataataatga ggaagaatca aggatttccc gtacatggct ttataatctc 780 
 gacaagaatc ttgacaacga atatatctct actctcaatt atctgtatga tagaattaca 840 
 aacgaattaa caaattcctt ctcaaagaat agtgcagcca acgtaaacta tatcgctgaa 900 
 acccttggta ttaatcctgc tgaatttgca gagcagtatt tcagattcag tatcatgaag 960 
 gaacagaaga atctcggttt caatattact aagctgagag aagtaatgct tgacagaaag 1020 
 gatatgtctg agatccgtaa aaatcataag gtctttgatt caatccgtac taaggtctat 1080 
 actatgatgg atttogttat ctacagatat tacattgaag aggatgcaaa ggttgctgct 1140 
 gccaacaagt ctctgccgga taacgaaaaa agcctcagtg aaaaggatat ctttgttata 1200 
 aatctcagag gaagctttaa cgatgatcag aaggatgccc tttattatga tgaggccaat 1260 
 cgtatttgga gaaagctcga aaacattatg cacaatatca aggaattcag aggcaataag 1320 
 acacgtgaat acaagaagaa ggatgctcca agactcccca gaattcttcc tgccggaagg 1380 
 gatgtttccg cgttctcaaa gttgatgtac gctcttacca tgttccttga tggtaaggag 1440 
 atcaatgatc ttctcaccac gctcatcaat aagttegata acatccagag tttcctcaag 1500 
 gtaatgcctc ttatcggagt gaatgcaaag tttgttgagg aatatgcctt cttcaaggac 1560 
 agcgcaaaga ttgctgacga actcaggctg attaagagct ttgccagaat gggagaacct 1620 
 atcgcagatg caagacgtgc tatgtatatc gatgctatca ggattctcgg aacaaacctc 1680 
 agctatgatg agcttaaggc ccttgccgat actttttcgc ttgatgaaaa cggcaacaag 1740 
 cttaagaagg gcaagcacgg catgagaaac ttcatcatta ataatgtaat cagtaacaag 1800 
 cgcttccatt atctcattcg ttacggtgat cctgcacatc tocatgagat cgccaagaat 1860 
 gaagctgttg taaagttogt cctcggcagg atagctgata tccagaagaa gcagggacag 1920 
 aacggaaaga atcagatcga caggtactat gagacctgta tcggcaagga caagggcaag 1980 
 tctgtctccg aaaaggttga tgccctcaca aagattatca ccggtatgaa ctacgatcag 2040 
 ttcgataaga agagaagcgt tattgaggat actggaagag aaaacgctga gagagaaaag 2100 
 ttcaagaaga tcatcagcct ctatcttact gtcatttatc acatccttaa gaatattgtt 2160",2720
79,79,"US 2018 / 0282715 A1 Oct . 4 , 2018 74 
 - continued 
 aatatcaatg cgcgttacgt tatcggetto cattgcgttg agcgtgatgc acagctctat 2220 
 aaggaaaagg gctatgatat caacctcaag aagctcgaag aaaaggggtt ttcatcagtc 2280 
 acaaagctgt gtgcaggtat tgatgagact gctcctgaca agcgtaagga tgttgaaaag 2340 
 gaaatggctg agcgtgcaaa ggaatctatc gatagccttg aatctgcaaa tcctaagctt 2400 
 tacgcaaact atatcaagta ttctgacgag aagaaggctg aggaatttac tagacagato 2460 
 aaccgtgaga aggcaaagac cgctctgaat gcatatctca gaaatactaa gtggaatgtg 2520 
 ataatcaggg aagatcttct tagaatcgat aataagacat gtacgctctt tagaaataag 2580 
 gccgttcatc ttgaagttgc aagatatgtt catgcatata tcaacgatat tgccgaagta 2640 
 aacagctatt tccagcttta tcattacatc atgcagagaa tcatcatgaa cgaaagatat 2700 
 gaaaagtctt ctggaaaggt aagcgaatac ttcgatgctg tgaacgatga aaagaagtac 2760 
 aacgacaggc ttctgaagct gttgtgcgtt ccatttggtt actgcatccc gagattcaag 2820 
 aatctctcca ttgaagcttt gttcgacagg aacgaagcag ctaagtttga caaggaaaag 2880 
 aagaaagtat caggtaattc atag 2904 
 < 210 > SEQ ID NO 36 < 211 > LENGTH : 2391 
 < 212 > TYPE : DNA < 213 > ORGANISM : Ruminococcus sp . 
 20 > FEATURE : 
 < 221 > NAME / KEY : misc _ feature 
 2 > LOCATION : ( 1 ) . . ( 2391 ) 
 < 223 > OTHER INFORMATION : native CasM DNA sequence from Ruminococcus sp . , isolate 2789STDY5834894 
 < 400 > SEQUENCE : 36 
 gtggagataa acacttcaaa ccctactcac agaagcggtg aaagctcgtc tgtaagaggg 60 
 gatatgctgg ggcttaaatc ggagcttgaa aagcgctttt tcggcaagac ttttgatgat 120 
 aatatacata tocagcttat ttacaacatt ctggatatcg aaaagatact tgcagtgtat 180 
 gtgacgaata tcgtttatge actgaacaat atgcttggtg taaagggttc tgaaagttat 240 
 gatgatttta tggggtatct ttctgcccaa aatacttatt atatttttac tcaccctgac 300 
 aaaagtaatc tttccgataa ggtaaagggt aatatcaaga aaagccttag caagtttaat 360 
 gacctgctga aaactaagcg tcttggctat tttggtcttg aagagcctaa gacgaaagat 420 
 aaaagagttt cggaggcata caaaaagcgt gtttatcata tgcttgcaat tgtggggcag 480 
 ataaggcaga gtgttttcca tgataagtca aatgagcttg atgagtacct ttacagcttt 540 
 attgacatta ttgattccga atacagagac actcttgact atcttgtaga tgagagattt 600 
 gattctataa ataagggctt tgtccagggc aacaaggtca atatcagctt gottattgat 660 
 atgatgaaag gctatgaggc tgatgatatc atacgccttt attatgattt cattgtgott 720 
 aaatctcaga aaaatctcgg tttttctatc aaaaagcttc gtgagaaaat gctggacgaa 780 
 tacggcttca gatttaagga caagcaatat gactctgtgc gctcaaagat gtacaagott 840 
 atggattttc tgcttttctg caactattac agaaatgacg ttgtcgcagg cgaagctctt 900 
 gtgcgcaaac tgcgtttttc aatgaccgat gatgaaaaag aggggatata tgctgatgaa 960 
 gcggaaaagc tttggggcaa attcaggaat gattttgaaa atatcgccga ccacatgaac 1020 
 ggtgacgtta tcaaggagct tggcaagget gacatggatt ttgatgagaa aattcttgac 1080 
 agcgaaaaga agaatgcgtc tgaccttttg tatttctcca aaatgatata tatgctcaca 1140",2654
80,80,"US 2018 / 0282715 A1 Oct . 4 , 2018 
 75 
 - continued 
 tattttcttg acggcaagga gataaacgat cttcttacaa cgcttatcag caagtttgat 1200 
 aacatcaagg agtttttgaa gataatgaaa agctctgctg ttgatgttga gtgtgagctt 1260 
 acggcgggct acaagctgtt caatgacago cagaggataa ccaacgagct ttttatcgta 1320 
 aagaacattg cttccatgag aaagcctgcg gottcggcga agcttacgat gttccgtgac 1380 
 gcactgacta tactcggtat agacgacaag atcacggacg ataggataag cgagatttta 1440 
 aaacttaaag aaaaaggcaa gggcatacat ggtctgagaa attttataac aaacaatgtt 1500 
 atcgagtcct ctcggtttgt ataccttatc aagtatgcga acgctcagaa gataagagaa 1560 
 gtggotaaga atgagaaagt tgtcatgttt gttcttgggg gtatccctga cacgcagata 1620 
 1680 gagcgttatt acaagagttg tgtggaattt cctgacatga acagttcttt ggaagcaaag 
 tgcagtgagc ttgcgagaat gataaagaac atcagctttg atgatttcaa aaatgtgaaa 1740 
 cagcaggcaa agggcagaga aaacgtggct aaggagaggg caaaggctgt tatcgggctt 1800 
 tatcttacgg tcatgtatct gctggtgaaa aatcttgtga atgtcaatge aaggtatgtt 1860 
 attgcgatac actgccttga acgtgatttt gggctgtata aggagataat tcctgagttg 1920 
 gottcaaaga acttgaaaaa tgactacagg atactttcac agacgctttg tgaactttgt 1980 
 gatgatcgtg atgagtcgcc gaatttgttc ttgaaaaaga acaagcggct gcgcaagtgc 2040 
 gttgaagttg atatcaataa tgcagacagc agcatgacaa gaaaataccg caactgtatt 2100 
 gctcatctta ctgtagtteg tgaactgaaa gaatacatag gagatattcg tacagtggat 2160 
 tcttacttct ccatttatca ttatgttatg cagcgctgta tcacgaaaag ggaagatgac 2220 
 acaaagcaag aagagaaaat aaagtatgag gacgatcttt taaaaaatca cggctatacg 2280 
 aaagactttg taaaggctct caactcgccg tttggataca acattccgag gtttaaaaat 2340 
 ctttcaattg agcagttgtt tgacagaaat gaatatctta ctgaaaagta g 2391 
 A 
 A 
 A 
 A < 210 > SEQ ID NO 37 < 211 > LENGTH : 954 
 < 212 > TYPE : PRT < 213 > ORGANISM : Eubacterium siraeum < 220 > FEATURE : < 221 > NAME / KEY : misc _ feature < 222 > LOCATION : ( 1 ) . . ( 954 ) < 223 > OTHER INFORMATION : native Casm protein sequence from 
 Eubacterium siraeum A 
 A 
 A 
 < 400 > SEQUENCE : 37 
 Met Gly Lys Lys Ile His Ala Arg Asp Leu Arg Glu Gin Arg Lys Thr van Asp Arg Thr Glu Lys Phe Ala Asp Gin Asn Lys Lys Arg Glu Ala Glu Date na 25 
 Arg Ala Val Pro Lys Lys Asp Ala Ala Val Ser Val Lys Ser Val Ser ala bi ose Ser Val Ser Ser Lys Lys Asp Asn Val Thr Lys Ser Met Ala Lys Ala 
 Ala Gly Val Lys Ser Val Phe Ala Val Gly Asn Thr Val Tyr Met Thr 
 70 75 ch ang Ser Phe Gly Arg Gly Asn Asp Ala Val Leu Glu Gin Lys Ile Val Asp 
 Thr Ser His Glu Pro Leu Asn Ile Asp Asp Pro Ala Tyr Gin Leu Asn 
 105",2408
81,81,"US 2018 / 0282715 Al Oct . 4 , 2018 
 m 
 - continued 
 Val Val Thr Met Asn Gly Tyr Ser Val Thr Gly His Arg Gly Glu Thr 
 115 120 125 
 Val Ser Ala Val Thr Asp Asn Pro Leu Arg Arg Phe Asn Gly Arg Lys | 3 ? 
 In A Lys Asp Glu Pro Glu Gin Ser Val Pro Thr Asp Met Leu Cys Leu Lys 
 160 
 Pro Thr Leu Glu Lys Lys Phe Phe Gly Lys Glu Phe Asp Asp Asn Ile 
 170 
 His Ile Gin Leu Ile Tyr Asn Ile Leu Asp Ile Glu Lys Ile Leu Ala 
 185 190 ? 
 ? & 
 & J EEE JET Val Tyr Ser Thr Asn Ala Ile Tyr Ala Leu Asn Asn Met Ser Ala Asp 
 195 200 205 
 Glu Asn Ile Glu Asn Ser Asp Phe Phe Met Lys Arg Thr Thr Asp Glu 
 Thr Phe Asp Asp Phe Glu Lys Lys Lys Glu Ser Thr Asn Ser Arg Glu 
 240 Rag Lys Ala Asp Phe Asp Ala Phe Glu Lys Phe Ile Gly Asn Tyr Arg Leu 250 
 & Ala Tyr Phe Ala Asp Ala Phe Tyr Val Asn Lys Lys Asn Pro Lys Gly 
 265 270 
 Lys Ala Lys Asn Val Leu Arg Glu Asp Lys Glu Leu Tyr Ser Val Leu 
 275 280 285 mmm mmmm mam mmmmmmm mmmmm Thr Leu Ile Gly Lys Leu Arg His Trp Cys Val His Ser Glu Glu Gly 
 Arg Ala Glu Phe Trp Leu Tyr Lys Leu Asp Glu Leu Lys Asp Asp Phe 
 320 
 Lys Asn Val Leu Asp Val Val Tyr Asn Arg Pro Val Glu Glu Ile Asn 
 330 
 Asn Arg Phe Ile Glu Asn Asn Lys Val Asn Ile Gin Ile Leu Gly Ser 
 345 350 
 Val Tyr Lys Asn Thr Asp Ile Ala Glu Leu Val Arg Ser Tyr Tyr Glu 
 355 360 365 mmmmm Phe Leu Ile Thr Lys Lys Tyr Lys Asn Met Gly Phe Ser Ile Lys Lys 
 Leu Arg Glu Ser Met Leu Glu Gly Lys Gly Tyr Ala Asp Lys Glu Tyr 
 400 
 Asp Ser Val Arg Asn Lys Leu Tyr Gin Met Thr Asp Phe Ile Leu Tyr 
 410 
 Thr Gly Tyr Ile Asn Glu Asp Ser Asp Arg Ala Asp Asp Leu Val Asn 
 425 | 430 | gg En Thr Leu Arg Ser Ser Leu Lys Glu Asp Asp Lys Thr Thr Val Tyr Cys 
 435 440 445 
 Lys Glu Ala Asp Tyr Leu Trp Lys Lys Tyr Arg Glu Ser Ile Arg Glu 
 Val Ala Asp Ala Leu Asp Gly Asp Asn Ile Lys Lys Leu Ser Lys Ser 
 480 
 Asn Ile Glu Ile Gin Glu Asp Lys Leu Arg Lys Cys Phe Ile Ser Tyr 
 490 495 
 Ala Asp Ser Val Ser Glu Phe Thr Lys Leu Ile Tyr Leu Leu Thr Arg 
 505 510 ?",1959
82,82,"m 
 US 2018 / 0282715 Al Oct . 4 , 2018 77 
 - continued 
 Phe Leu Ser Gly Lys Glu Ile Asn Asp Leu Val Thr Thr Leu Ile Asn 515 520 525 
 Lys Phe Asp Asn Ile Arg Ser Phe Leu Glu Ile Met Asp Glu Leu Gly 33 Leu Asp Arg Thr Phe Thr Ala Glu Tyr Ser Phe Phe Glu Gly Ser Thr 
 545 550 555 560 
 Lys Tyr Leu Ala Glu Leu Val Glu Leu Asn Ser Phe Val Lys Ser Cys 
 570 575 E 
 Ser Phe Asp Ile Asn Ala Lys Arg Thr Met Tyr Arg Asp Ala Leu Asp 
 590 
 Ile Leu Gly Ile Glu Ser Asp Lys Thr Glu Glu Asp Ile Glu Lys Met 
 595 600 605 
 Ile Asp Asn Ile Leu Gin Ile Asp Ala Asn Gly Asp Lys Lys Leu Lys 
 Lys Asn Asn Gly Leu Arg Asn Phe Ile Ala Ser Asn Val Ile Asp Ser 
 625 | 630 635 640 
 Asn Arg Phe Lys Tyr Leu Val Arg Tyr Gly Asn Pro Lys Lys Ile Arg 
 650 655 
 Glu Thr Ala Lys Cys Lys Pro Ala Val Arg Phe Val Leu Asn Glu Ile 
 670 
 Pro Asp Ala Gin Ile Glu Arg Tyr Tyr Glu Ala Cys Cys Pro Lys Asn 
 675 680 685 
 Thr Ala Leu Cys Ser Ala Asn Lys Arg Arg Glu Lys Leu Ala Asp Met mmmmm mmmmmm am mmmmm mmmmmmm mmmmmmmmm mmmm mmmmmmmmmmm mamma mmm mmmm Ile Ala Glu Ile Lys Phe Glu Asn Phe Ser Asp Ala Gly Asn Tyr Gln 
 705 710 715 720 
 Lys Ala Asn Val Thr Ser Arg Thr Ser Glu Ala Glu Ile Lys Arg Lys 
 730 735 
 Asn Gin Ala Ile Ile Arg Leu Tyr Leu Thr Val Met Tyr Ile Met Leu 
 750 
 Lys Asn Leu Val Asn Val Asn Ala Arq Tyr Val Ile Ala Phe His Cys 
 755 760 765 
 Val Glu Arg Asp Thr Lys Leu Tyr Ala Glu Ser Gly Leu Glu Val Gly 
 Asn Ile Glu Lys Asn Lys Thr Asn Leu Thr Met Ala Val Met Gly Val 
 785 795 800 790 
 Lys Leu Glu Asn Gly Ile Ile Lys Thr Glu Phe Asp Lys Ser Phe Ala 
 810 815 
 Glu Asn Ala Ala Asn Arg Tyr Leu Arg Asn Ala Arg Trp Tyr Lys Leu 
 830 | 
 Ile Leu Asp Asn Leu Lys Lys Ser Glu Arg Ala Val Val Asn Glu Phe 
 835 840 845 
 Arg Asn Thr Val Cys His Leu Asn Ala Ile Arg Asn Ile Asn Ile Asn 
 Ile Lys Glu Ile Lys Glu Val Glu Asn Tyr Phe Ala Leu Tyr His Tyr 
 865 870 875 880 
 Leu Ile Gin Lys His Leu Glu Asn Arg Phe Ala Asp Lys Lys Val Glu 
 890 895 
 Arg Asp Thr Gly Asp Phe Ile Ser Lys Leu Glu Glu His Lys Thr Tyr 
 910 
 Cys Lys Asp Phe Val Lys Ala Tyr Cys Thr Pro Phe Gly Tyr Asn Leu",2087
83,83,"US 2018 / 0282715 Al Oct . 4 , 2018 
 - continued 
 915 920 925 
 Val Arg Tyr Lys Asn Leu Thr Ile Asp Gly Leu Phe Asp Lys Asn Tyr 
 930 935 940 
 Pro Gly Lys Asp Asp Ser Asp Glu Gin Lys 
 945 950 m 
AAAAA < 210 > SEQ ID NO 38 < 211 > LENGTH : 919 < 212 > TYPE : PRT < 213 > ORGANISM : Ruminococcus sp . 
 < 220 > FEATURE : 
 < 221 > NAME / KEY : misc _ feature < 222 > LOCATION : ( 1 ) . . ( 919 ) < 223 > OTHER INFORMATION : native Casm protein sequence from Ruminococcus 
 sp . , isolate 2789STDY5834971 1 1 2 2 22 
 2 1 
 2 2 
 2 3 
 < 400 > SEQUENCE : 38 
 Met Ala Lys Lys Asn Lys Met Lys Pro Arg Glu Leu Arg Glu Ala Gln 
 | 5 15 
 Lys Lys Ala Arg Gin Leu Lys Ala Ala Glu Ile Asn Asn Asn Ala Ala 
 20 25 30 
 Pro Ala Ile Ala Ala Met Pro Ala Ala Glu Val Ile Ala Pro Ala Ala 
 35 
 Glu Lys Lys Lys Ser Ser Val Lys Ala Ala Gly Met Lys Ser Ile Leu 
 50 
 Val Ser Glu Asn Lys Met Tyr Ile Thr Ser Phe Gly Lys Gly Asn Ser 
 65 2 75 
 Ala Val Leu Glu Tyr Glu Val Asp Asn Asn Asp Tyr Asn Gin Thr Gln 
 185 95 
 Leu Ser Ser Lys Asp Asn Ser Asn Ile Gin Leu Gly Gly Val Asn Glu 
 100 105 110 
 Val Asn Ile Thr Phe Ser Ser Lys His Gly Phe Glu Ser Gly Val Glu 
 115 120 mmmmmm mmmm Ile Asn Thr Ser Asn Pro Thr His Arg Ser Gly Glu Ser Ser Pro Val 
 130 
 Arg Gly Asp Met Leu Gly Leu Lys Ser Glu Leu Glu Lys Arg Phe Phe 145 155 
 Gly Lys Thr Phe Asp Asp Asn Ile His Ile Gin Leu Ile Tyr Asn Ile 
 165 175 
 Leu Asp Ile Glu Lys Ile Leu Ala Val Tyr Val Thr Asn Ile Val Tyr 
 180 185 190 | 2 
 Ala Leu Asn Asn Met Leu Gly Val Lys Gly Ser Glu Ser His Asp Asp 
 195 200 
 Phe Ile Gly Tyr Leu Ser Thr Asn Asn Ile Tyr Asp Val Phe Ile Asp 
 210 
 Pro Asp Asn Ser Ser Leu Ser Asp Asp Lys Lys Ala Asn Val Arg Lys 
 225 235 240 
 Ser Leu Ser Lys Phe Asn Ala Leu Leu Lys Thr Lys Arg Leu Gly Tyr 
 245 255 
 Phe Gly Leu Glu Glu Pro Lys Thr Lys Asp Asn Arg Val Ser Gin Ala 
 260 265 270 
 | Tyr Lys Lys Arg Val Tyr His Met Leu Ala Ile Val Gly Gin Ile Arg 
 275 280 
 Gin Cys Val Phe His Asp Lys Ser Gly Ala Lys Arg Phe Asp Leu Tyr",2003
84,84,"US 2018 / 0282715 Al Oct . 4 , 2018 79 
 - continued 
 290 295 300 
 & E Ser Phe Ile Asn Asn Ile Asp Pro Glu Tyr Arg Asp Thr Leu Asp Tyr 
 305 310 
 Leu Val Glu Glu Arg Leu Lys Ser Ile Asn Lys Asp Phe Ile Glu Asp 
 325 1 335 
 Asn Lys Val Asn Ile Ser Leu Leu Ile Asp Met Met Lys Gly Tyr Glu 
 345 350 | 
 Ala Asp Asp Ile Ile Arg Leu Tyr Tyr Asp Phe Ile Val Leu Lys Ser 
 355 360 
 Gin Lys Asn Leu Gly Phe Ser Ile Lys Lys Leu Arg Glu Lys Met Leu 
 Asp Glu Tyr Gly Phe Arg Phe Lys Asp Lys Gin Tyr Asp Ser Val Arg 
 385 390 
 Ser Lys Met Tyr Lys Leu Met Asp Phe Leu Leu Phe Cys Asn Tyr Tyr 
 405 415 
 Arg Asn Asp Ile Ala Ala Gly Glu Ser Leu Val Arg Lys Leu Arg Phe 
 425 430 
 Ser Met Thr Asp Asp Glu Lys Glu Gly Ile Tyr Ala Asp Glu Ala Ala 
 435 440 
 Lys Leu Trp Gly Lys Phe Arg Asn Asp Phe Glu Asn Ile Ala Asp His 
 Met Asn Gly Asp Val Ile Lys Glu Leu Gly Lys Ala Asp Met Asp Phe 
 465 470 
 Asp Glu Lys Ile Leu Asp Ser Glu Lys Lys Asn Ala Ser Asp Leu Leu 
 485 495 
 Tyr Phe Ser Lys Met Ile Tyr Met Leu Thr Tyr Phe Leu Asp | PIIE meu AS 
 505 510 Gly uys mmmm - mm mmmm Glu Ile Asn Asp Leu Leu Thr Thr Leu Ile Ser Lys Phe Asp Asn Ile 
 515 520 mmmm mmmmm Lys Glu Phe Leu Lys Ile Met Lys Ser Ser Ala Val Asp Val Glu Cys mmmmm mmmmmmm Glu Leu Thr Ala Gly Tyr Lys Leu Phe Asn Asp Ser Gin Arg Ile Thr 
 545 550 
 Asn Glu Leu Phe Ile Val Lys Asn Ile Ala Ser Met Arg Lys Pro Ala 565 575 
 Ala Ser Ala Lys Leu Thr Met Phe Arg Asp Ala Leu Thr Ile Leu Gly 
 585 590 
 Ile Asp Asp Lys Ile Thr Asp Asp Arg Ile Ser Gly Ile Leu Lys Leu 
 595 600 
 Lys Glu Lys Gly Lys Gly Ile His Gly Leu Arg Asn Phe Ile Thr Asn 
 Asn Val Ile Glu Ser Ser Arg Phe Val Tyr Leu Ile Lys Tyr Ala Asn 
 625 630 
 Ala Gln Lys Ile Arq Glu Val Ala Lys Asn Glu Lys Val Val Met Phe 
 645 655 
 Val Leu Gly Gly Ile Pro Asp Thr Gin Ile Glu Arg Tyr Tyr Lys Ser 
 665 670 
 Cys Val Glu Phe Pro Asp Met Asn Ser Ser Leu Gly Val Lys Arg Ser 
 675 680 
 Glu Leu Ala Arg Met Ile Lys Asn Ile Ser Phe Asp Asp Phe Lys Asn 
 690",1976
85,85,"US 2018 / 0282715 Al Oct . 4 , 2018 80 
 - continued 
 Val Lys Gin Gin Ala Lys Gly Arg Glu Asn Val Ala Lys Glu Arg Ala 
 705 710 715 720 
 Lys Ala Val Ile Gly Leu Tyr Leu Thr Val Met Tyr Leu Leu Val Lys 
 735 
 Asn Leu Val Asn Val Asn Ala Arg Tyr Val Ile Ala Ile His Cys Leu 
 745 750 | 3 ? 
 ? 
 E 
 3 11 ? ?? 
 3 
 ES 
 E E 
 A Glu Arg Asp Phe Gly Leu Tyr Lys Glu Ile Ile Pro Glu Leu Ala Ser 
 765 
 Lys Asn Leu Lys Asn Asp Tyr Arg Ile Leu Ser Gin Thr Leu Cys Glu SEE RET 
 Leu Cys Asp Lys Ser Pro Asn Leu Phe Leu Lys Lys Asn Glu Arg Leu 
 785 790 795 800 
 Arg Lys Cys Val Glu Val Asp Ile Asn Asn Ala Asp Ser Ser Met Thr 
 815 
 Arg Lys Tyr Arg Asn Cys Ile Ala His Leu Thr Val Val Arg Glu Leu 
 825 mmmm mmmmm 830 
 Lys Glu Tyr Ile Gly Asp Ile Cys Thr Val Asp Ser Tyr Phe Ser Ile 
 845 
 Tyr His Tyr Val Met Gin Arg Cys Ile Thr Lys Arg Glu Asn Asp Thr 
 Lys Gin Glu Glu Lys Ile Lys Tyr Glu Asp Asp Leu Leu Lys Asn His 
 865 870 875 880 
 Gly Tyr Thr Lys Asp Phe Val Lys Ala Leu Asn Ser Pro Phe Gly Tyr 
 895 
 Asn Ile Pro Arg Phe Lys Asn Leu Ser Ile Glu Gin Leu Phe Asp Arg 
 900 905 910 
 Asn Glu Tyr Leu Thr Glu Lys 
 915 
 A 1 1 
 A 1 
 2 3 
 1 A < 210 > SEQ ID NO 39 < 211 > LENGTH : 918 
 < 212 > TYPE : PRT < 213 > ORGANISM : Ruminococcus bicirculans < 220 > FEATURE : < 221 > NAME / KEY : misc _ feature 
 < 222 > LOCATION : ( 1 ) . . ( 918 ) < 223 > OTHER INFORMATION : native CasM protein sequence from Ruminococcus 
 bicirculans A 
 A 
 A 
 A 
 < 400 > SEQUENCE : 39 
 ? Met Ala Lys Lys Asn Lys Met Lys Pro Arg Glu Leu Arg Glu Ala Gin 
 Lys Lys Ala Arg Gln Leu Lys Ala Ala Glu Ile Asn Asn Asn Ala Val 
 125 1 . Ho E 
 R Pro Ala Ile Ala Ala Met Pro Ala Ala Glu Ala Ala Ala Pro Ala Ala 
 35 ? 
 E & R R 1? 
 Glu Lys Lys Lys Ser Ser Val Lys Ala Ala Gly Met Lys Ser Ile Leu mmmm mam mms Val Ser Glu Asn Lys Met Tyr Ile Thr Ser Phe Gly Lys Gly Asn Ser 
 75 70 & 
 Ala Val Leu Glu Tyr Glu Val Asp Asn Asn Asp Tyr Asn Lys Thr Gin 
 ? Leu Ser Ser Lys Asp Asn Ser Asn Ile Glu Leu Cys Asp Val Gly Lys 
 105 110 .",2015
86,86,"US 2018 / 0282715 Al Oct . 4 , 2018 
 - continued 
 Glu Ser Gly Val Glu 115 120 e2 1 5 
 & Ile Asn Thr Ser Asn Pro Thr His Arq Ser Gly Glu Ser Ser Ser Val 
 135 
 Arg Gly Asp Met Leu Gly Leu Lys Ser Glu Leu Glu Lys Arg Phe Phe 
 145 160 T 
 Gly Lys Asn Phe Asp Asp Asn Ile His Ile Gin Leu Ile Tyr Asn Ile 
 Leu Asp Ile Glu Lys Ile Leu Ala Val Tyr Val Thr Asn Ile Val Tyr 
 180 185 
 Ala Leu Asn Asn Met Leu Gly Glu Gly Asp Glu Ser Asn Tyr Asp Phe 
 195 200 205 
 Met Gly Tyr Leu Ser Thr Phe Asn Thr Tyr Lys Val Phe Thr Asn Pro 
 215 
 Asn Gly Ser Thr Leu Ser Asp Asp Lys Lys Glu Asn Ile Arg Lys Ser 
 225 240 
 Leu Ser Lys Phe Asn Ala Leu Leu Lys Thr Lys Arg Leu Gly Tyr Phe 
 Gly Leu Glu Glu Pro Lys Thr Lys Asp Thr Arg Ala Ser Glu Ala Tyr 
 260 265 
 Lys Lys Arg Val Tyr His Met Leu Ala Ile Val Gly Gin Ile Arg Gin 
 275 280 285 
 Cys Val Phe His Asp Lys Ser Gly Ala Lys Arg Phe Asp Leu Tyr Ser 
 295 mmm mmm mmm mmm mmmm mmmmm mmm mmmmmmmm mmmmm mmmmmmm mmmmm Phe Ile Asn Asn Ile Asp Pro Glu Tyr Arg Glu Thr Leu Asp Tyr Leu 
 305 320 
 Val Asp Glu Arg Phe Asp Ser Ile Asn Lys Gly Phe Ile Gin Gly Asn 
 Lys Val Asn Ile Ser Leu Leu Ile Asp Met Met Lys Gly Tyr Glu Ala 
 340 345 
 Asp Asp Ile Ile Arg Leu Tyr Tyr Asp Phe Ile Val Leu Lys Ser Gin 
 355 360 365 
 Lys Asn Leu Gly Phe Ser Ile Lys Lys Leu Arg Glu Lys Met Leu Asp 
 375 
 Glu Tyr Gly Phe Arg Phe Lys Asp Lys Gin Tyr Asp Ser Val Arg Ser 
 385 400 
 Lys Met Tyr Lys Leu Met Asp Phe Leu Leu Phe Cys Asn Tyr Tyr Arg 
 Asn Asp Ile Ala Ala Gly Glu Ser Leu Val Arg Lys Leu Arg Phe Ser 
 420 425 
 Met Thr Asp Asp Glu Lys Glu Gly Ile Tyr Ala Asp Glu Ala Ala Lys 
 435 440 445 
 Leu Trp Gly Lys Phe Arg Asn Asp Phe Glu Asn Ile Ala Asp His Met 
 455 
 Asn Gly Asp Val Ile Lys Glu Leu Gly Lys Ala Asp Met Asp Phe Asp 
 465 480 
 Glu Lys Ile Leu Asp Ser Glu Lys Lys Asn Ala Ser Asp Leu Leu Tyr 
 495 
 Phe Ser Lys Met Ile Tyr Met Leu Thr Tyr Phe Leu Asp Gly Lys Glu 
 500 505",1924
87,87,"US 2018 / 0282715 Al Oct . 4 , 2018 
 - continued 
 Lie Aan sage Leu Leu The Thr ssy ile ser bye Phe see can Ile bye Ile Asn Asp Leu Leu Thr Thr Leu Ile Ser Lys Phe Asp Asn Ile Lys 
 515 520 525 
 Glu Phe Leu Lys Ile Met Lys Ser Ser Ala Val Asp Val Glu Cys Glu 
 Leu Thr Ala Gly Tyr Lys Leu Phe Asn Asp Ser Gin Arg Ile Thr Asn 
 545 550 
 Glu Leu Phe Ile Val Lys Asn Ile Ala Ser Met Arg Lys Pro Ala Ala 
 570 575 
 Ser Ala Lys Leu Thr Met Phe Arg Asp Ala Leu Thr Ile Leu Gly Ile 
 585 590 
 Asp Asp Lys Ile Thr Asp Asp Arg Ile Ser Glu Ile Leu Lys Leu Lys 
 595 600 
 Glu Lys Gly Lys Gly Ile His Gly Leu Arg Asn Phe Ile Thr Asn Asn 
 Val Ile Glu Ser Ser Arg Phe Val Tyr Leu Ile Lys Tyr Ala Asn Ala 
 625 630 
 Gln Lys Ile Arg Glu Val Ala Lys Asn Glu Lys Val Val Met Phe Val 
 650 655 
 Leu Gly Gly Ile Pro Asp Thr Gin Ile Glu Arg Tyr Tyr Lys Ser Cys 
 665 670 
 Val Glu Phe Pro Asp Met Asn Ser Ser Leu Gly Val Lys Arg Ser Glu 
 675 680 
 Leu Ala Arg Met Ile Lys Asn Ile Ser Phe Asp Asp Phe Lys Asn Val 
 Lys Gin Gin Ala Lys Gly Ara Glu Asn Val Ala Lys Glu Ara Ala Lys 
 705 710 . mmmmm mmmmmm mmm Ala Val Ile Gly Leu Tyr Leu Thr Val Met Tyr Leu Leu Val Lys Asn 
 730 735 mmmmmmm mmm mmmmmm mmmmmm mam mmmmmm Leu Val Asn Val Asn Ala Ara Tyr Val Ile Ala Ile His Cys Leu Glu 
 745 750 
 Arg Asp Phe Gly Leu Tyr Lys Glu Ile Ile Pro Glu Leu Ala Ser Lys 
 755 760 
 Asn Leu Lys Asn Asp Tyr Arg Ile Leu Ser Gin Thr Leu Cys Glu Leu 
 Cys Asp Lys Ser Pro Asn Leu Phe Leu Lys Lys Asn Glu Arg Leu Arg 
 785 790 
 Lys Cys Val Glu Val Asp Ile Asn Asn Ala Asp Ser Ser Met Thr Arg 
 810 815 
 Lys Tyr Arg Asn cys Ile Ala His Leu Thr Val Val Arg Glu Leu Lys 
 825 830 
 Glu Tyr Ile Gly Asp Ile Cys Thr Val Asp Ser Tyr Phe Ser Ile Tyr 
 835 840 
 His Tyr Val Met Gin Arg Cys Ile Thr Lys Arg Glu Asn Asp Thr Lys 
 850 | 
 Gin Glu Glu Lys Ile Lys Tyr Glu Asp Asp Leu Leu Lys Asn His Gly 
 865 880 870 
 Tyr Thr Lys Asp Phe Val Lys Ala Leu Asn Ser Pro Phe Gly Tyr Asn 
 890 
 Ile Pro Arg Phe Lys Asn Leu Ser Ile Glu Gin Leu Phe Asp Arg Asn 
 905 910 ? 
 Glu Tyr Leu Thr Glu Lys",2056
88,88,"US 2018 / 0282715 Al Oct . 4 , 2018 
 - continued 
 915 
 1 1 
 1 2 
 1 3 AAAAA < 210 > SEQ ID NO 40 < 211 > LENGTH : 922 | < 212 > TYPE : PRT < 213 > ORGANISM : Ruminococcus sp . 
 20 > FEATURE : 
 < 221 > NAME / KEY : misc _ feature < 222 > LOCATION : ( 1 ) . . ( 922 ) < 223 > OTHER INFORMATION : native CasM protein sequence from Ruminococcus sp . , isolate 2789STDY5608892 
 < 400 > SEQUENCE : 40 
 Met Ala Lys Lys Asn Lys Met Lys Pro Arg Glu Leu Arg Glu Ala Gin 
 101 
 Lys Lys Ala Arg Gln Leu Lys Ala Ala Glu Ile Asn Asn Asn Ala Ala 
 25 
 Pro Ala Ile Ala Ala Met Pro Ala Ala Glu Val Ile Ala Pro Val Ala 
 135 40 g I 
 Glu Lys Lys Lys Ser Ser Val Lys Ala Ala Gly Met Lys Ser Ile Leu 
 55 & SE 3 Val Ser Glu Asn Lys Met Tyr Ile Thr Ser Phe Gly Lys Gly Asn Ser 
 65 
 Ala Val Leu Glu Tyr Glu Val Asp Asn Asn Asp Tyr Asn Lys Thr Gin 
 Leu Ser Ser Lys Asp Asn Ser Asn Ile Glu Leu Gly Asp Val Asn Glu 
 105 
 Val Asn Ile Thr Phe Ser Ser Lys His Gly Phe Gly Ser Gly Val Glu 
 115 120 mmmmmmm ? mmmmm Ile Asn Thr Ser Asn Pro Thr His Arq Ser Gly Glu Ser Ser Pro Val 
 135 
 Arg Gly Asp Met Leu Gly Leu Lys Ser Glu Leu Glu Lys Arg Phe Phe 
 145 
 Gly Lys Thr Phe Asp Asp Asn Ile His Ile Gin Leu Ile Tyr Asn Ile 
 Leu Asp Ile Glu Lys Ile Leu Ala Val Tyr Val Thr Asn Ile Val Tyr 
 185 
 Ala Leu Asn Asn Met Leu Gly Ile Lys Asp Ser Glu Ser Tyr Asp Asp 
 195 200 
 Phe Met Gly Tyr Leu Ser Ala Arg Asn Thr Tyr Glu Val Phe Thr His 
 215 
 Pro Asp Lys Ser Asn Leu Ser Asp Lys Val Lys Gly Asn Ile Lys Lys 
 225 
 Ser Leu Ser Lys Phe Asn Asp Leu Leu Lys Thr Lys Arg Leu Gly Tyr 
 Phe Gly Leu Glu Glu Pro Lys Thr Lys Asp Thr Arg Ala Ser Glu Ala 
 265 
 Tyr Lys Lys Arg Val Tyr His Met Leu Ala Ile Val Gly Gin Ile Arg 
 275 280 
 Gin Cys Val Phe His Asp Lys Ser Gly Ala Lys Arg Phe Asp Leu Tyr 
 295 
 Ser Phe Ile Asn Asn Ile Asp Pro Glu Tyr Arg Asp Thr Leu Asp Tyr 
 305 320 
 Leu Val Glu Glu Arg Leu Lys Ser Ile Asn Lys Asp Phe Ile Glu Gly",1928
89,89,"US 2018 / 0282715 Al Oct . 4 , 2018 
 84 
 - continued 
 325 330 335 335 
 = Asn Lys Val Asn Ile Ser Leu Leu Ile Asp Met Met Lys Gly Tyr Glu 
 345 350 3 ° 
 ? 
 Ala Asp Asp Ile Ile Arg Leu Tyr Tyr Asp Phe Ile Val Leu Lys Ser 
 355 360 
 Gin Lys Asn Leu Gly Phe Ser Ile Lys Lys Leu Arg Glu Lys Met Leu 
 370 375 
 Glu Glu Tyr Gly Phe Arg Phe Lys Asp Lys Gin Tyr Asp Ser Val Arg 
 385 390 395 400 = = = 
 Ser Lys Met Tyr Lys Leu Met Asp Phe Leu Leu Phe Cys Asn Tyr Tyr 
 = Arg Asn Asp Val Ala Ala Gly Glu Ala Leu Val Arq Lys Leu Arq Phe 
 425 430 = 
 = Ser Met Thr Asp Asp Glu Lys Glu Gly Ile Tyr Ala Asp Glu Ala Ala 
 435 440 = = = 
 = Lys Leu Trp Gly Lys Phe Arg Asn Asp Phe Glu Asn Ile Ala Asp His 
 450 455 
 Met Asn Gly Asp Val Ile Lys Glu Leu Gly Lys Ala Asp Met Asp Phe 
 465 470 475 = 
 ? 480 = = = 
 Asp Glu Lys Ile Leu Asp Ser Glu Lys Lys Asn Ala Ser Asp Leu Leu = 
 = Tyr Phe Ser Lys Met Ile Tyr Met Leu Thr Tyr Phe Leu Asp Gly Lys 
 505 510 
 Glu Ile Asn Asp Leu Leu Thr Thr Leu Ile Ser Lys Phe Asp Asn Ile 
 515 520 
 Lys Glu Phe Leu Lys Ile Met Lys Ser Ser Ala Val Asp Val Glu Cys 
 530 535 3 
 3 mmmm mmmm mmmmm 8 
 mm mmm Glu Leu Thr Ala Gly Tyr Lys Leu Phe Asn Asp Ser Gin Arg Ile Thr 
 545 550 555 560 mmmmmmm mmmmm mmm Asn Glu Leu Phe Ile Val Lys Asn Ile Ala Ser Met Arq Lys Pro Ala 
 Ala Ser Ala Lys Leu Thr Met Phe Arg Asp Ala Leu Thr Ile Leu Gly 
 585 590 
 Ile Asp Asp Asn Ile Thr Asp Asp Arg Ile Ser Glu Ile Leu Lys Leu 
 595 
 Lys Glu Lys Gly Lys Gly Ile His Gly Leu Arg Asn Phe Ile Thr Asn 
 610 615 
 Asn Val Ile Glu Ser Ser Arg Phe Val Tyr Leu Ile Lys Tyr Ala Asn 
 625 630 635 640 
 Ala Gin Lys Ile Arg Glu Val Ala Lys Asn Glu Lys Val Val Met Phe 
 8 Val Leu Gly Gly Ile Pro Asp Thr Gin Ile Glu Arg Tyr Tyr Lys Ser 
 665 670 
 8 Cys Val Glu Phe Pro Asp Met Asn Ser Ser Leu Glu Ala Lys Arg Ser 
 675 680 
 8 Glu Leu Ala Arg Met Ile Lys Asn Ile Ser Phe Asp Asp Phe Lys Asn 
 690 695 
 5 Val Lys Gin Gin Ala Lys Gly Arg Glu Asn Val Ala Lys Glu Arg Ala 
 705 710 715 720 8 8 % 
 Lys Ala Val Ile Gly Leu Tyr Leu Thr Val Met Tyr Leu Leu Val Lys",2065
90,90,"US 2018 / 0282715 Al Oct . 4 , 2018 
 - continued 
 | 
 Asn Leu Val Asn Val Asn Ala Arq Tyr Val Ile Ala Ile His Cys Leu 
 745 750 ? 
 Glu Arg Asp Phe Gly Leu Tyr Lys Glu Ile Ile Pro Glu Leu Ala Ser 
 755 760 765 
 Lys Asn Leu Lys Asn Asp Tyr Arg Ile Leu Ser Gin Thr Leu cys Glu HERO Leu Cys Asp Asp Arg Asn Glu Ser Ser Asn Leu Phe Leu Lys Lys Asn 
 785 795 800 
 Lys Arg Leu Arg Lys Cys Val Glu Val Asp Ile Asn Asn Ala Asp Ser mmm Ser Met Thr Arg Lys Tyr Arg Asn Cys Ile Ala His Leu Thr Val Val 
 825 mm mmmm mmm mmmm mmm Arg Glu Leu Lys Glu Tyr Ile Gly Asp Ile Arg Thr Val Asp Ser Tyr 
 835 840 845 
 Phe Ser Ile Tyr His Tyr Val Met Gin Arg Cys Ile Thr Lys Arg Gly 
 Asp Asp Thr Lys Gin Glu Glu Lys Ile Lys Tyr Glu Asp Asp Leu Leu 865 875 880 
 Lys Asn His Gly Tyr Thr Lys Asp Phe Val Lys Ala Leu Asn Ser Pro 
 Phe Gly Tyr Asn Ile Pro Arg Phe Lys Asn Leu Ser Ile Glu Gin Leu 
 905 
 ? Phe Asp Arg Asn Glu Tyr Leu Thr Glu Lys 
 915 920 g 
AAAAAAAA < 210 > SEQ ID NO 41 < 211 > LENGTH : 922 
 < 212 > TYPE : PRT < 213 > ORGANISM : Ruminococcus sp . 
 FEATURE : 
 221 2 NAME / KEY : misc _ feature 
 22 > LOCATION : ( 1 ) . . ( 922 ) < 223 > OTHER INFORMATION : native CasM protein sequence from Ruminococcus 
 sp . CAG : 57 2 
 < 400 > SEQUENCE : 41 
 Met Ala Lys Lys Asn Lys Met Lys Pro Arg Glu Leu Arg Glu Ala Gin 
 15 . 
 Lys Lys Ala Arg Gin Leu Lys Ala Ala Glu Ile Asn Asn Asn Ala Ala 1 
 Ag R 
 & Pro Ala Ile Ala Ala Met Pro Ala Ala Glu Val Ile Ala Pro Val Ala 
 35 40 mmm Glu Lys Lys Lys Ser Ser Val Lys Ala Ala Gly Met Lys Ser Ile Leu 
 Val Ser Glu Asn Lys Met Tyr Ile Thr Ser Phe Gly Lys Gly Asn Ser ? 
 70 
 Ala Val Leu Glu Tyr Glu Val Asp Asn Asn Asp Tyr Asn Lys Thr Gin 
 95 & mmm mmmm mmm Leu Ser Ser Lys Asp Asn Ser Asn Ile Glu Leu Gly Asp Val Asn Glu 
 Val Asn Ile Thr Phe Ser Ser Lys His Gly Phe Gly Ser Gly Val Glu 
 115 120 
 Ile Asn Thr Ser Asn Pro Thr His Arg Ser Gly Glu Ser Ser Pro Val ?",1907
91,91,"US 2018 / 0282715 Al Oct . 4 , 2018 
 - continued 
 ? Arg Gly Asp Met Leu Gly Leu Lys Ser Glu Leu Glu Lys Arg Phe Phe 
 145 150 160 
 Gly Lys Thr Phe Asp Asp Asn Ile His Ile Gin Leu Ile Tyr Asn Ile 170 
 E 
 Leu Asp Ile Glu Lys Ile Leu Ala Val Tyr Val Thr Asn Ile Val Tyr 
 185 190 
 P Ala Leu Asn Asn Met Leu Gly Ile Lys Asp Ser Glu Ser Tyr Asp Asp 
 200 
 Phe Met Gly Tyr Leu Ser Ala Arg Asn Thr Tyr Glu Val Phe Thr His 
 Pro Asp Lys Ser Asn Leu Ser Asp Lys Val Lys Gly Asn Ile Lys Lys 
 225 230 240 
 Ser Leu Ser Lys Phe Asn Asp Leu Leu Lys Thr Lys Arg Leu Gly Tyr 
 250 
 Phe Gly Leu Glu Glu Pro Lys Thr Lys Asp Thr Arg Ala Ser Glu Ala 
 265 270 
 Tyr Lys Lys Arg Val Tyr His Met Leu Ala Ile Val Gly Gln Ile Arg 
 280 
 Gin Cys Val Phe His Asp Lys Ser Gly Ala Lys Arg Phe Asp Leu Tyr Ed ° 
 Ser Phe Ile Asn Asn Ile Asp Pro Glu Tyr Arg Asp Thr Leu Asp Tyr 305 310 320 
 Leu Val Glu Glu Arg Leu Lys Ser Ile Asn Lys Asp Phe Ile Glu Gly 
 330 mmmmm Asn Lys Val Asn Ile Ser Leu Leu Ile Asp Met Met Lys Gly Tyr Glu 
 345 
 Ala Asp Asp Ile Ile Arg Leu Tyr Tyr Asp Phe Ile Val Leu Lys Ser 360 mm mmmmmm mmmm mmmmmm mmmmm m mmm Gin Lys Asn Leu Gly Phe Ser Ile Lys Lys Leu Arg Glu Lys Met Leu mmmm Glu Glu Tyr Gly Phe Arg Phe Lys Asp Lys Gin Tyr Asp Ser Val Arg 
 385 390 400 
 Ser Lys Met Tyr Lys Leu Met Asp Phe Leu Leu Phe Cys Asn Tyr Tyr 
 410 
 Arg Asn Asp Val Ala Ala Gly Glu Ala Leu Val Arg Lys Leu Arg Phe 
 425 430 
 Ser Met Thr Asp Asp Glu Lys Glu Gly Ile Tyr Ala Asp Glu Ala Ala 
 440 
 Lys Leu Trp Gly Lys Phe Arg Asn Asp Phe Glu Asn Ile Ala Asp His 
 Met Asn Gly Asp Val Ile Lys Glu Leu Gly Lys Ala Asp Met Asp Phe 
 465 470 480 
 Asp Glu Lys Ile Leu Asp Ser Glu Lys Lys Asn Ala Ser Asp Leu Leu 
 490 
 Tyr Phe Ser Lys Met Ile Tyr Met Leu Thr Tyr Phe Leu Asp Gly Lys 
 505 
 Glu Ile Asn Asp Leu Leu Thr Thr Leu Ile Ser Lys Phe Asp Asn Ile 
 520 
 Lys Glu Phe Leu Lys Ile Met Lys Ser Ser Ala Val Asp Val Glu Cys",1917
92,92,"US 2018 / 0282715 Al Oct . 4 , 2018 
 27 
 - continued 
 Glu Leu Thr Ala Gly Tyr Lys Leu Phe Asn Asp Ser Gin Arg Ile Thr 
 545 560 
 Asn Glu Leu Phe Ile Val Lys Asn Ile Ala Ser Met Arq Lys Pro Ala 
 575 ?? ? 1? ? Ala Ser Ala Lys Leu Thr Met Phe Arg Asp Ala Leu Thr Ile Leu Gly 
 590 
 Ile Asp Asp Asn Ile Thr Asp Asp Arg Ile Ser Glu Ile Leu Lys Leu 
 595 600 ? 
 Lys Glu Lys Gly Lys Gly Ile His Gly Leu Arg Asn Phe Ile Thr Asn 
 615 
 Asn Val Ile Glu Ser Ser Arg Phe Val Tyr Leu Ile Lys Tyr Ala Asn 
 625 640 
 Ala Gin Lys Ile Arg Glu Val Ala Lys Asp Glu Lys Val Val Met Phe 
 655 
 Val Leu Gly Gly Ile Pro Asp Thr Gin Ile Glu Arg Tyr Tyr Lys Ser 
 670 
 Cys Val Glu Phe Pro Asp Met Asn Ser Ser Leu Glu Ala Lys Arg Ser 
 675 680 1 mmm mmmmm mmmm mam Glu Leu Ala Arg Met Ile Lys Asn Ile Ser Phe Asp Asp Phe Lys Asn 
 695 
 Val Lys Gin Gin Ala Lys Gly Arg Glu Asn Val Ala Lys Glu Arg Ala 705 720 2 
 Lys Ala Val Ile Gly Leu Tyr Leu Thr Val Met Tyr Leu Leu Val Lys 
 735 
 Asn Leu Val Asn Val Asn Ala Arg Tyr Val Ile Ala Ile His Cys Leu 
 750 mmmmmm mmmm mmmm mmmmma Glu Arg Asp Phe Gly Leu Tyr Lys Glu Ile Ile Pro Glu Leu Ala Ser 
 755 760 
 Lys Asn Leu Lys Asn Asp Tyr Arg Ile Leu Ser Gin Thr Leu Cys Glu 
 775 
 Leu Cys Asp Asp Arg Asn Glu Ser Ser Asn Leu Phe Leu Lys Lys Asn 
 785 800 mmm Lys Arg Leu Arg Lys Cys Val Glu Val Asp Ile Asn Asn Ala Asp Ser 
 815 
 Ser Met Thr Arg Lys Tyr Arg Asn Cys Ile Ala His Leu Thr Val Val 
 830 
 Arg Glu Leu Lys Glu Tyr Ile Gly Asp Ile Arg Thr Val Asp Ser Tyr 
 835 840 
 Phe Ser Ile Tyr His Tyr Val Met Gin Arg Cys Ile Thr Lys Arg Gly 
 855 
 Asp Asp Thr Lys Gin Glu Glu Lys Ile Lys Tyr Glu Asp Asp Leu Leu 865 880 
 Lys Asn His Gly Tyr Thr Lys Asp Phe Val Lys Ala Leu Asn Ser Pro 
 885 895 
 ° Phe Gly Tyr Asn Ile Pro Arg Phe Lys Asn Leu Ser Ile Glu Gin Leu 
 910 
 Phe Asp Arg Asn Glu Tyr Leu Thr Glu Lys 
 915 920 
 < 210 > SEQ ID NO 42 
 < 211 > LENGTH : 933 
 < 212 > TYPE : PRT",1922
93,93,"US 2018 / 0282715 Al Oct . 4 , 2018 
 - continued 
 < 213 > ORGANISM : Ruminococcus flavefaciens 
 < 220 > FEATURE : 
 19 NAME / KEY : misc _ feature 
 < 222 > LOCATION : ( 1 ) . . ( 933 ) 
 < 223 > OTHER INFORMATION : native CasM protein sequence from Ruminococcus 
 flavefaciens FD - 1 
 < 400 > SEQUENCE : 42 
 Met Lys Lys Lys Met Ser Leu Arg Glu Lys Arg Glu Ala Glu Lys Gin 
 10 
 Ala Lys Lys Ala Ala Tyr Ser Ala Ala Ser Lys Asn Thr Asp Ser Lys 
 25 30 1 
 ? 
 3 1 & E A gn e 20 
 Pro Ala Glu Lys Lys Ala Glu Thr Pro Lys Pro Ala Glu Ile Ile Ser 
 35 40 45 
 Asp Asn Ser Arg Asn Lys Thr Ala Val Lys Ala Ala Gly Leu Lys Ser 
 55 60 
 Thr Ile Ile Ser Gly Asp Lys Leu Tyr Met Thr Ser Phe Gly Lys Gly 
 Asn Ala Ala Val Ile Glu Gin Lys Ile Asp Ile Asn Asp Tyr Ser Phe 
 90 
 Ser Ala Met Lys Asp Thr Pro Ser Leu Glu Val Asp Lys Ala Glu Ser 
 100 105 110 T Lys Glu Ile Ser Phe Ser Ser His His Pro Phe Val Lys Asn Asp Lys 
 115 120 125 
 Leu Thr Thr Tyr Asn Pro Leu Tyr Gly Gly Lys Asp Asn Pro Glu Lys 
 135 140 8 mm mmmm Pro Val Gly Arg Asp Met Leu Gly Leu Lys Asp Lys Leu Glu Glu Arg mmm mmmmm mammm 
mmmmm Tyr Phe Gly Cys Thr Phe Asn Asp Asn Leu His Ile Gln Ile Ile Tyr 
 170 mem Asn Ile Leu Asp Ile Glu Lys Ile Leu Ala Val His Ser Ala Asn Ile 
 180 185 190 
 Thr Thr Ala Leu Asp His Met Val Asp Glu Asp Asp Glu Lys Tyr Leu 
 195 200 205 
 Asn Ser Asp Tyr Ile Gly Tyr Met Asn Thr Ile Asn Thr Tyr Asp Val 
 215 220 
 Phe Met Asp Pro Ser Lys Asn Ser Ser Leu Ser Pro Lys Asp Arg Lys 
 0 
 Asn Ile Asp Asn Ser Arg Ala Lys Phe Glu Lys Leu Leu Ser Thr Lys 
 250 
 Arg Leu Gly Tyr Phe Gly Phe Asp Tyr Asp Ala Asn Gly Lys Asp Lys 
 260 265 270 
 Lys Lys Asn Glu Glu Ile Lys Lys Arg Leu Tyr His Leu Thr Ala Phe 
 275 280 285 
 Ala Gly Gin Leu Arg Gin Trp Ser Phe His Ser Ala Gly Asn Tyr Pro 
 295 300 mmm | 
 Arg Thr Trp Leu Tyr Lys Leu Asp Ser Leu Asp Lys Glu Tyr Leu Asp 
 320 
 Thr Leu Asp His Tyr Phe Asp Lys Arg Phe Asn Asp Ile Asn Asp Asp 
 330 
 Phe Val Thr Lys Asn Ala Thr Asn Leu Tyr Ile Leu Lys Glu Val Phe 
 340 345 350 
 . 
 Pro Glu Ala Asn Phe Lys Asp Ile Ala Asp Leu Tyr Tyr Asp Phe Ile",2089
94,94,"m 
 US 2018 / 0282715 Al Oct . 4 , 2018 
 - continued 
 355 360 365 
 Val Ile Lys Ser His Lys Asn Met Gly Phe Ser Ile Lys Lys Leu Arg 
 370 
 Glu Lys Met Leu Glu Cys Asp Gly Ala Asp Arg Ile Lys Glu Gin Asp 
 385 395 3 % 3 
 Met Asp Ser Val Arg Ser Lys Leu Tyr Lys Leu Ile Asp Phe Cys Ile 
 410 
 Phe Lys Tyr Tyr His Glu Phe Pro Glu Leu Ser Glu Lys Asn Val Asp 
 425 430 
 Ile Leu Arg Ala Ala Val Ser Asp Thr Lys Lys Asp Asn Leu Tyr Ser 
 435 m 
 Asp Glu Ala Ala Arq Leu Trp Ser Ile Phe Lys Glu Lys Phe Leu Gly 
 450 
 Phe Cys Asp Lys Ile Val Val Trp Val Thr Gly Glu His Glu Lys Asp 
 465 475 8 8 8 
 Ile Thr Ser Val Ile Asp Lys Asp Ala Tyr Arg Asn Arg Ser Asn Val 
 490 
 Ser Tyr Phe Ser Lys Leu Met Tyr Ala Met Cys Phe Phe Leu Asp Gly 
 505 510 
 Lys Glu Ile Asn Asp Leu Leu Thr Thr Leu Ile Asn Lys Phe Asp Asn 
 515 
 Ile Ala Asn Gin Ile Lys Thr Ala Lys Glu Leu Gly Ile Asn Thr Ala 
 530 
 Phe Val Lys Asn Tyr Asp Phe Phe Asn His Ser Glu Lys Tyr Val Asp 
 545 555 = = = Hmmmm Glu Leu Asn Ile Val Lys Asn Ile Ala Arg Met Lys Lys Pro Ser Ser 
 570 mmmmm mmmmmmm Asn Ala Lys Lys Ala Met Tyr His Asp Ala Leu Thr Ile Leu Gly Ile 
 585 590 mmm mmmmm Pro Glu Asp Met Asp Glu Lys Ala Leu Asp Glu Glu Leu Asp Leu Ile 
 595 
 Leu Glu Lys Lys Thr Asp Pro Val Thr Gly Lys Pro Leu Lys Gly Lys 
 610 m? Asn Pro Leu Arg Asn Phe Ile Ala Asn Asn Val Ile Glu Asn Ser Arg 
 625 635 = = = 
 Phe Ile Tyr Leu Ile Lys Phe Cys Asn Pro Glu Asn Val Arg Lys Ile 
 650 mm mm = Val Asn Asn Thr Lys Val Thr Glu Phe Val Leu Lys Arg Ile Pro Asp 
 665 670 
 = Ala Gln Ile Glu Ara Tyr Tyr Lys Ser Cys Thr Asp Ser Glu Met Asn 
 1675 
 Pro Pro Thr Glu Lys Lys Ile Thr Glu Leu Ala Gly Lys Leu Lys Asp 
 690 = 
 Met Asn Phe Gly Asn Phe Ara Asn Val Ara Gln Ser Ala Lys Glu Asn 
 705 715 = = K 
 Met Glu Lys Glu Arg Phe Lys Ala Val Ile Gly Leu Tyr Leu Thr Val 
 730 
 Val Tyr Arg Val Val Lys Asn Leu Val Asp Val Asn Ser Arg Tyr Ile 
 745 750 
 Met Ala Phe His Ser Leu Glu Arg Asp Ser Gin Leu Tyr Asn Val Ser 
 755",1975
95,95,"US 2018 / 0282715 Al Oct . 4 , 2018 90 
 - continued 
 Val Asp Asn Asp Tyr Leu Ala Leu Thr Asp Thr Leu Val Lys Glu Gly 
 775 780 3 In Asp Asn Ser Arg Ser Arg Tyr Leu Ala Gly Asn Lys Arg Leu Arg Asp 
 785 790 795 800 IEEE Cys Val Lys Gin Asp Ile Asp Asn Ala Lys Lys Trp Phe Val Ser Asp 
 815 ? Re Lys Tyr Asn Ser Ile Thr Lys Tyr Arg Asn Asn Val Ala His Leu Thr 
 830 
 Ala Val Arg Asn Cys Ala Glu Phe Ile Gly Asp Ile Thr Lys Ile Asp 
 835 840 845 mmmm mmm Ser Tyr Phe Ala Leu Tyr His Tyr Leu Ile Gin Arg Gin Leu Ala Lys 
 855 860 
 Gly Leu Asp His Glu Arg Ser Gly Phe Asp Arg Asn Tyr Pro Gin Tyr 
 865 870 875 880 
 Ala Pro Leu Phe Lys Trp His Thr Tyr Val Lys Asp Val Val Lys Ala 
 895 
 Leu Asn Ala Pro Phe Gly Tyr Asn Ile Pro Arg Phe Lys Asn Leu Ser 
 910 
 Ile Asp Ala Leu Phe Asp Arg Asn Glu Ile Lys Lys Asn Asp Gly Glu 
 915 920 925 ? 
 | Lys Lys Ser Asp Asp 930 
 < 210 > SEQ ID NO 43 
 < 211 > LENGTH : 944 
 < 212 > TYPE : PRT < 213 > ORGANISM : Ruminococcus albus 
 209 FEATURE : 
 < 221 > NAME / KEY : misc _ feature < 222 > LOCATION : ( 1 ) . . ( 944 ) < 223 > OTHER INFORMATION : native CasM protein sequence from Ruminococcus 
 albus strain KH2T6 V 
 < 400 > SEQUENCE : 43 
 ? Met Ala Lys Lys Ser Lys Gly Met Ser Leu Arg Glu Lys Arg Glu Leu 
 15 
 Glu Lys Gin Lys Arg Ile Gin Lys Ala Ala Val Asn Ser Val Asn Asp 
 30 
 Thr Pro Glu Lys Thr Glu Glu Ala Asn Val Val Ser Val Asn Val Arq 
 35 Giu Lys Thr Giu Glu Ala Agn ? 
 Thr Ser Ala Glu Asn Lys His Ser Lys Lys Ser Ala Ala Lys Ala Leu 
 s 
 g Gly Leu Lys Ser Gly Leu Val Ile Gly Asp Glu Leu Tyr Leu Thr Ser 
 75 80 8 
 Phe Gly Arg Gly Asn Glu Ala Lys Leu Glu Lys Lys Ile Ser Gly Asp 
 95 mmmmmm mmm Thr Val Glu Lys Leu Gly Ile Gly Ala Phe Glu Val Ala Glu Arg Asp 
 110 
 Glu Ser Thr Leu Thr Leu Glu Ser Gly Arg Ile Lys Asp Lys Thr Ala 
 115 
 Arg Pro Lys Asp Pro Arg His Ile Thr Val Asp Thr Gin Gly Lys Phe ? 
 Lys Glu Asp Met Leu Gly Ile Arg Ser Val Leu Glu Lys Lys Ile Phe 
 155 160",1945
96,96,"US 2018 / 0282715 Al Oct . 4 , 2018 
 - continued DE Gly Lys Thr Phe Asp Asp Asn Ile His Val Gin Leu Ala Tyr Asn Ile 
 170 EP Red Leu Asp Val Glu Lys Ile Met Ala Gin Tyr Val Ser Asp Ile Val Tyr 
 180 185 190 | 
 Met Leu His Asn Thr Asp Lys Thr Glu Arg Asn Asp Asn Leu Met Gly 
 195 200 205 
 Tyr Met Ser Ile Arg Asn Thr Tyr Lys Thr Phe Cys Asp Thr Ser Asn 
 215 ? 
 Leu Pro Asp Asp Thr Lys Gin Lys Val Glu Asn Gin Lys Arg Glu Phe 225 235 240 3 13 g Asp Lys Ile Ile Lys Ser Gly Arg Leu Gly Tyr Phe Gly Glu Ala Phe 
 250 
 Met Val Asn Ser Gly Asn Ser Thr Lys Leu Arq Pro Glu Lys Glu Ile 
 260 265 270 
 Tyr His Ile Phe Ala Leu Met Ala Ser Leu Arq Gin Ser Tyr Phe His 
 275 280 2 8 
 Gly Tyr Val Lys Asp Thr Asp Tyr Gin Gly Thr Thr Trp Ala Tyr Thr 
 295 
 Leu Glu Asp Lys Leu Lys Gly Pro Ser His Glu Phe Arg Glu Thr Ile 
 305 315 
 Asp Lys Ile Phe Asp Glu Gly Phe Ser Lys Ile Ser Lys Asp Phe Gly 
 330 335 
 Lys Met Asn Lys Val Asn Leu Gin Ile Leu Glu Gin Met Ile Gly Glu 
 340 345 350 
 Leu Tyr Gly Ser Ile Glu Arg Gin Asn Leu Thr Cys Asp Tyr Tyr Asp 
 355 360 365 mmmmm mmm mmmmg mgm mmmm mmmmmm Phe Ile Gin Leu Lys Lys His Lys Tyr Leu Gly Phe Ser Ile Lys Arg 
 375 ggggggg D E 
? gg mmmmmm Leu Arq Glu Thr Met Leu Glu Thr Thr Pro Ala Glu Cys Tyr Lys Ala 
 385 395 
 Glu Cys Tyr Asn Ser Glu Arg Gin Lys Leu Tyr Lys Leu Ile Asp Phe 
 410 415 
 Leu Ile Tyr Asp Leu Tyr Tyr Asn Arg Lys Pro Ala Arg Ile Glu Glu 
 420 425 430 
 Ile Val Asp Lys Leu Arg Glu Ser Val Asn Asp Glu Glu Lys Glu Ser 
 435 440 445 
 Ile Tyr Ser Val Glu Ala Lys Tyr Val Tyr Glu Ser Leu Ser Lys Val 
 455 ? gggg mmm Leu Asp Lys Ser Leu Lys Asn Ser Val Ser Gly Glu Thr Ile Lys Asp 
 465 475 
 Leu Gin Lys Arg Tyr Asp Asp Glu Thr Ala Asn Arg Ile Trp Asp Ile 
 490 495 
 Ser Gin His Ser Ile Ser Gly Asn Val Asn Cys Phe Cys Lys Leu Ile 
 500 505 510 
 Tyr Ile Met Thr Leu Met Leu Asp Gly Lys Glu Ile Asn Asp Leu Leu 
 515 520 525 
 Thr Thr Leu Val Asn Lys Phe Asp Asn Ile Ala Ser Phe Ile Asp Val 
 535 540 Val Aøn Lys the Asp Asn 11e 
 Met Asp Glu Leu Gly Leu Glu His Ser Phe Thr Asp Asn Tyr Lys Met 
 545 555",2072
97,97,"US 2018 / 0282715 Al Oct . 4 , 2018 92 . . 
 - continued m Phe Ala Asp Ser Lys Ala Ile Cys Leu Asp Leu Gin Phe Ile Asn Ser 
 570 575 
 Phe Ala Arg Met Ser Lys Ile Asp Asp Glu Lys Ser Lys Arg Gin Leu 
 590 
 Phe Arg Asp Ala Leu Val Ile Leu Asp Ile Gly Asn Lys Asp Glu Thr 
 595 600 605 
 Trp Ile Asn Asn Tyr Leu Asp Ser Asp Ile Phe Lys Leu Asp Lys Glu 
 Gly Asn Lys Leu Lys Gly Ala Arg His Asp Phe Arg Asn Phe Ile Ala 
 625 630 
 Asn Asn Val Ile Lys Ser Ser Arg Phe Lys Tyr Leu Val Lys Tyr Ser 
 650 
 Ser Ala Asp Gly Met Ile Lys Leu Lys Thr Asn Glu Lys Leu Ile Gly 
 670 
 Phe Val Leu Asp Lys Leu Pro Glu Thr Gin Ile Asp Arg Tyr Tyr Glu 
 675 680 685 
 Ser Cys Gly Leu Asp Asn Ala Val Val Asp Lys Lys Val Arg Ile Glu 
 Lys Leu Ser Gly Leu Ile Arg Asp Met Lys Phe Asp Asp Phe Ser Gly 
 705 710 
 Val Lys Thr Ser Asn Lys Ala Gly Asp Asn Asp Lys Gin Asp Lys Ala 
 730 
 Lys Tyr Gin Ala Ile Ile Ser Leu Tyr Leu Met Val Leu Tyr Gin Ile 
 750 | | mmmmm R mmm Val Lys Asn Met Ile Tyr Val Asn Ser Arq Tyr Val Ile Ala Phe His 
 755 760 765 mmm mmmmmma mmmmmmmm mm Cys Leu Glu Arg Asp Phe Gly Met Tyr Gly Lys Asp Phe Gly Lys Tyr mmmmm mmmm mmmm mmmmm mmmmmm Tyr Gin Gly Cys Arg Lys Leu Thr Asp His Phe Ile Glu Glu Lys Tyr 
 785 790 
 Met Lys Glu Gly Lys Leu Gly Cys Asn Lys Lys Val Gly Arg Tyr Leu 
 810 
 Lys Asn Asn Ile Ser Cys Cys Thr Asp Gly Leu Ile Asn Thr Tyr Arg 
 830 
 Asn Gin Val Asp His Phe Ala Val Val Arg Lys Ile Gly Asn Tyr Ala 
 835 840 845 
 Ala Tyr Ile Lys Ser Ile Gly Ser Trp Phe Glu Leu Tyr His Tyr Val 
 Ile Gin Arg Ile Val Phe Asp Glu Tyr Arg Phe Ala Leu Asn Asn Thr 
 865 870 
 Glu Ser Asn Tyr Lys Asn Ser Ile Ile Lys His His Thr Tyr Cys Lys 
 890 
 Asp Met Val Lys Ala Leu Asn Thr Pro Phe Gly Tyr Asp Leu Pro Arg 
 910 
 Tyr Lys Asn Leu Ser Ile Gly Asp Leu Phe Asp Arg Asn Asn Tyr Leu 
 915 925 920 
 Asn Lys Thr Lys Glu Ser Ile Asp Ala Asn Ser Ser Ile Asp Ser Gln 
 930 Lys Glu ser lle Asp Ala Aøn ser 
 < 210 > SEQ ID NO 44 
 < 211 > LENGTH : 967 
 < 212 > TYPE : PRT",1982
98,98,"US 2018 / 0282715 Al Oct . 4 , 2018 
 - continued 
 < 213 > ORGANISM : Ruminococcus flavefaciens 
 < 220 > FEATURE : 
 19 NAME / KEY : misc _ feature 
 < 222 > LOCATION : ( 1 ) . . ( 967 ) < 223 > OTHER INFORMATION : native CasM protein sequence from Ruminococcus 
 flavefaciens strain XPD3002 
 < 400 > SEQUENCE : 44 
 Met Ile Glu Lys Lys Lys Ser Phe Ala Lys Gly Met Gly Val Lys Ser 
 10 15 
 Thr Leu Val Ser Gly Ser Lys Val Tyr Met Thr Thr Phe Ala Glu Gly 
 25 30 ? ? 
 Ser Asp Ala Arg Leu Glu Lys Ile Val Glu Gly Asp Ser Ile Arg Ser 
 45 
 Val Asn Glu Gly Glu Ala Phe Ser Ala Glu Met Ala Asp Lys Asn Ala 
 55 
 Gly Tyr Lys Ile Gly Asn Ala Lys Phe Ser His Pro Lys Gly Tyr Ala 
 75 70 
 Val Val Ala Asn Asn Pro Leu Tyr Thr Gly Pro Val Gin Gin Asp Met 
 90 95 & 3 n & Ep 
 Leu Gly Leu Lys Glu Thr Leu Glu Lys Arg Tyr Phe Gly Glu Ser Ala 
 105 110 ? 
 Asp Gly Asn Asp Asn Ile Cys Ile Gin Val Ile His Asn Ile Leu Asp 
 125 
 Ile Glu Lys Ile Leu Ala Glu Tyr Ile Thr Asn Ala Ala Tyr Ala Val 
 135 R 
 Asn Asn Ile Ser Gly Leu Asp Lys Asp Ile Ile Gly Phe Gly Lys Phe 
 150 155 msm mmmmmmm mmmmm mmmmm mmmm mmmmm Ser Thr Val Tyr Thr Tyr Asp Glu Phe Lys Asp Pro Glu His His Arg 
 170 175 mam mmmmmm Ala Ala Phe Asn Asn Asn Asp Lys Leu Ile Asn Ala Ile Lys Ala Gln 
 185 | 190 
 Tyr Asp Glu Phe Asp Asn Phe Leu Asp Asn Pro Arg Leu Gly Tyr Phe 
 205 
 Gly Gln Ala Phe Phe Ser Lys Glu Gly Arg Asn Tyr Ile Ile Asn Tyr 
 215 
 Gly Asn Glu Cys Tyr Asp Ile Leu Ala Leu Leu Ser Gly Leu Arg His 
 230 235 
 Trp Val Val His Asn Asn Glu Glu Glu Ser Arg Ile Ser Arg Thr Trp 
 250 255 
 Leu Tyr Asn Leu Asp Lys Asn Leu Asp Asn Glu Tyr Ile Ser Thr Leu 
 265 | 270 
 Asn Tyr Leu Tyr Asp Arg Ile Thr Asn Glu Leu Thr Asn Ser Phe Ser 
 285 
 Lys Asn Ser Ala Ala Asn Val Asn Tyr Ile Ala Glu Thr Leu Gly Ile 
 295 300 % 
 & Asn Pro Ala Glu Phe Ala Glu Gin Tyr Phe Arg Phe Ser Ile Met Lys 
 310 315 
 Glu Gin Lys Asn Leu Gly Phe Asn Ile Thr Lys Leu Arg Glu Val Met 
 330 335 
 Leu Asp Arg Lys Asp Met Ser Glu Ile Arg Lys Asn His Lys Val Phe 
 345 350 
 Asp Ser Ile Arg Thr Lys Val Tyr Thr Met Met Asp Phe Val Ile Tyr",2086
99,99,"US 2018 / 0282715 Al Oct . 4 , 2018 94 
 - continued 
 355 360 365 
 Arg Tyr Tyr Ile Glu Glu Asp Ala Lys Val Ala Ala Ala Asn Lys Ser 
 375 
 & Leu Pro Asp Asn Glu Lys Ser Leu Ser Glu Lys Asp Ile Phe Val Ile 
 385 390 395 400 
 Asn Leu Arg Gly Ser Phe Asn Asp Asp Gin Lys Asp Ala Leu Tyr Tyr 
 405 415 
 Asp Glu Ala Asn Arg Ile Trp Arg Lys Leu Glu Asn Ile Met His Asn 
 430 
 Ile Lys Glu Phe Arg Gly Asn Lys Thr Arg Glu Tyr Lys Lys Lys Asp 
 435 440 
 Ala Pro Arg Leu Pro Arg Ile Leu Pro Ala Gly Arg Asp Val Ser Ala 
 455 
 Phe Ser Lys Leu Met Tyr Ala Leu Thr Met Phe Leu Asp Gly Lys Glu 
 465 475 480 470 
 Ile Asn Asp Leu Leu Thr Thr Leu Ile Asn Lys Phe Asp Asn Ile Gln 
 495 485 
 Ser Phe Leu Lys Val Met Pro Leu Ile Gly Val Asn Ala Lys Phe Val 
 510 
 Glu Glu Tyr Ala Phe Phe Lys Asp Ser Ala Lys Ile Ala Asp Glu Leu 
 515 520 
 Arg Leu Ile Lys Ser Phe Ala Arg Met Gly Glu Pro Ile Ala Asp Ala 
 535 
 Arg Arg Ala Met Tyr Ile Asp Ala Ile Arg Ile Leu Gly Thr Asn Leu 
 545 550 555 560 m 
 3 mmmmmmm 8 mmmmm mmmm am Ser Tyr Asp Glu Leu Lys Ala Leu Ala Asp Thr Phe Ser Leu Asp Glu 
 565 575 mmmmmmmmm mmmmmmmm mmmmmmmm Asn Gly Asn Lys Leu Lys Lys Gly Lys His Gly Met Arg Asn Phe Ile 
 590 
 Ile Asn Asn Val Ile Ser Asn Lys Arg Phe His Tyr Leu Ile Arg Tyr 
 595 600 
 Gly Asp Pro Ala His Leu His Glu Ile Ala Lys Asn Glu Ala Val Val 
 615 mmmm Lys Phe Val Leu Gly Arg Ile Ala Asp Ile Gin Lys Lys Gin Gly Gin 
 625 630 635 640 
 Asn Gly Lys Asn Gin Ile Asp Arg Tyr Tyr Glu Thr Cys Ile Gly Lys 
 645 655 
 Asp Lys Gly Lys Ser Val Ser Glu Lys Val Asp Ala Leu Thr Lys Ile 
 670 
 Ile Thr Gly Met Asn Tyr Asp Gin Phe Asp Lys Lys Arg Ser Val Ile 
 675 680 
 Glu Asp Thr Gly Arg Glu Asn Ala Glu Arg Glu Lys Phe Lys Lys Ile 
 695 
 Ile Ser Leu Tyr Leu Thr Val Ile Tyr His Ile Leu Lys Asn Ile Val 
 705 710 715 720 
 Asn Ile Asn Ala Arg Tyr Val Ile Gly Phe His Cys Val Glu Arg Asp 
 725 735 
 Ala Gin Leu Tyr Lys Glu Lys Gly Tyr Asp Ile Asn Leu Lys Lys Leu 
 750 
 Glu Glu Lys Gly Phe Ser Ser Val Thr Lys Leu Cys Ala Gly Ile Asp 
 755 760",2025
